text,title,id,project_number,terms,administration,organization,mechanism,year,funding,score
"CENTER OF EXCELLENCE IN PUBLIC HEALTH INFORMATICS The University of Washington proposes to establish the Center of Excellence in Public Health Informatics: Improving the Public's Health through Information Integration. Partners include the Washington Department of Health, Kitsap County Health District, the Public Health Informatics Institute, and Inland Northwest Health Services. This Center will focus on three research topics: Project 1 (Surveillance Integration and Decision Support) will develop public health surveillance methodswithin the emerging health information infrastructure. We will: 1) develop methods by which regional health information organizations can enhance public health surveillance; 2) develop and evaluate a probabilistic decision support system classifier for disease surveillance; and 3) investigate the usability of a web survey-assessment system for population tracking and disease reporting. Project 2 (Customizable Knowledge Management Repository System for Prevention: Design, Development, and Evaluation) will develop an interactive digital knowledge management system to support the collection, management, and retrieval of public health documents, data,  earning objects, and tools. The focus will be the development of tools, including concept mapping services that will provide rapid access to answers from a variety of key resources, including the ""gray literature"". The system will focus on the application of natural language processing and information visualization techniques. Components will include a knowledge repository system, integrative web services and a role-based user  nterface to support access to information resources for enhanced decision-making by practitioners. The ong-term goal is to create an environment in which practitioners can pose questions in ""plain English"" and receive answers to their questions rather than simply a list of possible places to look for answers. Project 3  Supporting Integration: Work Process, Change Management and System Modeling) will: 1) refine and validate an integrated model of public health information technologywork; 2) provide a Change Management Toolkit to support public health agencies in making changes to current practice called for by the integrated model; and 3) build a Virtual Public Health Information Technology Environment to serve as a testbed and to explore informatics challenges. These projects are supported by three cores: Administration Core (Core A), Epidemiology and Biostatistics Science Core (Core B), and Technology and Design Science Core (Core C). n/a",CENTER OF EXCELLENCE IN PUBLIC HEALTH INFORMATICS,7284424,P01HK000027,[' '],ODCDC,UNIVERSITY OF WASHINGTON,P01,2007,1889501,0.14666637912035727
"CENTER OF EXCELLENCE IN PUBLIC HEALTH INFORMATICS    DESCRIPTION (provided by applicant): The University of Washington proposes to establish the Center of Excellence in Public Health Informatics: Improving the Public's Health through Information Integration. Partners include the Washington Department of Health, Kitsap County Health District, the Public Health Informatics Institute, and Inland Northwest Health Services. This Center will focus on three research topics: Project 1 (Surveillance Integration and Decision Support) will develop public health surveillance methods within the emerging health information infrastructure. We will: 1) develop methods by which regional health information organizations can enhance public health surveillance; 2) develop and evaluate a probabilistic decision support system classifier for disease surveillance; and 3) investigate the usability of a web survey-assessment system for population tracking and disease reporting. Project 2 (Customizable Knowledge Management Repository System for Prevention: Design, Development, and Evaluation) will develop an interactive digital knowledge management system to support the collection, management, and retrieval of public health documents, data, earning objects, and tools. The focus will be the development of tools, including concept mapping services that will provide rapid access to answers from a variety of key resources, including the ""gray literature"". The system will focus on the application of natural language processing and information visualization techniques. Components will include a knowledge repository system, integrative web services and a role-based user interface to support access to information resources for enhanced decision-making by practitioners. The long-term goal is to create an environment in which practitioners can pose questions in ""plain English"" and receive answers to their questions rather than simply a list of possible places to look for answers. Project 3 Supporting Integration: Work Process, Change Management and System Modeling) will: 1) refine and validate an integrated model of public health information technology work; 2) provide a Change Management Toolkit to support public health agencies in making changes to current practice called for by the integrated model; and 3) build a Virtual Public Health Information Technology Environment to serve as a testbed and to explore informatics challenges. These projects are supported by three cores: Administration Core (Core A), Epidemiology and Biostatistics Science Core (Core B), and Technology and Design Science Core (Core C).             n/a",CENTER OF EXCELLENCE IN PUBLIC HEALTH INFORMATICS,7084856,P01CD000261,[' '],ODCDC,UNIVERSITY OF WASHINGTON,P01,2005,1270432,0.14678767840118534
"FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE DESCRIPTION (provided by applicant): FlyBase is the core genomic / genetic Model Organism Database (MOD) for the important biomedical model, Drosophila melanogaster and related species of flies. Drosophila is one of the premiere animal research systems and can be used very cost-effectively to help understand the etiology of human genetic diseases and is the closest experimental model that care provide insights into the biology of insect vectors of human disease (such as mosquitos that carry major infectious diseases such as malaria. West Nile Virus. The goals are twofold: (1) to provide a centralized resource for Drosophila genetic/genomic data and experimental reagents in order to enable Drosophila research to advance as rapidly as possible and (2) to provide these results to the broader biomedical research community to further their own research. FlyBase captures data from the primary scientific literature and from large-scale genome analysis and functional genomics community resource projects through annotation by FlyBase curators, direct user submissions and automated text-mining. FlyBase and collaborating informatics resources extensively share data thereby leveraging the output of each group. These heterogeneous data are organized into coherent datasets and integrated in a central database according to a series of ontology organizing systems. On a bi-monthly basis, these data are extracted from the central FlyBase database and served to the entire scientific community through a freely accessible FlyBase website, which is accessed millions of times each month. In addition to providing the research community to ttie corpus of FlyBase-captured data in ways that can be readily interrogated and browsed, FlyBase also maintains millions of links to other biomedical websites providing other relevant information. Over the proposed 5-year grant period, FlyBase expects to contribute to the enhancement of MOD interoperability and to work with a broad range of informatics resources and journal publishers to provide as rich a set of data and data-mining tools as possible to the biomedical research community. RELEVANCE: FlyBase provides crucial data and informatic infrastructure to accelerate the pace of Drosophila research and for the broader biomedical sciences community to leverage these discoveries to further their own research. Drosophila is now a well-accepted experimental model for human disease research and is the closest genetic / genomic experimental model system for research on the insect vectors that carry human diseases.",FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE,9250186,U41HG000739,"['Animal Experimentation', 'Biological', 'Biology', 'Biomedical Research', 'Caring', 'Communicable Diseases', 'Communities', 'Culicidae', 'Data', 'Data Set', 'Databases', 'Development', 'Documentation', 'Drosophila genome', 'Drosophila genus', 'Drosophila melanogaster', 'Drosophilidae', 'Educational workshop', 'Etiology', 'Evolution', 'Experimental Models', 'Freezing', 'Genbank', 'Gene Family', 'Generations', 'Genes', 'Genetic', 'Genetic Databases', 'Genetic Models', 'Genome', 'Genomics', 'Goals', 'Grant', 'Hereditary Disease', 'Human Genetics', 'Individual', 'Insect Vectors', 'Journals', 'Link', 'Literature', 'Macromolecular Complexes', 'Malaria', 'Manuals', 'Maps', 'Metadata', 'Modeling', 'Molecular Genetics', 'Ontology', 'Output', 'Paper', 'Pathway interactions', 'Phenotype', 'Procedures', 'Production', 'Proteins', 'Reagent', 'Reporting', 'Research', 'Resource Informatics', 'Resources', 'Role', 'Running', 'Science', 'Series', 'Site', 'Structure', 'Study models', 'Suggestion', 'System', 'Time', 'Training', 'Triage', 'Update', 'West Nile virus', 'Work', 'cost', 'data access', 'data integration', 'data integrity', 'data mining', 'data resource', 'data sharing', 'fly', 'functional genomics', 'genome analysis', 'genome-wide', 'genomic data', 'human disease', 'informatics infrastructure', 'insight', 'interoperability', 'model organisms databases', 'outreach', 'symposium', 'systems research', 'text searching', 'tool', 'web interface', 'web site']",NHGRI,HARVARD UNIVERSITY,U41,2017,4342750,-0.03241346359601855
"FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE DESCRIPTION (provided by applicant): FlyBase is the core genomic / genetic Model Organism Database (MOD) for the important biomedical model, Drosophila melanogaster and related species of flies. Drosophila is one of the premiere animal research systems and can be used very cost-effectively to help understand the etiology of human genetic diseases and is the closest experimental model that care provide insights into the biology of insect vectors of human disease (such as mosquitos that carry major infectious diseases such as malaria. West Nile Virus. The goals are twofold: (1) to provide a centralized resource for Drosophila genetic/genomic data and experimental reagents in order to enable Drosophila research to advance as rapidly as possible and (2) to provide these results to the broader biomedical research community to further their own research. FlyBase captures data from the primary scientific literature and from large-scale genome analysis and functional genomics community resource projects through annotation by FlyBase curators, direct user submissions and automated text-mining. FlyBase and collaborating informatics resources extensively share data thereby leveraging the output of each group. These heterogeneous data are organized into coherent datasets and integrated in a central database according to a series of ontology organizing systems. On a bi-monthly basis, these data are extracted from the central FlyBase database and served to the entire scientific community through a freely accessible FlyBase website, which is accessed millions of times each month. In addition to providing the research community to ttie corpus of FlyBase-captured data in ways that can be readily interrogated and browsed, FlyBase also maintains millions of links to other biomedical websites providing other relevant information. Over the proposed 5-year grant period, FlyBase expects to contribute to the enhancement of MOD interoperability and to work with a broad range of informatics resources and journal publishers to provide as rich a set of data and data-mining tools as possible to the biomedical research community. RELEVANCE: FlyBase provides crucial data and informatic infrastructure to accelerate the pace of Drosophila research and for the broader biomedical sciences community to leverage these discoveries to further their own research. Drosophila is now a well-accepted experimental model for human disease research and is the closest genetic / genomic experimental model system for research on the insect vectors that carry human diseases.",FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE,9043157,U41HG000739,"['Ally', 'Animal Experimentation', 'Biological', 'Biological Models', 'Biology', 'Biomedical Research', 'Caring', 'Communicable Diseases', 'Communities', 'Culicidae', 'Data', 'Data Set', 'Databases', 'Development', 'Documentation', 'Drosophila genome', 'Drosophila genus', 'Drosophila melanogaster', 'Drosophilidae', 'Educational workshop', 'Etiology', 'Evolution', 'Experimental Models', 'Freezing', 'Genbank', 'Gene Family', 'Generations', 'Genes', 'Genetic', 'Genetic Databases', 'Genetic Models', 'Genome', 'Genomics', 'Goals', 'Grant', 'Hereditary Disease', 'Human Genetics', 'Individual', 'Insect Vectors', 'Journals', 'Link', 'Literature', 'Macromolecular Complexes', 'Malaria', 'Manuals', 'Maps', 'Metadata', 'Modeling', 'Molecular Genetics', 'Ontology', 'Output', 'Paper', 'Pathway interactions', 'Phenotype', 'Procedures', 'Production', 'Proteins', 'Reagent', 'Reporting', 'Research', 'Resource Informatics', 'Resources', 'Role', 'Running', 'Science', 'Series', 'Site', 'Structure', 'Study models', 'Suggestion', 'System', 'Time', 'Training', 'Triage', 'Update', 'West Nile virus', 'Work', 'base', 'cost', 'data access', 'data integration', 'data integrity', 'data mining', 'data sharing', 'fly', 'functional genomics', 'genome analysis', 'genomic data', 'human disease', 'informatics infrastructure', 'insight', 'interoperability', 'model organisms databases', 'outreach', 'symposium', 'systems research', 'text searching', 'tool', 'web interface', 'web site']",NHGRI,HARVARD UNIVERSITY,U41,2016,4342750,-0.03241346359601855
"FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE DESCRIPTION (provided by applicant): FlyBase is the core genomic / genetic Model Organism Database (MOD) for the important biomedical model, Drosophila melanogaster and related species of flies. Drosophila is one of the premiere animal research systems and can be used very cost-effectively to help understand the etiology of human genetic diseases and is the closest experimental model that care provide insights into the biology of insect vectors of human disease (such as mosquitos that carry major infectious diseases such as malaria. West Nile Virus. The goals are twofold: (1) to provide a centralized resource for Drosophila genetic/genomic data and experimental reagents in order to enable Drosophila research to advance as rapidly as possible and (2) to provide these results to the broader biomedical research community to further their own research. FlyBase captures data from the primary scientific literature and from large-scale genome analysis and functional genomics community resource projects through annotation by FlyBase curators, direct user submissions and automated text-mining. FlyBase and collaborating informatics resources extensively share data thereby leveraging the output of each group. These heterogeneous data are organized into coherent datasets and integrated in a central database according to a series of ontology organizing systems. On a bi-monthly basis, these data are extracted from the central FlyBase database and served to the entire scientific community through a freely accessible FlyBase website, which is accessed millions of times each month. In addition to providing the research community to ttie corpus of FlyBase-captured data in ways that can be readily interrogated and browsed, FlyBase also maintains millions of links to other biomedical websites providing other relevant information. Over the proposed 5-year grant period, FlyBase expects to contribute to the enhancement of MOD interoperability and to work with a broad range of informatics resources and journal publishers to provide as rich a set of data and data-mining tools as possible to the biomedical research community.         RELEVANCE: FlyBase provides crucial data and informatic infrastructure to accelerate the pace of Drosophila research and for the broader biomedical sciences community to leverage these discoveries to further their own research. Drosophila is now a well-accepted experimental model for human disease research and is the closest genetic / genomic experimental model system for research on the insect vectors that carry human diseases. n/a",FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE,8902241,U41HG000739,"['Ally', 'Animal Experimentation', 'Biological', 'Biological Models', 'Biology', 'Biomedical Research', 'Caring', 'Communicable Diseases', 'Communities', 'Culicidae', 'Data', 'Data Set', 'Databases', 'Development', 'Drosophila genome', 'Drosophila genus', 'Drosophila melanogaster', 'Drosophilidae', 'Educational workshop', 'Etiology', 'Evolution', 'Experimental Models', 'Freezing', 'Genbank', 'Gene Family', 'Genes', 'Genetic', 'Genetic Databases', 'Genetic Models', 'Genome', 'Genomics', 'Goals', 'Grant', 'Hereditary Disease', 'Human Genetics', 'Individual', 'Informatics', 'Insect Vectors', 'Journals', 'Link', 'Literature', 'Macromolecular Complexes', 'Malaria', 'Manuals', 'Maps', 'Metadata', 'Modeling', 'Molecular Genetics', 'Ontology', 'Output', 'Paper', 'Pathway interactions', 'Phenotype', 'Procedures', 'Production', 'Proteins', 'Reagent', 'Reporting', 'Research', 'Research Infrastructure', 'Resource Informatics', 'Resources', 'Role', 'Running', 'Series', 'Site', 'Structure', 'Study models', 'Suggestion', 'System', 'Time', 'Training', 'Triage', 'Update', 'West Nile virus', 'Work', 'citizen science', 'cost', 'data integration', 'data integrity', 'data mining', 'data sharing', 'fly', 'functional genomics', 'genome analysis', 'human disease', 'insight', 'interoperability', 'model organisms databases', 'outreach', 'symposium', 'systems research', 'text searching', 'tool', 'web interface', 'web site']",NHGRI,HARVARD UNIVERSITY,U41,2015,4234181,-0.03241346359601855
"FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE     DESCRIPTION (provided by applicant): FlyBase is the core genomic / genetic Model Organism Database (MOD) for the important biomedical model, Drosophila melanogaster and related species of flies. Drosophila is one of the premiere animal research systems and can be used very cost-effectively to help understand the etiology of human genetic diseases and is the closest experimental model that care provide insights into the biology of insect vectors of human disease (such as mosquitos that carry major infectious diseases such as malaria. West Nile Virus. The goals are twofold: (1) to provide a centralized resource for Drosophila genetic/genomic data and experimental reagents in order to enable Drosophila research to advance as rapidly as possible and (2) to provide these results to the broader biomedical research community to further their own research. FlyBase captures data from the primary scientific literature and from large-scale genome analysis and functional genomics community resource projects through annotation by FlyBase curators, direct user submissions and automated text-mining. FlyBase and collaborating informatics resources extensively share data thereby leveraging the output of each group. These heterogeneous data are organized into coherent datasets and integrated in a central database according to a series of ontology organizing systems. On a bi-monthly basis, these data are extracted from the central FlyBase database and served to the entire scientific community through a freely accessible FlyBase website, which is accessed millions of times each month. In addition to providing the research community to ttie corpus of FlyBase-captured data in ways that can be readily interrogated and browsed, FlyBase also maintains millions of links to other biomedical websites providing other relevant information. Over the proposed 5-year grant period, FlyBase expects to contribute to the enhancement of MOD interoperability and to work with a broad range of informatics resources and journal publishers to provide as rich a set of data and data-mining tools as possible to the biomedical research community.         RELEVANCE: FlyBase provides crucial data and informatic infrastructure to accelerate the pace of Drosophila research and for the broader biomedical sciences community to leverage these discoveries to further their own research. Drosophila is now a well-accepted experimental model for human disease research and is the closest genetic / genomic experimental model system for research on the insect vectors that carry human diseases.                   n/a",FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE,8665574,U41HG000739,"['Ally', 'Animal Experimentation', 'Biological', 'Biological Models', 'Biology', 'Biomedical Research', 'Caring', 'Communicable Diseases', 'Communities', 'Culicidae', 'Data', 'Data Set', 'Databases', 'Development', 'Drosophila genome', 'Drosophila genus', 'Drosophila melanogaster', 'Drosophilidae', 'Educational workshop', 'Etiology', 'Evolution', 'Experimental Models', 'Freezing', 'Genbank', 'Gene Family', 'Genes', 'Genetic', 'Genetic Databases', 'Genetic Models', 'Genome', 'Genomics', 'Goals', 'Grant', 'Hereditary Disease', 'Human Genetics', 'Individual', 'Informatics', 'Insect Vectors', 'Journals', 'Link', 'Literature', 'Macromolecular Complexes', 'Malaria', 'Manuals', 'Maps', 'Metadata', 'Modeling', 'Molecular Genetics', 'Ontology', 'Output', 'Paper', 'Pathway interactions', 'Phenotype', 'Procedures', 'Production', 'Proteins', 'Reagent', 'Reporting', 'Research', 'Research Infrastructure', 'Resource Informatics', 'Resources', 'Role', 'Running', 'Science', 'Series', 'Site', 'Structure', 'Study models', 'Suggestion', 'System', 'Time', 'Training', 'Triage', 'Update', 'West Nile virus', 'Work', 'cost', 'data integration', 'data integrity', 'data mining', 'data sharing', 'fly', 'functional genomics', 'genome analysis', 'human disease', 'insight', 'interoperability', 'model organisms databases', 'outreach', 'symposium', 'systems research', 'text searching', 'tool', 'web interface', 'web site']",NHGRI,HARVARD UNIVERSITY,U41,2014,3279871,-0.03241346359601855
"MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE The goal of this proposal is to continue the development of computational methods for molecular genetic information analyses and apply them to research problems arising in biological and clinical studies through the continuation and expansion of the Molecular Biology Commuter Research Resource (MBCRR) at the Dana-Farber Cancer Institute/Harvard School of Public Health.  The MBCRR provides research support, training and collaborative research opportunities in the interdisciplinary domain overlapping molecular biology, genetics, computer science and mathematics. The service and training components support a very active local molecular biology research community which in turn participates in the resource's collaborative and core research.  The Collaborative and Core Research goals are to continue research into the identification of the syntactic and semantic patterns in genetic sequences - for example, those DNA and protein sequence/structural patterns which trace the evolution and/or correlate with a given function.  The Technological Research goal is to continue the development of commuter science methods required for the practical implementation of pattern identification and other sequence analysis needs as they arise.  the Service and Dissemination goals are:  1) to provide local area researchers with on-line and down-loadable molecular genetics analysis software and data-bases; 2) to provide on-line specialized software for complex analyses; 3) to provide on-line documentation, help and analysis examples; 4) to maintain for distribution a set of public domain analysis software tools; 5) to sponsor and organize international scientific meetings within the interdisciplinary domain; and 6) to provide for local area researchers introductory tutorial support on the use and interpretation of analysis software.  The Training goals are to continue the interdisciplinary training of molecular biologists in statistical and computer science methodologies, and to educate mathematicians and computer scientists in the problems facing molecular biology.  To this end, the MBCRR will continue its post- doctoral fellowship program, the one-on-one training of local area new post-doctoral fellows and graduate students, and the visiting scientists molecular biological analysis program.  n/a",MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE,2237713,P41LM005205,"['artificial intelligence', ' biotechnology', ' computer assisted sequence analysis', ' computer center', ' molecular biology', ' nucleic acid sequence', ' protein structure function']",NLM,BOSTON UNIVERSITY MEDICAL CAMPUS,P41,1994,913090,0.05244943880364906
"MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE The goal of this proposal is to continue the development of computational methods for molecular genetic information analyses and apply them to research problems arising in biological and clinical studies through the continuation and expansion of the Molecular Biology Commuter Research Resource (MBCRR) at the Dana-Farber Cancer Institute/Harvard School of Public Health.  The MBCRR provides research support, training and collaborative research opportunities in the interdisciplinary domain overlapping molecular biology, genetics, computer science and mathematics. The service and training components support a very active local molecular biology research community which in turn participates in the resource's collaborative and core research.  The Collaborative and Core Research goals are to continue research into the identification of the syntactic and semantic patterns in genetic sequences - for example, those DNA and protein sequence/structural patterns which trace the evolution and/or correlate with a given function.  The Technological Research goal is to continue the development of commuter science methods required for the practical implementation of pattern identification and other sequence analysis needs as they arise.  the Service and Dissemination goals are:  1) to provide local area researchers with on-line and down-loadable molecular genetics analysis software and data-bases; 2) to provide on-line specialized software for complex analyses; 3) to provide on-line documentation, help and analysis examples; 4) to maintain for distribution a set of public domain analysis software tools; 5) to sponsor and organize international scientific meetings within the interdisciplinary domain; and 6) to provide for local area researchers introductory tutorial support on the use and interpretation of analysis software.  The Training goals are to continue the interdisciplinary training of molecular biologists in statistical and computer science methodologies, and to educate mathematicians and computer scientists in the problems facing molecular biology.  To this end, the MBCRR will continue its post- doctoral fellowship program, the one-on-one training of local area new post-doctoral fellows and graduate students, and the visiting scientists molecular biological analysis program.  n/a",MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE,3103604,P41LM005205,"['artificial intelligence', ' biotechnology', ' computer assisted sequence analysis', ' computer center', ' molecular biology', ' nucleic acid sequence', ' protein structure function']",NLM,BOSTON UNIVERSITY MEDICAL CAMPUS,P41,1993,884937,0.05244943880364906
"MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE The goal of this proposal is to continue the development of computational methods for molecular genetic information analyses and apply them to research problems arising in biological and clinical studies through the continuation and expansion of the Molecular Biology Commuter Research Resource (MBCRR) at the Dana-Farber Cancer Institute/Harvard School of Public Health.  The MBCRR provides research support, training and collaborative research opportunities in the interdisciplinary domain overlapping molecular biology, genetics, computer science and mathematics. The service and training components support a very active local molecular biology research community which in turn participates in the resource's collaborative and core research.  The Collaborative and Core Research goals are to continue research into the identification of the syntactic and semantic patterns in genetic sequences - for example, those DNA and protein sequence/structural patterns which trace the evolution and/or correlate with a given function.  The Technological Research goal is to continue the development of commuter science methods required for the practical implementation of pattern identification and other sequence analysis needs as they arise.  the Service and Dissemination goals are:  1) to provide local area researchers with on-line and down-loadable molecular genetics analysis software and data-bases; 2) to provide on-line specialized software for complex analyses; 3) to provide on-line documentation, help and analysis examples; 4) to maintain for distribution a set of public domain analysis software tools; 5) to sponsor and organize international scientific meetings within the interdisciplinary domain; and 6) to provide for local area researchers introductory tutorial support on the use and interpretation of analysis software.  The Training goals are to continue the interdisciplinary training of molecular biologists in statistical and computer science methodologies, and to educate mathematicians and computer scientists in the problems facing molecular biology.  To this end, the MBCRR will continue its post- doctoral fellowship program, the one-on-one training of local area new post-doctoral fellows and graduate students, and the visiting scientists molecular biological analysis program.  n/a",MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE,3103603,P41LM005205,"['artificial intelligence', ' biotechnology', ' computer assisted sequence analysis', ' computer center', ' molecular biology', ' nucleic acid sequence', ' protein structure function']",NLM,BOSTON UNIVERSITY MEDICAL CAMPUS,P41,1992,902510,0.05244943880364906
"MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE The goal of this proposal is to continue the development of computational methods for molecular genetic information analyses and apply them to research problems arising in biological and clinical studies through the continuation and expansion of the Molecular Biology Commuter Research Resource (MBCRR) at the Dana-Farber Cancer Institute/Harvard School of Public Health.  The MBCRR provides research support, training and collaborative research opportunities in the interdisciplinary domain overlapping molecular biology, genetics, computer science and mathematics. The service and training components support a very active local molecular biology research community which in turn participates in the resource's collaborative and core research.  The Collaborative and Core Research goals are to continue research into the identification of the syntactic and semantic patterns in genetic sequences - for example, those DNA and protein sequence/structural patterns which trace the evolution and/or correlate with a given function.  The Technological Research goal is to continue the development of commuter science methods required for the practical implementation of pattern identification and other sequence analysis needs as they arise.  the Service and Dissemination goals are:  1) to provide local area researchers with on-line and down-loadable molecular genetics analysis software and data-bases; 2) to provide on-line specialized software for complex analyses; 3) to provide on-line documentation, help and analysis examples; 4) to maintain for distribution a set of public domain analysis software tools; 5) to sponsor and organize international scientific meetings within the interdisciplinary domain; and 6) to provide for local area researchers introductory tutorial support on the use and interpretation of analysis software.  The Training goals are to continue the interdisciplinary training of molecular biologists in statistical and computer science methodologies, and to educate mathematicians and computer scientists in the problems facing molecular biology.  To this end, the MBCRR will continue its post- doctoral fellowship program, the one-on-one training of local area new post-doctoral fellows and graduate students, and the visiting scientists molecular biological analysis program.  n/a",MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE,3103605,P41LM005205,"['artificial intelligence', ' biotechnology', ' computer assisted sequence analysis', ' computer center', ' molecular biology', ' nucleic acid sequence', ' protein structure function']",NLM,BOSTON UNIVERSITY MEDICAL CAMPUS,P41,1991,544039,0.05244943880364906
"MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE The goal of this proposal is to continue the development of computational methods for molecular genetic information analyses and apply them to research problems arising in biological and clinical studies through the continuation and expansion of the Molecular Biology Commuter Research Resource (MBCRR) at the Dana-Farber Cancer Institute/Harvard School of Public Health.  The MBCRR provides research support, training and collaborative research opportunities in the interdisciplinary domain overlapping molecular biology, genetics, computer science and mathematics. The service and training components support a very active local molecular biology research community which in turn participates in the resource's collaborative and core research.  The Collaborative and Core Research goals are to continue research into the identification of the syntactic and semantic patterns in genetic sequences - for example, those DNA and protein sequence/structural patterns which trace the evolution and/or correlate with a given function.  The Technological Research goal is to continue the development of commuter science methods required for the practical implementation of pattern identification and other sequence analysis needs as they arise.  the Service and Dissemination goals are:  1) to provide local area researchers with on-line and down-loadable molecular genetics analysis software and data-bases; 2) to provide on-line specialized software for complex analyses; 3) to provide on-line documentation, help and analysis examples; 4) to maintain for distribution a set of public domain analysis software tools; 5) to sponsor and organize international scientific meetings within the interdisciplinary domain; and 6) to provide for local area researchers introductory tutorial support on the use and interpretation of analysis software.  The Training goals are to continue the interdisciplinary training of molecular biologists in statistical and computer science methodologies, and to educate mathematicians and computer scientists in the problems facing molecular biology.  To this end, the MBCRR will continue its post- doctoral fellowship program, the one-on-one training of local area new post-doctoral fellows and graduate students, and the visiting scientists molecular biological analysis program.  n/a",MOLECULAR BIOLOGY COMPUTER RESEARCH RESOURCE,3103601,P41LM005205,"['artificial intelligence', ' biotechnology', ' computer assisted sequence analysis', ' computer center', ' molecular biology', ' nucleic acid sequence', ' protein structure function']",NLM,DANA-FARBER CANCER INSTITUTE,P41,1990,635050,0.05244943880364906
"CENTER FOR ADVANCED MEDICAL INFORMATICS We propose creating a shared computing resource to support research              activities in biomedical informatics at the Stanford University School of        Medicine.  The School has established the Center for Advanced Medical            Informatics at Stanford (CAMIS), which unites academic, administrative,          and research computing.  The requested funds will support an active core         research program and the infrastructure and day-to-day computing needs of        a large number of researchers, each of whom has external support from NIH        or other agencies through grants or contracts.  No single research group         could support the complex set of infrastructural and system capabilities         needed to conduct advanced medical informatics research in the 1990's.           Our approach to designing, managing, and building the CAMIS resource will        be guided by a number of overall goals: (1) to foster scientific                 communication, collaboration, and sharing within a distributed research          environment; (2) to provide a superb setting for exploring biomedical            informatics topics; (3) to pursue a strong basic replications systems; (4)       to help define new ways to disseminate computing and                             information-management technologies into real-world settings; and (5) to         create a state-of-the-art computing and communication environment for our        research work.                                                                                                                                                    The specific aims for this undertaking fall under four categories that           define the functions of the CAMIS resources:                                                                                                                      Core Research and Development:  We are proposing core research projects in       several areas: (1) Clinical Trials Workstation (CTW) Project-generalize          and abstract system-design concepts and implementation solutions from our        ONCOCIN and T-HELPER projects so that they can be applied to facilitate          the most rapid development of integrated clinical-trials workstations in         any domain of clinical-trials management; (2) Understanding the Code for         Biological Molecules--development and generalize improved tools for              discovering and for understanding the structure relationships so these can       be used to understand the functions of genes identified in genome mapping        investigation; (3) Advanced Computing Systems and Environments--build upon       the extensive distributed-computing environment already in place and             improve, extend, and adapt new computing tools as necessary to support the       CAMIS community.  Specific systems research areas include gesture-based          portable computing information resource navigation and retrieval tools,          email management tools, high-speed networks, large-volume file storage,          and new workstations technologics.                                                                                                                                Collaborative Research:  A large community of researchers will be                supported by the CAMIS resource, doing work in areas such as clinical            trial protocol management, methods for uncertain reasoning,                      bioinformatics, health care outcomes and economics, basic artificial             intelligence research, human-computer interfaces, multimedia authoring and       delivery tools for  medical education programs, and distributed library          resources. We will accordingly encourage collaborations through improved         mechanisms for inter- and intra-group communications.                                                                                                             Service and Resource Operations: CAMIS will provide effective and widely         accessible communication and computing facilities, consulting services,          and managerial support and will serve in an advisory capacity to Medical         School administration.                                                                                                                                            Training, Education, and Dissemination: CAMIS will emphasize a strong user       orientation in its facilities management, will continue to run two formal        graduate degree programs (one in medical informatics and one in health           services research), and will actively disseminate research results through       publications, software exports, video presentations, visiting scholar            programs, and an annual CAMIS Symposium.                                          n/a",CENTER FOR ADVANCED MEDICAL INFORMATICS,2601716,P41LM005305,"['biomedical facility', ' computer center', ' information systems']",NLM,STANFORD UNIVERSITY,P41,1997,238169,0.03709263759639489
"CENTER FOR ADVANCED MEDICAL INFORMATICS We propose creating a shared computing resource to support research  activities in biomedical informatics at the Stanford University School of  Medicine.  The School has established the Center for Advanced Medical  Informatics at Stanford (CAMIS), which unites academic, administrative,  and research computing.  The requested funds will support an active core  research program and the infrastructure and day-to-day computing needs of  a large number of researchers, each of whom has external support from NIH  or other agencies through grants or contracts.  No single research group  could support the complex set of infrastructural and system capabilities  needed to conduct advanced medical informatics research in the 1990's.  Our approach to designing, managing, and building the CAMIS resource will  be guided by a number of overall goals: (1) to foster scientific  communication, collaboration, and sharing within a distributed research  environment; (2) to provide a superb setting for exploring biomedical  informatics topics; (3) to pursue a strong basic replications systems; (4)  to help define new ways to disseminate computing and  information-management technologies into real-world settings; and (5) to  create a state-of-the-art computing and communication environment for our  research work.    The specific aims for this undertaking fall under four categories that  define the functions of the CAMIS resources:    Core Research and Development:  We are proposing core research projects in  several areas: (1) Clinical Trials Workstation (CTW) Project-generalize  and abstract system-design concepts and implementation solutions from our  ONCOCIN and T-HELPER projects so that they can be applied to facilitate  the most rapid development of integrated clinical-trials workstations in  any domain of clinical-trials management; (2) Understanding the Code for  Biological Molecules--development and generalize improved tools for  discovering and for understanding the structure relationships so these can  be used to understand the functions of genes identified in genome mapping  investigation; (3) Advanced Computing Systems and Environments--build upon  the extensive distributed-computing environment already in place and  improve, extend, and adapt new computing tools as necessary to support the  CAMIS community.  Specific systems research areas include gesture-based  portable computing information resource navigation and retrieval tools,  email management tools, high-speed networks, large-volume file storage,  and new workstations technologics.    Collaborative Research:  A large community of researchers will be  supported by the CAMIS resource, doing work in areas such as clinical  trial protocol management, methods for uncertain reasoning,  bioinformatics, health care outcomes and economics, basic artificial  intelligence research, human-computer interfaces, multimedia authoring and  delivery tools for  medical education programs, and distributed library  resources. We will accordingly encourage collaborations through improved  mechanisms for inter- and intra-group communications.    Service and Resource Operations: CAMIS will provide effective and widely  accessible communication and computing facilities, consulting services,  and managerial support and will serve in an advisory capacity to Medical  School administration.    Training, Education, and Dissemination: CAMIS will emphasize a strong user  orientation in its facilities management, will continue to run two formal  graduate degree programs (one in medical informatics and one in health  services research), and will actively disseminate research results through  publications, software exports, video presentations, visiting scholar  programs, and an annual CAMIS Symposium.  n/a",CENTER FOR ADVANCED MEDICAL INFORMATICS,2237752,P41LM005305,"['biomedical facility', ' computer center', ' information systems']",NLM,STANFORD UNIVERSITY,P41,1995,1335028,0.03709263759639489
"CENTER FOR ADVANCED MEDICAL INFORMATICS We propose creating a shared computing resource to support research activities in biomedical informatics at the Stanford University School of Medicine.  The School has established the Center for Advanced Medical Informatics at Stanford (CAMIS), which unites academic, administrative, and research computing.  The requested funds will support an active core research program and the infrastructure and day-to-day computing needs of a large number of researchers, each of whom has external support from NIH or other agencies through grants or contracts.  No single research group could support the complex set of infrastructural and system capabilities needed to conduct advanced medical informatics research in the 1990's. Our approach to designing, managing, and building the CAMIS resource will be guided by a number of overall goals: (1) to foster scientific communication, collaboration, and sharing within a distributed research environment; (2) to provide a superb setting for exploring biomedical informatics topics; (3) to pursue a strong basic replications systems; (4) to help define new ways to disseminate computing and information-management technologies into real-world settings; and (5) to create a state-of-the-art computing and communication environment for our research work.  The specific aims for this undertaking fall under four categories that define the functions of the CAMIS resources:  Core Research and Development:  We are proposing core research projects in several areas: (1) Clinical Trials Workstation (CTW) Project-generalize and abstract system-design concepts and implementation solutions from our ONCOCIN and T-HELPER projects so that they can be applied to facilitate the most rapid development of integrated clinical-trials workstations in any domain of clinical-trials management; (2) Understanding the Code for Biological Molecules--development and generalize improved tools for discovering and for understanding the structure relationships so these can be used to understand the functions of genes identified in genome mapping investigation; (3) Advanced Computing Systems and Environments--build upon the extensive distributed-computing environment already in place and improve, extend, and adapt new computing tools as necessary to support the CAMIS community.  Specific systems research areas include gesture-based portable computing information resource navigation and retrieval tools, email management tools, high-speed networks, large-volume file storage, and new workstations technologics.  Collaborative Research:  A large community of researchers will be supported by the CAMIS resource, doing work in areas such as clinical trial protocol management, methods for uncertain reasoning, bioinformatics, health care outcomes and economics, basic artificial intelligence research, human-computer interfaces, multimedia authoring and delivery tools for  medical education programs, and distributed library resources. We will accordingly encourage collaborations through improved mechanisms for inter- and intra-group communications.  Service and Resource Operations: CAMIS will provide effective and widely accessible communication and computing facilities, consulting services, and managerial support and will serve in an advisory capacity to Medical School administration.  Training, Education, and Dissemination: CAMIS will emphasize a strong user orientation in its facilities management, will continue to run two formal graduate degree programs (one in medical informatics and one in health services research), and will actively disseminate research results through publications, software exports, video presentations, visiting scholar programs, and an annual CAMIS Symposium.  n/a",CENTER FOR ADVANCED MEDICAL INFORMATICS,2237751,P41LM005305,"['biomedical facility', ' computer center', ' information systems']",NLM,STANFORD UNIVERSITY,P41,1994,1894026,0.03709263759639489
"CTR FOR ADVANCED MEDICAL INFORMATICS AT STANFORD We propose creating a shared computing resource to support research activities in biomedical informatics at the Stanford University School of Medicine.  The School has established the Center for Advanced Medical Informatics at Stanford (CAMIS), which unites academic, administrative, and research computing.  The requested funds will support an active core research program and the infrastructure and day-to-day computing needs of a large number of researchers, each of whom has external support from NIH or other agencies through grants or contracts.  No single research group could support the complex set of infrastructural and system capabilities needed to conduct advanced medical informatics research in the 1990's. Our approach to designing, managing, and building the CAMIS resource will be guided by a number of overall goals: (1) to foster scientific communication, collaboration, and sharing within a distributed research environment; (2) to provide a superb setting for exploring biomedical informatics topics; (3) to pursue a strong basic replications systems; (4) to help define new ways to disseminate computing and information-management technologies into real-world settings; and (5) to create a state-of-the-art computing and communication environment for our research work.  The specific aims for this undertaking fall under four categories that define the functions of the CAMIS resources:  Core Research and Development:  We are proposing core research projects in several areas: (1) Clinical Trials Workstation (CTW) Project-generalize and abstract system-design concepts and implementation solutions from our ONCOCIN and T-HELPER projects so that they can be applied to facilitate the most rapid development of integrated clinical-trials workstations in any domain of clinical-trials management; (2) Understanding the Code for Biological Molecules--development and generalize improved tools for discovering and for understanding the structure relationships so these can be used to understand the functions of genes identified in genome mapping investigation; (3) Advanced Computing Systems and Environments--build upon the extensive distributed-computing environment already in place and improve, extend, and adapt new computing tools as necessary to support the CAMIS community.  Specific systems research areas include gesture-based portable computing information resource navigation and retrieval tools, email management tools, high-speed networks, large-volume file storage, and new workstations technologics.  Collaborative Research:  A large community of researchers will be supported by the CAMIS resource, doing work in areas such as clinical trial protocol management, methods for uncertain reasoning, bioinformatics, health care outcomes and economics, basic artificial intelligence research, human-computer interfaces, multimedia authoring and delivery tools for  medical education programs, and distributed library resources. We will accordingly encourage collaborations through improved mechanisms for inter- and intra-group communications.  Service and Resource Operations: CAMIS will provide effective and widely accessible communication and computing facilities, consulting services, and managerial support and will serve in an advisory capacity to Medical School administration.  Training, Education, and Dissemination: CAMIS will emphasize a strong user orientation in its facilities management, will continue to run two formal graduate degree programs (one in medical informatics and one in health services research), and will actively disseminate research results through publications, software exports, video presentations, visiting scholar programs, and an annual CAMIS Symposium.  n/a",CTR FOR ADVANCED MEDICAL INFORMATICS AT STANFORD,3103616,P41LM005305,"['biomedical facility', ' computer center', ' information systems']",NLM,STANFORD UNIVERSITY,P41,1993,1877980,0.03709263759639489
"CTR FOR ADVANCED MEDICAL INFORMATICS AT STANFORD We propose creating a shared computing resource to support research activities in biomedical informatics at the Stanford University School of Medicine.  The School has established the Center for Advanced Medical Informatics at Stanford (CAMIS), which unites academic, administrative, and research computing.  The requested funds will support an active core research program and the infrastructure and day-to-day computing needs of a large number of researchers, each of whom has external support from NIH or other agencies through grants or contracts.  No single research group could support the complex set of infrastructural and system capabilities needed to conduct advanced medical informatics research in the 1990's. Our approach to designing, managing, and building the CAMIS resource will be guided by a number of overall goals: (1) to foster scientific communication, collaboration, and sharing within a distributed research environment; (2) to provide a superb setting for exploring biomedical informatics topics; (3) to pursue a strong basic replications systems; (4) to help define new ways to disseminate computing and information-management technologies into real-world settings; and (5) to create a state-of-the-art computing and communication environment for our research work.  The specific aims for this undertaking fall under four categories that define the functions of the CAMIS resources:  Core Research and Development:  We are proposing core research projects in several areas: (1) Clinical Trials Workstation (CTW) Project-generalize and abstract system-design concepts and implementation solutions from our ONCOCIN and T-HELPER projects so that they can be applied to facilitate the most rapid development of integrated clinical-trials workstations in any domain of clinical-trials management; (2) Understanding the Code for Biological Molecules--development and generalize improved tools for discovering and for understanding the structure relationships so these can be used to understand the functions of genes identified in genome mapping investigation; (3) Advanced Computing Systems and Environments--build upon the extensive distributed-computing environment already in place and improve, extend, and adapt new computing tools as necessary to support the CAMIS community.  Specific systems research areas include gesture-based portable computing information resource navigation and retrieval tools, email management tools, high-speed networks, large-volume file storage, and new workstations technologics.  Collaborative Research:  A large community of researchers will be supported by the CAMIS resource, doing work in areas such as clinical trial protocol management, methods for uncertain reasoning, bioinformatics, health care outcomes and economics, basic artificial intelligence research, human-computer interfaces, multimedia authoring and delivery tools for  medical education programs, and distributed library resources. We will accordingly encourage collaborations through improved mechanisms for inter- and intra-group communications.  Service and Resource Operations: CAMIS will provide effective and widely accessible communication and computing facilities, consulting services, and managerial support and will serve in an advisory capacity to Medical School administration.  Training, Education, and Dissemination: CAMIS will emphasize a strong user orientation in its facilities management, will continue to run two formal graduate degree programs (one in medical informatics and one in health services research), and will actively disseminate research results through publications, software exports, video presentations, visiting scholar programs, and an annual CAMIS Symposium.  n/a",CTR FOR ADVANCED MEDICAL INFORMATICS AT STANFORD,3103615,P41LM005305,"['biomedical facility', ' computer center', ' information systems']",NLM,STANFORD UNIVERSITY,P41,1992,1800000,0.03709263759639489
"Center for Environmental Genetics This application requests a 5-year renewal of the Center for Environmental Genetics. The unified theme of  the proposal is to elucidate how gene and environment interaction through epigenetics influences disease  risks and health outcome. Ohioans are exposed to exceptionally bad air quality due to dated power plants  and the fact that it is situated in the nation's main artery of the north-south transportation route. These unique  geographical/economic features put the residents in the state at high risk of the following diseases: (a)  endocrine disruption and cancer; (b) immune and allergic diseases; (c) cardiovascular and lipid disorders;  and (d) neurology and behavior disorders. The CEG has 20-years' of accumulative success in environmental  health sciences (EHS) research, our aspiration is to help mitigate these environmental diseases, first in Ohio,  then extend our success to similar populations in the nation and around the globe. Here we propose to attain  our goal by (1) expanding EHS research human capital through the continued recruitment and support of  investigators of all levels to EHS research, (2) innovative ideas and collaborative work from new and  established investigators will be supported by the Pilot Project Program and Director's Fund, (3) junior  investigators will be mentored by a Career Development Program and strong mentor-mentee relationships;  (4) an Integrative Technology Support Core combined with a Bioinformatics Core will provide investigators  with leading-edge technologies and data analysis to attain a new level of system-biology approach to EHS;  (5) enhancement activities such as workshops, symposia and seminar series will be used to stimulate  collaboration and innovation; (6) an Integrative Health Sciences Facility Core will provide the toolbox for  translation of EHS to the clinical and human studies; and (7) a Community Outreach and Engagement Core  will serve to translate EHS to public health and health education for healthier living and disease prevention.  The center is led by an outstanding team of directors with visionary scientific and administrative experiences  and insights. The team will be assisted by Internal and External Advisory Boards to provide checks and  balances. CEG, through cooperation with other centers will strive to expand EHS capacity and beyond. Our environmental health center focuses on understanding how genes and environment affect our health,  serving the residents, communities of Ohio, the nation and the globe by generating knowledge that is  applicable to the general public and policymakers for healthier living.",Center for Environmental Genetics,9565110,P30ES006096,"['Acute', 'Affect', 'Air', 'Allergic Disease', 'Area', 'Arteries', 'Attention', 'Barker Hypothesis', 'Behavior Disorders', 'Biogenesis', 'Bioinformatics', 'Biological', 'Cardiovascular Diseases', 'Cells', 'Chronic', 'Clinical Data', 'Clinical Research', 'Collaborations', 'Communities', 'Community Outreach', 'Complex', 'Core Facility', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Disease', 'Dose', 'Economics', 'Educational workshop', 'Endocrine disruption', 'Environment', 'Environmental Health', 'Environmental Risk Factor', 'Epigenetic Process', 'Equilibrium', 'Equipment', 'Evolution', 'Exposure to', 'Funding', 'General Population', 'Generations', 'Genes', 'Genetic', 'Genetic Variation', 'Genome', 'Geography', 'Goals', 'Health', 'Health Sciences', 'Human', 'Human Genome Project', 'Immune System Diseases', 'Individual', 'Informatics', 'Integrative Medicine', 'Knowledge', 'Lead', 'Life', 'Life Style', 'Link', 'Machine Learning', 'Medicine', 'Mentors', 'Mission', 'Monozygotic twins', 'Nature', 'Neurology', 'Ohio', 'Organ', 'Outcome', 'Phenotype', 'Pilot Projects', 'Population', 'Power Plants', 'Predisposition', 'Program Development', 'Public Health', 'Public Health Education', 'Recruitment Activity', 'Request for Applications', 'Research', 'Research Personnel', 'Route', 'Series', 'Systems Biology', 'Technology', 'Time', 'Translating', 'Translations', 'Transportation', 'Update', 'Vision', 'Work', 'base', 'career development', 'clinical practice', 'disorder prevention', 'disorder risk', 'environmental agent', 'epigenome', 'experience', 'gene environment interaction', 'genome wide association study', 'high risk', 'human capital', 'innovation', 'insight', 'lipid disorder', 'malignant endocrine gland neoplasm', 'member', 'multidisciplinary', 'next generation sequencing', 'programs', 'response', 'success', 'symposium', 'translation to humans']",NIEHS,UNIVERSITY OF CINCINNATI,P30,2017,106418,0.04011960474003362
"Center for Environmental Genetics This application requests a 5-year renewal of the Center for Environmental Genetics. The unified theme of  the proposal is to elucidate how gene and environment interaction through epigenetics influences disease  risks and health outcome. Ohioans are exposed to exceptionally bad air quality due to dated power plants  and the fact that it is situated in the nation's main artery of the north-south transportation route. These unique  geographical/economic features put the residents in the state at high risk of the following diseases: (a)  endocrine disruption and cancer; (b) immune and allergic diseases; (c) cardiovascular and lipid disorders;  and (d) neurology and behavior disorders. The CEG has 20-years' of accumulative success in environmental  health sciences (EHS) research, our aspiration is to help mitigate these environmental diseases, first in Ohio,  then extend our success to similar populations in the nation and around the globe. Here we propose to attain  our goal by (1) expanding EHS research human capital through the continued recruitment and support of  investigators of all levels to EHS research, (2) innovative ideas and collaborative work from new and  established investigators will be supported by the Pilot Project Program and Director's Fund, (3) junior  investigators will be mentored by a Career Development Program and strong mentor-mentee relationships;  (4) an Integrative Technology Support Core combined with a Bioinformatics Core will provide investigators  with leading-edge technologies and data analysis to attain a new level of system-biology approach to EHS;  (5) enhancement activities such as workshops, symposia and seminar series will be used to stimulate  collaboration and innovation; (6) an Integrative Health Sciences Facility Core will provide the toolbox for  translation of EHS to the clinical and human studies; and (7) a Community Outreach and Engagement Core  will serve to translate EHS to public health and health education for healthier living and disease prevention.  The center is led by an outstanding team of directors with visionary scientific and administrative experiences  and insights. The team will be assisted by Internal and External Advisory Boards to provide checks and  balances. CEG, through cooperation with other centers will strive to expand EHS capacity and beyond. Our environmental health center focuses on understanding how genes and environment affect our health,  serving the residents, communities of Ohio, the nation and the globe by generating knowledge that is  applicable to the general public and policymakers for healthier living.",Center for Environmental Genetics,9565118,P30ES006096,"['Acute', 'Affect', 'Air', 'Allergic Disease', 'Area', 'Arteries', 'Attention', 'Barker Hypothesis', 'Behavior Disorders', 'Biogenesis', 'Bioinformatics', 'Biological', 'Cardiovascular Diseases', 'Cells', 'Chronic', 'Clinical Data', 'Clinical Research', 'Collaborations', 'Communities', 'Community Outreach', 'Complex', 'Core Facility', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Disease', 'Dose', 'Economics', 'Educational workshop', 'Endocrine disruption', 'Environment', 'Environmental Health', 'Environmental Risk Factor', 'Epigenetic Process', 'Equilibrium', 'Equipment', 'Evolution', 'Exposure to', 'Funding', 'General Population', 'Generations', 'Genes', 'Genetic', 'Genetic Variation', 'Genome', 'Geography', 'Goals', 'Health', 'Health Sciences', 'Human', 'Human Genome Project', 'Immune System Diseases', 'Individual', 'Informatics', 'Integrative Medicine', 'Knowledge', 'Lead', 'Life', 'Life Style', 'Link', 'Machine Learning', 'Medicine', 'Mentors', 'Mission', 'Monozygotic twins', 'Nature', 'Neurology', 'Ohio', 'Organ', 'Outcome', 'Phenotype', 'Pilot Projects', 'Population', 'Power Plants', 'Predisposition', 'Program Development', 'Public Health', 'Public Health Education', 'Recruitment Activity', 'Request for Applications', 'Research', 'Research Personnel', 'Route', 'Series', 'Systems Biology', 'Technology', 'Time', 'Translating', 'Translations', 'Transportation', 'Update', 'Vision', 'Work', 'base', 'career development', 'clinical practice', 'disorder prevention', 'disorder risk', 'environmental agent', 'epigenome', 'experience', 'gene environment interaction', 'genome wide association study', 'high risk', 'human capital', 'innovation', 'insight', 'lipid disorder', 'malignant endocrine gland neoplasm', 'member', 'multidisciplinary', 'next generation sequencing', 'programs', 'response', 'success', 'symposium', 'translation to humans']",NIEHS,UNIVERSITY OF CINCINNATI,P30,2017,52102,0.04011960474003362
"Center for Environmental Genetics This application requests a 5-year renewal of the Center for Environmental Genetics. The unified theme of  the proposal is to elucidate how gene and environment interaction through epigenetics influences disease  risks and health outcome. Ohioans are exposed to exceptionally bad air quality due to dated power plants  and the fact that it is situated in the nation's main artery of the north-south transportation route. These unique  geographical/economic features put the residents in the state at high risk of the following diseases: (a)  endocrine disruption and cancer; (b) immune and allergic diseases; (c) cardiovascular and lipid disorders;  and (d) neurology and behavior disorders. The CEG has 20-years' of accumulative success in environmental  health sciences (EHS) research, our aspiration is to help mitigate these environmental diseases, first in Ohio,  then extend our success to similar populations in the nation and around the globe. Here we propose to attain  our goal by (1) expanding EHS research human capital through the continued recruitment and support of  investigators of all levels to EHS research, (2) innovative ideas and collaborative work from new and  established investigators will be supported by the Pilot Project Program and Director's Fund, (3) junior  investigators will be mentored by a Career Development Program and strong mentor-mentee relationships;  (4) an Integrative Technology Support Core combined with a Bioinformatics Core will provide investigators  with leading-edge technologies and data analysis to attain a new level of system-biology approach to EHS;  (5) enhancement activities such as workshops, symposia and seminar series will be used to stimulate  collaboration and innovation; (6) an Integrative Health Sciences Facility Core will provide the toolbox for  translation of EHS to the clinical and human studies; and (7) a Community Outreach and Engagement Core  will serve to translate EHS to public health and health education for healthier living and disease prevention.  The center is led by an outstanding team of directors with visionary scientific and administrative experiences  and insights. The team will be assisted by Internal and External Advisory Boards to provide checks and  balances. CEG, through cooperation with other centers will strive to expand EHS capacity and beyond. Our environmental health center focuses on understanding how genes and environment affect our health,  serving the residents, communities of Ohio, the nation and the globe by generating knowledge that is  applicable to the general public and policymakers for healthier living.",Center for Environmental Genetics,9565126,P30ES006096,"['Acute', 'Affect', 'Air', 'Allergic Disease', 'Area', 'Arteries', 'Attention', 'Barker Hypothesis', 'Behavior Disorders', 'Biogenesis', 'Bioinformatics', 'Biological', 'Cardiovascular Diseases', 'Cells', 'Chronic', 'Clinical Data', 'Clinical Research', 'Collaborations', 'Communities', 'Community Outreach', 'Complex', 'Core Facility', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Disease', 'Dose', 'Economics', 'Educational workshop', 'Endocrine disruption', 'Environment', 'Environmental Health', 'Environmental Risk Factor', 'Epigenetic Process', 'Equilibrium', 'Equipment', 'Evolution', 'Exposure to', 'Funding', 'General Population', 'Generations', 'Genes', 'Genetic', 'Genetic Variation', 'Genome', 'Geography', 'Goals', 'Health', 'Health Sciences', 'Human', 'Human Genome Project', 'Immune System Diseases', 'Individual', 'Informatics', 'Integrative Medicine', 'Knowledge', 'Lead', 'Life', 'Life Style', 'Link', 'Machine Learning', 'Medicine', 'Mentors', 'Mission', 'Monozygotic twins', 'Nature', 'Neurology', 'Ohio', 'Organ', 'Outcome', 'Phenotype', 'Pilot Projects', 'Population', 'Power Plants', 'Predisposition', 'Program Development', 'Public Health', 'Public Health Education', 'Recruitment Activity', 'Request for Applications', 'Research', 'Research Personnel', 'Route', 'Series', 'Systems Biology', 'Technology', 'Time', 'Translating', 'Translations', 'Transportation', 'Update', 'Vision', 'Work', 'base', 'career development', 'clinical practice', 'disorder prevention', 'disorder risk', 'environmental agent', 'epigenome', 'experience', 'gene environment interaction', 'genome wide association study', 'high risk', 'human capital', 'innovation', 'insight', 'lipid disorder', 'malignant endocrine gland neoplasm', 'member', 'multidisciplinary', 'next generation sequencing', 'programs', 'response', 'success', 'symposium', 'translation to humans']",NIEHS,UNIVERSITY OF CINCINNATI,P30,2017,39875,0.04011960474003362
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs. PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,9386165,U54AT008909,"['Address', 'Archives', 'Clinical', 'Clinical Management', 'Clinical assessments', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Drug usage', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Physiological', 'Procedures', 'Process', 'Quality Control', 'Research', 'Research Infrastructure', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Vulnerable Populations', 'Work', 'base', 'clinical risk', 'clinically relevant', 'data archive', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository', 'web portal']",NCCIH,UNIVERSITY OF WASHINGTON,U54,2017,284531,0.18524960870018883
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs. PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,9592655,U54AT008909,"['Address', 'Archives', 'Clinical', 'Clinical Management', 'Clinical assessments', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Drug usage', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Physiological', 'Procedures', 'Process', 'Quality Control', 'Research', 'Research Infrastructure', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Vulnerable Populations', 'Work', 'base', 'clinical risk', 'clinically relevant', 'data archive', 'data warehouse', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository', 'web portal']",NCCIH,WASHINGTON STATE UNIVERSITY,U54,2018,151564,0.18524960870018883
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs.         PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.            ",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,9746827,U54AT008909,"['Address', 'Archives', 'Clinical', 'Clinical Management', 'Clinical assessments', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Drug usage', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Physiological', 'Procedures', 'Process', 'Quality Control', 'Research', 'Research Infrastructure', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Vulnerable Populations', 'Work', 'base', 'clinical risk', 'clinically relevant', 'data archive', 'data warehouse', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository', 'web portal']",NCCIH,WASHINGTON STATE UNIVERSITY,U54,2018,888473,0.18524960870018883
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs. PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,9902031,U54AT008909,"['Address', 'Archives', 'Clinical', 'Clinical Management', 'Clinical assessments', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Drug usage', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Infrastructure', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Physiological', 'Procedures', 'Process', 'Quality Control', 'Research', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Structure', 'Vulnerable Populations', 'Work', 'base', 'clinical risk', 'clinically relevant', 'data archive', 'data warehouse', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository', 'web portal']",NCCIH,WASHINGTON STATE UNIVERSITY,U54,2019,158967,0.18524960870018883
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs.         PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.            ",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,9776453,U54AT008909,"['Address', 'Archives', 'Clinical', 'Clinical Management', 'Clinical assessments', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Drug usage', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Infrastructure', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Physiological', 'Procedures', 'Process', 'Quality Control', 'Research', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Structure', 'Vulnerable Populations', 'Work', 'base', 'clinical risk', 'clinically relevant', 'data archive', 'data warehouse', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository', 'web portal']",NCCIH,WASHINGTON STATE UNIVERSITY,U54,2019,2464888,0.18524960870018883
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs.         PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.            ",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,9567502,U54AT008909,"['Address', 'Archives', 'Clinical', 'Clinical Management', 'Clinical assessments', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Drug usage', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Physiological', 'Procedures', 'Process', 'Quality Control', 'Research', 'Research Infrastructure', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Vulnerable Populations', 'Work', 'base', 'clinical risk', 'clinically relevant', 'data archive', 'data warehouse', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository', 'web portal']",NCCIH,WASHINGTON STATE UNIVERSITY,U54,2018,1776346,0.18524960870018883
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs.         PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.            ",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,9346658,U54AT008909,"['Address', 'Archives', 'Clinical', 'Clinical Management', 'Clinical assessments', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Drug usage', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Physiological', 'Procedures', 'Process', 'Quality Control', 'Research', 'Research Infrastructure', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Vulnerable Populations', 'Work', 'base', 'clinical risk', 'clinically relevant', 'data archive', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository', 'web portal']",NCCIH,WASHINGTON STATE UNIVERSITY,U54,2017,1832235,0.18524960870018883
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs.         PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.            ",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,9135193,U54AT008909,"['Address', 'Archives', 'Clinical', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Infrastructure Activities', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Procedures', 'Process', 'Qualifying', 'Quality Control', 'Research', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Vulnerable Populations', 'Work', 'base', 'clinically relevant', 'data archive', 'data mining', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'online repository', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository']",NCCIH,UNIVERSITY OF WASHINGTON,U54,2016,1928492,0.18524960870018883
"Natural Product-Drug Interaction Research: The Roadmap to Best Practices     DESCRIPTION (provided by applicant): As natural products (NP) sales increase, the risk of adverse NP-drug interactions (NPDIs) increases, yet the pharmacokinetic (PK) elucidation and clinical relevance of putative NPDIs remain elusive. Assessing the risk of NPDIs is more challenging than that of drug-drug interactions (DDIs), often due to relatively scant PK knowledge of individual NP constituents that perpetrate these interactions. The proposed U54 Center will develop a roadmap for NPDI research through a series of well-designed human in vitro and in vivo studies (termed Interaction Projects) on 4-6 priority NPs that pose a potential risk for clinically relevant NPDIs. A repository will be developed for the data generated from the Interaction Projects, and results will be communicated to various target audiences through a public portal. This U54 Center is composed of an accomplished team of investigators, including pharmacokineticists with expertise in NPDIs, complemented by expertise in NP chemistry, DDIs, and health information communication. In collaboration with the Steering Committee, an innovative strategy that combines a mechanistic approach with practical considerations (e.g., popularity of the NPs) will be used to select and prioritize 4-6 NPs for further investigation in te Interaction Projects. Mechanistic aspects include curated clinical NDPI data from the widely used Drug Interaction Database (DIDB) of the Informatics Core, structural alerts, and compelling preliminary clinical and in silico NPDI data. Once selected, the NPs will be entered into a Decision Tree for assessment of NPDI liability and probable significance of interactions with victim drugs. In parallel, the Pharmacology Core will develop detailed Statements of Work for the human in vitro and in vivo studies - while the Analytical Core will source, acquire, and characterize the selected NPs - for the Interaction Projects. Upon completion of each project, the Analytical Core will analyze the PK samples, and the Pharmacology Core will develop physiologically-based PK models for further assessment of the clinical relevance of the Interaction Project results. Throughout these projects, the Informatics Core will create a data repository embedded within a public portal web-based application named, NaPDI app, for Natural Product-Drug Interaction application. The repository, built using the DIDB framework, will allow researchers to access both raw data and summarized results. The U54 Center will also develop and share Best Practices recommended for the conduct of NPDI studies, based on the experience with and results from the Interaction Projects, with the research communities via the public portal. Effective dissemination of the Interaction Project results will be ensured through user experience and brand content studies with target audiences - researchers/practitioners and lay public - to refine the public portal content. The Informatics Core will ensure that the U54 Center's results are archived, organized, analyzed, and well-publicized, allowing for improved design of future NPDI research and ultimately, improved decisions on the optimal management of clinically relevant NPDIs.         PUBLIC HEALTH RELEVANCE: The goal of this proposed Center of Excellence is to provide leadership on how best to study potential adverse interactions between natural products and conventional medications. The uniquely experienced and multidisciplinary team of investigators will work with NCCAM officials to identify a priority list of natural products that could alter dru disposition and, in turn, significantly alter the efficacy and safety of conventional medications; challenges inherent to studying these interactions will be addressed using a combination of novel and established approaches. Upon assessment of the selected natural products and potential drug interactions through the Interaction Projects, a repository and web-based public portal will be developed that allows other researchers to access the generated data for further analysis and communicate the health implications of the results to health care practitioners and the public.            ",Natural Product-Drug Interaction Research: The Roadmap to Best Practices,8977997,U54AT008909,"['Address', 'Archives', 'Biological Factors', 'Clinical', 'Collaborations', 'Communication', 'Communities', 'Complement', 'Computer Simulation', 'Data', 'Databases', 'Decision Trees', 'Drug Interactions', 'Drug Kinetics', 'Ensure', 'Future', 'Goals', 'Health', 'Healthcare', 'Human', 'In Vitro', 'Individual', 'Informatics', 'Infrastructure Activities', 'Investigation', 'Knowledge', 'Leadership', 'Literature', 'Methods', 'Names', 'National Center for Complementary and Alternative Medicine', 'Natural Product Drug', 'Natural Products Chemistry', 'Nature', 'Online Systems', 'Pharmaceutical Preparations', 'Pharmacology', 'Procedures', 'Process', 'Qualifying', 'Quality Control', 'Research', 'Research Personnel', 'Risk', 'Safety', 'Sales', 'Sampling', 'Series', 'Source', 'Vulnerable Populations', 'Work', 'base', 'clinically relevant', 'data mining', 'design', 'experience', 'improved', 'in vivo', 'innovation', 'liquid chromatography mass spectrometry', 'models and simulation', 'multidisciplinary', 'novel', 'operation', 'perpetrators', 'pharmacokinetic model', 'public health relevance', 'quality assurance', 'repository']",NCCIH,UNIVERSITY OF WASHINGTON,U54,2015,2015154,0.18524960870018883
"THE XNAT IMAGING INFORMATICS PLATFORM PROJECT SUMMARY This proposal aims to continue the development of XNAT. XNAT is an imaging informatics platform designed to facilitate common management and productivity tasks for imaging and associated data. We will develop the next generation of XNAT technology to support the ongoing evolution of imaging research. Development will focus on modernizing and expanding the current system. In Aim 1, we will implement new web application infrastructure that includes a new archive file management system, a new event bus to manage cross-service orchestration and a new Javascript library to simplify user interface development. We will also implement new core services, including a Docker Container service, a dynamic scripting engine, and a global XNAT federation. In Aim 2, we will implement two innovative new capabilities that build on the services developed in Aim 1. The XNAT Publisher framework will streamline the process of data sharing by automating the creation and curation of data releases following best practices for data publication and stewardship. The XNAT Machine Learning framework will streamline the development and use of machine learning applications by integrating XNAT with the TensorFlow machine learning environment and implementing provenance and other monitoring features to help avoid the pitfalls that often plague machine learning efforts. For both Aim 1 and 2, all capabilities will be developed and evaluated in the context of real world scientific programs that are actively using the XNAT platform. In Aim 3, we will provide extensive support to the XNAT community, including training workshops, online documentation, discussion forums, and . These activities will be targeted at both XNAT users and developers. RELEVANCE Medical imaging is one of the key methods used by biomedical researchers to study human biology in health and disease. The imaging informatics platform described in this application will enable biomedical researchers to capture, analyze, and share imaging and related data. These capabilities address key bottlenecks in the pathway to discovering cures to complex diseases such as Alzheimer's disease, cancer, and heart disease.",THE XNAT IMAGING INFORMATICS PLATFORM,10002330,R01EB009352,"['Address', 'Administrator', 'Alzheimer&apos', 's Disease', 'Architecture', 'Archives', 'Area', 'Automation', 'Biomedical Research', 'Brain', 'Cardiology', 'Categories', 'Classification', 'Communities', 'Complex', 'Data', 'Data Set', 'Databases', 'Detection', 'Development', 'Disease', 'Docking', 'Documentation', 'Educational workshop', 'Ensure', 'Event', 'Evolution', 'Goals', 'Health', 'Heart Diseases', 'Human', 'Human Biology', 'Image', 'Individual', 'Informatics', 'Infrastructure', 'Instruction', 'Internet', 'Libraries', 'Machine Learning', 'Magnetic Resonance Imaging', 'Malignant Neoplasms', 'Medical Imaging', 'Methods', 'Modality', 'Modeling', 'Modernization', 'Monitor', 'Neurosciences', 'Newsletter', 'Optics', 'Paper', 'Pathway interactions', 'Peer Review', 'Persons', 'Plague', 'Positron-Emission Tomography', 'Principal Investigator', 'Process', 'Productivity', 'Publications', 'Publishing', 'Radiology Specialty', 'Research', 'Research Personnel', 'Security', 'Services', 'System', 'Technology', 'TensorFlow', 'Training', 'Validation', 'base', 'biomedical resource', 'computer framework', 'computing resources', 'data curation', 'data sharing', 'design', 'distributed data', 'educational atmosphere', 'hackathon', 'imaging informatics', 'imaging program', 'improved', 'informatics tool', 'innovation', 'next generation', 'online tutorial', 'open source', 'outreach program', 'pre-clinical', 'programs', 'skills', 'symposium', 'tool', 'virtual', 'web app']",NIBIB,WASHINGTON UNIVERSITY,R01,2020,653481,0.07563102681971101
"THE XNAT IMAGING INFORMATICS PLATFORM PROJECT SUMMARY This proposal aims to continue the development of XNAT. XNAT is an imaging informatics platform designed to facilitate common management and productivity tasks for imaging and associated data. We will develop the next generation of XNAT technology to support the ongoing evolution of imaging research. Development will focus on modernizing and expanding the current system. In Aim 1, we will implement new web application infrastructure that includes a new archive file management system, a new event bus to manage cross-service orchestration and a new Javascript library to simplify user interface development. We will also implement new core services, including a Docker Container service, a dynamic scripting engine, and a global XNAT federation. In Aim 2, we will implement two innovative new capabilities that build on the services developed in Aim 1. The XNAT Publisher framework will streamline the process of data sharing by automating the creation and curation of data releases following best practices for data publication and stewardship. The XNAT Machine Learning framework will streamline the development and use of machine learning applications by integrating XNAT with the TensorFlow machine learning environment and implementing provenance and other monitoring features to help avoid the pitfalls that often plague machine learning efforts. For both Aim 1 and 2, all capabilities will be developed and evaluated in the context of real world scientific programs that are actively using the XNAT platform. In Aim 3, we will provide extensive support to the XNAT community, including training workshops, online documentation, discussion forums, and . These activities will be targeted at both XNAT users and developers. RELEVANCE Medical imaging is one of the key methods used by biomedical researchers to study human biology in health and disease. The imaging informatics platform described in this application will enable biomedical researchers to capture, analyze, and share imaging and related data. These capabilities address key bottlenecks in the pathway to discovering cures to complex diseases such as Alzheimer's disease, cancer, and heart disease.",THE XNAT IMAGING INFORMATICS PLATFORM,9772886,R01EB009352,"['Address', 'Administrator', 'Alzheimer&apos', 's Disease', 'Architecture', 'Archives', 'Area', 'Automation', 'Biomedical Research', 'Brain', 'Cardiology', 'Categories', 'Classification', 'Communities', 'Complex', 'Data', 'Data Set', 'Databases', 'Detection', 'Development', 'Disease', 'Docking', 'Documentation', 'Educational workshop', 'Ensure', 'Event', 'Evolution', 'Goals', 'Health', 'Heart Diseases', 'Human', 'Human Biology', 'Image', 'Individual', 'Informatics', 'Infrastructure', 'Instruction', 'Internet', 'Libraries', 'Machine Learning', 'Magnetic Resonance Imaging', 'Malignant Neoplasms', 'Medical Imaging', 'Methods', 'Modality', 'Modeling', 'Modernization', 'Monitor', 'Neurosciences', 'Newsletter', 'Optics', 'Paper', 'Pathway interactions', 'Peer Review', 'Persons', 'Plague', 'Positron-Emission Tomography', 'Principal Investigator', 'Process', 'Productivity', 'Publications', 'Publishing', 'Radiology Specialty', 'Research', 'Research Personnel', 'Security', 'Services', 'System', 'Technology', 'TensorFlow', 'Training', 'Validation', 'base', 'biomedical resource', 'computer framework', 'computing resources', 'data sharing', 'design', 'distributed data', 'educational atmosphere', 'hackathon', 'imaging informatics', 'imaging program', 'improved', 'informatics\xa0tool', 'innovation', 'next generation', 'online tutorial', 'open source', 'outreach program', 'pre-clinical', 'programs', 'skills', 'symposium', 'tool', 'virtual', 'web app']",NIBIB,WASHINGTON UNIVERSITY,R01,2019,663419,0.07563102681971101
"THE XNAT IMAGING INFORMATICS PLATFORM PROJECT SUMMARY This proposal aims to continue the development of XNAT. XNAT is an imaging informatics platform designed to facilitate common management and productivity tasks for imaging and associated data. We will develop the next generation of XNAT technology to support the ongoing evolution of imaging research. Development will focus on modernizing and expanding the current system. In Aim 1, we will implement new web application infrastructure that includes a new archive file management system, a new event bus to manage cross-service orchestration and a new Javascript library to simplify user interface development. We will also implement new core services, including a Docker Container service, a dynamic scripting engine, and a global XNAT federation. In Aim 2, we will implement two innovative new capabilities that build on the services developed in Aim 1. The XNAT Publisher framework will streamline the process of data sharing by automating the creation and curation of data releases following best practices for data publication and stewardship. The XNAT Machine Learning framework will streamline the development and use of machine learning applications by integrating XNAT with the TensorFlow machine learning environment and implementing provenance and other monitoring features to help avoid the pitfalls that often plague machine learning efforts. For both Aim 1 and 2, all capabilities will be developed and evaluated in the context of real world scientific programs that are actively using the XNAT platform. In Aim 3, we will provide extensive support to the XNAT community, including training workshops, online documentation, discussion forums, and . These activities will be targeted at both XNAT users and developers. RELEVANCE Medical imaging is one of the key methods used by biomedical researchers to study human biology in health and disease. The imaging informatics platform described in this application will enable biomedical researchers to capture, analyze, and share imaging and related data. These capabilities address key bottlenecks in the pathway to discovering cures to complex diseases such as Alzheimer's disease, cancer, and heart disease.",THE XNAT IMAGING INFORMATICS PLATFORM,9749413,R01EB009352,"['Address', 'Administrator', 'Alzheimer&apos', 's Disease', 'Architecture', 'Archives', 'Area', 'Automation', 'Biomedical Research', 'Brain', 'Cardiology', 'Categories', 'Classification', 'Communities', 'Complex', 'Data', 'Data Set', 'Databases', 'Detection', 'Development', 'Disease', 'Docking', 'Documentation', 'Educational workshop', 'Ensure', 'Event', 'Evolution', 'Goals', 'Health', 'Heart Diseases', 'Human', 'Human Biology', 'Image', 'Individual', 'Informatics', 'Instruction', 'Internet', 'Libraries', 'Machine Learning', 'Magnetic Resonance Imaging', 'Malignant Neoplasms', 'Medical Imaging', 'Methods', 'Modality', 'Modeling', 'Modernization', 'Monitor', 'Neurosciences', 'Newsletter', 'Optics', 'Paper', 'Pathway interactions', 'Peer Review', 'Persons', 'Plague', 'Positron-Emission Tomography', 'Principal Investigator', 'Process', 'Productivity', 'Publications', 'Publishing', 'Radiology Specialty', 'Research', 'Research Infrastructure', 'Research Personnel', 'Security', 'Services', 'System', 'Technology', 'TensorFlow', 'Training', 'Validation', 'base', 'biomedical resource', 'computer framework', 'computing resources', 'data sharing', 'design', 'distributed data', 'educational atmosphere', 'hackathon', 'imaging informatics', 'imaging program', 'improved', 'innovation', 'next generation', 'online tutorial', 'open source', 'outreach program', 'pre-clinical', 'programs', 'skills', 'symposium', 'tool', 'virtual', 'web app']",NIBIB,WASHINGTON UNIVERSITY,R01,2018,155743,0.07563102681971101
"THE XNAT IMAGING INFORMATICS PLATFORM PROJECT SUMMARY This proposal aims to continue the development of XNAT. XNAT is an imaging informatics platform designed to facilitate common management and productivity tasks for imaging and associated data. We will develop the next generation of XNAT technology to support the ongoing evolution of imaging research. Development will focus on modernizing and expanding the current system. In Aim 1, we will implement new web application infrastructure that includes a new archive file management system, a new event bus to manage cross-service orchestration and a new Javascript library to simplify user interface development. We will also implement new core services, including a Docker Container service, a dynamic scripting engine, and a global XNAT federation. In Aim 2, we will implement two innovative new capabilities that build on the services developed in Aim 1. The XNAT Publisher framework will streamline the process of data sharing by automating the creation and curation of data releases following best practices for data publication and stewardship. The XNAT Machine Learning framework will streamline the development and use of machine learning applications by integrating XNAT with the TensorFlow machine learning environment and implementing provenance and other monitoring features to help avoid the pitfalls that often plague machine learning efforts. For both Aim 1 and 2, all capabilities will be developed and evaluated in the context of real world scientific programs that are actively using the XNAT platform. In Aim 3, we will provide extensive support to the XNAT community, including training workshops, online documentation, discussion forums, and . These activities will be targeted at both XNAT users and developers. RELEVANCE Medical imaging is one of the key methods used by biomedical researchers to study human biology in health and disease. The imaging informatics platform described in this application will enable biomedical researchers to capture, analyze, and share imaging and related data. These capabilities address key bottlenecks in the pathway to discovering cures to complex diseases such as Alzheimer's disease, cancer, and heart disease.",THE XNAT IMAGING INFORMATICS PLATFORM,9560825,R01EB009352,"['Address', 'Administrator', 'Alzheimer&apos', 's Disease', 'Architecture', 'Archives', 'Area', 'Automation', 'Biomedical Research', 'Brain', 'Cardiology', 'Categories', 'Classification', 'Communities', 'Complex', 'Data', 'Data Set', 'Databases', 'Detection', 'Development', 'Disease', 'Docking', 'Documentation', 'Educational workshop', 'Ensure', 'Event', 'Evolution', 'Goals', 'Health', 'Heart Diseases', 'Human', 'Human Biology', 'Image', 'Individual', 'Informatics', 'Instruction', 'Internet', 'Libraries', 'Machine Learning', 'Magnetic Resonance Imaging', 'Malignant Neoplasms', 'Medical Imaging', 'Methods', 'Modality', 'Modeling', 'Modernization', 'Monitor', 'Neurosciences', 'Newsletter', 'Optics', 'Paper', 'Pathway interactions', 'Peer Review', 'Persons', 'Plague', 'Positron-Emission Tomography', 'Principal Investigator', 'Process', 'Productivity', 'Publications', 'Publishing', 'Radiology Specialty', 'Research', 'Research Infrastructure', 'Research Personnel', 'Security', 'Services', 'System', 'Technology', 'TensorFlow', 'Training', 'Validation', 'base', 'biomedical resource', 'computer framework', 'computing resources', 'data sharing', 'design', 'distributed data', 'educational atmosphere', 'hackathon', 'imaging informatics', 'imaging program', 'improved', 'innovation', 'next generation', 'online tutorial', 'open source', 'outreach program', 'pre-clinical', 'programs', 'skills', 'symposium', 'tool', 'virtual', 'web app']",NIBIB,WASHINGTON UNIVERSITY,R01,2018,674602,0.07563102681971101
"THE XNAT IMAGING INFORMATICS PLATFORM PROJECT SUMMARY This proposal aims to continue the development of XNAT. XNAT is an imaging informatics platform designed to facilitate common management and productivity tasks for imaging and associated data. We will develop the next generation of XNAT technology to support the ongoing evolution of imaging research. Development will focus on modernizing and expanding the current system. In Aim 1, we will implement new web application infrastructure that includes a new archive file management system, a new event bus to manage cross-service orchestration and a new Javascript library to simplify user interface development. We will also implement new core services, including a Docker Container service, a dynamic scripting engine, and a global XNAT federation. In Aim 2, we will implement two innovative new capabilities that build on the services developed in Aim 1. The XNAT Publisher framework will streamline the process of data sharing by automating the creation and curation of data releases following best practices for data publication and stewardship. The XNAT Machine Learning framework will streamline the development and use of machine learning applications by integrating XNAT with the TensorFlow machine learning environment and implementing provenance and other monitoring features to help avoid the pitfalls that often plague machine learning efforts. For both Aim 1 and 2, all capabilities will be developed and evaluated in the context of real world scientific programs that are actively using the XNAT platform. In Aim 3, we will provide extensive support to the XNAT community, including training workshops, online documentation, discussion forums, and . These activities will be targeted at both XNAT users and developers. RELEVANCE Medical imaging is one of the key methods used by biomedical researchers to study human biology in health and disease. The imaging informatics platform described in this application will enable biomedical researchers to capture, analyze, and share imaging and related data. These capabilities address key bottlenecks in the pathway to discovering cures to complex diseases such as Alzheimer's disease, cancer, and heart disease.",THE XNAT IMAGING INFORMATICS PLATFORM,9384200,R01EB009352,"['Address', 'Administrator', 'Alzheimer&apos', 's Disease', 'Architecture', 'Archives', 'Area', 'Automation', 'Biomedical Research', 'Brain', 'Cardiology', 'Categories', 'Classification', 'Communities', 'Complex', 'Data', 'Data Set', 'Databases', 'Detection', 'Development', 'Disease', 'Docking', 'Documentation', 'Educational workshop', 'Ensure', 'Event', 'Evolution', 'Goals', 'Health', 'Heart Diseases', 'Human', 'Human Biology', 'Image', 'Individual', 'Informatics', 'Instruction', 'Internet', 'Libraries', 'Machine Learning', 'Magnetic Resonance Imaging', 'Malignant Neoplasms', 'Medical Imaging', 'Methods', 'Modality', 'Modeling', 'Modernization', 'Monitor', 'Neurosciences', 'Newsletter', 'Optics', 'Paper', 'Pathway interactions', 'Peer Review', 'Persons', 'Plague', 'Positron-Emission Tomography', 'Principal Investigator', 'Process', 'Productivity', 'Publications', 'Publishing', 'Radiology Specialty', 'Research', 'Research Infrastructure', 'Research Personnel', 'Security', 'Services', 'System', 'Technology', 'Training', 'Validation', 'base', 'biomedical resource', 'computer framework', 'computing resources', 'data sharing', 'design', 'distributed data', 'educational atmosphere', 'hackathon', 'imaging informatics', 'imaging program', 'improved', 'innovation', 'next generation', 'online tutorial', 'open source', 'outreach program', 'pre-clinical', 'programs', 'skills', 'symposium', 'tool', 'virtual', 'web app']",NIBIB,WASHINGTON UNIVERSITY,R01,2017,685783,0.07563102681971101
"Nathan Shock Center of Excellence in Basic Biology of Aging OVERALL PROJECT SUMMARY This application is for renewal of the Nathan Shock Center of Excellence in the Basic Biology of Aging at the University of Washington and affiliated institutions. This Center has over the past 25 years provided key resources in support of investigators who study the biology of aging. This application continues a theme that emphasizes outreach and service to the broadest community of investigators in the gerosciences. Of proximal relevance is the characterization of aging-related phenotypes of longevity and healthspan. As our Center services must be easily accessible to outside users, our Longevity and Healthspan Core (Core E) focuses on invertebrate assays, many of them novel. Two other Resources Cores focus on the high dimensional assessments that are closely related to aging phenotypes: Protein Phenotypes of Aging (Core C) and Metabolite Phenotypes of Aging (Core D). Sophisticated computational and bioinformatic tools for data analysis and optimal insight are provided by the Artificial Intelligence and Bioinformatics Core F. Each of these four Resource Cores is led by highly respected experts in that field, including Michael MacCoss and Judit Villen (Core C), Daniel Promislow (Core D), Matt Kaeberlein and Maitreya Dunham (Core E) and Su-In Lee (Core F). Each will push the envelope of appropriate technologies, developing new state-of-the art approaches for assessments that are the most applicable to gerontology and making them accessible to the national aging community. The Research Development Core (Core B) will continue to support pilot and junior faculty studies, with a firm focus on outreach of service to the national geroscience constituency. The Administrative and Program Enrichment Core (Core A) supports administrative management, an external advisory panel, courses, and data sharing and dissemination. Core As program of seminars and symposia will continue a focus on sponsorship and organization of national courses, meetings and pre-meetings, as well as workshops in the fields allied to our Resource Core Services. In coordination with other Nathan Shock Centers, we will support a new Geropathology Research initiative. UW NATHAN SHOCK CENTER OVERALL - PROJECT NARRATIVE We apply for renewal of the Nathan Shock Center of Excellence in the Basic Biology of Aging at the University of Washington, which has for 25 years provided key resources supporting investigators who study the biology of aging. The overarching goal of this Center is to have a positive impact on the field by accelerating research discovery and providing research support for investigators nationally and internationally, particularly junior investigators in the process of building their own research programs. We will accomplish this goal through six cores that function synergistically together: four Resource Cores with particular expertise in protein (Core C) and metabolite (Core D) phenotypes of aging, invertebrate longevity and healthspan phenotypes (Core E) and artificial intelligence and bioinformatics (Core F), along with a Research Development Core (Core B) that supports external pilot projects and junior faculty studies, and an Administrative and Program Enrichment Core (Core A) that supports administrative management, an external advisory panel, sponsorship and organization of national meetings and pre-meetings, courses, workshops and seminars, and, in coordination with other Nathan Shock Centers, a Geropathology Research initiative.",Nathan Shock Center of Excellence in Basic Biology of Aging,10042617,P30AG013280,"['Aging', 'Artificial Intelligence', 'Bioinformatics', 'Biological Assay', 'Biology of Aging', 'Collaborations', 'Communication', 'Communities', 'Consult', 'Data', 'Data Analyses', 'Development', 'Educational workshop', 'Environment', 'Experimental Designs', 'Faculty', 'Genes', 'Genetic study', 'Gerontology', 'Geroscience', 'Goals', 'Growth', 'Informatics', 'Institution', 'International', 'Invertebrates', 'Leadership', 'Longevity', 'Methodology', 'Methods', 'Microfluidics', 'Molecular Genetics', 'Office of Administrative Management', 'Pathway interactions', 'Phenotype', 'Philosophy', 'Pilot Projects', 'Post-Translational Protein Processing', 'Process', 'Proteins', 'Proteomics', 'Research', 'Research Activity', 'Research Personnel', 'Research Support', 'Resources', 'Robotics', 'Services', 'Shock', 'Statistical Data Interpretation', 'Technology', 'Transcript', 'Universities', 'Variant', 'Washington', 'bioinformatics tool', 'career development', 'cell age', 'computerized tools', 'data dissemination', 'data sharing', 'healthspan', 'high dimensionality', 'insight', 'meetings', 'metabolomics', 'multiple omics', 'novel', 'outreach', 'outreach services', 'programs', 'protein metabolite', 'research and development', 'symposium', 'tool', 'trait']",NIA,UNIVERSITY OF WASHINGTON,P30,2020,962037,0.22347908134297212
"Texas Gene Array Core    DESCRIPTION (provided by applicant): The overall objective of this INIA core is to continue to provide robust microarray analysis and informatics capabilities to INIA researchers. During the previous grant period, the INIA Microarray Core at UT Austin enabled the generation of large amounts of microarray data from INIA labs. In the next period, although we plan to generate microarray data, the emphasis of the Core will extend to carrying out novel analyses of consolidated datasets. At the same time we will enhance our microarray capabilities by enabling novel types of microarray profiling experiments such as microRNA (miRNA) profiling and chromatin immunoprecipitation (ChlP-chip) data analysis. The activities of this proposed INIA Core will include updating of our relational microarray database, the Longhorn Array Database (LAD), to accommodate these novel kinds of experimental platforms and datasets, and most importantly, developing completely new analysis capabilities that are not possible with the web browser model that is used by LAD. miRNAs provide a novel mechanism for changing function by changing the levels of brain proteins and we will enable INIA investigators to carry out pioneering neurobiological studies in this area. miRNAs have been shown to be important in post-transcriptionally regulating gene expression in cancer and miRNA profiling is likely to be valuable for understanding INIA models of excessive alcohol consumption.      This core will give INIA researchers free access to the analyses tools for DNA microarray data that we have developed and are developing by making these accessible from a web browser. For example, generalized singular value decomposition (GSVD) and pseudoinverse projection, allow construction of predictive models from DNA microarray data. This website will enable researchers without in-depth expertise in mathematics and computer programming to concentrate on the scientific questions they set out to answer by analyzing cDNA, miRNA and oligonucleotide microarray data.          n/a",Texas Gene Array Core,7920648,U01AA013518,"['Alcoholism', 'Alcohols', 'Algorithms', 'Architecture', 'Area', 'Back', 'Boutos', 'Brain', 'Client', 'Code', 'Collaborations', 'Complementary DNA', 'Computer software', 'Computing Methodologies', 'DNA Microarray Chip', 'Data', 'Data Analyses', 'Data Set', 'Data Storage and Retrieval', 'Databases', 'Development', 'Documentation', 'Ensure', 'Environment', 'Gene Expression', 'Gene Targeting', 'Generations', 'Genes', 'Grant', 'Heavy Drinking', 'Hybrids', 'Indiana', 'Informatics', 'Institutes', 'Internet', 'Java', 'Malignant Neoplasms', 'Maps', 'Mathematics', 'Methods', 'MicroRNAs', 'Microarray Analysis', 'Modeling', 'Molecular Profiling', 'Mus', 'Neurobiology', 'Oligonucleotide Microarrays', 'Oligonucleotides', 'Plug-in', 'Printing', 'Procedures', 'Proteins', 'Quantitative Trait Loci', 'Registries', 'Research Personnel', 'Spottings', 'Texas', 'Time', 'Universities', 'Untranslated Regions', 'Update', 'Withdrawal', 'austin', 'base', 'brain tissue', 'cDNA Arrays', 'chromatin immunoprecipitation', 'computer program', 'drinking', 'interest', 'mRNA Expression', 'novel', 'platform-independent', 'predictive modeling', 'research study', 'tool', 'web site']",NIAAA,"UNIVERSITY OF TEXAS, AUSTIN",U01,2009,71980,0.17416659769170348
"Texas Gene Array Core    DESCRIPTION (provided by applicant): The overall objective of this INIA core is to continue to provide robust microarray analysis and informatics capabilities to INIA researchers. During the previous grant period, the INIA Microarray Core at UT Austin enabled the generation of large amounts of microarray data from INIA labs. In the next period, although we plan to generate microarray data, the emphasis of the Core will extend to carrying out novel analyses of consolidated datasets. At the same time we will enhance our microarray capabilities by enabling novel types of microarray profiling experiments such as microRNA (miRNA) profiling and chromatin immunoprecipitation (ChlP-chip) data analysis. The activities of this proposed INIA Core will include updating of our relational microarray database, the Longhorn Array Database (LAD), to accommodate these novel kinds of experimental platforms and datasets, and most importantly, developing completely new analysis capabilities that are not possible with the web browser model that is used by LAD. miRNAs provide a novel mechanism for changing function by changing the levels of brain proteins and we will enable INIA investigators to carry out pioneering neurobiological studies in this area. miRNAs have been shown to be important in post-transcriptionally regulating gene expression in cancer and miRNA profiling is likely to be valuable for understanding INIA models of excessive alcohol consumption.      This core will give INIA researchers free access to the analyses tools for DNA microarray data that we have developed and are developing by making these accessible from a web browser. For example, generalized singular value decomposition (GSVD) and pseudoinverse projection, allow construction of predictive models from DNA microarray data. This website will enable researchers without in-depth expertise in mathematics and computer programming to concentrate on the scientific questions they set out to answer by analyzing cDNA, miRNA and oligonucleotide microarray data.          n/a",Texas Gene Array Core,7681752,U01AA013518,"['Alcoholism', 'Alcohols', 'Algorithms', 'Architecture', 'Area', 'Back', 'Boutos', 'Brain', 'Client', 'Code', 'Collaborations', 'Complementary DNA', 'Computer software', 'Computing Methodologies', 'DNA Microarray Chip', 'Data', 'Data Analyses', 'Data Set', 'Data Storage and Retrieval', 'Databases', 'Development', 'Documentation', 'Ensure', 'Environment', 'Gene Expression', 'Gene Targeting', 'Generations', 'Genes', 'Grant', 'Heavy Drinking', 'Hybrids', 'Indiana', 'Informatics', 'Institutes', 'Internet', 'Java', 'Malignant Neoplasms', 'Maps', 'Mathematics', 'Methods', 'MicroRNAs', 'Microarray Analysis', 'Modeling', 'Molecular Profiling', 'Mus', 'Neurobiology', 'Oligonucleotide Microarrays', 'Oligonucleotides', 'Plug-in', 'Printing', 'Procedures', 'Proteins', 'Quantitative Trait Loci', 'Registries', 'Research Personnel', 'Spottings', 'Texas', 'Time', 'Universities', 'Untranslated Regions', 'Update', 'Withdrawal', 'austin', 'base', 'brain tissue', 'cDNA Arrays', 'chromatin immunoprecipitation', 'computer program', 'drinking', 'interest', 'mRNA Expression', 'novel', 'platform-independent', 'predictive modeling', 'research study', 'tool', 'web site']",NIAAA,"UNIVERSITY OF TEXAS, AUSTIN",U01,2009,399293,0.17416659769170348
"Texas Gene Array Core    DESCRIPTION (provided by applicant): The overall objective of this INIA core is to continue to provide robust microarray analysis and informatics capabilities to INIA researchers. During the previous grant period, the INIA Microarray Core at UT Austin enabled the generation of large amounts of microarray data from INIA labs. In the next period, although we plan to generate microarray data, the emphasis of the Core will extend to carrying out novel analyses of consolidated datasets. At the same time we will enhance our microarray capabilities by enabling novel types of microarray profiling experiments such as microRNA (miRNA) profiling and chromatin immunoprecipitation (ChlP-chip) data analysis. The activities of this proposed INIA Core will include updating of our relational microarray database, the Longhorn Array Database (LAD), to accommodate these novel kinds of experimental platforms and datasets, and most importantly, developing completely new analysis capabilities that are not possible with the web browser model that is used by LAD. miRNAs provide a novel mechanism for changing function by changing the levels of brain proteins and we will enable INIA investigators to carry out pioneering neurobiological studies in this area. miRNAs have been shown to be important in post-transcriptionally regulating gene expression in cancer and miRNA profiling is likely to be valuable for understanding INIA models of excessive alcohol consumption.      This core will give INIA researchers free access to the analyses tools for DNA microarray data that we have developed and are developing by making these accessible from a web browser. For example, generalized singular value decomposition (GSVD) and pseudoinverse projection, allow construction of predictive models from DNA microarray data. This website will enable researchers without in-depth expertise in mathematics and computer programming to concentrate on the scientific questions they set out to answer by analyzing cDNA, miRNA and oligonucleotide microarray data.          n/a",Texas Gene Array Core,7493324,U01AA013518,"['Alcoholism', 'Alcohols', 'Algorithms', 'Architecture', 'Area', 'Back', 'Boutos', 'Brain', 'Client', 'Code', 'Collaborations', 'Complementary DNA', 'Computer software', 'Computing Methodologies', 'DNA Microarray Chip', 'DNA Microarray format', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Depth', 'Development', 'Documentation', 'Ensure', 'Environment', 'Facility Construction Funding Category', 'Gene Expression', 'Gene Targeting', 'Generations', 'Genes', 'Grant', 'Heavy Drinking', 'Hybrids', 'Indiana', 'Informatics', 'Information Storage', 'Institutes', 'Internet', 'Java', 'Malignant Neoplasms', 'Maps', 'Mathematics', 'Methods', 'MicroRNAs', 'Microarray Analysis', 'Modeling', 'Molecular Profiling', 'Mus', 'Neurobiology', 'Oligonucleotide Microarrays', 'Oligonucleotides', 'Plug-in', 'Polymerase Chain Reaction', 'Printing', 'Procedures', 'Proteins', 'Quantitative Trait Loci', 'Registries', 'Research Personnel', 'Spottings', 'Standards of Weights and Measures', 'Texas', 'Time', 'Universities', 'Untranslated Regions', 'Update', 'Withdrawal', 'austin', 'base', 'brain tissue', 'cDNA Arrays', 'chromatin immunoprecipitation', 'computer program', 'drinking', 'interest', 'mRNA Expression', 'novel', 'platform-independent', 'predictive modeling', 'research study', 'tool']",NIAAA,"UNIVERSITY OF TEXAS, AUSTIN",U01,2008,387663,0.17416659769170348
"Texas Gene Array Core    DESCRIPTION (provided by applicant): The overall objective of this INIA core is to continue to provide robust microarray analysis and informatics capabilities to INIA researchers. During the previous grant period, the INIA Microarray Core at UT Austin enabled the generation of large amounts of microarray data from INIA labs. In the next period, although we plan to generate microarray data, the emphasis of the Core will extend to carrying out novel analyses of consolidated datasets. At the same time we will enhance our microarray capabilities by enabling novel types of microarray profiling experiments such as microRNA (miRNA) profiling and chromatin immunoprecipitation (ChlP-chip) data analysis. The activities of this proposed INIA Core will include updating of our relational microarray database, the Longhorn Array Database (LAD), to accommodate these novel kinds of experimental platforms and datasets, and most importantly, developing completely new analysis capabilities that are not possible with the web browser model that is used by LAD. miRNAs provide a novel mechanism for changing function by changing the levels of brain proteins and we will enable INIA investigators to carry out pioneering neurobiological studies in this area. miRNAs have been shown to be important in post-transcriptionally regulating gene expression in cancer and miRNA profiling is likely to be valuable for understanding INIA models of excessive alcohol consumption.      This core will give INIA researchers free access to the analyses tools for DNA microarray data that we have developed and are developing by making these accessible from a web browser. For example, generalized singular value decomposition (GSVD) and pseudoinverse projection, allow construction of predictive models from DNA microarray data. This website will enable researchers without in-depth expertise in mathematics and computer programming to concentrate on the scientific questions they set out to answer by analyzing cDNA, miRNA and oligonucleotide microarray data.          n/a",Texas Gene Array Core,7921493,U01AA013518,"['Alcoholism', 'Alcohols', 'Algorithms', 'Architecture', 'Area', 'Back', 'Boutos', 'Brain', 'Client', 'Code', 'Collaborations', 'Complementary DNA', 'Computer software', 'Computing Methodologies', 'DNA Microarray Chip', 'Data', 'Data Analyses', 'Data Set', 'Data Storage and Retrieval', 'Databases', 'Development', 'Documentation', 'Ensure', 'Environment', 'Gene Expression', 'Gene Targeting', 'Generations', 'Genes', 'Grant', 'Heavy Drinking', 'Hybrids', 'Indiana', 'Informatics', 'Institutes', 'Internet', 'Java', 'Malignant Neoplasms', 'Maps', 'Mathematics', 'Methods', 'MicroRNAs', 'Microarray Analysis', 'Modeling', 'Molecular Profiling', 'Mus', 'Neurobiology', 'Oligonucleotide Microarrays', 'Oligonucleotides', 'Plug-in', 'Printing', 'Procedures', 'Proteins', 'Quantitative Trait Loci', 'Registries', 'Research Personnel', 'Spottings', 'Texas', 'Time', 'Universities', 'Untranslated Regions', 'Update', 'Withdrawal', 'austin', 'base', 'brain tissue', 'cDNA Arrays', 'chromatin immunoprecipitation', 'computer program', 'drinking', 'interest', 'mRNA Expression', 'novel', 'platform-independent', 'predictive modeling', 'research study', 'tool', 'web site']",NIAAA,"UNIVERSITY OF TEXAS, AUSTIN",U01,2010,480554,0.17416659769170348
"Texas Gene Array Core    DESCRIPTION (provided by applicant): The overall objective of this INIA core is to continue to provide robust microarray analysis and informatics capabilities to INIA researchers. During the previous grant period, the INIA Microarray Core at UT Austin enabled the generation of large amounts of microarray data from INIA labs. In the next period, although we plan to generate microarray data, the emphasis of the Core will extend to carrying out novel analyses of consolidated datasets. At the same time we will enhance our microarray capabilities by enabling novel types of microarray profiling experiments such as microRNA (miRNA) profiling and chromatin immunoprecipitation (ChlP-chip) data analysis. The activities of this proposed INIA Core will include updating of our relational microarray database, the Longhorn Array Database (LAD), to accommodate these novel kinds of experimental platforms and datasets, and most importantly, developing completely new analysis capabilities that are not possible with the web browser model that is used by LAD. miRNAs provide a novel mechanism for changing function by changing the levels of brain proteins and we will enable INIA investigators to carry out pioneering neurobiological studies in this area. miRNAs have been shown to be important in post-transcriptionally regulating gene expression in cancer and miRNA profiling is likely to be valuable for understanding INIA models of excessive alcohol consumption.      This core will give INIA researchers free access to the analyses tools for DNA microarray data that we have developed and are developing by making these accessible from a web browser. For example, generalized singular value decomposition (GSVD) and pseudoinverse projection, allow construction of predictive models from DNA microarray data. This website will enable researchers without in-depth expertise in mathematics and computer programming to concentrate on the scientific questions they set out to answer by analyzing cDNA, miRNA and oligonucleotide microarray data.          n/a",Texas Gene Array Core,7291096,U01AA013518,"['Alcoholism', 'Alcohols', 'Algorithms', 'Architecture', 'Area', 'Back', 'Boutos', 'Brain', 'Client', 'Code', 'Collaborations', 'Complementary DNA', 'Computer software', 'Computing Methodologies', 'DNA Microarray Chip', 'DNA Microarray format', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Depth', 'Development', 'Documentation', 'Ensure', 'Environment', 'Facility Construction Funding Category', 'Gene Expression', 'Gene Targeting', 'Generations', 'Genes', 'Grant', 'Heavy Drinking', 'Hybrids', 'Indiana', 'Informatics', 'Information Storage', 'Institutes', 'Internet', 'Java', 'Malignant Neoplasms', 'Maps', 'Mathematics', 'Methods', 'MicroRNAs', 'Microarray Analysis', 'Modeling', 'Molecular Profiling', 'Mus', 'Neurobiology', 'Oligonucleotide Microarrays', 'Oligonucleotides', 'Plug-in', 'Polymerase Chain Reaction', 'Printing', 'Procedures', 'Proteins', 'Quantitative Trait Loci', 'Registries', 'Research Personnel', 'Spottings', 'Standards of Weights and Measures', 'Texas', 'Time', 'Universities', 'Untranslated Regions', 'Update', 'Withdrawal', 'austin', 'base', 'brain tissue', 'cDNA Arrays', 'chromatin immunoprecipitation', 'computer program', 'drinking', 'interest', 'mRNA Expression', 'novel', 'platform-independent', 'predictive modeling', 'research study', 'tool']",NIAAA,"UNIVERSITY OF TEXAS, AUSTIN",U01,2007,384052,0.17416659769170348
"Texas Gene Array Core    DESCRIPTION (provided by applicant): The overall objective of this INIA core is to continue to provide robust microarray analysis and informatics capabilities to INIA researchers. During the previous grant period, the INIA Microarray Core at UT Austin enabled the generation of large amounts of microarray data from INIA labs. In the next period, although we plan to generate microarray data, the emphasis of the Core will extend to carrying out novel analyses of consolidated datasets. At the same time we will enhance our microarray capabilities by enabling novel types of microarray profiling experiments such as microRNA (miRNA) profiling and chromatin immunoprecipitation (ChlP-chip) data analysis. The activities of this proposed INIA Core will include updating of our relational microarray database, the Longhorn Array Database (LAD), to accommodate these novel kinds of experimental platforms and datasets, and most importantly, developing completely new analysis capabilities that are not possible with the web browser model that is used by LAD. miRNAs provide a novel mechanism for changing function by changing the levels of brain proteins and we will enable INIA investigators to carry out pioneering neurobiological studies in this area. miRNAs have been shown to be important in post-transcriptionally regulating gene expression in cancer and miRNA profiling is likely to be valuable for understanding INIA models of excessive alcohol consumption.      This core will give INIA researchers free access to the analyses tools for DNA microarray data that we have developed and are developing by making these accessible from a web browser. For example, generalized singular value decomposition (GSVD) and pseudoinverse projection, allow construction of predictive models from DNA microarray data. This website will enable researchers without in-depth expertise in mathematics and computer programming to concentrate on the scientific questions they set out to answer by analyzing cDNA, miRNA and oligonucleotide microarray data.          n/a",Texas Gene Array Core,7214413,U01AA013518,"['alcoholic beverage consumption', 'animal genetic material tag', 'biomedical facility', 'complementary DNA', 'cooperative study', 'fluorimetry', 'gene expression', 'immunologic assay /test', 'microarray technology', 'technology /technique development', 'tissue /cell culture']",NIAAA,UNIVERSITY OF TEXAS AUSTIN,U01,2006,419603,0.17416659769170348
"Integrated Neuroinformatics Resource for Alcoholism (IN* DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",Integrated Neuroinformatics Resource for Alcoholism (IN*,6943136,U01AA013524,"['alcoholic beverage consumption', 'alcoholism /alcohol abuse information system', 'bioinformatics', 'biomedical facility', 'computer data analysis', 'computer program /software', 'computer system design /evaluation', 'cooperative study', 'data collection methodology /evaluation', 'electrophysiology', 'neuroanatomy', 'neurochemistry', 'neurophysiology', 'neuroregulation', 'neurosciences']",NIAAA,UNIVERSITY OF COLORADO DENVER,U01,2005,467823,0.054366997161354166
"Integrated Neuroinformatics Resource for Alcoholism (IN* DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",Integrated Neuroinformatics Resource for Alcoholism (IN*,6795323,U01AA013524,"['alcoholic beverage consumption', 'alcoholism /alcohol abuse information system', 'bioinformatics', 'biomedical facility', 'computer data analysis', 'computer program /software', 'computer system design /evaluation', 'cooperative study', 'data collection methodology /evaluation', 'electrophysiology', 'neuroanatomy', 'neurochemistry', 'neurophysiology', 'neuroregulation', 'neurosciences']",NIAAA,UNIVERSITY OF COLORADO DENVER,U01,2004,754129,0.054366997161354166
"Integrated Neuroinformatics Resource for Alcoholism (IN* DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",Integrated Neuroinformatics Resource for Alcoholism (IN*,6647589,U01AA013524,"['alcoholic beverage consumption', ' alcoholism /alcohol abuse information system', ' biomedical facility', ' computer data analysis', ' computer program /software', ' computer system design /evaluation', ' cooperative study', ' data collection methodology /evaluation', ' electrophysiology', ' neuroanatomy', ' neurochemistry', ' neurophysiology', ' neuroregulation', ' neurosciences']",NIAAA,UNIVERSITY OF COLORADO DENVER,U01,2003,729100,0.054366997161354166
"Integrated Neuroinformatics Resource for Alcoholism (IN* DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",Integrated Neuroinformatics Resource for Alcoholism (IN*,6533705,U01AA013524,"['alcoholic beverage consumption', ' alcoholism /alcohol abuse information system', ' biomedical facility', ' computer data analysis', ' computer program /software', ' computer system design /evaluation', ' cooperative study', ' data collection methodology /evaluation', ' electrophysiology', ' neuroanatomy', ' neurochemistry', ' neurophysiology', ' neuroregulation', ' neurosciences']",NIAAA,UNIVERSITY OF COLORADO DENVER,U01,2002,688297,0.054366997161354166
"Integrated Neuroinformatics Resource for Alcoholism (IN* DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",Integrated Neuroinformatics Resource for Alcoholism (IN*,6449653,U01AA013524,"['alcoholic beverage consumption', ' alcoholism /alcohol abuse information system', ' biomedical facility', ' computer data analysis', ' computer program /software', ' computer system design /evaluation', ' cooperative study', ' data collection methodology /evaluation', ' electrophysiology', ' neuroanatomy', ' neurochemistry', ' neurophysiology', ' neuroregulation', ' neurosciences']",NIAAA,UNIVERSITY OF COLORADO DENVER,U01,2001,658874,0.054366997161354166
"Computational Anatomy and Multidimensional Modeling    DESCRIPTION (provided by applicant):  This competitive renewal application to continue a Resource for Computational Anatomy and Multidimensional Modeling will go beyond current atlases and maps of brain that assume a static morphology and prohibit the examination of time varying changes. Building upon considerable productivity and success, we will continue to develop the framework and tools to rigorously evaluate dynamic changes in brain structure and function focusing particularly on processes such as development, aging and the progression of specific diseases. There are four areas of research that are of critical importance: 1) Image Processing and Segmentation, 2) Deformation Morphometry and Registration, 3) Aliasing, and 4) Informatics. Each of these compliments the others to form an integrated and comprehensive research program. This unique focus on computational anatomy and multidimensional modeling is in contrast to many other neuroimaging centers where the focus is on image acquisition. Our efforts include numerous collaborations with a diverse and well-funded group of basic, applied and clinical scientists working on neuroscientific problems in health and disease. These active and productive collaborative projects were selected on the basis of their mutually beneficial and symbiotic relationship with our core research efforts and the specific aims of their funded projects. We will continue to provide service to other investigators in the form of robust software, access to our computer hardware resources and production of animations and image renderings. We disseminate information about our Resource by publication, electronic media, a brochure, and the creation of mini-CD's describing our Resource, its software, expertise, training and collaborative opportunities. Training opportunities for students and colleagues are available on site and remotely and include hands-on experiences, prepared material, workshops, and interactive electronic presentations. An administrative structure and nationally recognized advisory board help us manage the responsibilities of the Resource. Our plans for this Resource build upon an extensive history of research in image analysis, morphometric variability, brain mapping and visualization. This, coupled with our successes in the active period of the Resource, positions us perfectly to continue the growth of our Resource.           n/a",Computational Anatomy and Multidimensional Modeling,7928517,P41RR013642,"['Address', 'Aging', 'Algorithms', 'Anatomy', 'Applications Grants', 'Area', 'Atlases', 'Automation', 'Brain', 'Brain Mapping', 'Brain imaging', 'Brain scan', 'Cerebellum', 'Cerebral cortex', 'Childhood', 'Clinical', 'Collaborations', 'Communities', 'Complex', 'Computer Hardware', 'Computer software', 'Coupled', 'Data', 'Data Analyses', 'Data Base Management', 'Data Display', 'Data Set', 'Data Sources', 'Databases', 'Detection', 'Development', 'Diagnostic', 'Diffusion', 'Disease', 'Documentation', 'Educational workshop', 'Elasticity', 'Electronics', 'Ensure', 'Entropy', 'Environment', 'Fiber', 'Freedom', 'Funding', 'Goals', 'Growth', 'Hand', 'Head', 'Health', 'Human', 'Image', 'Image Analysis', 'Imagery', 'Imagination', 'Informatics', 'Information Theory', 'Joints', 'Label', 'Least-Squares Analysis', 'Life', 'Liquid substance', 'Location', 'Magnetic Resonance Imaging', 'Maps', 'Measures', 'Mechanics', 'Methods', 'Metric', 'Modeling', 'Morphology', 'Nature', 'Nerve Degeneration', 'Pamphlets', 'Pattern', 'Population', 'Population Control', 'Positioning Attribute', 'Principal Component Analysis', 'Probability', 'Procedures', 'Process', 'Production', 'Productivity', 'Publications', 'Recording of previous events', 'Reproducibility', 'Research', 'Research Design', 'Research Personnel', 'Research Project Grants', 'Resolution', 'Resources', 'Sampling', 'Scheme', 'Scientist', 'Services', 'Site', 'Speed', 'Structure', 'Students', 'Surface', 'Techniques', 'Testing', 'Thick', 'Time', 'Tissues', 'Training', 'Validation', 'Work', 'animation', 'base', 'computational anatomy', 'computer framework', 'data acquisition', 'data management', 'data modeling', 'design', 'empowered', 'experience', 'flexibility', 'image processing', 'imaging Segmentation', 'improved', 'independent component analysis', 'innovation', 'morphometry', 'neurogenetics', 'neuroimaging', 'neuropsychological', 'novel', 'patient population', 'programs', 'remediation', 'research and development', 'statistics', 'success', 'theories', 'tool']",NCRR,UNIVERSITY OF CALIFORNIA LOS ANGELES,P41,2009,378888,0.018717762132814238
"Administrative Core of the CIFASD  DESCRIPTION (provided by applicant): This is a competitive renewal for the Administrative Core (AdminC) of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) in response to RFA-AA-12-005. The AdminC oversees a multidisciplinary, multisite consortium consisting of both basic science and clinical components, with the aim of improving the diagnostic criteria for the range of outcomes following prenatal alcohol exposure. The consortium consists of three cores (AdminC, Dysmorphology, and Informatics), 5 clinical U01s, and 2 basic science UOIs. These projects are structured to be collaborative and interrelated. The AdminC maintains the organizational framework for the CIFASD, managing and supporting the two components and their Steering Committees, and providing support to the Science Advisory Board. Besides its administrative functions, the AdminC is also responsible for two additional components, the Developmental and Educational Components of the CIFASD. The Developmental Component provides a mechanism for the inclusion of new research ideas, potential new sites, and higher risk/higher payoff projects. The Educational Component provides a new mechanism to ensure that consortium findings are widely circulated to the public and other stakeholders in a timely fashion. The Specific Aims of the AdminC are to: 1) Provide scientific and administrative leadership and oversight, ensuring that CIFASD investigators adhere to its goals and mission, as well as assisting and coordinating interactions between the various projects. Function as the main liaison to NIAAA regarding the CIFASD; 2) Facilitate communication between the various projects by maintaining the CIFASD web site, scheduling monthly conference calls, convening the biannual meetings of the Steering Committees, and preparing and distributing annual progress reports; 3) Provide assistance with data collection and distribution by working with the Informatics Core. Work with the Informatics Core to develop online interactive capacity among CIFASD investigators, and make most of these databases available to outside, interested scientists; 4) Assist the Science Advisory Board and the Steering Committees in their annual evaluations of progress for each of the projects. In conjunction with the Steering Committees, it will establish annual priorities and address issues related to allocation of resources; and 5) Administer the Developmental and Educational Components of the CIFASD. PUBLIC HEALTH RELEVANCE: The consequences resulting from prenatal alcohol exposure are wide-ranging and are major public health issues. The goal of the research proposed by the CIFASD is to enhance the diagnosis of fetal alcohol spectrum disorders across the range of outcomes, using a multisite, multidisciplinary consortium consisting of both basic science and clinical projects.",Administrative Core of the CIFASD ,9063013,U24AA014811,"['3-Dimensional', 'ARHGEF5 gene', 'Address', 'Age', 'Animals', 'Area', 'Basic Science', 'Behavior', 'Behavior Disorders', 'Behavior assessment', 'Behavioral', 'Biological', 'Brain', 'Brain imaging', 'Child', 'Clinical', 'Collaborations', 'Communication', 'Data', 'Data Collection', 'Databases', 'Development', 'Diagnosis', 'Diagnostic', 'Differential Diagnosis', 'Dysmorphology', 'Early Diagnosis', 'Early Intervention', 'Ensure', 'Evaluation', 'Face', 'Fetal Alcohol Exposure', 'Fetal Alcohol Spectrum Disorder', 'Genetic', 'Goals', 'Image Analysis', 'Individual', 'Informatics', 'Institutes', 'Intervention', 'Knowledge', 'Leadership', 'Longevity', 'Machine Learning', 'Mission', 'Modality', 'National Institute on Alcohol Abuse and Alcoholism', 'Neurologic', 'Outcome', 'Phenotype', 'Policy Maker', 'Population Policies', 'Preparation', 'Probability', 'Progress Reports', 'Public Health', 'Request for Applications', 'Research', 'Research Personnel', 'Research Project Grants', 'Resource Allocation', 'Risk', 'Role', 'Schedule', 'Science', 'Scientist', 'Sensitivity and Specificity', 'Site', 'Specificity', 'Staging', 'Structure', 'Techniques', 'Telemedicine', 'Three-Dimensional Image', 'Training', 'Translating', 'Work', 'alcohol exposure', 'base', 'craniofacial', 'high risk', 'improved', 'interest', 'meetings', 'multidisciplinary', 'neurobehavioral', 'neuropathology', 'nutrition related genetics', 'patient population', 'potential biomarker', 'public health relevance', 'repository', 'response', 'symposium', 'web site']",NIAAA,SAN DIEGO STATE UNIVERSITY,U24,2016,755809,-0.045113872207609776
"Administrative Core of the CIFASD  DESCRIPTION (provided by applicant): This is a competitive renewal for the Administrative Core (AdminC) of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) in response to RFA-AA-12-005. The AdminC oversees a multidisciplinary, multisite consortium consisting of both basic science and clinical components, with the aim of improving the diagnostic criteria for the range of outcomes following prenatal alcohol exposure. The consortium consists of three cores (AdminC, Dysmorphology, and Informatics), 5 clinical U01s, and 2 basic science UOIs. These projects are structured to be collaborative and interrelated. The AdminC maintains the organizational framework for the CIFASD, managing and supporting the two components and their Steering Committees, and providing support to the Science Advisory Board. Besides its administrative functions, the AdminC is also responsible for two additional components, the Developmental and Educational Components of the CIFASD. The Developmental Component provides a mechanism for the inclusion of new research ideas, potential new sites, and higher risk/higher payoff projects. The Educational Component provides a new mechanism to ensure that consortium findings are widely circulated to the public and other stakeholders in a timely fashion. The Specific Aims of the AdminC are to: 1) Provide scientific and administrative leadership and oversight, ensuring that CIFASD investigators adhere to its goals and mission, as well as assisting and coordinating interactions between the various projects. Function as the main liaison to NIAAA regarding the CIFASD; 2) Facilitate communication between the various projects by maintaining the CIFASD web site, scheduling monthly conference calls, convening the biannual meetings of the Steering Committees, and preparing and distributing annual progress reports; 3) Provide assistance with data collection and distribution by working with the Informatics Core. Work with the Informatics Core to develop online interactive capacity among CIFASD investigators, and make most of these databases available to outside, interested scientists; 4) Assist the Science Advisory Board and the Steering Committees in their annual evaluations of progress for each of the projects. In conjunction with the Steering Committees, it will establish annual priorities and address issues related to allocation of resources; and 5) Administer the Developmental and Educational Components of the CIFASD. PUBLIC HEALTH RELEVANCE: The consequences resulting from prenatal alcohol exposure are wide-ranging and are major public health issues. The goal of the research proposed by the CIFASD is to enhance the diagnosis of fetal alcohol spectrum disorders across the range of outcomes, using a multisite, multidisciplinary consortium consisting of both basic science and clinical projects.",Administrative Core of the CIFASD ,8922188,U24AA014811,"['3-Dimensional', 'ARHGEF5 gene', 'Address', 'Age', 'Animals', 'Area', 'Basic Science', 'Behavior', 'Behavior Disorders', 'Behavior assessment', 'Behavioral', 'Biological', 'Biological Markers', 'Brain', 'Brain imaging', 'Child', 'Clinical', 'Collaborations', 'Communication', 'Data', 'Data Collection', 'Databases', 'Development', 'Diagnosis', 'Diagnostic', 'Differential Diagnosis', 'Dysmorphology', 'Early Diagnosis', 'Early Intervention', 'Ensure', 'Evaluation', 'Face', 'Fetal Alcohol Exposure', 'Fetal Alcohol Spectrum Disorder', 'Genetic', 'Goals', 'Image Analysis', 'Individual', 'Informatics', 'Institutes', 'Intervention', 'Knowledge', 'Leadership', 'Longevity', 'Machine Learning', 'Mission', 'Modality', 'National Institute on Alcohol Abuse and Alcoholism', 'Neurologic', 'Outcome', 'Phenotype', 'Policy Maker', 'Population Policies', 'Preparation', 'Probability', 'Progress Reports', 'Public Health', 'Request for Applications', 'Research', 'Research Personnel', 'Research Project Grants', 'Resource Allocation', 'Risk', 'Role', 'Schedule', 'Science', 'Scientist', 'Sensitivity and Specificity', 'Site', 'Specificity', 'Staging', 'Structure', 'Techniques', 'Telemedicine', 'Three-Dimensional Image', 'Training', 'Translating', 'Work', 'alcohol exposure', 'base', 'craniofacial', 'high risk', 'improved', 'interest', 'meetings', 'multidisciplinary', 'neurobehavioral', 'neuropathology', 'nutrition related genetics', 'patient population', 'public health relevance', 'repository', 'response', 'symposium', 'web site']",NIAAA,SAN DIEGO STATE UNIVERSITY,U24,2014,118167,-0.045113872207609776
"Administrative Core of the CIFASD      DESCRIPTION (provided by applicant): This is a competitive renewal for the Administrative Core (AdminC) of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) in response to RFA-AA-12-005. The AdminC oversees a multidisciplinary, multisite consortium consisting of both basic science and clinical components, with the aim of improving the diagnostic criteria for the range of outcomes following prenatal alcohol exposure. The consortium consists of three cores (AdminC, Dysmorphology, and Informatics), 5 clinical U01s, and 2 basic science UOIs. These projects are structured to be collaborative and interrelated. The AdminC maintains the organizational framework for the CIFASD, managing and supporting the two components and their Steering Committees, and providing support to the Science Advisory Board. Besides its administrative functions, the AdminC is also responsible for two additional components, the Developmental and Educational Components of the CIFASD. The Developmental Component provides a mechanism for the inclusion of new research ideas, potential new sites, and higher risk/higher payoff projects. The Educational Component provides a new mechanism to ensure that consortium findings are widely circulated to the public and other stakeholders in a timely fashion. The Specific Aims of the AdminC are to: 1) Provide scientific and administrative leadership and oversight, ensuring that CIFASD investigators adhere to its goals and mission, as well as assisting and coordinating interactions between the various projects. Function as the main liaison to NIAAA regarding the CIFASD; 2) Facilitate communication between the various projects by maintaining the CIFASD web site, scheduling monthly conference calls, convening the biannual meetings of the Steering Committees, and preparing and distributing annual progress reports; 3) Provide assistance with data collection and distribution by working with the Informatics Core. Work with the Informatics Core to develop online interactive capacity among CIFASD investigators, and make most of these databases available to outside, interested scientists; 4) Assist the Science Advisory Board and the Steering Committees in their annual evaluations of progress for each of the projects. In conjunction with the Steering Committees, it will establish annual priorities and address issues related to allocation of resources; and 5) Administer the Developmental and Educational Components of the CIFASD.         PUBLIC HEALTH RELEVANCE: The consequences resulting from prenatal alcohol exposure are wide-ranging and are major public health issues. The goal of the research proposed by the CIFASD is to enhance the diagnosis of fetal alcohol spectrum disorders across the range of outcomes, using a multisite, multidisciplinary consortium consisting of both basic science and clinical projects.            ",Administrative Core of the CIFASD ,8527617,U24AA014811,"['3-Dimensional', 'ARHGEF5 gene', 'Address', 'Age', 'Animals', 'Area', 'Basic Science', 'Behavior', 'Behavior Disorders', 'Behavior assessment', 'Behavioral', 'Biological', 'Biological Markers', 'Brain', 'Brain imaging', 'Child', 'Clinical', 'Collaborations', 'Communication', 'Data', 'Data Collection', 'Databases', 'Development', 'Diagnosis', 'Diagnostic', 'Differential Diagnosis', 'Dysmorphology', 'Early Diagnosis', 'Early Intervention', 'Ensure', 'Evaluation', 'Face', 'Fetal Alcohol Exposure', 'Fetal Alcohol Spectrum Disorder', 'Genetic', 'Goals', 'Image Analysis', 'Individual', 'Informatics', 'Institutes', 'Intervention', 'Knowledge', 'Leadership', 'Longevity', 'Machine Learning', 'Mission', 'Modality', 'National Institute on Alcohol Abuse and Alcoholism', 'Neurologic', 'Outcome', 'Phenotype', 'Policy Maker', 'Population Policies', 'Preparation', 'Probability', 'Progress Reports', 'Public Health', 'Request for Applications', 'Research', 'Research Personnel', 'Research Project Grants', 'Resource Allocation', 'Risk', 'Role', 'Schedule', 'Science', 'Scientist', 'Sensitivity and Specificity', 'Site', 'Specificity', 'Staging', 'Structure', 'Techniques', 'Telemedicine', 'Three-Dimensional Image', 'Training', 'Translating', 'Work', 'alcohol exposure', 'base', 'craniofacial', 'high risk', 'improved', 'interest', 'meetings', 'multidisciplinary', 'neurobehavioral', 'neuropathology', 'nutrition related genetics', 'patient population', 'public health relevance', 'repository', 'response', 'symposium', 'web site']",NIAAA,SAN DIEGO STATE UNIVERSITY,U24,2013,698738,-0.045113872207609776
"Informatics Core for the Collaborative Initiative on Fetal Alcohol Spectrum disor    DESCRIPTION (provided by applicant): The Informatics Core is part of the Consortium for the ""Collaborative Initiative on Fetal Alcohol Spectrum Disorders"" (CIFASD). The theme of this collaborative initiative is a cross-cultural assessment of ""fetal alcohol spectrum disorder"" (FASD). The CIFASD will coordinate basic, behavioral, and clinical investigators in a multidisciplinary research project to better inform approaches aimed at developing effective intervention and treatment approaches for FASD. It will involve the input and contributions from basic researchers, behavioral scientists, and clinical investigators with the willingness to utilize novel and cutting-edge techniques so as not to simply replicate previous or ongoing work, but rather to try and move it forward in a rigorous fashion. The Informatics Core will develop and maintain the CIFASD Data Repository, which will be used to collect, maintain and distribute data generated by the various participants in the consortium. The Informatics Core will be responsible for working with the other consortium participants to define a Data Dictionary to be used in standardizing data collection, enabling the transfer of data to and from the CIFASD Data Repository, consulting on how to establish local data management systems, providing both software tools and consulting to consortium participants, and producing status reports about the progress of the various projects within the consortium. The Informatics Core draws on a wealth of resources, experience, and expertise at Indiana University in information technology infrastructure and data management, The CIFASD Data Repository will be developed on Indiana University's state-of-the-art central supercomputing facilities, taking advantage of Indiana University's strong commitment to institutional computational resources. Resources that will be used to implement the CIFASD Data Repository include multiple supercomputers, an array of readily available database and statistical software, and a high- speed, secure, robust data archiving system capable of storing duplicate copies in multiple physical locations separated by more than fifty miles. The Informatics Core will use these extraordinary computational resources to provide a single, highly secure location for consortium participants to obtain the cross-cultural data that will enable the CIFASD to meet its goals of developing novel techniques for intervention and treatment of FASD.           n/a",Informatics Core for the Collaborative Initiative on Fetal Alcohol Spectrum disor,7900050,U24AA014818,"['Address', 'Adolescent', 'Affect', 'Africa', 'Alcohol consumption', 'Alcohol-Related Neurodevelopmental Disorder', 'Alcohols', 'Animal Model', 'Animals', 'Archives', 'Arts', 'Basic Science', 'Behavioral', 'Binding Sites', 'Biology', 'Brain', 'Brain imaging', 'Cells', 'Characteristics', 'Child', 'Choline', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Collaborations', 'Computer Systems', 'Computer software', 'Consult', 'Data', 'Data Analyses', 'Data Collection', 'Data Storage and Retrieval', 'Databases', 'Development', 'Diagnosis', 'Diagnostic', 'Dictionary', 'Dietary Intervention', 'Drug Design', 'Dysmorphology', 'Early Diagnosis', 'Early treatment', 'Elements', 'Emotional', 'Ethanol', 'Ethnic group', 'Face', 'Fetal Alcohol Exposure', 'Fetal Alcohol Spectrum Disorder', 'Fetal Alcohol Syndrome', 'Frequencies', 'Future', 'Genetic Polymorphism', 'Goals', 'Human', 'Image', 'Image Analysis', 'Indiana', 'Individual', 'Infant', 'Informal Social Control', 'Informatics', 'Information Technology', 'Interdisciplinary Study', 'Internet', 'Intervention', 'Knowledge', 'Label', 'Language', 'Language Development', 'Life', 'Location', 'Los Angeles', 'Machine Learning', 'Magnetic Resonance Imaging', 'Manuals', 'Measures', 'Methods', 'Mission', 'Modeling', 'Moscow', 'Mothers', 'Mus', 'Names', 'Neonatal', 'Neural Cell Adhesion Molecule L1', 'Neurobiology', 'New Mexico', 'Outcome', 'Participant', 'Pattern', 'Performance', 'Phenotype', 'Pilot Projects', 'Play', 'Population', 'Pregnancy', 'Rattus', 'Recording of previous events', 'Reporting', 'Request for Applications', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Resolution', 'Resources', 'Role', 'Schools', 'Scientist', 'Secure', 'Sensitivity and Specificity', 'Sheep', 'Signal Pathway', 'Signal Transduction', 'Site', 'Software Tools', 'Specificity', 'Speed', 'Structure', 'Sum', 'Supercomputing', 'Supplementation', 'System', 'Techniques', 'Technology', 'Therapeutic', 'Three-Dimensional Image', 'Time', 'Toddler', 'Ukraine', 'Ultrasonography', 'Universities', 'Woman', 'Work', 'alcohol exposure', 'alcohol sensitivity', 'analog', 'brain behavior', 'brain morphology', 'cognitive control', 'computing resources', 'critical period', 'data exchange', 'data integration', 'data management', 'data sharing', 'distributed data', 'drinking', 'effective intervention', 'experience', 'fetal', 'flexibility', 'follow-up', 'imaging modality', 'improved', 'in utero', 'infancy', 'literacy', 'meetings', 'mouse model', 'multidisciplinary', 'neurobehavioral', 'northern plains', 'novel', 'offspring', 'prenatal', 'prospective', 'quality assurance', 'reconstruction', 'repository', 'social', 'supercomputer', 'three dimensional structure', 'willingness']",NIAAA,INDIANA UNIVERSITY BLOOMINGTON,U24,2010,192573,0.06723724825727827
"Informatics Core for the Collaborative Initiative on Fetal Alcohol Spectrum disor    DESCRIPTION (provided by applicant): The Informatics Core is part of the Consortium for the ""Collaborative Initiative on Fetal Alcohol Spectrum Disorders"" (CIFASD). The theme of this collaborative initiative is a cross-cultural assessment of ""fetal alcohol spectrum disorder"" (FASD). The CIFASD will coordinate basic, behavioral, and clinical investigators in a multidisciplinary research project to better inform approaches aimed at developing effective intervention and treatment approaches for FASD. It will involve the input and contributions from basic researchers, behavioral scientists, and clinical investigators with the willingness to utilize novel and cutting-edge techniques so as not to simply replicate previous or ongoing work, but rather to try and move it forward in a rigorous fashion. The Informatics Core will develop and maintain the CIFASD Data Repository, which will be used to collect, maintain and distribute data generated by the various participants in the consortium. The Informatics Core will be responsible for working with the other consortium participants to define a Data Dictionary to be used in standardizing data collection, enabling the transfer of data to and from the CIFASD Data Repository, consulting on how to establish local data management systems, providing both software tools and consulting to consortium participants, and producing status reports about the progress of the various projects within the consortium. The Informatics Core draws on a wealth of resources, experience, and expertise at Indiana University in information technology infrastructure and data management, The CIFASD Data Repository will be developed on Indiana University's state-of-the-art central supercomputing facilities, taking advantage of Indiana University's strong commitment to institutional computational resources. Resources that will be used to implement the CIFASD Data Repository include multiple supercomputers, an array of readily available database and statistical software, and a high- speed, secure, robust data archiving system capable of storing duplicate copies in multiple physical locations separated by more than fifty miles. The Informatics Core will use these extraordinary computational resources to provide a single, highly secure location for consortium participants to obtain the cross-cultural data that will enable the CIFASD to meet its goals of developing novel techniques for intervention and treatment of FASD.           n/a",Informatics Core for the Collaborative Initiative on Fetal Alcohol Spectrum disor,7668731,U24AA014818,"['Address', 'Adolescent', 'Affect', 'Africa', 'Alcohol consumption', 'Alcohol-Related Neurodevelopmental Disorder', 'Alcohols', 'Animal Model', 'Animals', 'Archives', 'Arts', 'Basic Science', 'Behavioral', 'Binding Sites', 'Biology', 'Brain', 'Brain imaging', 'Cells', 'Characteristics', 'Child', 'Choline', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Collaborations', 'Computer Systems', 'Computer software', 'Consult', 'Data', 'Data Analyses', 'Data Collection', 'Data Storage and Retrieval', 'Databases', 'Development', 'Diagnosis', 'Diagnostic', 'Dictionary', 'Dietary Intervention', 'Drug Design', 'Dysmorphology', 'Early Diagnosis', 'Early treatment', 'Elements', 'Emotional', 'Ethanol', 'Ethnic group', 'Face', 'Fetal Alcohol Exposure', 'Fetal Alcohol Spectrum Disorder', 'Fetal Alcohol Syndrome', 'Frequencies', 'Future', 'Genetic Polymorphism', 'Goals', 'Human', 'Image', 'Image Analysis', 'Indiana', 'Individual', 'Infant', 'Informal Social Control', 'Informatics', 'Information Technology', 'Interdisciplinary Study', 'Internet', 'Intervention', 'Knowledge', 'Label', 'Language', 'Language Development', 'Life', 'Location', 'Los Angeles', 'Machine Learning', 'Magnetic Resonance Imaging', 'Manuals', 'Measures', 'Methods', 'Mission', 'Modeling', 'Moscow', 'Mothers', 'Mus', 'Names', 'Neonatal', 'Neural Cell Adhesion Molecule L1', 'Neurobiology', 'New Mexico', 'Outcome', 'Participant', 'Pattern', 'Performance', 'Phenotype', 'Pilot Projects', 'Play', 'Population', 'Pregnancy', 'Rattus', 'Recording of previous events', 'Reporting', 'Request for Applications', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Resolution', 'Resources', 'Role', 'Schools', 'Scientist', 'Secure', 'Sensitivity and Specificity', 'Sheep', 'Signal Pathway', 'Signal Transduction', 'Site', 'Software Tools', 'Specificity', 'Speed', 'Structure', 'Sum', 'Supercomputing', 'Supplementation', 'System', 'Techniques', 'Technology', 'Therapeutic', 'Three-Dimensional Image', 'Time', 'Toddler', 'Ukraine', 'Ultrasonography', 'Universities', 'Woman', 'Work', 'alcohol exposure', 'alcohol sensitivity', 'analog', 'brain behavior', 'brain morphology', 'cognitive control', 'computing resources', 'critical period', 'data exchange', 'data integration', 'data management', 'data sharing', 'distributed data', 'drinking', 'effective intervention', 'experience', 'fetal', 'flexibility', 'follow-up', 'imaging modality', 'improved', 'in utero', 'infancy', 'literacy', 'meetings', 'mouse model', 'multidisciplinary', 'neurobehavioral', 'northern plains', 'novel', 'offspring', 'prenatal', 'prospective', 'quality assurance', 'reconstruction', 'repository', 'social', 'supercomputer', 'three dimensional structure', 'willingness']",NIAAA,INDIANA UNIVERSITY BLOOMINGTON,U24,2009,185188,0.06723724825727827
"Informatics Core for the Collaborative Initiative on Fetal Alcohol Spectrum disor    DESCRIPTION (provided by applicant): The Informatics Core is part of the Consortium for the ""Collaborative Initiative on Fetal Alcohol Spectrum Disorders"" (CIFASD). The theme of this collaborative initiative is a cross-cultural assessment of ""fetal alcohol spectrum disorder"" (FASD). The CIFASD will coordinate basic, behavioral, and clinical investigators in a multidisciplinary research project to better inform approaches aimed at developing effective intervention and treatment approaches for FASD. It will involve the input and contributions from basic researchers, behavioral scientists, and clinical investigators with the willingness to utilize novel and cutting-edge techniques so as not to simply replicate previous or ongoing work, but rather to try and move it forward in a rigorous fashion. The Informatics Core will develop and maintain the CIFASD Data Repository, which will be used to collect, maintain and distribute data generated by the various participants in the consortium. The Informatics Core will be responsible for working with the other consortium participants to define a Data Dictionary to be used in standardizing data collection, enabling the transfer of data to and from the CIFASD Data Repository, consulting on how to establish local data management systems, providing both software tools and consulting to consortium participants, and producing status reports about the progress of the various projects within the consortium. The Informatics Core draws on a wealth of resources, experience, and expertise at Indiana University in information technology infrastructure and data management, The CIFASD Data Repository will be developed on Indiana University's state-of-the-art central supercomputing facilities, taking advantage of Indiana University's strong commitment to institutional computational resources. Resources that will be used to implement the CIFASD Data Repository include multiple supercomputers, an array of readily available database and statistical software, and a high- speed, secure, robust data archiving system capable of storing duplicate copies in multiple physical locations separated by more than fifty miles. The Informatics Core will use these extraordinary computational resources to provide a single, highly secure location for consortium participants to obtain the cross-cultural data that will enable the CIFASD to meet its goals of developing novel techniques for intervention and treatment of FASD.           n/a",Informatics Core for the Collaborative Initiative on Fetal Alcohol Spectrum disor,7502758,U24AA014818,"['Address', 'Adolescent', 'Affect', 'Africa', 'Alcohol consumption', 'Alcohol-Related Neurodevelopmental Disorder', 'Alcohols', 'Animal Model', 'Animals', 'Archives', 'Arts', 'Basic Science', 'Behavioral', 'Binding Sites', 'Biology', 'Brain', 'Brain imaging', 'Cells', 'Characteristics', 'Child', 'Choline', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Collaborations', 'Computer software', 'Condition', 'Consult', 'Data', 'Data Analyses', 'Data Collection', 'Data Storage and Retrieval', 'Databases', 'Development', 'Diagnosis', 'Diagnostic', 'Dictionary', 'Dietary Intervention', 'Drug Design', 'Dysmorphology', 'Early Diagnosis', 'Early Intervention', 'Elements', 'Emotional', 'Ethanol', 'Ethnic group', 'Face', 'Fetal Alcohol Exposure', 'Fetal Alcohol Spectrum Disorder', 'Fetal Alcohol Syndrome', 'Frequencies', 'Future', 'Genetic Polymorphism', 'Goals', 'Human', 'Image', 'Image Analysis', 'Indiana', 'Individual', 'Infant', 'Infant Development', 'Informal Social Control', 'Informatics', 'Information Storage', 'Information Technology', 'Interdisciplinary Study', 'Internet', 'Intervention', 'Knowledge', 'Label', 'Language', 'Language Development', 'Life', 'Location', 'Los Angeles', 'Machine Learning', 'Magnetic Resonance Imaging', 'Manuals', 'Measures', 'Methods', 'Mission', 'Modeling', 'Moscow', 'Mothers', 'Mus', 'Names', 'Neonatal', 'Neural Cell Adhesion Molecule L1', 'Neurobiology', 'New Mexico', 'Outcome', 'Participant', 'Pattern', 'Performance', 'Phenotype', 'Pilot Projects', 'Play', 'Population', 'Pregnancy', 'Principal Investigator', 'Range', 'Rattus', 'Recording of previous events', 'Reporting', 'Request for Applications', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Resolution', 'Resources', 'Role', 'Schools', 'Scientist', 'Secure', 'Sensitivity and Specificity', 'Sheep', 'Signal Pathway', 'Signal Transduction', 'Site', 'Software Tools', 'Specificity', 'Speed', 'Structure', 'Sum', 'Supercomputing', 'Supplementation', 'System', 'Techniques', 'Technology', 'Therapeutic', 'Three-Dimensional Image', 'Three-Dimensional Imaging', 'Time', 'Toddler', 'Ukraine', 'Ultrasonography', 'Universities', 'Woman', 'Work', 'alcohol exposure', 'alcohol sensitivity', 'analog', 'brain behavior', 'brain morphology', 'cognitive control', 'critical developmental period', 'data integration', 'data management', 'distributed data', 'drinking', 'experience', 'fetal', 'follow-up', 'improved', 'in utero', 'infancy', 'literacy', 'mouse model', 'multidisciplinary', 'neurobehavioral', 'northern plains', 'novel', 'prenatal', 'programs', 'prospective', 'quality assurance', 'reconstruction', 'repository', 'social', 'supercomputer', 'three dimensional structure', 'transmission process', 'willingness']",NIAAA,INDIANA UNIVERSITY BLOOMINGTON,U24,2008,186589,0.06723724825727827
"Informatics Core for the Collaborative Initiative on Fetal Alcohol Spectrum disor    DESCRIPTION (provided by applicant): The Informatics Core is part of the Consortium for the ""Collaborative Initiative on Fetal Alcohol Spectrum Disorders"" (CIFASD). The theme of this collaborative initiative is a cross-cultural assessment of ""fetal alcohol spectrum disorder"" (FASD). The CIFASD will coordinate basic, behavioral, and clinical investigators in a multidisciplinary research project to better inform approaches aimed at developing effective intervention and treatment approaches for FASD. It will involve the input and contributions from basic researchers, behavioral scientists, and clinical investigators with the willingness to utilize novel and cutting-edge techniques so as not to simply replicate previous or ongoing work, but rather to try and move it forward in a rigorous fashion. The Informatics Core will develop and maintain the CIFASD Data Repository, which will be used to collect, maintain and distribute data generated by the various participants in the consortium. The Informatics Core will be responsible for working with the other consortium participants to define a Data Dictionary to be used in standardizing data collection, enabling the transfer of data to and from the CIFASD Data Repository, consulting on how to establish local data management systems, providing both software tools and consulting to consortium participants, and producing status reports about the progress of the various projects within the consortium. The Informatics Core draws on a wealth of resources, experience, and expertise at Indiana University in information technology infrastructure and data management, The CIFASD Data Repository will be developed on Indiana University's state-of-the-art central supercomputing facilities, taking advantage of Indiana University's strong commitment to institutional computational resources. Resources that will be used to implement the CIFASD Data Repository include multiple supercomputers, an array of readily available database and statistical software, and a high- speed, secure, robust data archiving system capable of storing duplicate copies in multiple physical locations separated by more than fifty miles. The Informatics Core will use these extraordinary computational resources to provide a single, highly secure location for consortium participants to obtain the cross-cultural data that will enable the CIFASD to meet its goals of developing novel techniques for intervention and treatment of FASD.           n/a",Informatics Core for the Collaborative Initiative on Fetal Alcohol Spectrum disor,7343355,U24AA014818,"['Address', 'Adolescent', 'Affect', 'Africa', 'Alcohol consumption', 'Alcohol-Related Neurodevelopmental Disorder', 'Alcohols', 'Animal Model', 'Animals', 'Archives', 'Arts', 'Basic Science', 'Behavioral', 'Binding Sites', 'Biology', 'Brain', 'Brain imaging', 'Cells', 'Characteristics', 'Child', 'Choline', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Collaborations', 'Computer software', 'Condition', 'Consult', 'Data', 'Data Analyses', 'Data Collection', 'Data Storage and Retrieval', 'Databases', 'Development', 'Diagnosis', 'Diagnostic', 'Dictionary', 'Dietary Intervention', 'Drug Design', 'Dysmorphology', 'Early Diagnosis', 'Early Intervention', 'Elements', 'Emotional', 'Ethanol', 'Ethnic group', 'Face', 'Fetal Alcohol Exposure', 'Fetal Alcohol Spectrum Disorder', 'Fetal Alcohol Syndrome', 'Frequencies', 'Future', 'Genetic Polymorphism', 'Goals', 'Human', 'Image', 'Image Analysis', 'Indiana', 'Individual', 'Infant', 'Infant Development', 'Informal Social Control', 'Informatics', 'Information Storage', 'Information Technology', 'Interdisciplinary Study', 'Internet', 'Intervention', 'Knowledge', 'Label', 'Language', 'Language Development', 'Life', 'Location', 'Los Angeles', 'Machine Learning', 'Magnetic Resonance Imaging', 'Manuals', 'Measures', 'Methods', 'Mission', 'Modeling', 'Moscow', 'Mothers', 'Mus', 'Names', 'Neonatal', 'Neural Cell Adhesion Molecule L1', 'Neurobiology', 'New Mexico', 'Outcome', 'Participant', 'Pattern', 'Performance', 'Phenotype', 'Pilot Projects', 'Play', 'Population', 'Pregnancy', 'Principal Investigator', 'Range', 'Rattus', 'Recording of previous events', 'Reporting', 'Request for Applications', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Resolution', 'Resources', 'Role', 'Schools', 'Scientist', 'Secure', 'Sensitivity and Specificity', 'Sheep', 'Signal Pathway', 'Signal Transduction', 'Site', 'Software Tools', 'Specificity', 'Speed', 'Structure', 'Sum', 'Supercomputing', 'Supplementation', 'System', 'Techniques', 'Technology', 'Therapeutic', 'Three-Dimensional Image', 'Three-Dimensional Imaging', 'Time', 'Toddler', 'Ukraine', 'Ultrasonography', 'Universities', 'Woman', 'Work', 'alcohol exposure', 'alcohol sensitivity', 'analog', 'brain behavior', 'brain morphology', 'cognitive control', 'critical developmental period', 'data integration', 'data management', 'distributed data', 'drinking', 'experience', 'fetal', 'follow-up', 'improved', 'in utero', 'infancy', 'literacy', 'mouse model', 'multidisciplinary', 'neurobehavioral', 'northern plains', 'novel', 'prenatal', 'programs', 'prospective', 'quality assurance', 'reconstruction', 'repository', 'social', 'supercomputer', 'three dimensional structure', 'transmission process', 'willingness']",NIAAA,INDIANA UNIVERSITY BLOOMINGTON,U24,2007,178873,0.06723724825727827
"Brain Science Computer Cluster     DESCRIPTION (provided by applicant): Computational requirements of contemporary brain science research often exceed financial and resource management limits of individual investigator laboratories. Many contemporary neuroscience research projects require analysis of large data sets with advanced statistical methods and anatomical reconstruction techniques. These methods require high speed computational and graphics engines operating in a multiple processor environments equipped with large capacity, high-speed storage devices. A limitation in the Brown brain science effort at understanding neural processing is the lack of a readily accessible high-speed computational resource. A central computational resource based on a unified cluster of contemporary Linux CPUs and GPUs will serve the computational needs of a core group of brain science investigators at Brown without compromising individual access common to stand-alone workstations. The requested computer cluster has system software that automatically balances CPU and GPU usage, thereby ensuring maximum access to the computational resource for all users. Intensive 3D graphics are off-loaded either to GPUs or to client workstations, thereby further reducing the central computational load. Commercial or open-source software with an open operating environment will be used for analysis using standard and novel statistical and machine learning approaches to assess significance of large data sets. This proposal details the architecture and benefits of a contemporary computational resource for the major and minor users, and more generally the Brown brain science community. The resource was designed to fill immediate and near-term computational and storage needs of a core group of Brown brain scientists. The system can be readily expansion as needs, either computational, storage, or new users, arise. Expansion of the existing core investigators group can occur easily since the computational power or storage capacity of the system can be readily enhanced at relatively low cost. The flexible nature of the system will serve a variety of research needs of the Brown brain science community. The computational resource is expected to bring together researchers at Brown working on the common problem of neural processing.             n/a",Brain Science Computer Cluster,8447697,S10OD016366,"['Architecture', 'Brain', 'Client', 'Communities', 'Computer software', 'Data Set', 'Devices', 'Ensure', 'Environment', 'Equilibrium', 'Individual', 'Laboratories', 'Linux', 'Machine Learning', 'Methods', 'Minor', 'Nature', 'Neurosciences Research', 'Process', 'Research', 'Research Personnel', 'Research Project Grants', 'Resources', 'Science', 'Scientist', 'Speed', 'Statistical Methods', 'System', 'Techniques', 'Work', 'base', 'computer cluster', 'computing resources', 'cost', 'design', 'flexibility', 'novel', 'open source', 'reconstruction', 'relating to nervous system', 'software systems']",OD,BROWN UNIVERSITY,S10,2013,599598,0.0843369776259149
"NEW DRUG TARGETS FOR APOPTOSIS DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",NEW DRUG TARGETS FOR APOPTOSIS,7284550,P01CA017094,"['antineoplastics', 'biomedical facility', 'chemosensitizing agent', 'clinical research', 'drug design /synthesis /production', 'drug resistance', 'drug screening /evaluation', 'neoplasm /cancer chemotherapy']",NCI,UNIVERSITY OF ARIZONA,P01,2006,498959,0.054366997161354166
"NEW DRUG TARGETS FOR APOPTOSIS DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",NEW DRUG TARGETS FOR APOPTOSIS,6848697,P01CA017094,"['antineoplastics', 'biomedical facility', 'chemosensitizing agent', 'clinical research', 'drug design /synthesis /production', 'drug resistance', 'drug screening /evaluation', 'neoplasm /cancer chemotherapy']",NCI,UNIVERSITY OF ARIZONA,P01,2005,1446246,0.054366997161354166
"NEW DRUG TARGETS FOR APOPTOSIS DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",NEW DRUG TARGETS FOR APOPTOSIS,6699330,P01CA017094,"['antineoplastics', 'biomedical facility', 'chemosensitizing agent', 'clinical research', 'drug design /synthesis /production', 'drug resistance', 'drug screening /evaluation', 'neoplasm /cancer chemotherapy']",NCI,UNIVERSITY OF ARIZONA,P01,2004,1405759,0.054366997161354166
"NEW DRUG TARGETS FOR APOPTOSIS DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",NEW DRUG TARGETS FOR APOPTOSIS,6626535,P01CA017094,"['antineoplastics', ' biomedical facility', ' chemosensitizing agent', ' drug design /synthesis /production', ' drug resistance', ' drug screening /evaluation', ' neoplasm /cancer chemotherapy']",NCI,UNIVERSITY OF ARIZONA,P01,2003,1357166,0.054366997161354166
"NEW DRUG TARGETS FOR APOPTOSIS DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",NEW DRUG TARGETS FOR APOPTOSIS,6489015,P01CA017094,"['antineoplastics', ' biomedical facility', ' chemosensitizing agent', ' drug design /synthesis /production', ' drug resistance', ' drug screening /evaluation', ' neoplasm /cancer chemotherapy']",NCI,UNIVERSITY OF ARIZONA,P01,2002,1329187,0.054366997161354166
"NEW DRUG TARGETS FOR APOPTOSIS DESCRIPTION (provided by applicant): The aim of this proposal is to establish an Integrated Neuroinformatics Resource on Alcoholism (INRA) as the informatics core component of the Integrative Neuroscience Initiative on Alcoholism Consortium (INIA). The overall goal of the INRA will be to create an integrated, multiresolution repository of neuroscience data, ranging from molecules to behavior for collaborative research on alcoholism. As the neuroinformatics core of the INIAC, the INRA will enable the integration of all data generated by all components of the INIAC. Furthermore, it will support synthesis of new knowledge through computational neurobiology tools for exploratory analysis including visualization, data mining and simulation. The INRA will represent a synthesis of emerging approaches in bioinformatics and existing methods of neuroinformatics to provide the INIAC a versatile toolbox of computational methods for elucidating the effects of alcohol on the nervous system. The specific aims of the INRA will be: (i) implementation of an informatics infrastructure for integrating complex neuroscience data, from molecules to behavior, generated by the consortium and relevant data available in the public domain; (ii) development of an integrated secure web-based environment so that consortium members can interactively visualize, search and update the integrated neuroscience knowledge; and (iii) development of data mining tools, including biomolecular sequence analysis, gene expression array analysis, characterization of Biochemical pathways, and natural language processing to support hypothesis generation and testing regarding ethanol Consumption and neuroadaptation to alcohol. We will also collaborate with related neuroscience projects to utilize existing resources for brain atlases, neuronal circuits and neuronal properties. The INRA will The made available to the INIAC through a Neb-based system through interactive graphical user interfaces that will seamlessly integrate tools for data entry, modification, search, retrieval and mining. The core of the INRA will be based on robust knowledge management methods and tools that will Effectively integrate disparate forms of neuroscience data and make it amenable to complex inferences. Our proposed strategy ensures that the informatics resource is: (i) flexible and scalable to address the evolving needs of the INIAC, and (ii) highly intuitive and user-friendly to ensure optimal utilization by the INIAC members. The proposed INRA is a novel system for Collaborative research in neuroscience and alcoholism which will be developed by an interdisciplinary team of experts in Bioinformatics, computational biology, neuroscience and alcoholism research. We believe the INRA will greatly enhance the Dace of discovery in the area of ethanol consumption and neuroadaptation to alcohol within the INIAC as well as the general research community. n/a",NEW DRUG TARGETS FOR APOPTOSIS,6230917,P01CA017094,"['antineoplastics', ' biomedical facility', ' chemosensitizing agent', ' drug design /synthesis /production', ' drug resistance', ' drug screening /evaluation', ' neoplasm /cancer chemotherapy']",NCI,UNIVERSITY OF ARIZONA,P01,2001,1291932,0.054366997161354166
"Alzheimer's Disease Neuroimaging Initiative INTRODUCTION: The Introduction portion of this proposal provides a general overview of the entire proj ect including Aims, Background, Preliminary results, and our Methodological approach. Our overall strategy to achieving the goals of the Alzheimer's Disease Neuroimaging Initiative (ADNI) are described, as well as a specific plan for implementation including governance structure, deliverables and timelines. ADMINISTRATIVE CORE: The Administrative Core, is directed by Dr. Michael Weiner, PI of the entire ADNI application, based at UCSF. This Core will be responsible for overseeing all aspects of the entire ADNI including the monitoring all financial and budetary aspects of the project. INFORMATICS CORE: The Informatics Core (IC), based at the Laboratory ofNeuroimaging (LONI) at UCLA will be directed by Dr. Arthur Toga. The IC will be responsible for receving, archiving, and displaying all MRI  and PET data including all raw and processed data. All of this data will be available to ADNI investigators, and to  the general public within weeks-months after receipt. The IC also describes a number of informatics and image  processing and image display tools which will be used by the ADNI. Finally, the IC describes mechanisms by  which clinical and cognitive data, stored at the UCSD ADCS group will be linked to the image data at LONI. This  will facilitate queries and analyses which utilize clinical, cognitive, and imaging data. All raw and processed  image data, as well as all clinical and biomarker data, will rapidly be made avialable on public websites.  BIOSTATISTICS CORE: The Biostatistics Core (BC) will be directed by Dr. Laurel Beckett at UC Davis, and  will consist of statisticans at UCSD and UCSF as well. The BC will implement mechanisms for data monitoring as  data is acquired, to identify outliers and errrors. In addition, the BC describes a statistical approach to analyze data  acquired by the ADNI, in order to test the apriori hypotheses described in the proposal, and presents a power  analysis to justify the proposed sample size. n/a",Alzheimer's Disease Neuroimaging Initiative,7624015,U01AG024904,"['Accounting', 'Alzheimer&apos', 's Disease', 'Archives', 'Attention', 'Biological Markers', 'Biostatistics Core', 'Blood', 'Brain', 'Brain Mapping', 'Clinical', 'Clinical Trials', 'Clinical Trials Design', 'Clinical assessments', 'Cognition', 'Cognitive', 'Data', 'Data Analyses', 'Data Collection', 'Databases', 'Diagnostic', 'Disadvantaged', 'Future', 'General Population', 'Generations', 'Goals', 'Hippocampus (Brain)', 'Image', 'Impaired cognition', 'Informatics', 'Laboratories', 'Language', 'Lead', 'Link', 'Magnetic Resonance Imaging', 'Manufacturer Name', 'Measures', 'Medial', 'Memory', 'Metabolism', 'Methods', 'Modification', 'Monitor', 'Motion', 'Noise', 'Numbers', 'Photons', 'Positron-Emission Tomography', 'Prevention', 'Process', 'Rate', 'Research Design', 'Research Personnel', 'Resolution', 'Sample Size', 'Site', 'Staging', 'Standards of Weights and Measures', 'Statistical Models', 'Structure', 'Supervision', 'Temporal Lobe', 'Testing', 'Time', 'TimeLine', 'Urine', 'Week', 'age effect', 'attenuation', 'base', 'brain volume', 'clinical research site', 'cognitive function', 'computerized data processing', 'cost effectiveness', 'design', 'entorhinal cortex', 'executive function', 'fluorodeoxyglucose positron emission tomography', 'follow-up', 'frontal lobe', 'image processing', 'improved', 'instrumentation', 'neuroimaging', 'normal aging', 'programs', 'regional difference', 'repository', 'size', 'tool', 'treatment effect', 'treatment trial', 'willingness']",NIA,NORTHERN CALIFORNIA INSTITUTE/RES/EDU,U01,2008,800688,0.17256759177722752
"Alzheimer's Disease Neuroimaging Initiative INTRODUCTION: The Introduction portion of this proposal provides a general overview of the entire proj ect including Aims, Background, Preliminary results, and our Methodological approach. Our overall strategy to achieving the goals of the Alzheimer's Disease Neuroimaging Initiative (ADNI) are described, as well as a specific plan for implementation including governance structure, deliverables and timelines. ADMINISTRATIVE CORE: The Administrative Core, is directed by Dr. Michael Weiner, PI of the entire ADNI application, based at UCSF. This Core will be responsible for overseeing all aspects of the entire ADNI including the monitoring all financial and budetary aspects of the project. INFORMATICS CORE: The Informatics Core (IC), based at the Laboratory ofNeuroimaging (LONI) at UCLA will be directed by Dr. Arthur Toga. The IC will be responsible for receving, archiving, and displaying all MRI  and PET data including all raw and processed data. All of this data will be available to ADNI investigators, and to  the general public within weeks-months after receipt. The IC also describes a number of informatics and image  processing and image display tools which will be used by the ADNI. Finally, the IC describes mechanisms by  which clinical and cognitive data, stored at the UCSD ADCS group will be linked to the image data at LONI. This  will facilitate queries and analyses which utilize clinical, cognitive, and imaging data. All raw and processed  image data, as well as all clinical and biomarker data, will rapidly be made avialable on public websites.  BIOSTATISTICS CORE: The Biostatistics Core (BC) will be directed by Dr. Laurel Beckett at UC Davis, and  will consist of statisticans at UCSD and UCSF as well. The BC will implement mechanisms for data monitoring as  data is acquired, to identify outliers and errrors. In addition, the BC describes a statistical approach to analyze data  acquired by the ADNI, in order to test the apriori hypotheses described in the proposal, and presents a power  analysis to justify the proposed sample size. n/a",Alzheimer's Disease Neuroimaging Initiative,7596019,U01AG024904,"['Accounting', 'Age', 'Aging', 'Alzheimer&apos', 's Disease', 'Archives', 'Attention', 'Biological Markers', 'Biostatistics Core', 'Blood', 'Brain', 'Brain Mapping', 'Clinical', 'Clinical Data', 'Clinical Trials', 'Clinical Trials Design', 'Clinical assessments', 'Cognition', 'Cognitive', 'Collaborations', 'Data', 'Data Analyses', 'Data Collection', 'Databases', 'Diagnostic', 'Disadvantaged', 'Elderly', 'Future', 'General Population', 'Generations', 'Goals', 'Hippocampus (Brain)', 'Image', 'Impaired cognition', 'Informatics', 'Internet', 'Laboratories', 'Language', 'Lead', 'Link', 'Magnetic Resonance Imaging', 'Manufacturer Name', 'Measures', 'Medial', 'Memory', 'Metabolism', 'Methods', 'Modification', 'Monitor', 'Motion', 'Noise', 'Numbers', 'Patients', 'Pennsylvania', 'Photons', 'Positron-Emission Tomography', 'Prevention', 'Process', 'Rate', 'Recording of previous events', 'Research Design', 'Research Personnel', 'Resolution', 'Risk', 'Sample Size', 'Sampling', 'Scanning', 'Site', 'Staging', 'Standards of Weights and Measures', 'Statistical Models', 'Structure', 'Supervision', 'Techniques', 'Temporal Lobe', 'Testing', 'Time', 'TimeLine', 'Universities', 'Urine', 'Validation', 'Week', 'age effect', 'attenuation', 'base', 'brain volume', 'clinical research site', 'cognitive function', 'computerized data processing', 'cooperative study', 'cost effectiveness', 'day', 'design', 'entorhinal cortex', 'executive function', 'experience', 'fluorodeoxyglucose positron emission tomography', 'follow-up', 'frontal lobe', 'image processing', 'improved', 'instrumentation', 'mild neurocognitive impairment', 'neuroimaging', 'normal aging', 'programs', 'regional difference', 'repository', 'response', 'size', 'statistics', 'time interval', 'tool', 'treatment effect', 'treatment trial', 'willingness']",NIA,NORTHERN CALIFORNIA INSTITUTE/RES/EDU,U01,2008,2000000,0.17256759177722752
"Brain Science Compute Cluster Computational requirements of contemporary brain science research typically exceed financial and resource management limits of individual investigator laboratories. Many brain science research projects require analysis of large data sets with advanced statistical methods and anatomical reconstruction techniques. These methods require high speed computational and graphics engines operating in a multiple processor environments equipped with large capacity, high speed storage devices. An ongoing limitation in the Brown brain science effort at understanding neural processing is the lack of a contemporary and readily accessible high-speed computational resource.  We plan to replace an existing, but 5 year old and now outmoded, central computational resource that has outdated graphic processing units (GPU) and central processing units (CPU) and and limited storage that will serve the computational needs of a core group of brain science investigators at Brown without compromising individual access to stand-alone workstations. The requested computation equipment comprises 13 GPU nodes (total of 52 cores), 12 CPU nodes (288 cores) and 1.2 petabytes of disk storage, which will serve the needs of the assembled brain science researchers. The equipment will become integrated into Brown's high performance Compute Cluster, which has system software that automatically balances GPU and CPU usage, thereby ensuring maximum access to the computational resource for all users. Intensive 3D graphics are off- loaded either to GPUs or to client workstations, thereby further reducing the central computational load. Commercial or open-source software with an open operating environment will be used for analysis using standard and novel statistical and machine learning approaches to assess significance of large data sets.  This proposal details the architecture and benefits of a contemporary computational resource for the major and minor users, and more generally the Brown brain science community. The resource was designed to fill immediate and near-term computational and storage needs of a core group of Brown brain scientists. The system can be readily expansion as needs, either computational, storage, or new users, arise. Expansion of the existing core investigators group can occur easily since the computational power or storage capacity of the system can be readily enhanced at relatively low cost.  The flexible nature of the system will serve a variety of research needs of the Brown brain science community. The computational resource is expected to bring together researchers at Brown working on the common problem of neural processing. Relevance Gaining insights into the neural and brain mechanisms that underlie normal brain function and malfunction in disease requires analysis of large and complex data sets related to behavior and brain physiology, chemistry and structure. This proposals requests support to develop a computing infrastructure devoted to researchers in Brown's Carney Institute for Brain Science who investigate brain structure and function.",Brain Science Compute Cluster,9708078,S10OD025181,"['3-Dimensional', '5 year old', 'Anatomy', 'Architecture', 'Brain', 'Client', 'Communities', 'Computer software', 'Data Set', 'Devices', 'Ensure', 'Environment', 'Equilibrium', 'Equipment', 'High Performance Computing', 'Individual', 'Laboratories', 'Machine Learning', 'Methods', 'Minor', 'Nature', 'Research', 'Research Personnel', 'Research Project Grants', 'Resources', 'Science', 'Scientist', 'Speed', 'Statistical Methods', 'System', 'Techniques', 'cluster computing', 'computing resources', 'cost', 'design', 'flexibility', 'novel', 'open source', 'petabyte', 'reconstruction', 'relating to nervous system', 'software systems']",OD,BROWN UNIVERSITY,S10,2019,300000,0.12247608541831466
"2018 Image Science Gordon Research Conference & Gordon Research Seminar Project Summary: The proposal requests support for early-career investigators to attend the 2018 Gordon Research Conference on Image Science. The unique feature of this conference in its third offering compared with others in medical imaging is the bringing together of renown speakers from disparate application areas, including astronomy, biology, medicine, remote sensing, and security and defense industries, in a forum that encourages each to describe their greatest challenges and most promising solutions. All speakers are invited based on their leadership in their field and their willingness to debate fundamental issues shared by everyone developing, evaluating, and applying imaging in medicine and biology. We believe the GRC format placed in the context of a small-college venue promotes the type of innovative interdisciplinary thinking that leads to breakthroughs. An environment where leading senior scientists debate core issues is valuable to young investigators trying to build successful independent careers in medical imaging in industry and academia. All attendees are invited to present a poster describing their research in poster sessions that are a key element of the Gordon Conference format. The June 17-22, 2018 GRC conference theme is Image Science: Creating Knowledge from Information, which is focused on appropriate acquisition and efficient uses of the massive volume of imaging information now collected from patients. Speakers give 40 minutes presentations in a single-track format with 20 minute discussions following each presentation that are led by experts in the field. Topic range from Imaging in Brain Science Discovery to Advanced Machine Learning and Computational Imaging. At the center of each presentation is a discussion of the core challenges shared by image scientists and novel techniques for acquiring and displaying information in a manner that maximizes decision performance. Given the success of the previous meeting, we will hold the first-ever, student-run Gordon Research Seminars (GRS) on Image Science June 16, 17, 2018. Our aim is to build Image Science as an independent field of study through detailed interdisciplinary discussions and by fostering the success of a new generation of image scientists. Project Narrative: Solutions to very difficult problems often emerge from discussions among experts in different fields of study being challenged by the same core problems. The 2018 GRC on Imaging Science strives to build a community of problem solvers by creating an environment for detailed discussions among senior investigators that involves young investigators at a time when they are building careers. This is a proposal to fund young investigators to attend the conference.",2018 Image Science Gordon Research Conference & Gordon Research Seminar,9461211,R13EB025662,"['Academia', 'Area', 'Astronomy', 'Big Data', 'Biology', 'Brain', 'Collaborations', 'Communities', 'Computational Science', 'Data', 'Data Analytics', 'Development', 'Disabled Persons', 'Discipline', 'Elements', 'Engineering', 'Ensure', 'Environment', 'Evaluation', 'Event', 'Fees', 'Female', 'Financial Support', 'Fostering', 'Funding', 'Housing', 'Human', 'Image', 'Industry', 'Information Sciences', 'Interdisciplinary Study', 'Knowledge', 'Leadership', 'Machine Learning', 'Medical', 'Medical Imaging', 'Medicine', 'Methods', 'Minority', 'Modeling', 'Patients', 'Performance', 'Play', 'Postdoctoral Fellow', 'Recruitment Activity', 'Request for Proposals', 'Research', 'Research Personnel', 'Resource Development', 'Risk-Taking', 'Role', 'Running', 'Science', 'Scientist', 'Security', 'Senior Scientist', 'Series', 'Societies', 'Source', 'Statistical Models', 'Students', 'Systems Development', 'Techniques', 'Thinking', 'Time', 'Training', 'United States National Institutes of Health', 'base', 'career', 'college', 'cost', 'design', 'disabled students', 'educational atmosphere', 'field study', 'frontier', 'graduate student', 'image reconstruction', 'imaging scientist', 'imaging system', 'information display', 'innovation', 'instrument', 'meetings', 'minority student', 'multidisciplinary', 'next generation', 'novel', 'posters', 'preference', 'remote sensing', 'skills', 'success', 'symposium', 'training opportunity', 'virtual', 'willingness']",NIBIB,GORDON RESEARCH CONFERENCES,R13,2018,10000,0.023442005074282516
"The Center for Innovation in Intensive Longitudinal Studies (CIILS) PROJECT SUMMARY Significance. The Intensive Longitudinal Behavior Network (ILHBN) provides an unprecedented opportunity to advance and shape the future landscape of health behavior science and related intervention practice. The proposed Research Coordinating Center, the Center for Innovation in Intensive Longitudinal Studies (CIILS), housed at the Pennsylvania State University (Penn State), will bring together an interdisciplinary team to synergistically support and coordinate research activities across a diverse portfolio of anticipated U01 projects to accomplish the Networks larger goal of sustained innovation in the use of intensive longitudinal data (ILD) and associated methods in the study of health behavior change, and in informing prevention and intervention designs. Innovation. The proposed organizational structure of the ILHBN as a small-world network is motivated by our teams collective decades of experience with multidisciplinary and multi-site collaborations, and is designed to facilitate information flow, collective decision making, and coordination of goals and effort within the ILHBN. Approach. CIILS consists of five Cores with expertise in management of multi-site projects and coordinating centers (Administrative Core); development of novel methods for analysis of ILD (Methods Core); ILD collection, harmonization, sharing, security, as well as collection of digital footprints (Data Core); ILD design, harmonization and instrumentation support (Design Core); and integration of health behavior theories, translation, and implementation of within-person health preventions/interventions (Theory Core). Key personnel with rich and complementary expertise are supported by a roster of advisory Co-Is at Penn State and distributed consultants who are leaders and innovators in their respective fields. Institutional support and contributed staff time by Penn State provide robust infrastructure, expertise, and boots on the ground to support the operation and coordination activities of ILHBN; and a wealth of additional resources to elevate and broaden the collective impacts of the Network. PROJECT NARRATIVE This project proposes an RCC, the Center for Innovation in Intensive Longitudinal Studies (CIILS), housed at the Pennsylvania State University, to provide a repertoire of expertise and resources to support the Intensive Longitudinal Health Behavior Network (ILHBN). Our interdisciplinary team  consisting of social scientists with expertise in design and management of intensive longitudinal studies; methodological experts who are leading figures in developing novel within-person analytic techniques; health theorists and prevention/intervention experts well-versed in the translation of health theories into within-person health intervention; cyberscience experts with expertise in collection of digital footprints, data security and data sharing issues; and administrative personnel with expertise in management and coordination of network activities  is uniquely poised to advance the collective innovations of the ILHBN by synergistically supporting and coordinating research activities across a diverse portfolio of anticipated U01 projects.",The Center for Innovation in Intensive Longitudinal Studies (CIILS),9788202,U24AA027684,"['Administrative Personnel', 'Algorithms', 'Behavior', 'Big Data', 'Collaborations', 'Collection', 'Communication', 'Communities', 'Consultations', 'Data', 'Data Analyses', 'Data Analytics', 'Data Collection', 'Data Security', 'Databases', 'Decision Making', 'Development', 'Devices', 'Future', 'General Population', 'Goals', 'Health', 'Health Sciences', 'Health behavior', 'Health behavior change', 'Healthcare', 'Human Resources', 'Individual', 'Infrastructure', 'Intervention', 'Lead', 'Link', 'Longitudinal Studies', 'Machine Learning', 'Manuals', 'Measures', 'Methodology', 'Methods', 'Neurobiology', 'Pennsylvania', 'Persons', 'Positioning Attribute', 'Preventive Intervention', 'Privacy', 'Process', 'Production', 'Progress Reports', 'Protocols documentation', 'Publications', 'Records', 'Regulation', 'Reporting', 'Research', 'Research Activity', 'Research Design', 'Resources', 'Science', 'Scientist', 'Security', 'Shapes', 'Site', 'Social Work', 'Source', 'Structure', 'Technical Expertise', 'Techniques', 'Testing', 'Time', 'Training', 'Translations', 'United States National Institutes of Health', 'Universities', 'Update', 'Visualization software', 'Workplace', 'control theory', 'data management', 'data portal', 'data sharing', 'data visualization', 'data warehouse', 'design', 'digital', 'dynamic system', 'experience', 'human subject', 'innovation', 'instrumentation', 'member', 'multidisciplinary', 'novel', 'operation', 'organizational structure', 'preservation', 'social', 'success', 'theories', 'therapy design', 'tool']",NIAAA,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,U24,2019,250000,0.12463620738346227
"The Center for Innovation in Intensive Longitudinal Studies (CIILS) PROJECT SUMMARY Significance. The Intensive Longitudinal Behavior Network (ILHBN) provides an unprecedented opportunity to advance and shape the future landscape of health behavior science and related intervention practice. The proposed Research Coordinating Center, the Center for Innovation in Intensive Longitudinal Studies (CIILS), housed at the Pennsylvania State University (Penn State), will bring together an interdisciplinary team to synergistically support and coordinate research activities across a diverse portfolio of anticipated U01 projects to accomplish the Networks larger goal of sustained innovation in the use of intensive longitudinal data (ILD) and associated methods in the study of health behavior change, and in informing prevention and intervention designs. Innovation. The proposed organizational structure of the ILHBN as a small-world network is motivated by our teams collective decades of experience with multidisciplinary and multi-site collaborations, and is designed to facilitate information flow, collective decision making, and coordination of goals and effort within the ILHBN. Approach. CIILS consists of five Cores with expertise in management of multi-site projects and coordinating centers (Administrative Core); development of novel methods for analysis of ILD (Methods Core); ILD collection, harmonization, sharing, security, as well as collection of digital footprints (Data Core); ILD design, harmonization and instrumentation support (Design Core); and integration of health behavior theories, translation, and implementation of within-person health preventions/interventions (Theory Core). Key personnel with rich and complementary expertise are supported by a roster of advisory Co-Is at Penn State and distributed consultants who are leaders and innovators in their respective fields. Institutional support and contributed staff time by Penn State provide robust infrastructure, expertise, and boots on the ground to support the operation and coordination activities of ILHBN; and a wealth of additional resources to elevate and broaden the collective impacts of the Network. PROJECT NARRATIVE This project proposes an RCC, the Center for Innovation in Intensive Longitudinal Studies (CIILS), housed at the Pennsylvania State University, to provide a repertoire of expertise and resources to support the Intensive Longitudinal Health Behavior Network (ILHBN). Our interdisciplinary team  consisting of social scientists with expertise in design and management of intensive longitudinal studies; methodological experts who are leading figures in developing novel within-person analytic techniques; health theorists and prevention/intervention experts well-versed in the translation of health theories into within-person health intervention; cyberscience experts with expertise in collection of digital footprints, data security and data sharing issues; and administrative personnel with expertise in management and coordination of network activities  is uniquely poised to advance the collective innovations of the ILHBN by synergistically supporting and coordinating research activities across a diverse portfolio of anticipated U01 projects.",The Center for Innovation in Intensive Longitudinal Studies (CIILS),9571275,U24AA027684,"['Administrative Personnel', 'Algorithms', 'Behavior', 'Big Data', 'Collaborations', 'Collection', 'Communication', 'Communities', 'Consultations', 'Data', 'Data Analyses', 'Data Analytics', 'Data Collection', 'Data Security', 'Databases', 'Decision Making', 'Development', 'Devices', 'Future', 'General Population', 'Goals', 'Health', 'Health Sciences', 'Health behavior', 'Health behavior change', 'Healthcare', 'Human Resources', 'Individual', 'Intervention', 'Lead', 'Link', 'Longitudinal Studies', 'Machine Learning', 'Manuals', 'Measures', 'Methodology', 'Methods', 'Neurobiology', 'Pennsylvania', 'Persons', 'Positioning Attribute', 'Preventive Intervention', 'Privacy', 'Process', 'Production', 'Progress Reports', 'Protocols documentation', 'Publications', 'Records', 'Regulation', 'Reporting', 'Research', 'Research Activity', 'Research Design', 'Research Infrastructure', 'Resources', 'Science', 'Scientist', 'Security', 'Shapes', 'Site', 'Social Work', 'Source', 'Structure', 'Technical Expertise', 'Techniques', 'Testing', 'Time', 'Training', 'Translations', 'United States National Institutes of Health', 'Universities', 'Update', 'Visualization software', 'Workplace', 'control theory', 'data management', 'data portal', 'data sharing', 'data visualization', 'data warehouse', 'design', 'digital', 'dynamic system', 'experience', 'human subject', 'innovation', 'instrumentation', 'member', 'multidisciplinary', 'novel', 'operation', 'organizational structure', 'social', 'success', 'theories', 'therapy design', 'tool']",NIAAA,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,U24,2018,250000,0.12463620738346227
"The Center for Innovation in Intensive Longitudinal Studies (CIILS) PROJECT SUMMARY Significance. The Intensive Longitudinal Behavior Network (ILHBN) provides an unprecedented opportunity to advance and shape the future landscape of health behavior science and related intervention practice. The proposed Research Coordinating Center, the Center for Innovation in Intensive Longitudinal Studies (CIILS), housed at the Pennsylvania State University (Penn State), will bring together an interdisciplinary team to synergistically support and coordinate research activities across a diverse portfolio of anticipated U01 projects to accomplish the Networks larger goal of sustained innovation in the use of intensive longitudinal data (ILD) and associated methods in the study of health behavior change, and in informing prevention and intervention designs. Innovation. The proposed organizational structure of the ILHBN as a small-world network is motivated by our teams collective decades of experience with multidisciplinary and multi-site collaborations, and is designed to facilitate information flow, collective decision making, and coordination of goals and effort within the ILHBN. Approach. CIILS consists of five Cores with expertise in management of multi-site projects and coordinating centers (Administrative Core); development of novel methods for analysis of ILD (Methods Core); ILD collection, harmonization, sharing, security, as well as collection of digital footprints (Data Core); ILD design, harmonization and instrumentation support (Design Core); and integration of health behavior theories, translation, and implementation of within-person health preventions/interventions (Theory Core). Key personnel with rich and complementary expertise are supported by a roster of advisory Co-Is at Penn State and distributed consultants who are leaders and innovators in their respective fields. Institutional support and contributed staff time by Penn State provide robust infrastructure, expertise, and boots on the ground to support the operation and coordination activities of ILHBN; and a wealth of additional resources to elevate and broaden the collective impacts of the Network. PROJECT NARRATIVE This project proposes an RCC, the Center for Innovation in Intensive Longitudinal Studies (CIILS), housed at the Pennsylvania State University, to provide a repertoire of expertise and resources to support the Intensive Longitudinal Health Behavior Network (ILHBN). Our interdisciplinary team  consisting of social scientists with expertise in design and management of intensive longitudinal studies; methodological experts who are leading figures in developing novel within-person analytic techniques; health theorists and prevention/intervention experts well-versed in the translation of health theories into within-person health intervention; cyberscience experts with expertise in collection of digital footprints, data security and data sharing issues; and administrative personnel with expertise in management and coordination of network activities  is uniquely poised to advance the collective innovations of the ILHBN by synergistically supporting and coordinating research activities across a diverse portfolio of anticipated U01 projects.",The Center for Innovation in Intensive Longitudinal Studies (CIILS),10007746,U24AA027684,"['Administrative Personnel', 'Algorithms', 'Behavior', 'Big Data', 'Collaborations', 'Collection', 'Communication', 'Communities', 'Consultations', 'Data', 'Data Analyses', 'Data Analytics', 'Data Collection', 'Data Security', 'Databases', 'Decision Making', 'Development', 'Devices', 'Future', 'General Population', 'Goals', 'Health', 'Health Sciences', 'Health behavior', 'Health behavior change', 'Healthcare', 'Human Resources', 'Individual', 'Infrastructure', 'Intervention', 'Lead', 'Link', 'Longitudinal Studies', 'Machine Learning', 'Manuals', 'Measures', 'Methodology', 'Methods', 'Neurobiology', 'Pennsylvania', 'Persons', 'Positioning Attribute', 'Preventive Intervention', 'Process', 'Production', 'Progress Reports', 'Protocols documentation', 'Publications', 'Records', 'Regulation', 'Reporting', 'Research', 'Research Activity', 'Research Design', 'Resources', 'Science', 'Scientist', 'Security', 'Shapes', 'Site', 'Social Work', 'Source', 'Structure', 'Technical Expertise', 'Techniques', 'Testing', 'Time', 'Training', 'Translations', 'United States National Institutes of Health', 'Universities', 'Update', 'Visualization software', 'Workplace', 'control theory', 'data de-identification', 'data harmonization', 'data management', 'data portal', 'data privacy', 'data sharing', 'data tools', 'data visualization', 'data warehouse', 'design', 'digital', 'dynamic system', 'experience', 'human subject', 'innovation', 'instrumentation', 'member', 'multidisciplinary', 'novel', 'operation', 'organizational structure', 'preservation', 'social', 'success', 'theories', 'therapy design']",NIAAA,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,U24,2020,250000,0.12463620738346227
"UK-ADRC neuroimaging supplement: LATE and PART PROJECT SUMMARY/ABSTRACT  OVERALL (Adapted from Abstract of parent grant, UK-ADC) This is a proposal for a University of Kentucky Alzheimers Disease Research Center (UK-ADRC) neuroimaging supplement. This purpose of the supplement is to provide neuroimaging data on the UK-ADRCs deeply phenotyped clinical cohort to the NIHs recently funded initiative, Standardized Centralized Alzheimer's and Related Dementias Neuroimaging (SCAN). In addition, a secondary purpose of this supplement is to identify neuroimaging correlates of two AD-mimics: limbic-predominant age-related TDP-43 encephalopathy (LATE) and primary age-related tauopathy (PART). The UK-ADRC is an experienced and collaborative ADRC originally funded in 1985. Our principal mission is to serve as the focal point for all AD-related activities at UK and this region of the United States, by providing an environment and core resources that catalyze innovative research, outreach, education, and clinical programs. Our signature resources include: 1) a cognitively normal group of ~500 subjects followed longitudinally, with all committed to brain autopsy upon death; 2) a strong program in clinical-neuropathological correlations and short postmortem interval autopsies; 3) an established program studying preclinical biomarkers of AD using neuroimaging and biofluids; 4) an integrated centralized database and innovative biostatistical expertise to characterize clinical and biological transitions; and 5) a successful and close partnership with the African-American community and increased participation of underrepresented individuals in our longitudinal cohort and ADRC-affiliated research studies and clinical trials. The overall scientific emphasis of the UK-ADRC continues to be on our interrelated themes: Transitions & Translation. Our well-characterized, longitudinal cohort and historically strong neuropathology program focused on normal aging, preclinical disease states and early cognitive transitions have been central to our success in defining early pathogenic mechanisms underlying the transitions from normal cognitive aging to impairment. The depth of expertise and collaborative nature of our investigators have also resulted in substantial progress on translation of that knowledge into new targets and novel therapeutic strategies. The UK-ADRC provides an infrastructure and environment that focuses on these integrated themes and advances AD research, education, outreach, and clinical programs through highly interactive and effective components: Administrative Core, Clinical Core, Data Management and Statistics Core, Neuropathology Core, Outreach and Recruitment Core, Biomarker Core, and Research Education Component. The UK-ADRC will make resources from these Cores available to support the success of this ADRC neuroimaging supplement. NARRATIVE This supplement will fill a critical gap in the field by focusing on the development of neuroimaging biomarkers of two common AD mimics: LATE and PART. By imaging subjects who are A negative and without significant cerebrovascular disease, we will identify MRI patterns characteristic of these AD mimics. We will share the UK SCAN neuroimaging data, combined with our deep clinical, biofluid, and genetic phenotyping of these longitudinally followed subjects, to stimulate additional research on AD mimics across the ADRC network.",UK-ADRC neuroimaging supplement: LATE and PART,10170755,P30AG028383,"['Address', 'African American', 'Alzheimer&apos', 's Disease', 'Alzheimer&apos', 's disease related dementia', 'Amyloid', 'Autopsy', 'Biological', 'Biological Markers', 'Biometry', 'Brain', 'Brain imaging', 'Cerebrovascular Disorders', 'Cessation of life', 'Characteristics', 'Clinical', 'Clinical Trials', 'Clinical assessments', 'Cognitive', 'Cognitive aging', 'Collection', 'Communities', 'Data', 'Data Set', 'Degenerative Disorder', 'Dementia', 'Development', 'Disease', 'Education', 'Education and Outreach', 'Elderly', 'Environment', 'Fostering', 'Funding', 'Genetic', 'Goals', 'High Prevalence', 'Image', 'Impairment', 'Individual', 'Infrastructure', 'Kentucky', 'Letters', 'Liquid substance', 'Longitudinal cohort', 'Magnetic Resonance Imaging', 'Mission', 'Nature', 'Participant', 'Pathogenicity', 'Pathologic', 'Pathology', 'Pattern', 'Phenotype', 'Protocols documentation', 'Research', 'Research Personnel', 'Resources', 'Scanning', 'Spectrum Analysis', 'Standardization', 'Tauopathies', 'Time', 'Translations', 'United States', 'United States National Institutes of Health', 'Universities', 'age related', 'aged', 'aging population', 'base', 'biomarker development', 'biomarker discovery', 'central database', 'clinical development', 'clinical phenotype', 'cohort', 'data management', 'education research', 'experience', 'hippocampal atrophy', 'human old age (65+)', 'in vivo', 'innovation', 'knowledge translation', 'limbic-predominant age-related TDP-43 encephalopathy', 'longitudinal analysis', 'machine learning algorithm', 'neurochemistry', 'neuroimaging', 'neuroimaging marker', 'neuropathology', 'new therapeutic target', 'normal aging', 'novel marker', 'novel therapeutics', 'outreach', 'parent grant', 'pre-clinical', 'preclinical study', 'programs', 'recruit', 'research study', 'statistics', 'success', 'tau Proteins', 'vascular cognitive impairment and dementia', 'white matter']",NIA,UNIVERSITY OF KENTUCKY,P30,2020,367200,-0.06383706111385178
"High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research Project Summary/Abstract Fred Hutch respectfully requests funds to upgrade the current 523-node, 3328-core high performance computing (HPC) cluster, which was created in 2004 and expanded in 2006, 2010 (S10 funds), 2013, 2015 (S10 funds), and 2018. 456 end of life nodes (1824 cores) will be replaced and 144 nodes (3456 cores) will be added, creating a new 211-node, 4996-core system with an overall 50% increase in core count, 60% increase in processing power, and more than 100% increase in memory capacity over the old system. The expanded capacity will enable deep and efficient analysis of our research studies and accommodate 20% annual growth in computing intensive research, much of which is not possible on the current cluster. The core user group for the new HPC cluster consists of at least 37 NIH-funded research groups participating in this proposal, however as much as 85 groups use the cluster regularly. Their biomedical research is aimed at eradicating cancer and other diseases and dependent on computationally intensive technical approaches such as development of novel statistical analysis or machine learning methods, for example for assessing immune correlates to facilitate vaccine development, analyzing large scale clinical trials or to develop software tools for the analysis of large-scale immunological datasets, DNA and RNA sequencing, modeling prostate cancer outcomes, studies of the human microbiome, modeling of cancers, mRNA, miRNA, and structural variant detection, structural biology with Cryo- EM, modeling of infectious agents and pandemics, computational modeling, prediction and design of macromolecular structures and interactions, identifying drivers of neoplasia and an international consortium improving colorectal cancer detection using GWAS, whole genome sequencing and genome-wide gene- environment (GxE) studies as well as research in diabetes, mhealth and cardiovascular diseases. Several of the Major Users at Fred Hutch are currently experiencing substantial delays in accomplishing their work using the current cluster. Others have projects that cannot be done at all on the existing instrument. (see Research Projects section for details). The Scientific Computing department (SciComp) has operated the current HPC cluster for more than 10 years and has a staff with a combined experience of over 150 years. The proposed new HPC cluster will be installed in available space in a Fred Hutch datacenter. The expanded cluster will address both immediate and future needs of our user community, supporting NIH-funded research at Fred Hutch. Funded research at our Center will greatly benefit from the increased data-processing capacity and improved performance of the requested HPC cluster, including applications of machine learning to the study of clinical trial efficacy, comparison of immune system receptors to identify responses to specific pathogens/diseases, modeling of carcinogenesis. Besides multiple infectious diseases Fred Hutch researches all types of cancer and our computationally intensive investigators tend to focus on colon, prostate, brain, Barretts esophagus, lung and liquid tumors such as leukemia. Project Narrative (Public Health Relevance) We are requesting an expansion of our high-performance computing (HPC) cluster to provide capacity for the growing computational needs in a broad range of biomedical research studies at our Center. Access to fast and reliable computational power is critically important for analyzing the exploding amounts of data produced by large-scale clinical and epidemiological studies, as well as scientific instruments such as genome sequencers and electron microscopes. The prevention, detection, and treatment of cancer, HIV, and other life-threatening diseases are major areas of NIH-funded research at our Center that will greatly benefit from the improved performance of the requested HPC cluster, including large-scale clinical and epidemiologic studies of various cancers, modeling of vaccine efficacy, and infectious disease transmission and proteomic-based biomarker discovery.",High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research,9940345,S10OD028685,"['Address', 'Barrett Esophagus', 'Biomedical Research', 'Brain', 'Cancer Model', 'Cardiovascular Diseases', 'Clinical Trials', 'Colon', 'Communicable Diseases', 'Communities', 'Computer Models', 'Cryoelectron Microscopy', 'DNA sequencing', 'Data Set', 'Development', 'Diabetes Mellitus', 'Disease', 'Disease model', 'Environment', 'Funding', 'Future', 'Genes', 'Growth', 'High Performance Computing', 'Human Microbiome', 'Immune', 'Immune system', 'Immunologics', 'Infectious Agent', 'Infectious Diseases Research', 'International', 'Liquid substance', 'Lung', 'Machine Learning', 'Malignant Neoplasms', 'Memory', 'Messenger RNA', 'MicroRNAs', 'Modeling', 'Molecular Structure', 'Neoplasms', 'Performance', 'Prostate', 'Prostate Cancer Outcomes Study', 'Research', 'Research Personnel', 'Research Project Grants', 'Software Tools', 'Statistical Data Interpretation', 'Structure', 'System', 'United States National Institutes of Health', 'Work', 'cancer type', 'carcinogenesis', 'cluster computing', 'colorectal cancer screening', 'computerized data processing', 'design', 'efficacy clinical trial', 'end of life', 'experience', 'genome sequencing', 'genome wide association study', 'genome-wide', 'improved', 'instrument', 'leukemia', 'mHealth', 'machine learning method', 'microbiome research', 'novel', 'pandemic disease', 'pathogen', 'prostate cancer model', 'receptor', 'research study', 'response', 'scientific computing', 'software development', 'structural biology', 'transcriptome sequencing', 'tumor', 'vaccine development', 'variant detection', 'whole genome']",OD,FRED HUTCHINSON CANCER RESEARCH CENTER,S10,2020,2000000,-0.0036312549341902664
"NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR) DESCRIPTION (provided by applicant):  We propose to establish a NIDA Center of Excellence for Computational Drug Abuse Research (CDAR) between the University of Pittsburgh (Pitt) and (CMU), with the goal of advancing and ensuring the productive and broad usage of state-of-the-art computational technologies that will facilitate and enhance drug abuse (DA) research, both in the local (Pittsburgh) area and nationwide. To this end, we will develop/integrate tools for DA-domain-specific chemical-to-protein-to-genomics mapping using cheminformatics, computational biology and computational genomics methods by centralizing computational chemical genomics (or chemogenomics) resources while also making them available on a cloud server. The Center will foster collaboration and advance knowledge-based translational research and increase the effectiveness of ongoing funded research project (FRPs) via the following Research Support Cores: (1) The Computational Chemogenomics Core for DA (CC4DA) will help address polydrug addiction/polypharmacology by developing new chemogenomics tools and by compiling the data collected/generated, along with those from other Cores, into a DA knowledge-based chemogenomics (DA-KB) repository that will be made accessible to the DA community. (2) The Computational Biology Core (CB4DA) will focus on developing a resource for structure-based investigation of the interactions among substances of DA and their target proteins, in addition to assessing the drugability of receptors and transporters involved in DA and addiction. These activities will be complemented by quantitative systems pharmacology methods to enable a systems-level approach to DA research. (3) The Computational Genomics Core (CG4DA) will carry out genome-wide discovery of new DA targets, markers, and epigenetic influences using developed machine learning models and algorithms. (4) The Administrative Core will coordinate Center activities, provide management to oversee the CDAR activities in consultation with the Scientific Steering Committee (SSC) and an External Advisory Board (EAB), ensure the effective dissemination of software/data among the Cores and the FRPs, and establish mentoring mechanisms to train junior researchers. Overall, the Center will strive to achieve the long-term goal of translating advances in computational chemistry, biology and genomics toward the development of novel personalized DA therapeutics. We propose a Computational Drug Abuse Research (CDAR) Center, as a joint initiative between the  University of Pittsburgh and Carnegie Mellon University. The Center consist of three Cores (CC4DA, CB4DA  and CG4DA) that will leverage our expertise in computational chemogenomics, computational biology, and  computational genomics to facilitate basic and translational drug abuse and medication research.",NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR),9527792,P30DA035778,"['Address', 'Algorithms', 'Area', 'Biological', 'Biology', 'Cannabinoids', 'Categories', 'Cells', 'Chemicals', 'Clinical Trials Network', 'Cloud Computing', 'Cocaine', 'Collaborations', 'Communities', 'Complement', 'Computational Biology', 'Computer software', 'Consultations', 'Data', 'Databases', 'Development', 'Doctor of Philosophy', 'Drug Addiction', 'Drug Receptors', 'Drug abuse', 'Effectiveness', 'Endocytosis', 'Ensure', 'Environmental Risk Factor', 'Epigenetic Process', 'Feedback', 'Fostering', 'Funding', 'Genetic', 'Genomics', 'Genotype', 'Goals', 'Human Genome', 'Intervention', 'Investigation', 'Joints', 'Leadership', 'Link', 'Machine Learning', 'Mentors', 'Methods', 'Modeling', 'Molecular', 'N-Methyl-D-Aspartate Receptors', 'National Institute of Drug Abuse', 'Neuropharmacology', 'Pharmaceutical Preparations', 'Pharmacologic Substance', 'Pharmacology', 'Phenotype', 'Proteins', 'Regulation', 'Research', 'Research Activity', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Science', 'Signal Transduction', 'Software Tools', 'Source', 'Structure', 'Substance Use Disorder', 'System', 'Systems Biology', 'Technology', 'Therapeutic', 'Training', 'Translating', 'Translational Research', 'Universities', 'addiction', 'algorithmic methodologies', 'base', 'biobehavior', 'cheminformatics', 'cloud based', 'cloud platform', 'computational chemistry', 'computer science', 'data mining', 'design', 'distinguished professor', 'dopamine transporter', 'drug abuse prevention', 'falls', 'genome-wide', 'genome-wide analysis', 'improved', 'insight', 'knowledge base', 'member', 'novel', 'novel therapeutics', 'operation', 'prevent', 'professor', 'repository', 'tool']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P30,2018,1080816,0.19259861404206946
"NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR) DESCRIPTION (provided by applicant):  We propose to establish a NIDA Center of Excellence for Computational Drug Abuse Research (CDAR) between the University of Pittsburgh (Pitt) and (CMU), with the goal of advancing and ensuring the productive and broad usage of state-of-the-art computational technologies that will facilitate and enhance drug abuse (DA) research, both in the local (Pittsburgh) area and nationwide. To this end, we will develop/integrate tools for DA-domain-specific chemical-to-protein-to-genomics mapping using cheminformatics, computational biology and computational genomics methods by centralizing computational chemical genomics (or chemogenomics) resources while also making them available on a cloud server. The Center will foster collaboration and advance knowledge-based translational research and increase the effectiveness of ongoing funded research project (FRPs) via the following Research Support Cores: (1) The Computational Chemogenomics Core for DA (CC4DA) will help address polydrug addiction/polypharmacology by developing new chemogenomics tools and by compiling the data collected/generated, along with those from other Cores, into a DA knowledge-based chemogenomics (DA-KB) repository that will be made accessible to the DA community. (2) The Computational Biology Core (CB4DA) will focus on developing a resource for structure-based investigation of the interactions among substances of DA and their target proteins, in addition to assessing the drugability of receptors and transporters involved in DA and addiction. These activities will be complemented by quantitative systems pharmacology methods to enable a systems-level approach to DA research. (3) The Computational Genomics Core (CG4DA) will carry out genome-wide discovery of new DA targets, markers, and epigenetic influences using developed machine learning models and algorithms. (4) The Administrative Core will coordinate Center activities, provide management to oversee the CDAR activities in consultation with the Scientific Steering Committee (SSC) and an External Advisory Board (EAB), ensure the effective dissemination of software/data among the Cores and the FRPs, and establish mentoring mechanisms to train junior researchers. Overall, the Center will strive to achieve the long-term goal of translating advances in computational chemistry, biology and genomics toward the development of novel personalized DA therapeutics. We propose a Computational Drug Abuse Research (CDAR) Center, as a joint initiative between the  University of Pittsburgh and Carnegie Mellon University. The Center consist of three Cores (CC4DA, CB4DA  and CG4DA) that will leverage our expertise in computational chemogenomics, computational biology, and  computational genomics to facilitate basic and translational drug abuse and medication research.",NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR),9321115,P30DA035778,"['Address', 'Algorithms', 'Area', 'Biological', 'Biology', 'Cannabinoids', 'Categories', 'Cells', 'Chemicals', 'Clinical Trials Network', 'Cloud Computing', 'Cocaine', 'Collaborations', 'Communities', 'Complement', 'Computational Biology', 'Computer software', 'Consultations', 'Data', 'Databases', 'Development', 'Doctor of Philosophy', 'Drug Addiction', 'Drug Receptors', 'Drug abuse', 'Effectiveness', 'Endocytosis', 'Ensure', 'Environmental Risk Factor', 'Epigenetic Process', 'Feedback', 'Fostering', 'Funding', 'Genetic', 'Genomics', 'Genotype', 'Goals', 'Human Genome', 'Intervention', 'Investigation', 'Joints', 'Leadership', 'Link', 'Machine Learning', 'Mentors', 'Methods', 'Modeling', 'Molecular', 'N-Methyl-D-Aspartate Receptors', 'National Institute of Drug Abuse', 'Neuropharmacology', 'Pharmaceutical Preparations', 'Pharmacologic Substance', 'Pharmacology', 'Phenotype', 'Proteins', 'Regulation', 'Research', 'Research Activity', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Science', 'Signal Transduction', 'Software Tools', 'Source', 'Structure', 'Substance Use Disorder', 'System', 'Systems Biology', 'Technology', 'Therapeutic', 'Training', 'Translating', 'Translational Research', 'Universities', 'addiction', 'algorithmic methodologies', 'base', 'biobehavior', 'cheminformatics', 'cloud based', 'cloud platform', 'computational chemistry', 'computer science', 'data mining', 'design', 'distinguished professor', 'dopamine transporter', 'drug abuse prevention', 'falls', 'genome-wide', 'genome-wide analysis', 'improved', 'insight', 'knowledge base', 'member', 'novel', 'novel therapeutics', 'operation', 'prevent', 'professor', 'repository', 'tool']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P30,2017,1080816,0.19259861404206946
"NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR) DESCRIPTION (provided by applicant):  We propose to establish a NIDA Center of Excellence for Computational Drug Abuse Research (CDAR) between the University of Pittsburgh (Pitt) and (CMU), with the goal of advancing and ensuring the productive and broad usage of state-of-the-art computational technologies that will facilitate and enhance drug abuse (DA) research, both in the local (Pittsburgh) area and nationwide. To this end, we will develop/integrate tools for DA-domain-specific chemical-to-protein-to-genomics mapping using cheminformatics, computational biology and computational genomics methods by centralizing computational chemical genomics (or chemogenomics) resources while also making them available on a cloud server. The Center will foster collaboration and advance knowledge-based translational research and increase the effectiveness of ongoing funded research project (FRPs) via the following Research Support Cores: (1) The Computational Chemogenomics Core for DA (CC4DA) will help address polydrug addiction/polypharmacology by developing new chemogenomics tools and by compiling the data collected/generated, along with those from other Cores, into a DA knowledge-based chemogenomics (DA-KB) repository that will be made accessible to the DA community. (2) The Computational Biology Core (CB4DA) will focus on developing a resource for structure-based investigation of the interactions among substances of DA and their target proteins, in addition to assessing the drugability of receptors and transporters involved in DA and addiction. These activities will be complemented by quantitative systems pharmacology methods to enable a systems-level approach to DA research. (3) The Computational Genomics Core (CG4DA) will carry out genome-wide discovery of new DA targets, markers, and epigenetic influences using developed machine learning models and algorithms. (4) The Administrative Core will coordinate Center activities, provide management to oversee the CDAR activities in consultation with the Scientific Steering Committee (SSC) and an External Advisory Board (EAB), ensure the effective dissemination of software/data among the Cores and the FRPs, and establish mentoring mechanisms to train junior researchers. Overall, the Center will strive to achieve the long-term goal of translating advances in computational chemistry, biology and genomics toward the development of novel personalized DA therapeutics. We propose a Computational Drug Abuse Research (CDAR) Center, as a joint initiative between the  University of Pittsburgh and Carnegie Mellon University. The Center consist of three Cores (CC4DA, CB4DA  and CG4DA) that will leverage our expertise in computational chemogenomics, computational biology, and  computational genomics to facilitate basic and translational drug abuse and medication research.",NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR),9118144,P30DA035778,"['Address', 'Algorithms', 'Area', 'Biological', 'Biology', 'Cannabinoids', 'Categories', 'Cells', 'Chemicals', 'Clinical Trials Network', 'Cloud Computing', 'Cocaine', 'Collaborations', 'Communities', 'Complement', 'Computational Biology', 'Computer software', 'Consultations', 'Data', 'Databases', 'Development', 'Doctor of Philosophy', 'Drug abuse', 'Effectiveness', 'Endocytosis', 'Ensure', 'Environmental Risk Factor', 'Feedback', 'Fostering', 'Funding', 'Genetic', 'Genomics', 'Genotype', 'Goals', 'Human Genome', 'Intervention', 'Investigation', 'Joints', 'Leadership', 'Link', 'Machine Learning', 'Maps', 'Mentors', 'Methods', 'Modeling', 'Molecular', 'N-Methyl-D-Aspartate Receptors', 'National Institute of Drug Abuse', 'Neuropharmacology', 'Pharmaceutical Preparations', 'Pharmacologic Substance', 'Pharmacology', 'Phenotype', 'Proteins', 'Regulation', 'Research', 'Research Activity', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Science', 'Signal Transduction', 'Software Tools', 'Structure', 'Substance Use Disorder', 'System', 'Systems Biology', 'Technology', 'Therapeutic', 'Training', 'Translating', 'Translational Research', 'Universities', 'addiction', 'base', 'biobehavior', 'cheminformatics', 'cloud based', 'cloud platform', 'computational chemistry', 'computer science', 'data mining', 'design', 'distinguished professor', 'dopamine transporter', 'drug abuse prevention', 'epigenetic marker', 'falls', 'genome-wide', 'improved', 'insight', 'knowledge base', 'member', 'novel', 'operation', 'predictive modeling', 'prevent', 'professor', 'receptor', 'repository', 'tool']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P30,2016,1070007,0.19259861404206946
"NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR) DESCRIPTION (provided by applicant):  We propose to establish a NIDA Center of Excellence for Computational Drug Abuse Research (CDAR) between the University of Pittsburgh (Pitt) and (CMU), with the goal of advancing and ensuring the productive and broad usage of state-of-the-art computational technologies that will facilitate and enhance drug abuse (DA) research, both in the local (Pittsburgh) area and nationwide. To this end, we will develop/integrate tools for DA-domain-specific chemical-to-protein-to-genomics mapping using cheminformatics, computational biology and computational genomics methods by centralizing computational chemical genomics (or chemogenomics) resources while also making them available on a cloud server. The Center will foster collaboration and advance knowledge-based translational research and increase the effectiveness of ongoing funded research project (FRPs) via the following Research Support Cores: (1) The Computational Chemogenomics Core for DA (CC4DA) will help address polydrug addiction/polypharmacology by developing new chemogenomics tools and by compiling the data collected/generated, along with those from other Cores, into a DA knowledge-based chemogenomics (DA-KB) repository that will be made accessible to the DA community. (2) The Computational Biology Core (CB4DA) will focus on developing a resource for structure-based investigation of the interactions among substances of DA and their target proteins, in addition to assessing the drugability of receptors and transporters involved in DA and addiction. These activities will be complemented by quantitative systems pharmacology methods to enable a systems-level approach to DA research. (3) The Computational Genomics Core (CG4DA) will carry out genome-wide discovery of new DA targets, markers, and epigenetic influences using developed machine learning models and algorithms. (4) The Administrative Core will coordinate Center activities, provide management to oversee the CDAR activities in consultation with the Scientific Steering Committee (SSC) and an External Advisory Board (EAB), ensure the effective dissemination of software/data among the Cores and the FRPs, and establish mentoring mechanisms to train junior researchers. Overall, the Center will strive to achieve the long-term goal of translating advances in computational chemistry, biology and genomics toward the development of novel personalized DA therapeutics. We propose a Computational Drug Abuse Research (CDAR) Center, as a joint initiative between the  University of Pittsburgh and Carnegie Mellon University. The Center consist of three Cores (CC4DA, CB4DA  and CG4DA) that will leverage our expertise in computational chemogenomics, computational biology, and  computational genomics to facilitate basic and translational drug abuse and medication research.",NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR),8896676,P30DA035778,"['Address', 'Algorithms', 'Area', 'Biological', 'Biology', 'Cannabinoids', 'Categories', 'Cells', 'Chemicals', 'Clinical Trials Network', 'Cloud Computing', 'Cocaine', 'Collaborations', 'Communities', 'Complement', 'Computational Biology', 'Computer software', 'Consultations', 'Data', 'Databases', 'Development', 'Doctor of Philosophy', 'Drug abuse', 'Effectiveness', 'Endocytosis', 'Ensure', 'Environmental Risk Factor', 'Feedback', 'Fostering', 'Funding', 'Genetic', 'Genomics', 'Genotype', 'Goals', 'Human Genome', 'Intervention', 'Investigation', 'Joints', 'Leadership', 'Link', 'Machine Learning', 'Maps', 'Mentors', 'Methods', 'Modeling', 'Molecular', 'N-Methyl-D-Aspartate Receptors', 'National Institute of Drug Abuse', 'Neuropharmacology', 'Pharmaceutical Preparations', 'Pharmacologic Substance', 'Pharmacology', 'Phenotype', 'Proteins', 'Regulation', 'Research', 'Research Activity', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Science', 'Signal Transduction', 'Software Tools', 'Structure', 'Substance Use Disorder', 'System', 'Systems Biology', 'Technology', 'Therapeutic', 'Training', 'Translating', 'Translational Research', 'Universities', 'addiction', 'base', 'biobehavior', 'cheminformatics', 'cloud based', 'computational chemistry', 'computer science', 'data mining', 'design', 'dopamine transporter', 'drug abuse prevention', 'epigenetic marker', 'falls', 'genome-wide', 'improved', 'insight', 'knowledge base', 'member', 'novel', 'operation', 'predictive modeling', 'prevent', 'professor', 'receptor', 'repository', 'tool']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P30,2015,1064603,0.19259861404206946
"NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR) DESCRIPTION (provided by applicant):  We propose to establish a NIDA Center of Excellence for Computational Drug Abuse Research (CDAR) between the University of Pittsburgh (Pitt) and (CMU), with the goal of advancing and ensuring the productive and broad usage of state-of-the-art computational technologies that will facilitate and enhance drug abuse (DA) research, both in the local (Pittsburgh) area and nationwide. To this end, we will develop/integrate tools for DA-domain-specific chemical-to-protein-to-genomics mapping using cheminformatics, computational biology and computational genomics methods by centralizing computational chemical genomics (or chemogenomics) resources while also making them available on a cloud server. The Center will foster collaboration and advance knowledge-based translational research and increase the effectiveness of ongoing funded research project (FRPs) via the following Research Support Cores: (1) The Computational Chemogenomics Core for DA (CC4DA) will help address polydrug addiction/polypharmacology by developing new chemogenomics tools and by compiling the data collected/generated, along with those from other Cores, into a DA knowledge-based chemogenomics (DA-KB) repository that will be made accessible to the DA community. (2) The Computational Biology Core (CB4DA) will focus on developing a resource for structure-based investigation of the interactions among substances of DA and their target proteins, in addition to assessing the drugability of receptors and transporters involved in DA and addiction. These activities will be complemented by quantitative systems pharmacology methods to enable a systems-level approach to DA research. (3) The Computational Genomics Core (CG4DA) will carry out genome-wide discovery of new DA targets, markers, and epigenetic influences using developed machine learning models and algorithms. (4) The Administrative Core will coordinate Center activities, provide management to oversee the CDAR activities in consultation with the Scientific Steering Committee (SSC) and an External Advisory Board (EAB), ensure the effective dissemination of software/data among the Cores and the FRPs, and establish mentoring mechanisms to train junior researchers. Overall, the Center will strive to achieve the long-term goal of translating advances in computational chemistry, biology and genomics toward the development of novel personalized DA therapeutics. We propose a Computational Drug Abuse Research (CDAR) Center, as a joint initiative between the  University of Pittsburgh and Carnegie Mellon University. The Center consist of three Cores (CC4DA, CB4DA  and CG4DA) that will leverage our expertise in computational chemogenomics, computational biology, and  computational genomics to facilitate basic and translational drug abuse and medication research.",NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR),8743368,P30DA035778,"['Address', 'Algorithms', 'Area', 'Biological', 'Biology', 'Cannabinoids', 'Categories', 'Cells', 'Chemicals', 'Clinical Trials Network', 'Cloud Computing', 'Cocaine', 'Collaborations', 'Communities', 'Complement', 'Computational Biology', 'Computer software', 'Consultations', 'Data', 'Databases', 'Development', 'Doctor of Philosophy', 'Drug abuse', 'Effectiveness', 'Endocytosis', 'Ensure', 'Environmental Risk Factor', 'Feedback', 'Fostering', 'Funding', 'Genetic', 'Genome', 'Genomics', 'Genotype', 'Goals', 'Human Genome', 'Intervention', 'Investigation', 'Joints', 'Leadership', 'Link', 'Machine Learning', 'Maps', 'Mentors', 'Methods', 'Modeling', 'Molecular', 'N-Methyl-D-Aspartate Receptors', 'National Institute of Drug Abuse', 'Neuropharmacology', 'Pharmaceutical Preparations', 'Pharmacologic Substance', 'Pharmacology', 'Phenotype', 'Proteins', 'Regulation', 'Research', 'Research Activity', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Science', 'Signal Transduction', 'Software Tools', 'Structure', 'Substance Use Disorder', 'System', 'Systems Biology', 'Technology', 'Therapeutic', 'Training', 'Translating', 'Translational Research', 'Universities', 'addiction', 'base', 'biobehavior', 'cheminformatics', 'cloud based', 'computational chemistry', 'computer science', 'data mining', 'design', 'dopamine transporter', 'drug abuse prevention', 'epigenetic marker', 'falls', 'genome-wide', 'improved', 'insight', 'knowledge base', 'member', 'novel', 'operation', 'predictive modeling', 'prevent', 'professor', 'receptor', 'repository', 'tool']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P30,2014,1094316,0.19259861404206946
"SINGLE-UNIT ZERO ORDER DRUG DELIVERY SYSTEM Many of the new drug delivery systems (DDS) are designed to deliver drug at a controlled rate over an extended period of time. This extended drug delivery results in plasma drug levels within the therapeutic range longer than expected from the biological half-life of the drug, thereby prolonging the pharmacological benefits of the drug, while minimizing ineffective or toxic concentrations.  The DDS should maintain a constant (zero-order) drug delivery rate for 10 to 14 hours, and be easily adaptable to a variety of drugs, requiring different delivery rates.  One such design involves press-coating a drug core with a rate controlling membrane.  The rate of drug delivery is modified by altering the porosity of the coating, which changes and rate of water penetration, and thus alters the core dissolution profile and rate of drug release.  To predictably modify drug delivery rate by incorporation of porosity modifiers in the coating, requires an understanding of the interplay between physical-chemical properties of the porosity modifier and the change in DDS porosity/surface area.  This proposal investigates relationships between properties of porosity modifiers and coating porosity/surface area, which are used in the design of a cost effective press-coated DDS.  Powder characteristics and compression profiles of core and coating materials are used in the selection of proper approaches to the initial DDS design.  To alter drug release, porosity modifiers of different properties are incorporated into the coating.  The dependence of the rate and extent of porosity/surface area modifications on the porosity modifier properties and subsequent influence on drug delivery rate will be studied.  The relationships will be tested by determining the accuracy with which drug delivery profile can be predicted by apriori selection of porosity modifier with cores of varying dissolution profiles.  Future studies will involve a series of drugs with different properties and the in-vivo evaluation of the DDS. The relationships developed in this investigation will allow use of the same DDS housing, which is adaptable to drugs requiring different delivery rates.  This reduces the time and cost involved in developing DDS for new drug entities.  n/a",SINGLE-UNIT ZERO ORDER DRUG DELIVERY SYSTEM,3438677,R15GM040078,"['dosage forms', ' drug administration rate /duration', ' drug adverse effect', ' drug delivery systems', ' molecular film', ' pharmacokinetics', ' slow release drug']",NIGMS,UNIVERSITY OF CINCINNATI,R15,1988,69937,0.05579486600201326
"Population Research Institute    DESCRIPTION (provided by applicant): This is an application for renewed NICHD (R24) infrastructure support for the Population Research Institute (PRI) at The Pennsylvania State University. The requested funding, combined with generous University matching support, will allow PRI to continue developing as a center of excellence in population science and to achieve its fundamental mission of promoting innovative demographic research and training at Penn State. PRI was formed in 1972 and has had continued NICHD infrastructure support since 1991. It is a large and highly multidisciplinary institute, with its 73 tenure-track Research Associates and Affiliates distributed across 17 departments and seven colleges. Recent developments at Penn State, including the formation of the Children, Youth, and Families Consortium and the Survey Research Center, coupled with PRI's new institutional links with the College of Medicine, first-time support from the College of Education, and strengthened ties to the College of Health and Human Development, infuse new energy and resources that will allow PRI to pursue work on three signature themes: interdisciplinary perspectives on family processes and change; interdisciplinary perspectives linking individual, family, and population health overtime; and demographic perspectives on inequality and opportunity. Within each theme we identify broad questions which motivate and structure PRI's ambitious research plans for the next five-year cycle. The productivity of PRI researchers and the quality of their work relies on five forward-looking and cost-effective service cores and a Developmental Infrastructure. The Administrative Core provides expert application assembly and submission service and post-award administration. The Computer Core provides cutting-edge hardware and software support and high-end computer programming. The Geographic Information Analysis Core provides high quality mapping, visualization, contextual data manipulation and spatial analysis capabilities. The Information Core provides literature search and article retrieval services, and maintains both a demography library and a vast social science data archive. The reorganized Statistics Core provides statistical consulting, organizes informative workshops and seminars, and ensures PRI's currency in statistical software. PRI's Developmental Infrastructure draws on new faculty leadership to provide a seed grant program, working group opportunities, and peer review capabilities, all targeted toward junior faculty.              n/a",Population Research Institute,7471433,R24HD041025,"['Archives', 'Award', 'Child', 'Computer software', 'Computers', 'Consult', 'Coupled', 'Data', 'Demography', 'Development', 'Education', 'Educational workshop', 'Ensure', 'Faculty', 'Family', 'Family Process', 'Funding', 'Grant', 'Health', 'Human Development', 'Imagery', 'Individual', 'Inequality', 'Institutes', 'Leadership', 'Libraries', 'Link', 'Maps', 'Medicine', 'Mission', 'Monoclonal Antibody R24', 'National Institute of Child Health and Human Development', 'Peer Review', 'Pennsylvania', 'Population', 'Population Research', 'Population Sciences', 'Postdoctoral Fellow', 'Productivity', 'Research', 'Research Infrastructure', 'Research Institute', 'Research Personnel', 'Research Training', 'Resources', 'Retrieval', 'Seeds', 'Services', 'Social Sciences', 'Structure', 'Surveys', 'Time', 'Universities', 'Work', 'college', 'computer program', 'cost', 'innovation', 'multidisciplinary', 'programs', 'statistics', 'text searching']",NICHD,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2008,616897,0.11323494591245563
"Population Research Institute    DESCRIPTION (provided by applicant): This is an application for renewed NICHD (R24) infrastructure support for the Population Research Institute (PRI) at The Pennsylvania State University. The requested funding, combined with generous University matching support, will allow PRI to continue developing as a center of excellence in population science and to achieve its fundamental mission of promoting innovative demographic research and training at Penn State. PRI was formed in 1972 and has had continued NICHD infrastructure support since 1991. It is a large and highly multidisciplinary institute, with its 73 tenure-track Research Associates and Affiliates distributed across 17 departments and seven colleges. Recent developments at Penn State, including the formation of the Children, Youth, and Families Consortium and the Survey Research Center, coupled with PRI's new institutional links with the College of Medicine, first-time support from the College of Education, and strengthened ties to the College of Health and Human Development, infuse new energy and resources that will allow PRI to pursue work on three signature themes: interdisciplinary perspectives on family processes and change; interdisciplinary perspectives linking individual, family, and population health overtime; and demographic perspectives on inequality and opportunity. Within each theme we identify broad questions which motivate and structure PRI's ambitious research plans for the next five-year cycle. The productivity of PRI researchers and the quality of their work relies on five forward-looking and cost-effective service cores and a Developmental Infrastructure. The Administrative Core provides expert application assembly and submission service and post-award administration. The Computer Core provides cutting-edge hardware and software support and high-end computer programming. The Geographic Information Analysis Core provides high quality mapping, visualization, contextual data manipulation and spatial analysis capabilities. The Information Core provides literature search and article retrieval services, and maintains both a demography library and a vast social science data archive. The reorganized Statistics Core provides statistical consulting, organizes informative workshops and seminars, and ensures PRI's currency in statistical software. PRI's Developmental Infrastructure draws on new faculty leadership to provide a seed grant program, working group opportunities, and peer review capabilities, all targeted toward junior faculty.              n/a",Population Research Institute,7618031,R24HD041025,"['Archives', 'Award', 'Child', 'Computer software', 'Computers', 'Consult', 'Coupled', 'Data', 'Demography', 'Development', 'Education', 'Educational workshop', 'Ensure', 'Faculty', 'Family', 'Family Process', 'Funding', 'Grant', 'Health', 'Human Development', 'Imagery', 'Individual', 'Inequality', 'Institutes', 'Leadership', 'Libraries', 'Link', 'Maps', 'Medicine', 'Mission', 'Monoclonal Antibody R24', 'National Institute of Child Health and Human Development', 'Peer Review', 'Pennsylvania', 'Population Research', 'Population Sciences', 'Postdoctoral Fellow', 'Productivity', 'Research', 'Research Infrastructure', 'Research Institute', 'Research Personnel', 'Research Training', 'Resources', 'Retrieval', 'Seeds', 'Services', 'Social Sciences', 'Structure', 'Surveys', 'Time', 'Universities', 'Work', 'college', 'computer program', 'cost', 'innovation', 'multidisciplinary', 'population health', 'programs', 'statistics', 'text searching', 'working group']",NICHD,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2009,631118,0.11323494591245563
"Population Research Institute    DESCRIPTION (provided by applicant): This is an application for renewed NICHD (R24) infrastructure support for the Population Research Institute (PRI) at The Pennsylvania State University. The requested funding, combined with generous University matching support, will allow PRI to continue developing as a center of excellence in population science and to achieve its fundamental mission of promoting innovative demographic research and training at Penn State. PRI was formed in 1972 and has had continued NICHD infrastructure support since 1991. It is a large and highly multidisciplinary institute, with its 73 tenure-track Research Associates and Affiliates distributed across 17 departments and seven colleges. Recent developments at Penn State, including the formation of the Children, Youth, and Families Consortium and the Survey Research Center, coupled with PRI's new institutional links with the College of Medicine, first-time support from the College of Education, and strengthened ties to the College of Health and Human Development, infuse new energy and resources that will allow PRI to pursue work on three signature themes: interdisciplinary perspectives on family processes and change; interdisciplinary perspectives linking individual, family, and population health overtime; and demographic perspectives on inequality and opportunity. Within each theme we identify broad questions which motivate and structure PRI's ambitious research plans for the next five-year cycle. The productivity of PRI researchers and the quality of their work relies on five forward-looking and cost-effective service cores and a Developmental Infrastructure. The Administrative Core provides expert application assembly and submission service and post-award administration. The Computer Core provides cutting-edge hardware and software support and high-end computer programming. The Geographic Information Analysis Core provides high quality mapping, visualization, contextual data manipulation and spatial analysis capabilities. The Information Core provides literature search and article retrieval services, and maintains both a demography library and a vast social science data archive. The reorganized Statistics Core provides statistical consulting, organizes informative workshops and seminars, and ensures PRI's currency in statistical software. PRI's Developmental Infrastructure draws on new faculty leadership to provide a seed grant program, working group opportunities, and peer review capabilities, all targeted toward junior faculty.              n/a",Population Research Institute,7858162,R24HD041025,"['Archives', 'Award', 'Child', 'Computer software', 'Computers', 'Consult', 'Coupled', 'Data', 'Demography', 'Development', 'Education', 'Educational workshop', 'Ensure', 'Faculty', 'Family', 'Family Process', 'Funding', 'Grant', 'Health', 'Human Development', 'Imagery', 'Individual', 'Inequality', 'Institutes', 'Leadership', 'Libraries', 'Link', 'Maps', 'Medicine', 'Mission', 'Monoclonal Antibody R24', 'National Institute of Child Health and Human Development', 'Peer Review', 'Pennsylvania', 'Population Research', 'Population Sciences', 'Postdoctoral Fellow', 'Productivity', 'Research', 'Research Infrastructure', 'Research Institute', 'Research Personnel', 'Research Training', 'Resources', 'Retrieval', 'Seeds', 'Services', 'Social Sciences', 'Structure', 'Surveys', 'Time', 'Universities', 'Work', 'college', 'computer program', 'cost', 'high end computer', 'innovation', 'multidisciplinary', 'population health', 'programs', 'statistics', 'text searching', 'working group']",NICHD,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2010,644778,0.11323494591245563
"Population Research Institute    DESCRIPTION (provided by applicant): This is an application for renewed NICHD (R24) infrastructure support for the Population Research Institute (PRI) at The Pennsylvania State University. The requested funding, combined with generous University matching support, will allow PRI to continue developing as a center of excellence in population science and to achieve its fundamental mission of promoting innovative demographic research and training at Penn State. PRI was formed in 1972 and has had continued NICHD infrastructure support since 1991. It is a large and highly multidisciplinary institute, with its 73 tenure-track Research Associates and Affiliates distributed across 17 departments and seven colleges. Recent developments at Penn State, including the formation of the Children, Youth, and Families Consortium and the Survey Research Center, coupled with PRI's new institutional links with the College of Medicine, first-time support from the College of Education, and strengthened ties to the College of Health and Human Development, infuse new energy and resources that will allow PRI to pursue work on three signature themes: interdisciplinary perspectives on family processes and change; interdisciplinary perspectives linking individual, family, and population health overtime; and demographic perspectives on inequality and opportunity. Within each theme we identify broad questions which motivate and structure PRI's ambitious research plans for the next five-year cycle. The productivity of PRI researchers and the quality of their work relies on five forward-looking and cost-effective service cores and a Developmental Infrastructure. The Administrative Core provides expert application assembly and submission service and post-award administration. The Computer Core provides cutting-edge hardware and software support and high-end computer programming. The Geographic Information Analysis Core provides high quality mapping, visualization, contextual data manipulation and spatial analysis capabilities. The Information Core provides literature search and article retrieval services, and maintains both a demography library and a vast social science data archive. The reorganized Statistics Core provides statistical consulting, organizes informative workshops and seminars, and ensures PRI's currency in statistical software. PRI's Developmental Infrastructure draws on new faculty leadership to provide a seed grant program, working group opportunities, and peer review capabilities, all targeted toward junior faculty.              n/a",Population Research Institute,7286631,R24HD041025,"['Archives', 'Award', 'Child', 'Computer software', 'Computers', 'Consult', 'Coupled', 'Data', 'Demography', 'Development', 'Education', 'Educational workshop', 'Ensure', 'Faculty', 'Family', 'Family Process', 'Funding', 'Grant', 'Health', 'Human Development', 'Imagery', 'Individual', 'Inequality', 'Institutes', 'Leadership', 'Libraries', 'Link', 'Maps', 'Medicine', 'Mission', 'Monoclonal Antibody R24', 'National Institute of Child Health and Human Development', 'Peer Review', 'Pennsylvania', 'Population', 'Population Research', 'Population Sciences', 'Postdoctoral Fellow', 'Productivity', 'Research', 'Research Infrastructure', 'Research Institute', 'Research Personnel', 'Research Training', 'Resources', 'Retrieval', 'Seeds', 'Services', 'Social Sciences', 'Structure', 'Surveys', 'Time', 'Universities', 'Work', 'college', 'computer program', 'cost', 'innovation', 'multidisciplinary', 'programs', 'statistics', 'text searching']",NICHD,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2007,605084,0.11323494591245563
"Overall NIDA Core ""Center of Excellence"" in Transcriptomics, Systems Genetics and the Addictome Addiction is a highly complex disease with risk factors that include genetic variants and differences in development, sex, and environment. The long term potential of precision medicine to improve drug treatment and prevention depends on gaining a much better understanding how genetics, drugs, brain cells, and neuronal circuitry interact to influence behavior. There are serious technical barriers that prevent researchers and clinicians from incorporating more powerful computational and predictive methods in addiction research. The purpose of the NIDA P30 Core Center of Excellence in Omics, Systems Genetics, and the Addictome is to empower and train researchers supported by NIH, NIDA, NIAAA, and other federal and state institutions to use more quantitative and testable ways to analyze genetic, epigenetic, and the environmental factors that influence drug abuse risk and treatment. In the Transcriptome Informatics and Mechanisms research core we assemble and upgrade hundreds of large genome (DNA) and transcriptome (RNA) datasets for experimental rodent (rat) models of addiction. In the Systems Analytics and Modeling research core, we are using innovative systems genetics methods (gene mapping) to understand the linkage between DNA differences, environmental risks such as stress, and the differential risk of drug abuse and relapse. Our Pilot core is catalyzing new collaborations among young investigator in the field of addiction research. In sum the Center is a national resource for more reproducible research in addiction. We are centralizing, archiving, distributing, analyzing and integrating high quality data, metadata, using open software systems in collaboration with many other teams of researchers. Our goal is to help build toward an NIDA Addictome Portal that will include all genomic research relevant to addiction research. PROJECT NARRATIVE The NIDA Core Center of Excellence in Omics, Systems Genetics, and the Addictome (OSGA) provides genomic and computational support to a large number of research scientists working on mechanisms and treatment of addiction. The two main research cores of OSGA are providing support for transcriptome, epigenome, and metagenome studies of rat models of addiction at many levels of analysis. We are also creating open access tools and a powerful web portal to catalyze more effective and replicable use of massive datasets generated by programs in addiction biology and treatment.","Overall NIDA Core ""Center of Excellence"" in Transcriptomics, Systems Genetics and the Addictome",9929423,P30DA044223,"['Archives', 'Bayesian Modeling', 'Behavior', 'Behavioral', 'Bioinformatics', 'Biology', 'Biometry', 'Cellular Assay', 'Chromosome Mapping', 'Collaborations', 'Communities', 'Complex', 'Computer software', 'Computing Methodologies', 'Consult', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Drug Interactions', 'Drug abuse', 'Educational workshop', 'Ensure', 'Environment', 'Environmental Risk Factor', 'Epigenetic Process', 'Foundations', 'Funding', 'Future', 'Genes', 'Genetic', 'Genetic Variation', 'Genome', 'Genomics', 'Genotype', 'Goals', 'Human', 'Hybrids', 'Image', 'Informatics', 'Institution', 'Joints', 'Leadership', 'Machine Learning', 'Metadata', 'Methods', 'Modeling', 'Molecular', 'National Institute of Drug Abuse', 'National Institute on Alcohol Abuse and Alcoholism', 'Neurosciences Research', 'Pharmaceutical Preparations', 'Pharmacotherapy', 'Population', 'Prevention', 'Proteome', 'Publications', 'Publishing', 'Quantitative Genetics', 'Quantitative Trait Loci', 'RNA', 'Rattus', 'Relapse', 'Reproducibility', 'Research', 'Research Personnel', 'Resources', 'Risk', 'Risk Factors', 'Rodent', 'Role', 'Scientist', 'Site', 'Standardization', 'Statistical Models', 'Stress', 'Sum', 'System', 'Systems Analysis', 'Testing', 'Training', 'Translations', 'United States National Institutes of Health', 'Update', 'Variant', 'Visualization', 'Work', 'addiction', 'base', 'behavior influence', 'brain cell', 'career', 'cohort', 'computerized tools', 'computing resources', 'data archive', 'data integration', 'data modeling', 'data tools', 'data warehouse', 'deep learning', 'digital imaging', 'drug relapse', 'epigenome', 'experience', 'genetic analysis', 'genetic variant', 'genomic variation', 'graphical user interface', 'health record', 'high dimensionality', 'improved', 'innovation', 'insight', 'metagenome', 'mouse model', 'multiple omics', 'neurogenomics', 'neuronal circuitry', 'novel', 'precision medicine', 'prevent', 'programs', 'ranpirnase', 'rat genome', 'repository', 'sex', 'single cell analysis', 'software systems', 'tool', 'transcriptome', 'transcriptomics', 'web portal']",NIDA,UNIVERSITY OF TENNESSEE HEALTH SCI CTR,P30,2020,754121,0.15069863377216314
"Overall NIDA Core ""Center of Excellence"" in Transcriptomics, Systems Genetics and the Addictome Addiction is a highly complex disease with risk factors that include genetic variants and differences in development, sex, and environment. The long term potential of precision medicine to improve drug treatment and prevention depends on gaining a much better understanding how genetics, drugs, brain cells, and neuronal circuitry interact to influence behavior. There are serious technical barriers that prevent researchers and clinicians from incorporating more powerful computational and predictive methods in addiction research. The purpose of the NIDA P30 Core Center of Excellence in Omics, Systems Genetics, and the Addictome is to empower and train researchers supported by NIH, NIDA, NIAAA, and other federal and state institutions to use more quantitative and testable ways to analyze genetic, epigenetic, and the environmental factors that influence drug abuse risk and treatment. In the Transcriptome Informatics and Mechanisms research core we assemble and upgrade hundreds of large genome (DNA) and transcriptome (RNA) datasets for experimental rodent (rat) models of addiction. In the Systems Analytics and Modeling research core, we are using innovative systems genetics methods (gene mapping) to understand the linkage between DNA differences, environmental risks such as stress, and the differential risk of drug abuse and relapse. Our Pilot core is catalyzing new collaborations among young investigator in the field of addiction research. In sum the Center is a national resource for more reproducible research in addiction. We are centralizing, archiving, distributing, analyzing and integrating high quality data, metadata, using open software systems in collaboration with many other teams of researchers. Our goal is to help build toward an NIDA Addictome Portal that will include all genomic research relevant to addiction research. PROJECT NARRATIVE The NIDA Core Center of Excellence in Omics, Systems Genetics, and the Addictome (OSGA) provides genomic and computational support to a large number of research scientists working on mechanisms and treatment of addiction. The two main research cores of OSGA are providing support for transcriptome, epigenome, and metagenome studies of rat models of addiction at many levels of analysis. We are also creating open access tools and a powerful web portal to catalyze more effective and replicable use of massive datasets generated by programs in addiction biology and treatment.","Overall NIDA Core ""Center of Excellence"" in Transcriptomics, Systems Genetics and the Addictome",9716628,P30DA044223,"['Archives', 'Bayesian Modeling', 'Behavior', 'Behavioral', 'Bioinformatics', 'Biology', 'Biometry', 'Cellular Assay', 'Chromosome Mapping', 'Collaborations', 'Communities', 'Complex', 'Computer software', 'Computing Methodologies', 'Consult', 'DNA', 'DNA Sequence', 'Data', 'Data Quality', 'Data Set', 'Databases', 'Development', 'Disease', 'Drug Interactions', 'Drug abuse', 'Educational workshop', 'Ensure', 'Environment', 'Environmental Risk Factor', 'Epigenetic Process', 'Foundations', 'Funding', 'Future', 'Genes', 'Genetic', 'Genetic Variation', 'Genome', 'Genomics', 'Genotype', 'Goals', 'Human', 'Hybrids', 'Image', 'Imagery', 'Informatics', 'Institution', 'Joints', 'Leadership', 'Machine Learning', 'Metadata', 'Methods', 'Modeling', 'Molecular', 'National Institute of Drug Abuse', 'National Institute on Alcohol Abuse and Alcoholism', 'Neurosciences Research', 'Pharmaceutical Preparations', 'Pharmacotherapy', 'Population', 'Prevention', 'Proteome', 'Publications', 'Publishing', 'Quantitative Genetics', 'Quantitative Trait Loci', 'RNA', 'Rattus', 'Relapse', 'Reproducibility', 'Research', 'Research Personnel', 'Resources', 'Risk', 'Risk Factors', 'Rodent', 'Role', 'Scientist', 'Site', 'Standardization', 'Statistical Models', 'Stress', 'Sum', 'System', 'Systems Analysis', 'Testing', 'Training', 'Translations', 'United States National Institutes of Health', 'Update', 'Variant', 'Work', 'addiction', 'base', 'behavior influence', 'brain cell', 'career', 'cohort', 'computerized tools', 'computing resources', 'data archive', 'data integration', 'data modeling', 'data warehouse', 'deep learning', 'digital imaging', 'drug relapse', 'epigenome', 'experience', 'genetic analysis', 'genetic variant', 'genomic variation', 'graphical user interface', 'health record', 'high dimensionality', 'improved', 'innovation', 'insight', 'metagenome', 'mouse model', 'multiple omics', 'neurogenomics', 'neuronal circuitry', 'novel', 'precision medicine', 'prevent', 'programs', 'ranpirnase', 'rat genome', 'repository', 'sex', 'single cell analysis', 'software systems', 'tool', 'transcriptome', 'transcriptomics', 'web portal']",NIDA,UNIVERSITY OF TENNESSEE HEALTH SCI CTR,P30,2019,763474,0.15069863377216314
"Overall NIDA Core ""Center of Excellence"" in Transcriptomics, Systems Genetics and the Addictome Addiction is a highly complex disease with risk factors that include genetic variants and differences in development, sex, and environment. The long term potential of precision medicine to improve drug treatment and prevention depends on gaining a much better understanding how genetics, drugs, brain cells, and neuronal circuitry interact to influence behavior. There are serious technical barriers that prevent researchers and clinicians from incorporating more powerful computational and predictive methods in addiction research. The purpose of the NIDA P30 Core Center of Excellence in Omics, Systems Genetics, and the Addictome is to empower and train researchers supported by NIH, NIDA, NIAAA, and other federal and state institutions to use more quantitative and testable ways to analyze genetic, epigenetic, and the environmental factors that influence drug abuse risk and treatment. In the Transcriptome Informatics and Mechanisms research core we assemble and upgrade hundreds of large genome (DNA) and transcriptome (RNA) datasets for experimental rodent (rat) models of addiction. In the Systems Analytics and Modeling research core, we are using innovative systems genetics methods (gene mapping) to understand the linkage between DNA differences, environmental risks such as stress, and the differential risk of drug abuse and relapse. Our Pilot core is catalyzing new collaborations among young investigator in the field of addiction research. In sum the Center is a national resource for more reproducible research in addiction. We are centralizing, archiving, distributing, analyzing and integrating high quality data, metadata, using open software systems in collaboration with many other teams of researchers. Our goal is to help build toward an NIDA Addictome Portal that will include all genomic research relevant to addiction research. PROJECT NARRATIVE The NIDA Core Center of Excellence in Omics, Systems Genetics, and the Addictome (OSGA) provides genomic and computational support to a large number of research scientists working on mechanisms and treatment of addiction. The two main research cores of OSGA are providing support for transcriptome, epigenome, and metagenome studies of rat models of addiction at many levels of analysis. We are also creating open access tools and a powerful web portal to catalyze more effective and replicable use of massive datasets generated by programs in addiction biology and treatment.","Overall NIDA Core ""Center of Excellence"" in Transcriptomics, Systems Genetics and the Addictome",9531327,P30DA044223,"['Archives', 'Bayesian Modeling', 'Behavior', 'Behavioral', 'Bioinformatics', 'Biology', 'Biometry', 'Cellular Assay', 'Chromosome Mapping', 'Collaborations', 'Communities', 'Complex', 'Computer software', 'Computing Methodologies', 'Consult', 'DNA', 'DNA Sequence', 'Data', 'Data Quality', 'Data Set', 'Databases', 'Development', 'Disease', 'Drug Interactions', 'Drug abuse', 'Educational workshop', 'Ensure', 'Environment', 'Environmental Risk Factor', 'Epigenetic Process', 'Foundations', 'Funding', 'Future', 'Genes', 'Genetic', 'Genetic Variation', 'Genome', 'Genomics', 'Genotype', 'Goals', 'Human', 'Hybrids', 'Image', 'Imagery', 'Informatics', 'Institution', 'Joints', 'Leadership', 'Machine Learning', 'Metadata', 'Methods', 'Modeling', 'Molecular', 'National Institute of Drug Abuse', 'National Institute on Alcohol Abuse and Alcoholism', 'Neurosciences Research', 'Pharmaceutical Preparations', 'Pharmacotherapy', 'Population', 'Prevention', 'Proteome', 'Publications', 'Publishing', 'Quantitative Genetics', 'Quantitative Trait Loci', 'RNA', 'Rattus', 'Relapse', 'Reproducibility', 'Research', 'Research Personnel', 'Resources', 'Risk', 'Risk Factors', 'Rodent', 'Role', 'Scientist', 'Site', 'Standardization', 'Statistical Models', 'Stress', 'Sum', 'System', 'Systems Analysis', 'Testing', 'Training', 'Translations', 'United States National Institutes of Health', 'Update', 'Variant', 'Work', 'addiction', 'base', 'behavior influence', 'brain cell', 'career', 'cohort', 'computerized tools', 'computing resources', 'data archive', 'data integration', 'data modeling', 'data warehouse', 'deep learning', 'digital imaging', 'drug relapse', 'epigenome', 'experience', 'genetic analysis', 'genetic variant', 'genomic variation', 'graphical user interface', 'health record', 'high dimensionality', 'improved', 'innovation', 'insight', 'metagenome', 'mouse model', 'multiple omics', 'neurogenomics', 'neuronal circuitry', 'novel', 'precision medicine', 'prevent', 'programs', 'ranpirnase', 'rat genome', 'repository', 'sex', 'single cell analysis', 'software systems', 'tool', 'transcriptome', 'transcriptomics', 'web portal']",NIDA,UNIVERSITY OF TENNESSEE HEALTH SCI CTR,P30,2018,773018,0.15069863377216314
"Overall NIDA Core ""Center of Excellence"" in Transcriptomics, Systems Genetics and the Addictome Addiction is a highly complex disease with risk factors that include genetic variants and differences in development, sex, and environment. The long term potential of precision medicine to improve drug treatment and prevention depends on gaining a much better understanding how genetics, drugs, brain cells, and neuronal circuitry interact to influence behavior. There are serious technical barriers that prevent researchers and clinicians from incorporating more powerful computational and predictive methods in addiction research. The purpose of the NIDA P30 Core Center of Excellence in Omics, Systems Genetics, and the Addictome is to empower and train researchers supported by NIH, NIDA, NIAAA, and other federal and state institutions to use more quantitative and testable ways to analyze genetic, epigenetic, and the environmental factors that influence drug abuse risk and treatment. In the Transcriptome Informatics and Mechanisms research core we assemble and upgrade hundreds of large genome (DNA) and transcriptome (RNA) datasets for experimental rodent (rat) models of addiction. In the Systems Analytics and Modeling research core, we are using innovative systems genetics methods (gene mapping) to understand the linkage between DNA differences, environmental risks such as stress, and the differential risk of drug abuse and relapse. Our Pilot core is catalyzing new collaborations among young investigator in the field of addiction research. In sum the Center is a national resource for more reproducible research in addiction. We are centralizing, archiving, distributing, analyzing and integrating high quality data, metadata, using open software systems in collaboration with many other teams of researchers. Our goal is to help build toward an NIDA Addictome Portal that will include all genomic research relevant to addiction research. PROJECT NARRATIVE The NIDA Core Center of Excellence in Omics, Systems Genetics, and the Addictome (OSGA) provides genomic and computational support to a large number of research scientists working on mechanisms and treatment of addiction. The two main research cores of OSGA are providing support for transcriptome, epigenome, and metagenome studies of rat models of addiction at many levels of analysis. We are also creating open access tools and a powerful web portal to catalyze more effective and replicable use of massive datasets generated by programs in addiction biology and treatment.","Overall NIDA Core ""Center of Excellence"" in Transcriptomics, Systems Genetics and the Addictome",9360448,P30DA044223,"['Archives', 'Bayesian Modeling', 'Behavior', 'Behavioral', 'Bioinformatics', 'Biological Assay', 'Biology', 'Biometry', 'Cells', 'Chromosome Mapping', 'Collaborations', 'Communities', 'Complex', 'Computer software', 'Computing Methodologies', 'Consult', 'DNA', 'DNA Sequence', 'Data', 'Data Quality', 'Data Set', 'Databases', 'Development', 'Disease', 'Drug Interactions', 'Drug abuse', 'Educational workshop', 'Ensure', 'Environment', 'Environmental Risk Factor', 'Epigenetic Process', 'Foundations', 'Funding', 'Future', 'Genes', 'Genetic', 'Genetic Variation', 'Genome', 'Genomics', 'Genotype', 'Goals', 'Human', 'Hybrids', 'Image', 'Imagery', 'Informatics', 'Institution', 'Joints', 'Leadership', 'Learning', 'Machine Learning', 'Metadata', 'Methods', 'Modeling', 'Molecular', 'National Institute of Drug Abuse', 'National Institute on Alcohol Abuse and Alcoholism', 'Neurosciences Research', 'Pharmaceutical Preparations', 'Pharmacotherapy', 'Population', 'Prevention', 'Proteome', 'Publications', 'Publishing', 'Quantitative Genetics', 'Quantitative Trait Loci', 'RNA', 'Rattus', 'Relapse', 'Reproducibility', 'Research', 'Research Personnel', 'Resources', 'Risk', 'Risk Factors', 'Rodent', 'Role', 'Scientist', 'Site', 'Standardization', 'Statistical Models', 'Stress', 'Sum', 'System', 'Systems Analysis', 'Testing', 'Training', 'Translations', 'United States National Institutes of Health', 'Update', 'Variant', 'Work', 'addiction', 'base', 'behavior influence', 'brain cell', 'career', 'cohort', 'computerized tools', 'computing resources', 'data archive', 'data integration', 'data modeling', 'digital imaging', 'drug relapse', 'epigenome', 'experience', 'genetic analysis', 'genetic variant', 'genomic variation', 'graphical user interface', 'health record', 'high dimensionality', 'improved', 'innovation', 'insight', 'metagenome', 'mouse model', 'neuronal circuitry', 'novel', 'precision medicine', 'prevent', 'programs', 'ranpirnase', 'rat genome', 'repository', 'sex', 'single cell analysis', 'software systems', 'tool', 'transcriptome', 'transcriptomics', 'web portal']",NIDA,UNIVERSITY OF TENNESSEE HEALTH SCI CTR,P30,2017,906404,0.15069863377216314
"Carolina Population Center PROJECT SUMMARY/ABSTRACT The Carolina Population Center requests infrastructure support that will advance population dynamics research at CPC by increasing research impact, innovation, and productivity, supporting the development of junior scientists, and reducing the administrative burden on scientists. Infrastructure support will advance science in three primary research areas: Sexuality, Reproduction, Fertility, and Families; Population, Health, and the Environment; and Inequality, Mobility, Disparities, and Well-Being. Much of the research at CPC draws on large publicly available longitudinal data sets that our faculty have designed and collected, including the National Longitudinal Study of Adolescent to Adult Health, the China Health and Nutrition Survey, newer surveys associated with the Transfer Project, and the Study of the Tsunami Aftermath and Recovery, all of which will continue to be important in work related to our primary research areas over the next five years. These projects embody several themes that have guided research at CPC since the Center's inception. These themes, which will continue to shape our work, are the importance of life course processes and longitudinal data, multi-level processes and measurement of context, interventions and natural experiments as means of learning about causal processes, and the relevance of sociodemographic variables such as age, gender, race- ethnicity, and socioeconomic status for disparities in health and well-being. By embedding these themes, our projects provide data that enable us to address barriers that otherwise impede progress in the population sciences generally, and in our primary research areas in particular. We request support for three cores which in combination will provide an institutional infrastructure that will push populations dynamics research forward by empowering CPC faculty to tackle challenging questions using state of the art measurement techniques and methods. The Administrative Core plans activities that maintain a stimulating intellectual community, streamlines administrative processes so that scientists can focus on research, coordinates activities of the Cores so that services are offered efficiently, and communicates information about research and data more broadly. The Development Core supports early stage investigators and other faculty with exciting new ideas through multiple mechanisms: workshops, access to technical expertise in measurement, and seed grants. The Research Services Core enables scientists to address complex and important population research issues by providing access to state-of-the-art research tools and professional support for programming, survey development, and analysis. NARRATIVE This project will provide infrastructure support for a cutting edge program of research on population dynamics at the Carolina Population Center. Research at the Center will analyze state-of-the art data to address fundamental questions regarding fertility, adolescent health, and links between the environment and health. Special attention will be paid to factors creating health disparities.",Carolina Population Center,10005569,P2CHD050924,"['Address', 'Adolescent', 'Adopted', 'Adult', 'Age', 'Applications Grants', 'Area', 'Attention', 'Biological Markers', 'China', 'Cognitive', 'Collaborations', 'Communication', 'Communities', 'Complex', 'Computer Vision Systems', 'Creativeness', 'Data', 'Data Collection', 'Development', 'Diffuse', 'Educational workshop', 'Environment', 'Ethnic Origin', 'Extramural Activities', 'Faculty', 'Family', 'Fertility', 'Fostering', 'Funding', 'Gender', 'Genetic', 'Grant', 'Hand', 'Health', 'Health Surveys', 'Home environment', 'Inequality', 'Infrastructure', 'Intervention', 'Journals', 'Learning', 'Life Cycle Stages', 'Link', 'Longitudinal Studies', 'Machine Learning', 'Mainstreaming', 'Measurement', 'Mentors', 'Methods', 'Natural experiment', 'Nutrition Surveys', 'Personal Satisfaction', 'Phase', 'Policy Making', 'Population', 'Population Dynamics', 'Population Research', 'Population Sciences', 'Postdoctoral Fellow', 'Process', 'Production', 'Productivity', 'Publishing', 'Race', 'Recovery', 'Reproduction', 'Research', 'Research Design', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Resources', 'Schools', 'Science', 'Scientific Advances and Accomplishments', 'Scientist', 'Seeds', 'Services', 'Sexuality', 'Shapes', 'Socioeconomic Status', 'Structure', 'Students', 'Surveys', 'Talents', 'Teacher Professional Development', 'Technical Expertise', 'Techniques', 'Training Programs', 'Tsunami', 'Universities', 'Work', 'adolescent health', 'career', 'collaborative environment', 'cost', 'data access', 'design', 'empowered', 'experience', 'faculty support', 'health disparity', 'innovation', 'interdisciplinary collaboration', 'longitudinal dataset', 'novel strategies', 'population health', 'privacy protection', 'programs', 'research and development', 'response', 'sociodemographic variables', 'success', 'tool']",NICHD,UNIV OF NORTH CAROLINA CHAPEL HILL,P2C,2020,774402,0.08007517002629794
"Integrating experiment and theory for predicting protein folding pathways and structure Project Summary/Abstract  Protein folding and dynamics are integral to many biological activities, including chaperone action, degradation, amyloid diseases and aging. Our goal is to combine experimental and computational studies to produce a predictive understanding of protein dynamics through the development of methods capable of simulating folding and dynamics just using physio-chemical principles. Our past studies have focused on single domain proteins. Our efforts have expanded to more complicated systems including the snow flea anti-freeze protein (sfAFP) and TonB-dependent transporters (TBDT) that are relevant to iron sequestration in pathogenic bacteria. Tying these studies together is our new molecular dynamics (MD) package, Upside, which can reversibly fold some proteins up to 97 AA to under 4  C-RMSD in cpu-days without the use of fragments, homology or evolution. Upside utilizes a number of unique features, including rapid side chain packing that enables simulations using only 3 backbone atoms while retaining considerable detail and avoiding side chain rattling, which slows all-atom methods. We will improve Upside and implement enhanced sampling methods to increase our accuracy and size range, and study protein dynamics as monitored by hydrogen exchange.  sfAFP's unique structure challenges conventional wisdom regarding cooperative folding and stability. Lacking a hydrophobic core to promote folding, other factors must contribute to sfAFP's stability. We will test our quantum calculations that sfAFP's H-bonds are unusually stable by measuring amide H/D fractionation factors and NMR J-couplings. We will evaluate whether intrinsic biases in backbone dihedral angles for the PP2 basin in the unfolded state are another major stabilizing factor. This information will be used to improve the Upside simulations. Finally, we will apply our standard folding tools to characterize the folding pathway and compare it to the behavior we expect based on principles derived from proteins with hydrophobic cores.  Many aspects of the transport cycle in TBDT remain unknown despite protracted study, including the conformational rearrangement of the plug domain during transport. We will provide the first structure of the plug domain outside the barrel, and so answer whether this structure matches the crystal structure in the barrel. Additionally, the study of Nakamoto's V10C-S120C variant of the BtuB plug enables the investigation of a possible folding or transport intermediate. We will characterize the plug's dynamics while it is in the barrel using HX to observe possible transport-competent states. The mechanism of plug folding and insertion into the barrel will be investigated, with comparative studies for FhuA, a TBDT whose plug domain is intrinsically disordered in solution. These studies represent an exciting combination of protein folding and function, at the interface between soluble and membrane folding, using experiments and complementary folding simulations. Project Narrative We are combining experimental and computational approaches to produce a predictive understanding of protein folding and dynamics. Our focus has expanded to more complicated systems, including an anti-freeze protein and the plug domain of the TonB-dependent transporters involved in pathogenic bacterial iron sequestration. Tying these studies together is our new molecular dynamics Upside package, which is capable of predicting protein folding, dynamics and structure.",Integrating experiment and theory for predicting protein folding pathways and structure,9938596,R01GM055694,"['Aging', 'Amides', 'Amyloidosis', 'Antifreeze Proteins', 'Behavior', 'Binding', 'Biological', 'Biological Models', 'Burial', 'Chemicals', 'Communities', 'Comparative Study', 'Crystallization', 'Development', 'Disease', 'Equilibrium', 'Evolution', 'Fleas', 'Fractionation', 'Free Energy', 'Future', 'Glycine', 'Goals', 'Host Defense Mechanism', 'Hydrogen', 'Hydrogen Bonding', 'Hydrophobicity', 'Investigation', 'Iron', 'Measures', 'Membrane', 'Membrane Proteins', 'Membrane Transport Proteins', 'Metals', 'Methods', 'Mind', 'Molecular Chaperones', 'Molecular Conformation', 'Monitor', 'Neisseria', 'Pathogenicity', 'Pathway interactions', 'Procedures', 'Property', 'Protein Conformation', 'Protein Dynamics', 'Proteins', 'Race', 'Sampling', 'Shigella', 'Side', 'Structure', 'System', 'Tertiary Protein Structure', 'Testing', 'Time', 'Training', 'Variant', 'Vertebral column', 'Yersinia', 'arm', 'base', 'computer studies', 'conformer', 'design', 'disulfide bond', 'experimental study', 'improved', 'machine learning method', 'method development', 'molecular dynamics', 'pathogen', 'pathogenic bacteria', 'polyproline', 'pressure', 'protein degradation', 'protein folding', 'protein function', 'quantum', 'simulation', 'theories', 'tool']",NIGMS,UNIVERSITY OF CHICAGO,R01,2020,399787,0.054408553557086486
"Integrating experiment and theory for predicting protein folding pathways and structure Project Summary/Abstract  Protein folding and dynamics are integral to many biological activities, including chaperone action, degradation, amyloid diseases and aging. Our goal is to combine experimental and computational studies to produce a predictive understanding of protein dynamics through the development of methods capable of simulating folding and dynamics just using physio-chemical principles. Our past studies have focused on single domain proteins. Our efforts have expanded to more complicated systems including the snow flea anti-freeze protein (sfAFP) and TonB-dependent transporters (TBDT) that are relevant to iron sequestration in pathogenic bacteria. Tying these studies together is our new molecular dynamics (MD) package, Upside, which can reversibly fold some proteins up to 97 AA to under 4  C-RMSD in cpu-days without the use of fragments, homology or evolution. Upside utilizes a number of unique features, including rapid side chain packing that enables simulations using only 3 backbone atoms while retaining considerable detail and avoiding side chain rattling, which slows all-atom methods. We will improve Upside and implement enhanced sampling methods to increase our accuracy and size range, and study protein dynamics as monitored by hydrogen exchange.  sfAFP's unique structure challenges conventional wisdom regarding cooperative folding and stability. Lacking a hydrophobic core to promote folding, other factors must contribute to sfAFP's stability. We will test our quantum calculations that sfAFP's H-bonds are unusually stable by measuring amide H/D fractionation factors and NMR J-couplings. We will evaluate whether intrinsic biases in backbone dihedral angles for the PP2 basin in the unfolded state are another major stabilizing factor. This information will be used to improve the Upside simulations. Finally, we will apply our standard folding tools to characterize the folding pathway and compare it to the behavior we expect based on principles derived from proteins with hydrophobic cores.  Many aspects of the transport cycle in TBDT remain unknown despite protracted study, including the conformational rearrangement of the plug domain during transport. We will provide the first structure of the plug domain outside the barrel, and so answer whether this structure matches the crystal structure in the barrel. Additionally, the study of Nakamoto's V10C-S120C variant of the BtuB plug enables the investigation of a possible folding or transport intermediate. We will characterize the plug's dynamics while it is in the barrel using HX to observe possible transport-competent states. The mechanism of plug folding and insertion into the barrel will be investigated, with comparative studies for FhuA, a TBDT whose plug domain is intrinsically disordered in solution. These studies represent an exciting combination of protein folding and function, at the interface between soluble and membrane folding, using experiments and complementary folding simulations. Project Narrative We are combining experimental and computational approaches to produce a predictive understanding of protein folding and dynamics. Our focus has expanded to more complicated systems, including an anti-freeze protein and the plug domain of the TonB-dependent transporters involved in pathogenic bacterial iron sequestration. Tying these studies together is our new molecular dynamics Upside package, which is capable of predicting protein folding, dynamics and structure.",Integrating experiment and theory for predicting protein folding pathways and structure,9535348,R01GM055694,"['Aging', 'Amides', 'Amyloidosis', 'Antifreeze Proteins', 'Behavior', 'Binding', 'Biological', 'Biological Models', 'Burial', 'Chemicals', 'Communities', 'Comparative Study', 'Crystallization', 'Development', 'Disease', 'Equilibrium', 'Evolution', 'Fleas', 'Fractionation', 'Free Energy', 'Future', 'Glycine', 'Goals', 'Host Defense Mechanism', 'Hydrogen', 'Hydrogen Bonding', 'Hydrophobicity', 'Investigation', 'Iron', 'Machine Learning', 'Measures', 'Membrane', 'Membrane Proteins', 'Membrane Transport Proteins', 'Metals', 'Methods', 'Mind', 'Molecular Chaperones', 'Molecular Conformation', 'Monitor', 'Neisseria', 'Pathogenicity', 'Pathway interactions', 'Procedures', 'Property', 'Protein Conformation', 'Protein Dynamics', 'Proteins', 'Race', 'Sampling', 'Shigella', 'Side', 'Structure', 'System', 'Tertiary Protein Structure', 'Testing', 'Time', 'Training', 'Variant', 'Vertebral column', 'Yersinia', 'arm', 'base', 'computer studies', 'conformer', 'design', 'disulfide bond', 'experimental study', 'improved', 'learning strategy', 'method development', 'molecular dynamics', 'pathogen', 'pathogenic bacteria', 'polyproline', 'pressure', 'protein degradation', 'protein folding', 'protein function', 'quantum', 'simulation', 'theories', 'tool']",NIGMS,UNIVERSITY OF CHICAGO,R01,2018,399787,0.054408553557086486
"Integrating experiment and theory for predicting protein folding pathways and structure Project Summary/Abstract  Protein folding and dynamics are integral to many biological activities, including chaperone action, degradation, amyloid diseases and aging. Our goal is to combine experimental and computational studies to produce a predictive understanding of protein dynamics through the development of methods capable of simulating folding and dynamics just using physio-chemical principles. Our past studies have focused on single domain proteins. Our efforts have expanded to more complicated systems including the snow flea anti-freeze protein (sfAFP) and TonB-dependent transporters (TBDT) that are relevant to iron sequestration in pathogenic bacteria. Tying these studies together is our new molecular dynamics (MD) package, Upside, which can reversibly fold some proteins up to 97 AA to under 4  C-RMSD in cpu-days without the use of fragments, homology or evolution. Upside utilizes a number of unique features, including rapid side chain packing that enables simulations using only 3 backbone atoms while retaining considerable detail and avoiding side chain rattling, which slows all-atom methods. We will improve Upside and implement enhanced sampling methods to increase our accuracy and size range, and study protein dynamics as monitored by hydrogen exchange.  sfAFP's unique structure challenges conventional wisdom regarding cooperative folding and stability. Lacking a hydrophobic core to promote folding, other factors must contribute to sfAFP's stability. We will test our quantum calculations that sfAFP's H-bonds are unusually stable by measuring amide H/D fractionation factors and NMR J-couplings. We will evaluate whether intrinsic biases in backbone dihedral angles for the PP2 basin in the unfolded state are another major stabilizing factor. This information will be used to improve the Upside simulations. Finally, we will apply our standard folding tools to characterize the folding pathway and compare it to the behavior we expect based on principles derived from proteins with hydrophobic cores.  Many aspects of the transport cycle in TBDT remain unknown despite protracted study, including the conformational rearrangement of the plug domain during transport. We will provide the first structure of the plug domain outside the barrel, and so answer whether this structure matches the crystal structure in the barrel. Additionally, the study of Nakamoto's V10C-S120C variant of the BtuB plug enables the investigation of a possible folding or transport intermediate. We will characterize the plug's dynamics while it is in the barrel using HX to observe possible transport-competent states. The mechanism of plug folding and insertion into the barrel will be investigated, with comparative studies for FhuA, a TBDT whose plug domain is intrinsically disordered in solution. These studies represent an exciting combination of protein folding and function, at the interface between soluble and membrane folding, using experiments and complementary folding simulations. Project Narrative We are combining experimental and computational approaches to produce a predictive understanding of protein folding and dynamics. Our focus has expanded to more complicated systems, including an anti-freeze protein and the plug domain of the TonB-dependent transporters involved in pathogenic bacterial iron sequestration. Tying these studies together is our new molecular dynamics Upside package, which is capable of predicting protein folding, dynamics and structure.",Integrating experiment and theory for predicting protein folding pathways and structure,9403133,R01GM055694,"['Aging', 'Amides', 'Amyloidosis', 'Antifreeze Proteins', 'Behavior', 'Binding', 'Biological', 'Biological Models', 'Burial', 'Chemicals', 'Communities', 'Comparative Study', 'Crystallization', 'Development', 'Disease', 'Equilibrium', 'Evolution', 'Fleas', 'Fractionation', 'Free Energy', 'Future', 'Glycine', 'Goals', 'Host Defense Mechanism', 'Hydrogen', 'Hydrogen Bonding', 'Hydrophobicity', 'Investigation', 'Iron', 'Machine Learning', 'Measures', 'Membrane', 'Membrane Proteins', 'Membrane Transport Proteins', 'Metals', 'Methods', 'Mind', 'Molecular Chaperones', 'Molecular Conformation', 'Monitor', 'Neisseria', 'Pathogenicity', 'Pathway interactions', 'Procedures', 'Property', 'Protein Conformation', 'Protein Dynamics', 'Proteins', 'Race', 'Sampling', 'Shigella', 'Side', 'Snow', 'Structure', 'System', 'Tertiary Protein Structure', 'Testing', 'Time', 'Training', 'Variant', 'Vertebral column', 'Yersinia', 'arm', 'base', 'computer studies', 'conformer', 'design', 'disulfide bond', 'experimental study', 'improved', 'learning strategy', 'method development', 'molecular dynamics', 'pathogen', 'pathogenic bacteria', 'polyproline', 'pressure', 'protein degradation', 'protein folding', 'protein function', 'quantum', 'simulation', 'theories', 'tool']",NIGMS,UNIVERSITY OF CHICAGO,R01,2017,399787,0.054408553557086486
"Integrating experiment and theory for predicting protein folding pathways and structure Project Summary/Abstract  Protein folding and dynamics are integral to many biological activities, including chaperone action, degradation, amyloid diseases and aging. Our goal is to combine experimental and computational studies to produce a predictive understanding of protein dynamics through the development of methods capable of simulating folding and dynamics just using physio-chemical principles. Our past studies have focused on single domain proteins. Our efforts have expanded to more complicated systems including the snow flea anti-freeze protein (sfAFP) and TonB-dependent transporters (TBDT) that are relevant to iron sequestration in pathogenic bacteria. Tying these studies together is our new molecular dynamics (MD) package, Upside, which can reversibly fold some proteins up to 97 AA to under 4  C-RMSD in cpu-days without the use of fragments, homology or evolution. Upside utilizes a number of unique features, including rapid side chain packing that enables simulations using only 3 backbone atoms while retaining considerable detail and avoiding side chain rattling, which slows all-atom methods. We will improve Upside and implement enhanced sampling methods to increase our accuracy and size range, and study protein dynamics as monitored by hydrogen exchange.  sfAFP's unique structure challenges conventional wisdom regarding cooperative folding and stability. Lacking a hydrophobic core to promote folding, other factors must contribute to sfAFP's stability. We will test our quantum calculations that sfAFP's H-bonds are unusually stable by measuring amide H/D fractionation factors and NMR J-couplings. We will evaluate whether intrinsic biases in backbone dihedral angles for the PP2 basin in the unfolded state are another major stabilizing factor. This information will be used to improve the Upside simulations. Finally, we will apply our standard folding tools to characterize the folding pathway and compare it to the behavior we expect based on principles derived from proteins with hydrophobic cores.  Many aspects of the transport cycle in TBDT remain unknown despite protracted study, including the conformational rearrangement of the plug domain during transport. We will provide the first structure of the plug domain outside the barrel, and so answer whether this structure matches the crystal structure in the barrel. Additionally, the study of Nakamoto's V10C-S120C variant of the BtuB plug enables the investigation of a possible folding or transport intermediate. We will characterize the plug's dynamics while it is in the barrel using HX to observe possible transport-competent states. The mechanism of plug folding and insertion into the barrel will be investigated, with comparative studies for FhuA, a TBDT whose plug domain is intrinsically disordered in solution. These studies represent an exciting combination of protein folding and function, at the interface between soluble and membrane folding, using experiments and complementary folding simulations. Project Narrative We are combining experimental and computational approaches to produce a predictive understanding of protein folding and dynamics. Our focus has expanded to more complicated systems, including an anti-freeze protein and the plug domain of the TonB-dependent transporters involved in pathogenic bacterial iron sequestration. Tying these studies together is our new molecular dynamics Upside package, which is capable of predicting protein folding, dynamics and structure.",Integrating experiment and theory for predicting protein folding pathways and structure,9706861,R01GM055694,"['Aging', 'Amides', 'Amyloidosis', 'Antifreeze Proteins', 'Behavior', 'Binding', 'Biological', 'Biological Models', 'Burial', 'Chemicals', 'Communities', 'Comparative Study', 'Crystallization', 'Development', 'Disease', 'Equilibrium', 'Evolution', 'Fleas', 'Fractionation', 'Free Energy', 'Future', 'Glycine', 'Goals', 'Host Defense Mechanism', 'Hydrogen', 'Hydrogen Bonding', 'Hydrophobicity', 'Investigation', 'Iron', 'Machine Learning', 'Measures', 'Membrane', 'Membrane Proteins', 'Membrane Transport Proteins', 'Metals', 'Methods', 'Mind', 'Molecular Chaperones', 'Molecular Conformation', 'Monitor', 'Neisseria', 'Pathogenicity', 'Pathway interactions', 'Procedures', 'Property', 'Protein Conformation', 'Protein Dynamics', 'Proteins', 'Race', 'Sampling', 'Shigella', 'Side', 'Structure', 'System', 'Tertiary Protein Structure', 'Testing', 'Time', 'Training', 'Variant', 'Vertebral column', 'Yersinia', 'arm', 'base', 'computer studies', 'conformer', 'design', 'disulfide bond', 'experimental study', 'improved', 'learning strategy', 'method development', 'molecular dynamics', 'pathogen', 'pathogenic bacteria', 'polyproline', 'pressure', 'protein degradation', 'protein folding', 'protein function', 'quantum', 'simulation', 'theories', 'tool']",NIGMS,UNIVERSITY OF CHICAGO,R01,2019,399787,0.054408553557086486
"Psoriasis Center of Research Translation The Psoriasis Center of Research Translation at Case Western Reserve University (CORT) will advance translational discovery and application in psoriasis using a cutting-edge systems biology approach that integrates patient-centered data within a rich and synergistic /collaborative institutional environment. We will leverage extensive preclinical, clinical and translational resources with the expertise and experience of our CWRU interdisciplinary research team, which encompasses bioinformatics, micro/myocobiome, psoriasis patient care, cutaneous immunology and transgenic models.  The overall goal of the CORT is to combine new bioinformatic methodologies with advanced murine and human experimental approaches to translate scientific findings into clinical applications that more nimbly advance therapy for psoriasis and related inflammatory comorbidities. Our highly innovative, synergistic and cross-disciplinary CORT model will use a collaborative research project (CRP) as a central hub with bi- directional input from 2 highly interactive research cores, to refine and test hypotheses, identify and test drug leads and advance understanding of psoriasis and related inflammatory comorbidities. To do so, the CRP will integrate input from the: 1) Preclinical Modeling Core (PMC), that will provide and customize our many validated, unique transgenic psoriasiform animal models and translatable human xenograft approaches, essential to translating new mediator/pathway roles and drug leads; 2) Applied Meta-`Omics Core (AMC), that will apply multi-platform (transcriptome, metabolome, micro/mycobiome) bioinformatics to individual patient and murine samples to identify novel pathway-specific targets. Iterative experimental testing of these targets and feedback from the PMC and CRP will identify key novel pathways critical for psoriasis pathogenesis likely to benefit from intervention by new drugs or repurposed existing drugs for psoriasis therapy.  Our patient-centered translational approach will exploit and enhance a novel, comprehensive and highly annotated database of ~850 psoriasis/psoriatic arthritis single-patient case records that combines clinical information derived from CLEARPATH (an Ohio medical provider consortium-based unified EMR repository for research access), with inflammation markers that stratify subsets. Into each patient's EMR, we will directly integrate his/her meta'Omics data created by the AMC working with the CRP, to create an 'Omics-integrated EMR (EMRi) data set. These cohesive multi-platform personal data records will identify psoriasis patient endotypes based upon unique perturbations identified from their meta'Omics analyses. Our overarching hypothesis is that by powerfully combining existing and developing psoriasis basic science datasets, patient records, bioinformatics and computational systems biology with bi-directional mouse and human studies, we will identify new therapeutic targets and repurposed drugs that can be expeditiously moved to clinical trials, improving psoriasis treatment and patient care. The Psoriasis CORT at Case Western Reserve University and University Hospitals Cleveland Medical Center uses emerging capabilities of data analyses that can assemble many aspects of a single psoriasis patient in great detail, including their gene expression in skin and blood cells, the skin microbes (both bacterial and fungal) and the clinical features that are recorded in their electronic medical record (EMR). Using advanced computer algorithms to compare in-house patient data against externally available large databases, we can identify drugs already approved by the FDA that may be repurposed to treat psoriasis, and validate/invalidate them in animal models and patient cells.",Psoriasis Center of Research Translation,10005116,P50AR070590,"['Advisory Committees', 'Animal Model', 'Artificial Intelligence', 'Basic Science', 'Bioinformatics', 'Biological', 'Biological Markers', 'Biological Models', 'Blood Cells', 'Cells', 'Clinical', 'Clinical Trials', 'Computational Biology', 'Computational algorithm', 'Computerized Medical Record', 'Coupled', 'Critical Pathways', 'Custom', 'Cutaneous', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Decision Making', 'Development', 'Drug Targeting', 'Environment', 'FDA approved', 'Feedback', 'Gene Expression', 'Gene Targeting', 'Goals', 'Growth', 'Human', 'Human Resources', 'Immunology', 'Inflammatory', 'Interdisciplinary Study', 'Intervention', 'Laboratories', 'Leadership', 'Link', 'Machine Learning', 'Mediator of activation protein', 'Medical', 'Medical center', 'Methodology', 'Methods', 'Microbe', 'Modeling', 'Molecular', 'Mus', 'Ohio', 'Pathogenesis', 'Pathogenicity', 'Pathway interactions', 'Patient Care', 'Patients', 'Pharmaceutical Preparations', 'Pre-Clinical Model', 'Provider', 'Psoriasis', 'Psoriatic Arthritis', 'Records', 'Records Controls', 'Research', 'Research Project Grants', 'Resource Allocation', 'Resources', 'Role', 'Sampling', 'Skin', 'Systems Biology', 'Techniques', 'Technology', 'Testing', 'Transgenic Model', 'Transgenic Organisms', 'Translating', 'Translational Research', 'Universities', 'University Hospitals', 'Xenograft procedure', 'base', 'clinical application', 'cohesion', 'cohort', 'comorbidity', 'data mining', 'design', 'differential expression', 'drug development', 'drug discovery', 'drug testing', 'effective intervention', 'experience', 'improved', 'individual patient', 'inflammatory marker', 'innovation', 'meetings', 'metabolome', 'metabolomics', 'microbiome', 'multimodality', 'mycobiome', 'new therapeutic target', 'novel', 'novel strategies', 'novel therapeutics', 'patient oriented', 'pre-clinical', 'pre-clinical research', 'programs', 'repository', 'response', 'synergism', 'therapeutic target', 'transcriptome', 'transcriptomics', 'translational approach']",NIAMS,CASE WESTERN RESERVE UNIVERSITY,P50,2020,1316550,0.08614699772966652
"Psoriasis Center of Research Translation The Psoriasis Center of Research Translation at Case Western Reserve University (CORT) will advance translational discovery and application in psoriasis using a cutting-edge systems biology approach that integrates patient-centered data within a rich and synergistic /collaborative institutional environment. We will leverage extensive preclinical, clinical and translational resources with the expertise and experience of our CWRU interdisciplinary research team, which encompasses bioinformatics, micro/myocobiome, psoriasis patient care, cutaneous immunology and transgenic models.  The overall goal of the CORT is to combine new bioinformatic methodologies with advanced murine and human experimental approaches to translate scientific findings into clinical applications that more nimbly advance therapy for psoriasis and related inflammatory comorbidities. Our highly innovative, synergistic and cross-disciplinary CORT model will use a collaborative research project (CRP) as a central hub with bi- directional input from 2 highly interactive research cores, to refine and test hypotheses, identify and test drug leads and advance understanding of psoriasis and related inflammatory comorbidities. To do so, the CRP will integrate input from the: 1) Preclinical Modeling Core (PMC), that will provide and customize our many validated, unique transgenic psoriasiform animal models and translatable human xenograft approaches, essential to translating new mediator/pathway roles and drug leads; 2) Applied Meta-`Omics Core (AMC), that will apply multi-platform (transcriptome, metabolome, micro/mycobiome) bioinformatics to individual patient and murine samples to identify novel pathway-specific targets. Iterative experimental testing of these targets and feedback from the PMC and CRP will identify key novel pathways critical for psoriasis pathogenesis likely to benefit from intervention by new drugs or repurposed existing drugs for psoriasis therapy.  Our patient-centered translational approach will exploit and enhance a novel, comprehensive and highly annotated database of ~850 psoriasis/psoriatic arthritis single-patient case records that combines clinical information derived from CLEARPATH (an Ohio medical provider consortium-based unified EMR repository for research access), with inflammation markers that stratify subsets. Into each patient's EMR, we will directly integrate his/her meta'Omics data created by the AMC working with the CRP, to create an 'Omics-integrated EMR (EMRi) data set. These cohesive multi-platform personal data records will identify psoriasis patient endotypes based upon unique perturbations identified from their meta'Omics analyses. Our overarching hypothesis is that by powerfully combining existing and developing psoriasis basic science datasets, patient records, bioinformatics and computational systems biology with bi-directional mouse and human studies, we will identify new therapeutic targets and repurposed drugs that can be expeditiously moved to clinical trials, improving psoriasis treatment and patient care. The Psoriasis CORT at Case Western Reserve University and University Hospitals Cleveland Medical Center uses emerging capabilities of data analyses that can assemble many aspects of a single psoriasis patient in great detail, including their gene expression in skin and blood cells, the skin microbes (both bacterial and fungal) and the clinical features that are recorded in their electronic medical record (EMR). Using advanced computer algorithms to compare in-house patient data against externally available large databases, we can identify drugs already approved by the FDA that may be repurposed to treat psoriasis, and validate/invalidate them in animal models and patient cells.",Psoriasis Center of Research Translation,9792242,P50AR070590,"['Advisory Committees', 'Animal Model', 'Artificial Intelligence', 'Basic Science', 'Bioinformatics', 'Biological', 'Biological Markers', 'Biological Models', 'Blood Cells', 'Cells', 'Clinical', 'Clinical Trials', 'Comorbidity', 'Computational Biology', 'Computational algorithm', 'Computerized Medical Record', 'Coupled', 'Critical Pathways', 'Custom', 'Cutaneous', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Decision Making', 'Development', 'Drug Targeting', 'Environment', 'FDA approved', 'Feedback', 'Gene Expression', 'Gene Targeting', 'Goals', 'Growth', 'Human', 'Human Resources', 'Immunology', 'Inflammatory', 'Interdisciplinary Study', 'Intervention', 'Laboratories', 'Leadership', 'Link', 'Machine Learning', 'Mediator of activation protein', 'Medical', 'Medical center', 'Methodology', 'Methods', 'Microbe', 'Modeling', 'Molecular', 'Mus', 'Ohio', 'Pathogenesis', 'Pathogenicity', 'Pathway interactions', 'Patient Care', 'Patients', 'Pharmaceutical Preparations', 'Pre-Clinical Model', 'Provider', 'Psoriasis', 'Psoriatic Arthritis', 'Records', 'Records Controls', 'Research', 'Research Project Grants', 'Resource Allocation', 'Resources', 'Role', 'Sampling', 'Skin', 'Systems Biology', 'Techniques', 'Technology', 'Testing', 'Transgenic Model', 'Transgenic Organisms', 'Translating', 'Translational Research', 'Universities', 'University Hospitals', 'Xenograft procedure', 'base', 'clinical application', 'cohesion', 'cohort', 'data mining', 'design', 'differential expression', 'drug development', 'drug discovery', 'drug testing', 'effective intervention', 'experience', 'improved', 'individual patient', 'inflammatory marker', 'innovation', 'meetings', 'metabolome', 'metabolomics', 'microbiome', 'multimodality', 'mycobiome', 'new therapeutic target', 'novel', 'novel strategies', 'novel therapeutics', 'patient oriented', 'pre-clinical', 'pre-clinical research', 'programs', 'repository', 'response', 'synergism', 'therapeutic target', 'transcriptome', 'transcriptomics', 'translational approach']",NIAMS,CASE WESTERN RESERVE UNIVERSITY,P50,2019,1308373,0.08614699772966652
"Psoriasis Center of Research Translation The Psoriasis Center of Research Translation at Case Western Reserve University (CORT) will advance translational discovery and application in psoriasis using a cutting-edge systems biology approach that integrates patient-centered data within a rich and synergistic /collaborative institutional environment. We will leverage extensive preclinical, clinical and translational resources with the expertise and experience of our CWRU interdisciplinary research team, which encompasses bioinformatics, micro/myocobiome, psoriasis patient care, cutaneous immunology and transgenic models.  The overall goal of the CORT is to combine new bioinformatic methodologies with advanced murine and human experimental approaches to translate scientific findings into clinical applications that more nimbly advance therapy for psoriasis and related inflammatory comorbidities. Our highly innovative, synergistic and cross-disciplinary CORT model will use a collaborative research project (CRP) as a central hub with bi- directional input from 2 highly interactive research cores, to refine and test hypotheses, identify and test drug leads and advance understanding of psoriasis and related inflammatory comorbidities. To do so, the CRP will integrate input from the: 1) Preclinical Modeling Core (PMC), that will provide and customize our many validated, unique transgenic psoriasiform animal models and translatable human xenograft approaches, essential to translating new mediator/pathway roles and drug leads; 2) Applied Meta-`Omics Core (AMC), that will apply multi-platform (transcriptome, metabolome, micro/mycobiome) bioinformatics to individual patient and murine samples to identify novel pathway-specific targets. Iterative experimental testing of these targets and feedback from the PMC and CRP will identify key novel pathways critical for psoriasis pathogenesis likely to benefit from intervention by new drugs or repurposed existing drugs for psoriasis therapy.  Our patient-centered translational approach will exploit and enhance a novel, comprehensive and highly annotated database of ~850 psoriasis/psoriatic arthritis single-patient case records that combines clinical information derived from CLEARPATH (an Ohio medical provider consortium-based unified EMR repository for research access), with inflammation markers that stratify subsets. Into each patient's EMR, we will directly integrate his/her meta'Omics data created by the AMC working with the CRP, to create an 'Omics-integrated EMR (EMRi) data set. These cohesive multi-platform personal data records will identify psoriasis patient endotypes based upon unique perturbations identified from their meta'Omics analyses. Our overarching hypothesis is that by powerfully combining existing and developing psoriasis basic science datasets, patient records, bioinformatics and computational systems biology with bi-directional mouse and human studies, we will identify new therapeutic targets and repurposed drugs that can be expeditiously moved to clinical trials, improving psoriasis treatment and patient care. The Psoriasis CORT at Case Western Reserve University and University Hospitals Cleveland Medical Center uses emerging capabilities of data analyses that can assemble many aspects of a single psoriasis patient in great detail, including their gene expression in skin and blood cells, the skin microbes (both bacterial and fungal) and the clinical features that are recorded in their electronic medical record (EMR). Using advanced computer algorithms to compare in-house patient data against externally available large databases, we can identify drugs already approved by the FDA that may be repurposed to treat psoriasis, and validate/invalidate them in animal models and patient cells.",Psoriasis Center of Research Translation,9568310,P50AR070590,"['Advisory Committees', 'Animal Model', 'Artificial Intelligence', 'Basic Science', 'Bioinformatics', 'Biological', 'Biological Markers', 'Biological Models', 'Blood Cells', 'Cells', 'Clinical', 'Clinical Trials', 'Comorbidity', 'Computational Biology', 'Computational algorithm', 'Computerized Medical Record', 'Coupled', 'Critical Pathways', 'Custom', 'Cutaneous', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Decision Making', 'Development', 'Drug Targeting', 'Environment', 'FDA approved', 'Feedback', 'Gene Expression', 'Gene Targeting', 'Goals', 'Growth', 'Human', 'Human Resources', 'Immunology', 'Inflammatory', 'Interdisciplinary Study', 'Intervention', 'Laboratories', 'Leadership', 'Link', 'Machine Learning', 'Mediator of activation protein', 'Medical', 'Medical center', 'Methodology', 'Methods', 'Microbe', 'Modeling', 'Molecular', 'Mus', 'Ohio', 'Pathogenesis', 'Pathogenicity', 'Pathway interactions', 'Patient Care', 'Patients', 'Pharmaceutical Preparations', 'Pre-Clinical Model', 'Provider', 'Psoriasis', 'Psoriatic Arthritis', 'Records', 'Records Controls', 'Research', 'Research Project Grants', 'Resource Allocation', 'Resources', 'Role', 'Sampling', 'Skin', 'Systems Biology', 'Techniques', 'Technology', 'Testing', 'Transgenic Model', 'Transgenic Organisms', 'Translating', 'Translational Research', 'Universities', 'University Hospitals', 'Xenograft procedure', 'base', 'clinical application', 'cohesion', 'cohort', 'data mining', 'design', 'differential expression', 'drug development', 'drug discovery', 'drug testing', 'effective intervention', 'experience', 'improved', 'individual patient', 'inflammatory marker', 'innovation', 'meetings', 'metabolome', 'metabolomics', 'microbiome', 'multimodality', 'multiple omics', 'mycobiome', 'new therapeutic target', 'novel', 'novel strategies', 'novel therapeutics', 'patient oriented', 'pre-clinical', 'pre-clinical research', 'programs', 'repository', 'response', 'synergism', 'therapeutic target', 'transcriptome', 'transcriptomics', 'translational approach']",NIAMS,CASE WESTERN RESERVE UNIVERSITY,P50,2018,1308227,0.08614699772966652
"Psoriasis Center of Research Translation The Psoriasis Center of Research Translation at Case Western Reserve University (CORT) will advance translational discovery and application in psoriasis using a cutting-edge systems biology approach that integrates patient-centered data within a rich and synergistic /collaborative institutional environment. We will leverage extensive preclinical, clinical and translational resources with the expertise and experience of our CWRU interdisciplinary research team, which encompasses bioinformatics, micro/myocobiome, psoriasis patient care, cutaneous immunology and transgenic models.  The overall goal of the CORT is to combine new bioinformatic methodologies with advanced murine and human experimental approaches to translate scientific findings into clinical applications that more nimbly advance therapy for psoriasis and related inflammatory comorbidities. Our highly innovative, synergistic and cross-disciplinary CORT model will use a collaborative research project (CRP) as a central hub with bi- directional input from 2 highly interactive research cores, to refine and test hypotheses, identify and test drug leads and advance understanding of psoriasis and related inflammatory comorbidities. To do so, the CRP will integrate input from the: 1) Preclinical Modeling Core (PMC), that will provide and customize our many validated, unique transgenic psoriasiform animal models and translatable human xenograft approaches, essential to translating new mediator/pathway roles and drug leads; 2) Applied Meta-`Omics Core (AMC), that will apply multi-platform (transcriptome, metabolome, micro/mycobiome) bioinformatics to individual patient and murine samples to identify novel pathway-specific targets. Iterative experimental testing of these targets and feedback from the PMC and CRP will identify key novel pathways critical for psoriasis pathogenesis likely to benefit from intervention by new drugs or repurposed existing drugs for psoriasis therapy.  Our patient-centered translational approach will exploit and enhance a novel, comprehensive and highly annotated database of ~850 psoriasis/psoriatic arthritis single-patient case records that combines clinical information derived from CLEARPATH (an Ohio medical provider consortium-based unified EMR repository for research access), with inflammation markers that stratify subsets. Into each patient's EMR, we will directly integrate his/her meta'Omics data created by the AMC working with the CRP, to create an 'Omics-integrated EMR (EMRi) data set. These cohesive multi-platform personal data records will identify psoriasis patient endotypes based upon unique perturbations identified from their meta'Omics analyses. Our overarching hypothesis is that by powerfully combining existing and developing psoriasis basic science datasets, patient records, bioinformatics and computational systems biology with bi-directional mouse and human studies, we will identify new therapeutic targets and repurposed drugs that can be expeditiously moved to clinical trials, improving psoriasis treatment and patient care. The Psoriasis CORT at Case Western Reserve University and University Hospitals Cleveland Medical Center uses emerging capabilities of data analyses that can assemble many aspects of a single psoriasis patient in great detail, including their gene expression in skin and blood cells, the skin microbes (both bacterial and fungal) and the clinical features that are recorded in their electronic medical record (EMR). Using advanced computer algorithms to compare in-house patient data against externally available large databases, we can identify drugs already approved by the FDA that may be repurposed to treat psoriasis, and validate/invalidate them in animal models and patient cells.",Psoriasis Center of Research Translation,9370683,P50AR070590,"['Advisory Committees', 'Animal Model', 'Artificial Intelligence', 'Basic Science', 'Bioinformatics', 'Biological', 'Biological Markers', 'Biological Models', 'Blood Cells', 'Cells', 'Clinical', 'Clinical Trials', 'Comorbidity', 'Computational Biology', 'Computational algorithm', 'Computerized Medical Record', 'Coupled', 'Critical Pathways', 'Custom', 'Cutaneous', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Decision Making', 'Development', 'Drug Targeting', 'Environment', 'FDA approved', 'Feedback', 'Gene Expression', 'Gene Targeting', 'Goals', 'Growth', 'Human', 'Human Resources', 'Immunology', 'Inflammatory', 'Interdisciplinary Study', 'Intervention', 'Laboratories', 'Leadership', 'Link', 'Machine Learning', 'Mediator of activation protein', 'Medical', 'Medical center', 'Methodology', 'Methods', 'Microbe', 'Modeling', 'Molecular', 'Mus', 'Ohio', 'Pathogenesis', 'Pathogenicity', 'Pathway interactions', 'Patient Care', 'Patients', 'Pharmaceutical Preparations', 'Pre-Clinical Model', 'Provider', 'Psoriasis', 'Psoriatic Arthritis', 'Records', 'Records Controls', 'Research', 'Research Project Grants', 'Resource Allocation', 'Resources', 'Role', 'Sampling', 'Skin', 'Systems Biology', 'Techniques', 'Technology', 'Testing', 'Transgenic Model', 'Transgenic Organisms', 'Translating', 'Translational Research', 'Universities', 'University Hospitals', 'Xenograft procedure', 'base', 'clinical application', 'cohesion', 'cohort', 'data mining', 'design', 'differential expression', 'drug development', 'drug discovery', 'drug testing', 'effective intervention', 'experience', 'improved', 'individual patient', 'inflammatory marker', 'innovation', 'meetings', 'metabolome', 'metabolomics', 'microbiome', 'multimodality', 'new therapeutic target', 'novel', 'novel strategies', 'novel therapeutics', 'patient oriented', 'pre-clinical', 'pre-clinical research', 'programs', 'repository', 'response', 'synergism', 'therapeutic target', 'transcriptome', 'transcriptomics', 'translational approach']",NIAMS,CASE WESTERN RESERVE UNIVERSITY,P50,2017,1276741,0.08614699772966652
"A Core Database of Interacting Proteins (DIP) The Database of Interacting Proteins (DIP) is the original and one of the most extensive databases of information on interacting proteins. It was founded on the assumption that macromoleQular interactions are at the basis of all biomedical science, and that researchers in many branches of biology and medicine can benefit from access to an accurate repository of what is known of protein interactions. To continue its expansion, DIP will adopt a procedure of direct deposition of experimental data by primary authors. Accuracy of interaction data being essential, methods for the assessment of data quality will be extended and applied to DIP, to define a Core set of highly reliable interaction data. The Core interactions will permit construction of networks of interacting proteins, useful to cell and systems biologists.  From its inception, DIP has been guided by a program of research into methods for extracting knowledge of networks from genomic and proteomic data. This research emphasis will be will be deepened by introducing new methods for extraction of information on protein networks from genomic and proteomic data, including logical triplet analysis of genomic and microarray data.  LiveDIP is the extension of DIP that concentrates on the interactions among proteins in defined states. A second extension of DIP, ProLinks, catalogs functional linkages between pairs of proteins inferred from genomic and proteomic data; it identifies pathways and complexes, and will serve as a feeder to DIP, as its inferred linkages are validated as true interactions. To provide faster and more reliable access to DIP, its IT infrastructure will be upgraded. n/a",A Core Database of Interacting Proteins (DIP),7569365,R01GM071909,"['Adopted', 'Binding', 'Biology', 'Cataloging', 'Catalogs', 'Cells', 'Communities', 'Complex', 'Data', 'Data Display', 'Data Quality', 'Databases', 'Deposition', 'Genomics', 'Knowledge', 'Link', 'Literature', 'Manuals', 'Medicine', 'Methods', 'Modeling', 'Paper', 'Pathway interactions', 'Procedures', 'Protein Databases', 'Protein Structure Initiative', 'Proteins', 'Proteomics', 'Publications', 'Ramp', 'Research', 'Research Infrastructure', 'Research Personnel', 'Science', 'Services', 'System', 'Time', 'Triplet Multiple Birth', 'Validation', 'Work', 'base', 'flexibility', 'programs', 'repository', 'text searching', 'tool', 'user-friendly']",NIGMS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2009,415414,0.15753769453148922
"A Core Database of Interacting Proteins (DIP) The Database of Interacting Proteins (DIP) is the original and one of the most extensive databases of information on interacting proteins. It was founded on the assumption that macromoleQular interactions are at the basis of all biomedical science, and that researchers in many branches of biology and medicine can benefit from access to an accurate repository of what is known of protein interactions. To continue its expansion, DIP will adopt a procedure of direct deposition of experimental data by primary authors. Accuracy of interaction data being essential, methods for the assessment of data quality will be extended and applied to DIP, to define a Core set of highly reliable interaction data. The Core interactions will permit construction of networks of interacting proteins, useful to cell and systems biologists.  From its inception, DIP has been guided by a program of research into methods for extracting knowledge of networks from genomic and proteomic data. This research emphasis will be will be deepened by introducing new methods for extraction of information on protein networks from genomic and proteomic data, including logical triplet analysis of genomic and microarray data.  LiveDIP is the extension of DIP that concentrates on the interactions among proteins in defined states. A second extension of DIP, ProLinks, catalogs functional linkages between pairs of proteins inferred from genomic and proteomic data; it identifies pathways and complexes, and will serve as a feeder to DIP, as its inferred linkages are validated as true interactions. To provide faster and more reliable access to DIP, its IT infrastructure will be upgraded. n/a",A Core Database of Interacting Proteins (DIP),7339283,R01GM071909,"['Adopted', 'Binding', 'Biology', 'Cataloging', 'Catalogs', 'Cells', 'Communities', 'Complex', 'Data', 'Data Display', 'Data Quality', 'Databases', 'Deposition', 'Facility Construction Funding Category', 'Genomics', 'Knowledge', 'Link', 'Literature', 'Manuals', 'Medicine', 'Methods', 'Modeling', 'Paper', 'Pathway interactions', 'Procedures', 'Protein Databases', 'Protein Structure Initiative', 'Proteins', 'Proteomics', 'Publications', 'Ramp', 'Research', 'Research Infrastructure', 'Research Personnel', 'Science', 'Services', 'Standards of Weights and Measures', 'System', 'Time', 'Triplet Multiple Birth', 'Validation', 'Work', 'base', 'programs', 'repository', 'text searching', 'tool', 'user-friendly']",NIGMS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2008,403544,0.15753769453148922
"A Core Database of Interacting Proteins (DIP)    DESCRIPTION (provided by applicant):  The Database of Interacting Proteins (DIP) is the original and one of the most extensive databases of information on interacting proteins. It was founded on the assumption that macromolecular interactions are at the basis of all biomedical science, and that researchers in many branches of biology and medicine can benefit from access to an accurate repository of what is known of protein interactions. To continue its expansion, DIP will adopt a procedure of direct deposition of experimental data by primary authors. Accuracy of interaction data being essential, methods for the assessment of data quality will be extended and applied to DIP, to define a Core set of highly reliable interaction data. The Core interactions will permit construction of networks of interacting proteins, useful to cell and systems biologists. From its inception, DIP has been guided by a program of research into methods for extracting knowledge of networks from genomic and proteomic data. This research emphasis will be will be deepened by introducing new methods for extraction of information on protein networks from genomic and proteomic data, including logical triplet analysis of genomic and microarray data. LiveDIP is the extension of DIP that concentrates on the interactions among proteins in defined states. A second extension of DIP, ProLinks, catalogs functional linkages between pairs of proteins inferred from genomic and proteomic data; it identifies pathways and complexes, and will serve as a feeder to DIP, as its inferred linkages are validated as true interactions. To provide faster and more reliable access to DIP, its IT infrastructure will be upgraded.         n/a",A Core Database of Interacting Proteins (DIP),7168832,R01GM071909,"['Adopted', 'Binding', 'Biology', 'Cataloging', 'Catalogs', 'Cells', 'Communities', 'Complex', 'Data', 'Data Display', 'Data Quality', 'Databases', 'Deposition', 'Facility Construction Funding Category', 'Genomics', 'Knowledge', 'Link', 'Literature', 'Manuals', 'Medicine', 'Methods', 'Modeling', 'Paper', 'Pathway interactions', 'Procedures', 'Protein Databases', 'Protein Structure Initiative', 'Proteins', 'Proteomics', 'Publications', 'Ramp', 'Research', 'Research Infrastructure', 'Research Personnel', 'Science', 'Services', 'Standards of Weights and Measures', 'System', 'Time', 'Triplet Multiple Birth', 'Validation', 'Work', 'base', 'programs', 'repository', 'text searching', 'tool', 'user-friendly']",NIGMS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2007,403719,0.15753769453148922
"Boston University CCCR OVERALL ABSTRACT The Boston University CCCR will serve as a central resource for clinical research focused mostly on the most common musculoskeletal disorders, osteoarthritis and gout and will also provide research resources for investigator based research in scleroderma, spondyloarthritis, musculoskeletal pain and osteoporosis. Center grant funding has supported 30-35 papers annually in peer reviewed journals, most in the leading arthritis journals and some in leading general medical journals. This center has trained many of the leading clinical researchers in rheumatology throughout the US and internationally, and many of these former trainees have active collaborations with the center. We will include a broad research community and a core group of faculty in this CCCR. The research community's ready access to core faculty and to the sophisticated research methods and assistance they provide will enhance the clinical and translational research of the community and will increase collaborative opportunities for the core faculty and the community. The CCCR updates BU's historical focus on epidemiologic methods to include new approaches to causal inference and adds new methods in machine learning and mobile health. The Research and Evaluation Support Core Unit (RESCU) is the focal point of this CCCR. A key feature is the weekly research (RESCU meetings in which ongoing and proposed research projects are critically evaluated. This feature ensures frequent interactions between clinician researchers, epidemiologists and biostatisticians who are the core members of the CCCR. The RESCU core unit has provided critical support for other Center grants related to rheumatic and arthritic disorders at Boston University, three current R01/U01's; five current NIH K awards (one K24, 3 K23's, one K01), an R03, an NIH trial planning grant (U34), and multiple ACR RRF awards. The overall goal of this center is to carry out and disseminate high-level clinical research informed both by state of the art clinical research methods and by clinical and biological scientific discoveries. Ultimately, we aim either to prevent the diseases we are studying or to improve the lives of those living with the diseases. NARRATIVE The Boston University Core Center for Clinical Research will provide broad clinical research methods expertise to a large multidisciplinary group of investigators whose research focuses on osteoarthritis and gout with a secondary emphasis on scleroderma, spondyloarthritis, osteoporosis and musculoskeletal pain. The group, which includes persons with backgrounds in rheumatology, physical therapy, epidemiology, biostatistics and  . behavioral science, meets weekly to critically review research projects and serves a broad research community with which it actively engages. It has been successful in publishing influential papers on the diseases of focus and in training many of the clinical research faculty in the US and internationally",Boston University CCCR,10017004,P30AR072571,"['Allied Health Profession', 'Area', 'Arthritis', 'Award', 'Behavioral Sciences', 'Biological', 'Biometry', 'Boston', 'Clinical', 'Clinical Research', 'Cohort Studies', 'Collaborations', 'Communities', 'Complement', 'Computerized Medical Record', 'Consensus', 'Consultations', 'Databases', 'Degenerative polyarthritis', 'Disease', 'Ensure', 'Environment', 'Epidemiologic Methods', 'Epidemiologist', 'Epidemiology', 'Europe', 'Evaluation', 'Excision', 'Faculty', 'Funding', 'Goals', 'Gout', 'Grant', 'Health', 'Influentials', 'Infusion procedures', 'Institutes', 'Institution', 'International', 'Journals', 'K-Series Research Career Programs', 'Machine Learning', 'Medical', 'Medical Research', 'Medical center', 'Methods', 'Musculoskeletal Diseases', 'Musculoskeletal Pain', 'New England', 'Osteoporosis', 'Outcome', 'Pain', 'Paper', 'Peer Review', 'Persons', 'Physical therapy', 'Privatization', 'Productivity', 'Public Health Schools', 'Publications', 'Publishing', 'Research', 'Research Design', 'Research Methodology', 'Research Personnel', 'Research Project Grants', 'Resources', 'Rheumatism', 'Rheumatoid Arthritis', 'Rheumatology', 'Risk Factors', 'Schools', 'Scleroderma', 'Spondylarthritis', 'Talents', 'Training', 'Translational Research', 'United States National Institutes of Health', 'Universities', 'Update', 'base', 'clinical center', 'cohort', 'design', 'epidemiology study', 'faculty community', 'faculty research', 'improved', 'innovation', 'interdisciplinary collaboration', 'mHealth', 'machine learning method', 'medical schools', 'meetings', 'member', 'multidisciplinary', 'novel', 'novel strategies', 'patient oriented', 'prevent', 'programs', 'protocol development', 'statistical service', 'success']",NIAMS,BOSTON UNIVERSITY MEDICAL CAMPUS,P30,2020,725375,0.0931976121934471
"Boston University CCCR OVERALL ABSTRACT The Boston University CCCR will serve as a central resource for clinical research focused mostly on the most common musculoskeletal disorders, osteoarthritis and gout and will also provide research resources for investigator based research in scleroderma, spondyloarthritis, musculoskeletal pain and osteoporosis. Center grant funding has supported 30-35 papers annually in peer reviewed journals, most in the leading arthritis journals and some in leading general medical journals. This center has trained many of the leading clinical researchers in rheumatology throughout the US and internationally, and many of these former trainees have active collaborations with the center. We will include a broad research community and a core group of faculty in this CCCR. The research community's ready access to core faculty and to the sophisticated research methods and assistance they provide will enhance the clinical and translational research of the community and will increase collaborative opportunities for the core faculty and the community. The CCCR updates BU's historical focus on epidemiologic methods to include new approaches to causal inference and adds new methods in machine learning and mobile health. The Research and Evaluation Support Core Unit (RESCU) is the focal point of this CCCR. A key feature is the weekly research (RESCU meetings in which ongoing and proposed research projects are critically evaluated. This feature ensures frequent interactions between clinician researchers, epidemiologists and biostatisticians who are the core members of the CCCR. The RESCU core unit has provided critical support for other Center grants related to rheumatic and arthritic disorders at Boston University, three current R01/U01's; five current NIH K awards (one K24, 3 K23's, one K01), an R03, an NIH trial planning grant (U34), and multiple ACR RRF awards. The overall goal of this center is to carry out and disseminate high-level clinical research informed both by state of the art clinical research methods and by clinical and biological scientific discoveries. Ultimately, we aim either to prevent the diseases we are studying or to improve the lives of those living with the diseases. NARRATIVE The Boston University Core Center for Clinical Research will provide broad clinical research methods expertise to a large multidisciplinary group of investigators whose research focuses on osteoarthritis and gout with a secondary emphasis on scleroderma, spondyloarthritis, osteoporosis and musculoskeletal pain. The group, which includes persons with backgrounds in rheumatology, physical therapy, epidemiology, biostatistics and  . behavioral science, meets weekly to critically review research projects and serves a broad research community with which it actively engages. It has been successful in publishing influential papers on the diseases of focus and in training many of the clinical research faculty in the US and internationally",Boston University CCCR,9851583,P30AR072571,"['Allied Health Profession', 'Area', 'Arthritis', 'Award', 'Behavioral Sciences', 'Biological', 'Biometry', 'Boston', 'Clinical', 'Clinical Research', 'Cohort Studies', 'Collaborations', 'Communities', 'Complement', 'Computerized Medical Record', 'Consensus', 'Consultations', 'Databases', 'Degenerative polyarthritis', 'Disease', 'Ensure', 'Environment', 'Epidemiologic Methods', 'Epidemiologist', 'Epidemiology', 'Europe', 'Evaluation', 'Excision', 'Faculty', 'Funding', 'Goals', 'Gout', 'Grant', 'Health', 'Influentials', 'Infusion procedures', 'Institutes', 'Institution', 'International', 'Journals', 'K-Series Research Career Programs', 'Machine Learning', 'Medical', 'Medical Research', 'Medical center', 'Methods', 'Musculoskeletal Diseases', 'Musculoskeletal Pain', 'New England', 'Osteoporosis', 'Outcome', 'Pain', 'Paper', 'Peer Review', 'Persons', 'Physical therapy', 'Privatization', 'Productivity', 'Public Health Schools', 'Publications', 'Publishing', 'Research', 'Research Design', 'Research Methodology', 'Research Personnel', 'Research Project Grants', 'Resources', 'Rheumatism', 'Rheumatology', 'Risk Factors', 'Schools', 'Scleroderma', 'Spondylarthritis', 'Talents', 'Training', 'Translational Research', 'United States National Institutes of Health', 'Universities', 'Update', 'base', 'cohort', 'design', 'epidemiology study', 'faculty community', 'faculty research', 'improved', 'innovation', 'interdisciplinary collaboration', 'learning strategy', 'mHealth', 'medical schools', 'meetings', 'member', 'multidisciplinary', 'novel', 'novel strategies', 'patient oriented', 'prevent', 'programs', 'protocol development', 'statistical service', 'success']",NIAMS,BOSTON UNIVERSITY MEDICAL CAMPUS,P30,2019,741688,0.0931976121934471
"VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics PROJECT ABSTRACT  Pediatric and adult rheumatic and musculoskeletal (MSK) diseases challenge the clinical researcher: they affect the population across the lifespan, impact a broad range of patient-centered outcomes, are rarely cured, and often have multiple possible treatment strategies. If properly addressed, these factors present tremendous opportunities for improving patient care and outcomes of patients. The overarching goal of the Brigham and Womens Hospital (BWH) CCCR is to facilitate advancements in the methodologic sciences supporting clinical research within the NIAMS pediatric and adult rheumatic and musculoskeletal (MSK) disease missions.  VERITY is organized around central scientific themes that can be applied to multiple rheumatic and MSK diseases. The Cores address the following cross-cutting areas: 1) including patients in clinical trial design, outcome selection, result interpretation, and dissemination; 2) integrating behavioral economics to enhance benefits of known interventions, i.e., adherence to medications, engagement in physical activity and weight loss; 3) extracting maximum information content from big data; 4) using smart technologies (mobile health) to advance clinical research; and 5) disseminating knowledge and mentoring of local and national rheumatic and MSK disease clinical researchers through distributed learning models. These scientific themes will be approached through several Cores described in the following Specific Aims. 1. To strategically direct, supervise, and provide financial accountability to VERITY and to train a broad group of local and national investigators for patient-oriented clinical research in pediatric and adult rheumatic and MSK diseases. (Administrative Core) 2. To develop and implement state of the art methods in innovative trials and longitudinal comparative effectiveness studies for rheumatic and MSK disease research. (Methodology Core) 3. To support bioinformatic approaches to enhance utilization of large databases for phenotyping relevant patients, and implementing biomarker, electronic medical record, and comparative effectiveness analyses. (Bioinformatics Resource Core) PROJECT NARRATIVE  The BWH CCCR, or VERITY (Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics) Cores will implement novel analytic methods and outcome measures that address existing and emerging needs in clinical research for preventing and treating rheumatic and musculoskeletal disorders. The pressing clinical research needs addressed by VERITY include: a) integration of patients point of view (patient-centeredness); b) facilitation of innovative trials; c) incorporation of state of the art comparative effectiveness research methods to determine optimal treatments; d) development and testing of innovative behavioral interventions; and e) identification of relevant phenotypes and sub-phenotypes of common and uncommon rheumatic and MSK diseases using electronic medical records (EMRs), registries, cohorts and insurance claims.","VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics",10017653,P30AR072577,"['ARHGEF5 gene', 'Accountability', 'Address', 'Adherence', 'Adult', 'Affect', 'Algorithms', 'Americas', 'Area', 'Arthritis', 'Behavior Therapy', 'Big Data', 'Bioinformatics', 'Biological Markers', 'Biosensor', 'Body Weight decreased', 'Childhood', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Clinical Trials Design', 'Communities', 'Comparative Effectiveness Research', 'Computerized Medical Record', 'Country', 'Data', 'Data Collection', 'Databases', 'Development', 'Disease', 'Evolution', 'Faculty', 'Feeds', 'Foundations', 'Funding', 'Future', 'Generations', 'Goals', 'Grant', 'Harvest', 'Health Technology', 'Hospitals', 'Infrastructure', 'International', 'Intervention', 'Knowledge', 'Learning', 'Longevity', 'Lupus', 'Measurable', 'Mentors', 'Methodology', 'Methods', 'Mission', 'Modeling', 'Musculoskeletal Diseases', 'National Institute of Arthritis and Musculoskeletal and Skin Diseases', 'Natural Language Processing', 'Outcome', 'Outcome Measure', 'Participant', 'Patient Care', 'Patient-Focused Outcomes', 'Patients', 'Pharmaceutical Preparations', 'Phenotype', 'Physical activity', 'Population', 'Protocols documentation', 'Psoriatic Arthritis', 'Registries', 'Research', 'Research Design', 'Research Methodology', 'Research Personnel', 'Resources', 'Rheumatism', 'Rheumatology', 'Science', 'Seeds', 'Services', 'Societies', 'Supervision', 'Technology', 'Testing', 'Training', 'Woman', 'Work', 'advanced analytics', 'analytical method', 'behavioral economics', 'bioinformatics resource', 'care outcomes', 'clinical care', 'clinical research site', 'cohort', 'comparative effectiveness', 'comparative effectiveness study', 'design', 'distributed data', 'improved', 'innovation', 'insurance claims', 'mHealth', 'medical schools', 'multidimensional data', 'next generation', 'novel', 'optimal treatments', 'patient engagement', 'patient oriented', 'prevent', 'programs', 'skills', 'tool', 'translational study', 'treatment strategy']",NIAMS,BRIGHAM AND WOMEN'S HOSPITAL,P30,2020,893894,0.05615375014652602
"VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics PROJECT ABSTRACT  Pediatric and adult rheumatic and musculoskeletal (MSK) diseases challenge the clinical researcher: they affect the population across the lifespan, impact a broad range of patient-centered outcomes, are rarely cured, and often have multiple possible treatment strategies. If properly addressed, these factors present tremendous opportunities for improving patient care and outcomes of patients. The overarching goal of the Brigham and Womens Hospital (BWH) CCCR is to facilitate advancements in the methodologic sciences supporting clinical research within the NIAMS pediatric and adult rheumatic and musculoskeletal (MSK) disease missions.  VERITY is organized around central scientific themes that can be applied to multiple rheumatic and MSK diseases. The Cores address the following cross-cutting areas: 1) including patients in clinical trial design, outcome selection, result interpretation, and dissemination; 2) integrating behavioral economics to enhance benefits of known interventions, i.e., adherence to medications, engagement in physical activity and weight loss; 3) extracting maximum information content from big data; 4) using smart technologies (mobile health) to advance clinical research; and 5) disseminating knowledge and mentoring of local and national rheumatic and MSK disease clinical researchers through distributed learning models. These scientific themes will be approached through several Cores described in the following Specific Aims. 1. To strategically direct, supervise, and provide financial accountability to VERITY and to train a broad group of local and national investigators for patient-oriented clinical research in pediatric and adult rheumatic and MSK diseases. (Administrative Core) 2. To develop and implement state of the art methods in innovative trials and longitudinal comparative effectiveness studies for rheumatic and MSK disease research. (Methodology Core) 3. To support bioinformatic approaches to enhance utilization of large databases for phenotyping relevant patients, and implementing biomarker, electronic medical record, and comparative effectiveness analyses. (Bioinformatics Resource Core) PROJECT NARRATIVE  The BWH CCCR, or VERITY (Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics) Cores will implement novel analytic methods and outcome measures that address existing and emerging needs in clinical research for preventing and treating rheumatic and musculoskeletal disorders. The pressing clinical research needs addressed by VERITY include: a) integration of patients point of view (patient-centeredness); b) facilitation of innovative trials; c) incorporation of state of the art comparative effectiveness research methods to determine optimal treatments; d) development and testing of innovative behavioral interventions; and e) identification of relevant phenotypes and sub-phenotypes of common and uncommon rheumatic and MSK diseases using electronic medical records (EMRs), registries, cohorts and insurance claims.","VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics",9768189,P30AR072577,"['ARHGEF5 gene', 'Accountability', 'Address', 'Adherence', 'Adult', 'Affect', 'Algorithms', 'Americas', 'Area', 'Arthritis', 'Behavior Therapy', 'Big Data', 'Bioinformatics', 'Biological Markers', 'Biosensor', 'Body Weight decreased', 'Childhood', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Clinical Trials Design', 'Communities', 'Computerized Medical Record', 'Country', 'Data', 'Data Collection', 'Databases', 'Development', 'Disease', 'Evolution', 'Faculty', 'Feeds', 'Foundations', 'Funding', 'Future', 'Generations', 'Goals', 'Grant', 'Harvest', 'Health Technology', 'Hospitals', 'Infrastructure', 'International', 'Intervention', 'Knowledge', 'Learning', 'Longevity', 'Lupus', 'Measurable', 'Mentors', 'Methodology', 'Methods', 'Mission', 'Modeling', 'Musculoskeletal Diseases', 'National Institute of Arthritis and Musculoskeletal and Skin Diseases', 'Natural Language Processing', 'Outcome', 'Outcome Measure', 'Participant', 'Patient Care', 'Patient-Focused Outcomes', 'Patients', 'Pharmaceutical Preparations', 'Phenotype', 'Physical activity', 'Population', 'Protocols documentation', 'Psoriasis', 'Psoriatic Arthritis', 'Registries', 'Research', 'Research Design', 'Research Methodology', 'Research Personnel', 'Resources', 'Rheumatism', 'Rheumatology', 'Science', 'Seeds', 'Services', 'Societies', 'Supervision', 'Technology', 'Testing', 'Training', 'Woman', 'Work', 'analytical method', 'behavioral economics', 'bioinformatics resource', 'care outcomes', 'clinical care', 'clinical research site', 'cohort', 'comparative effectiveness', 'design', 'distributed data', 'effectiveness research', 'feeding', 'improved', 'innovation', 'insurance claims', 'mHealth', 'medical schools', 'multidimensional data', 'next generation', 'novel', 'optimal treatments', 'patient engagement', 'patient oriented', 'prevent', 'programs', 'skills', 'tool', 'translational study', 'treatment strategy']",NIAMS,BRIGHAM AND WOMEN'S HOSPITAL,P30,2019,894906,0.05615375014652602
"VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics PROJECT ABSTRACT  Pediatric and adult rheumatic and musculoskeletal (MSK) diseases challenge the clinical researcher: they affect the population across the lifespan, impact a broad range of patient-centered outcomes, are rarely cured, and often have multiple possible treatment strategies. If properly addressed, these factors present tremendous opportunities for improving patient care and outcomes of patients. The overarching goal of the Brigham and Womens Hospital (BWH) CCCR is to facilitate advancements in the methodologic sciences supporting clinical research within the NIAMS pediatric and adult rheumatic and musculoskeletal (MSK) disease missions.  VERITY is organized around central scientific themes that can be applied to multiple rheumatic and MSK diseases. The Cores address the following cross-cutting areas: 1) including patients in clinical trial design, outcome selection, result interpretation, and dissemination; 2) integrating behavioral economics to enhance benefits of known interventions, i.e., adherence to medications, engagement in physical activity and weight loss; 3) extracting maximum information content from big data; 4) using smart technologies (mobile health) to advance clinical research; and 5) disseminating knowledge and mentoring of local and national rheumatic and MSK disease clinical researchers through distributed learning models. These scientific themes will be approached through several Cores described in the following Specific Aims. 1. To strategically direct, supervise, and provide financial accountability to VERITY and to train a broad group of local and national investigators for patient-oriented clinical research in pediatric and adult rheumatic and MSK diseases. (Administrative Core) 2. To develop and implement state of the art methods in innovative trials and longitudinal comparative effectiveness studies for rheumatic and MSK disease research. (Methodology Core) 3. To support bioinformatic approaches to enhance utilization of large databases for phenotyping relevant patients, and implementing biomarker, electronic medical record, and comparative effectiveness analyses. (Bioinformatics Resource Core) PROJECT NARRATIVE  The BWH CCCR, or VERITY (Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics) Cores will implement novel analytic methods and outcome measures that address existing and emerging needs in clinical research for preventing and treating rheumatic and musculoskeletal disorders. The pressing clinical research needs addressed by VERITY include: a) integration of patients point of view (patient-centeredness); b) facilitation of innovative trials; c) incorporation of state of the art comparative effectiveness research methods to determine optimal treatments; d) development and testing of innovative behavioral interventions; and e) identification of relevant phenotypes and sub-phenotypes of common and uncommon rheumatic and MSK diseases using electronic medical records (EMRs), registries, cohorts and insurance claims.","VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics",9568320,P30AR072577,"['ARHGEF5 gene', 'Accountability', 'Address', 'Adherence', 'Adult', 'Affect', 'Algorithms', 'Americas', 'Area', 'Arthritis', 'Behavior Therapy', 'Big Data', 'Bioinformatics', 'Biological Markers', 'Biosensor', 'Body Weight decreased', 'Childhood', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Clinical Trials Design', 'Communities', 'Computerized Medical Record', 'Country', 'Data', 'Data Collection', 'Databases', 'Development', 'Disease', 'Evolution', 'Faculty', 'Feeds', 'Foundations', 'Funding', 'Future', 'Generations', 'Goals', 'Grant', 'Harvest', 'Health Technology', 'Hospitals', 'International', 'Intervention', 'Knowledge', 'Learning', 'Longevity', 'Lupus', 'Measurable', 'Mentors', 'Methodology', 'Methods', 'Mission', 'Modeling', 'Musculoskeletal Diseases', 'National Institute of Arthritis and Musculoskeletal and Skin Diseases', 'Natural Language Processing', 'Outcome', 'Outcome Measure', 'Participant', 'Patient Care', 'Patient-Focused Outcomes', 'Patients', 'Pharmaceutical Preparations', 'Phenotype', 'Physical activity', 'Population', 'Protocols documentation', 'Psoriasis', 'Psoriatic Arthritis', 'Registries', 'Research', 'Research Design', 'Research Infrastructure', 'Research Methodology', 'Research Personnel', 'Resources', 'Rheumatism', 'Rheumatology', 'Science', 'Seeds', 'Services', 'Societies', 'Supervision', 'Technology', 'Testing', 'Training', 'Woman', 'Work', 'analytical method', 'behavioral economics', 'bioinformatics resource', 'care outcomes', 'clinical care', 'clinical research site', 'cohort', 'comparative effectiveness', 'design', 'distributed data', 'effectiveness research', 'feeding', 'improved', 'innovation', 'insurance claims', 'mHealth', 'medical schools', 'next generation', 'novel', 'optimal treatments', 'patient engagement', 'patient oriented', 'prevent', 'programs', 'skills', 'tool', 'translational study', 'treatment strategy']",NIAMS,BRIGHAM AND WOMEN'S HOSPITAL,P30,2018,895176,0.05615375014652602
"VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics PROJECT ABSTRACT  Pediatric and adult rheumatic and musculoskeletal (MSK) diseases challenge the clinical researcher: they affect the population across the lifespan, impact a broad range of patient-centered outcomes, are rarely cured, and often have multiple possible treatment strategies. If properly addressed, these factors present tremendous opportunities for improving patient care and outcomes of patients. The overarching goal of the Brigham and Womens Hospital (BWH) CCCR is to facilitate advancements in the methodologic sciences supporting clinical research within the NIAMS pediatric and adult rheumatic and musculoskeletal (MSK) disease missions.  VERITY is organized around central scientific themes that can be applied to multiple rheumatic and MSK diseases. The Cores address the following cross-cutting areas: 1) including patients in clinical trial design, outcome selection, result interpretation, and dissemination; 2) integrating behavioral economics to enhance benefits of known interventions, i.e., adherence to medications, engagement in physical activity and weight loss; 3) extracting maximum information content from big data; 4) using smart technologies (mobile health) to advance clinical research; and 5) disseminating knowledge and mentoring of local and national rheumatic and MSK disease clinical researchers through distributed learning models. These scientific themes will be approached through several Cores described in the following Specific Aims. 1. To strategically direct, supervise, and provide financial accountability to VERITY and to train a broad group of local and national investigators for patient-oriented clinical research in pediatric and adult rheumatic and MSK diseases. (Administrative Core) 2. To develop and implement state of the art methods in innovative trials and longitudinal comparative effectiveness studies for rheumatic and MSK disease research. (Methodology Core) 3. To support bioinformatic approaches to enhance utilization of large databases for phenotyping relevant patients, and implementing biomarker, electronic medical record, and comparative effectiveness analyses. (Bioinformatics Resource Core) PROJECT NARRATIVE  The BWH CCCR, or VERITY (Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics) Cores will implement novel analytic methods and outcome measures that address existing and emerging needs in clinical research for preventing and treating rheumatic and musculoskeletal disorders. The pressing clinical research needs addressed by VERITY include: a) integration of patients point of view (patient-centeredness); b) facilitation of innovative trials; c) incorporation of state of the art comparative effectiveness research methods to determine optimal treatments; d) development and testing of innovative behavioral interventions; and e) identification of relevant phenotypes and sub-phenotypes of common and uncommon rheumatic and MSK diseases using electronic medical records (EMRs), registries, cohorts and insurance claims.","VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics",9413618,P30AR072577,"['ARHGEF5 gene', 'Accountability', 'Address', 'Adherence', 'Adult', 'Affect', 'Algorithms', 'Americas', 'Area', 'Arthritis', 'Behavior Therapy', 'Big Data', 'Bioinformatics', 'Biological Markers', 'Biosensor', 'Body Weight decreased', 'Childhood', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Clinical Trials Design', 'Communities', 'Computerized Medical Record', 'Country', 'Data', 'Data Collection', 'Databases', 'Development', 'Disease', 'Evolution', 'Faculty', 'Feeds', 'Foundations', 'Funding', 'Future', 'Generations', 'Goals', 'Grant', 'Harvest', 'Health Technology', 'Hospitals', 'Insurance', 'International', 'Intervention', 'Knowledge', 'Learning', 'Longevity', 'Lupus', 'Measurable', 'Mentors', 'Methodology', 'Methods', 'Mission', 'Modeling', 'Musculoskeletal Diseases', 'National Institute of Arthritis and Musculoskeletal and Skin Diseases', 'Natural Language Processing', 'Outcome', 'Outcome Measure', 'Participant', 'Patient Care', 'Patient-Focused Outcomes', 'Patients', 'Pharmaceutical Preparations', 'Phenotype', 'Physical activity', 'Population', 'Protocols documentation', 'Psoriasis', 'Psoriatic Arthritis', 'Registries', 'Research', 'Research Design', 'Research Infrastructure', 'Research Methodology', 'Research Personnel', 'Resources', 'Rheumatism', 'Rheumatology', 'Science', 'Seeds', 'Services', 'Societies', 'Supervision', 'Technology', 'Testing', 'Training', 'Woman', 'Work', 'analytical method', 'behavioral economics', 'clinical care', 'clinical research site', 'cohort', 'comparative effectiveness', 'design', 'distributed data', 'effectiveness research', 'feeding', 'improved', 'innovation', 'mHealth', 'medical schools', 'next generation', 'novel', 'patient oriented', 'prevent', 'programs', 'skills', 'tool', 'translational study', 'treatment strategy']",NIAMS,BRIGHAM AND WOMEN'S HOSPITAL,P30,2017,907543,0.05615375014652602
"Neurobehavioral Contributors to Math Failure: A Reward-Based Learning Framework DESCRIPTION (provided by applicant): In this set of applications, we propose to initiate a new Learning Disabilities Research Hub focusing initially on high risk for mathematics failure. We proposed to situate this new Hub within an existing strong infrastructure for pediatric neurobehavioral and imaging research, the Pediatric Neurocognition, Imaging, and Genetics (PING) data resource. PING infrastructure provides many important advantages for building a new cross disciplinary and multiple-investigator program, as it has already brought together a strong team of behavioral, clinical, imaging, computational, and genetics investigators as a closely integrated team, and most importantly has attracted a very talented group of young investigators and graduate students focused on the problems addressed in the proposed research. A unifying theme of the studies that our team has proposed is the notion that math failure, and perhaps academic failure more broadly, emerges gradually through interactions of putative early conceptual weaknesses, attributable in some cases to poor functioning and anomalous neural architecture in specific neural systems, with increasing reward-based biases that contribute, additively or non-additively, to suppression of the normal learning trajectory. Consistent with this theme we refer to our proposed research hub as the Roles of Emotion and Choice (REaCh) in Learning Disabilities Research Hub (LDRH). The proposed REaCh Hub has 3 components: a new research project to investigate key questions about learning and the neural architecture during early development in children at high risk for math failure, and two cores. The Administrative Core proposal describes the management plan for the new Hub and the PING infrastructure that will be adapted for the new studies; and focuses on a nested mentoring plan for ensuring close interaction between trainees at different levels with mid-level and senior investigators within focused workgroups. The assets of the Core for within-Hub and extra-Hub data sharing are also described. A Developmental Infrastructure Core proposal describes the administration of a small grant program to support novel work within the Hub by junior investigators, trainees, and investigators from disciplines outside of the original REaCh LDRH group. A new Learning Disabilities Research Hub would be created to bring scientists with different kinds of expertise together to study learning disabilities, focusing initially on risk for math failure in young children. The scientists would study learning and brain development in children and focus specifically on the importance of the children's emotional responses to mathematical information.",Neurobehavioral Contributors to Math Failure: A Reward-Based Learning Framework,8885862,R24HD075489,"['12 year old', 'Accounting', 'Achievement', 'Address', 'Affect', 'Affective', 'Animals', 'Anisotropy', 'Anxiety', 'Architecture', 'Area', 'Association Learning', 'Attention', 'Behavioral', 'Brain', 'Child', 'Childhood', 'Choice Behavior', 'Clinical', 'Cognition', 'Cognitive', 'Complement', 'Complex', 'Data', 'Development', 'Discipline', 'Emotional', 'Emotions', 'Ensure', 'Exposure to', 'Failure', 'Genetic', 'Genotype', 'Grant', 'Growth', 'Human', 'Image', 'Individual', 'Individual Differences', 'Knowledge', 'Learning', 'Learning Disabilities', 'Literature', 'Longitudinal Studies', 'Machine Learning', 'Mathematics', 'Measures', 'Mentors', 'Methods', 'Modeling', 'Neurocognition', 'Neurocognitive', 'Outcome', 'Parietal', 'Patient Self-Report', 'Pediatric Research', 'Perception', 'Perceptual learning', 'Phenotype', 'Play', 'Prefrontal Cortex', 'Psychological reinforcement', 'Relative (related person)', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Resources', 'Rewards', 'Risk', 'Role', 'School-Age Population', 'Scientist', 'Statistical Methods', 'Stimulus', 'Surface', 'System', 'Time', 'Work', 'base', 'classical conditioning', 'computational neuroscience', 'data sharing', 'elementary school', 'emotional factor', 'experience', 'genome-wide', 'graduate student', 'high risk', 'imaging modality', 'intraparietal sulcus', 'mathematical ability', 'mathematical learning', 'mathematical model', 'neurobehavioral', 'neuroimaging', 'novel', 'preference', 'programs', 'prospective', 'relating to nervous system', 'response', 'reward processing', 'skills']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R24,2015,547017,-0.0036789701000494177
"Neurobehavioral Contributors to Math Failure: A Reward-Based Learning Framework DESCRIPTION (provided by applicant): In this set of applications, we propose to initiate a new Learning Disabilities Research Hub focusing initially on high risk for mathematics failure. We proposed to situate this new Hub within an existing strong infrastructure for pediatric neurobehavioral and imaging research, the Pediatric Neurocognition, Imaging, and Genetics (PING) data resource. PING infrastructure provides many important advantages for building a new cross disciplinary and multiple-investigator program, as it has already brought together a strong team of behavioral, clinical, imaging, computational, and genetics investigators as a closely integrated team, and most importantly has attracted a very talented group of young investigators and graduate students focused on the problems addressed in the proposed research. A unifying theme of the studies that our team has proposed is the notion that math failure, and perhaps academic failure more broadly, emerges gradually through interactions of putative early conceptual weaknesses, attributable in some cases to poor functioning and anomalous neural architecture in specific neural systems, with increasing reward-based biases that contribute, additively or non-additively, to suppression of the normal learning trajectory. Consistent with this theme we refer to our proposed research hub as the Roles of Emotion and Choice (REaCh) in Learning Disabilities Research Hub (LDRH). The proposed REaCh Hub has 3 components: a new research project to investigate key questions about learning and the neural architecture during early development in children at high risk for math failure, and two cores. The Administrative Core proposal describes the management plan for the new Hub and the PING infrastructure that will be adapted for the new studies; and focuses on a nested mentoring plan for ensuring close interaction between trainees at different levels with mid-level and senior investigators within focused workgroups. The assets of the Core for within-Hub and extra-Hub data sharing are also described. A Developmental Infrastructure Core proposal describes the administration of a small grant program to support novel work within the Hub by junior investigators, trainees, and investigators from disciplines outside of the original REaCh LDRH group. A new Learning Disabilities Research Hub would be created to bring scientists with different kinds of expertise together to study learning disabilities, focusing initially on risk for math failure in young children. The scientists would study learning and brain development in children and focus specifically on the importance of the children's emotional responses to mathematical information.",Neurobehavioral Contributors to Math Failure: A Reward-Based Learning Framework,8705558,R24HD075489,"['12 year old', 'Accounting', 'Achievement', 'Address', 'Affect', 'Affective', 'Animals', 'Anisotropy', 'Anxiety', 'Architecture', 'Area', 'Association Learning', 'Attention', 'Behavioral', 'Brain', 'Child', 'Childhood', 'Choice Behavior', 'Clinical', 'Cognition', 'Cognitive', 'Complement', 'Complex', 'Data', 'Development', 'Discipline', 'Emotional', 'Emotions', 'Ensure', 'Exposure to', 'Failure', 'Genetic', 'Genotype', 'Grant', 'Growth', 'Human', 'Image', 'Individual', 'Individual Differences', 'Knowledge', 'Learning', 'Learning Disabilities', 'Literature', 'Longitudinal Studies', 'Machine Learning', 'Mathematics', 'Measures', 'Mentors', 'Methods', 'Modeling', 'Neurocognition', 'Neurocognitive', 'Outcome', 'Parietal', 'Patient Self-Report', 'Pediatric Research', 'Perception', 'Perceptual learning', 'Phenotype', 'Play', 'Prefrontal Cortex', 'Psychological reinforcement', 'Relative (related person)', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Resources', 'Rewards', 'Risk', 'Role', 'School-Age Population', 'Scientist', 'Statistical Methods', 'Stimulus', 'Surface', 'System', 'Time', 'Work', 'base', 'classical conditioning', 'computational neuroscience', 'data sharing', 'elementary school', 'emotional factor', 'experience', 'genome-wide', 'graduate student', 'high risk', 'imaging modality', 'intraparietal sulcus', 'mathematical ability', 'mathematical learning', 'mathematical model', 'neurobehavioral', 'neuroimaging', 'novel', 'preference', 'programs', 'prospective', 'relating to nervous system', 'response', 'reward processing', 'skills']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R24,2014,538747,-0.0036789701000494177
"Neurobehavioral Contributors to Math Failure: A Reward-Based Learning Framework DESCRIPTION (provided by applicant): In this set of applications, we propose to initiate a new Learning Disabilities Research Hub focusing initially on high risk for mathematics failure. We proposed to situate this new Hub within an existing strong infrastructure for pediatric neurobehavioral and imaging research, the Pediatric Neurocognition, Imaging, and Genetics (PING) data resource. PING infrastructure provides many important advantages for building a new cross disciplinary and multiple-investigator program, as it has already brought together a strong team of behavioral, clinical, imaging, computational, and genetics investigators as a closely integrated team, and most importantly has attracted a very talented group of young investigators and graduate students focused on the problems addressed in the proposed research. A unifying theme of the studies that our team has proposed is the notion that math failure, and perhaps academic failure more broadly, emerges gradually through interactions of putative early conceptual weaknesses, attributable in some cases to poor functioning and anomalous neural architecture in specific neural systems, with increasing reward-based biases that contribute, additively or non-additively, to suppression of the normal learning trajectory. Consistent with this theme we refer to our proposed research hub as the Roles of Emotion and Choice (REaCh) in Learning Disabilities Research Hub (LDRH). The proposed REaCh Hub has 3 components: a new research project to investigate key questions about learning and the neural architecture during early development in children at high risk for math failure, and two cores. The Administrative Core proposal describes the management plan for the new Hub and the PING infrastructure that will be adapted for the new studies; and focuses on a nested mentoring plan for ensuring close interaction between trainees at different levels with mid-level and senior investigators within focused workgroups. The assets of the Core for within-Hub and extra-Hub data sharing are also described. A Developmental Infrastructure Core proposal describes the administration of a small grant program to support novel work within the Hub by junior investigators, trainees, and investigators from disciplines outside of the original REaCh LDRH group. A new Learning Disabilities Research Hub would be created to bring scientists with different kinds of expertise together to study learning disabilities, focusing initially on risk for math failure in young children. The scientists would study learning and brain development in children and focus specifically on the importance of the children's emotional responses to mathematical information.",Neurobehavioral Contributors to Math Failure: A Reward-Based Learning Framework,8554790,R24HD075489,"['12 year old', 'Accounting', 'Achievement', 'Address', 'Affect', 'Affective', 'Animals', 'Anisotropy', 'Anxiety', 'Architecture', 'Area', 'Association Learning', 'Attention', 'Behavioral', 'Brain', 'Child', 'Childhood', 'Choice Behavior', 'Clinical', 'Cognition', 'Cognitive', 'Complement', 'Complex', 'Data', 'Development', 'Discipline', 'Emotional', 'Emotions', 'Ensure', 'Exposure to', 'Failure', 'Genetic', 'Genotype', 'Grant', 'Growth', 'Human', 'Image', 'Individual', 'Individual Differences', 'Knowledge', 'Learning', 'Learning Disabilities', 'Literature', 'Longitudinal Studies', 'Machine Learning', 'Mathematics', 'Measures', 'Mentors', 'Methods', 'Modeling', 'Neurocognition', 'Neurocognitive', 'Outcome', 'Parietal', 'Patient Self-Report', 'Pediatric Research', 'Perception', 'Perceptual learning', 'Phenotype', 'Play', 'Prefrontal Cortex', 'Psychological reinforcement', 'Relative (related person)', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Resources', 'Rewards', 'Risk', 'Role', 'School-Age Population', 'Scientist', 'Statistical Methods', 'Stimulus', 'Surface', 'System', 'Time', 'Work', 'base', 'classical conditioning', 'computational neuroscience', 'data sharing', 'elementary school', 'emotional factor', 'experience', 'genome-wide', 'graduate student', 'high risk', 'imaging modality', 'intraparietal sulcus', 'mathematical model', 'neurobehavioral', 'neuroimaging', 'novel', 'preference', 'programs', 'prospective', 'relating to nervous system', 'response', 'reward processing', 'skills']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R24,2013,529465,-0.0036789701000494177
"CORE CENTER FOR CLINICAL RESEACH IN TOTAL JOINT ARTHROPLASTY (CORE-TJA) ABSTRACT - OVERALL Total joint arthroplasty (TJA) is the most common and fastest growing surgery in the nation. There are currently more than 7 million Americans living with artificial joints. Despite the high surgery volume, the evidence base for TJA procedures, technologies and associated interventions are limited. Many surgical approaches and implant technologies in TJA are adopted based on theoretical grounds with limited clinical evidence. The wider TJA research community needs access to large, high quality and rich data sources and state-of-the-art clinical research standards and information technologies to overcome methodological and practical challenges in studies of surgical and nonsurgical interventions in TJA. The overarching goal of Mayo Core Center for Clinical Research in Total Joint Arthroplasty (CORE-TJA) is to facilitate innovative, methodologically rigorous and interdisciplinary clinical research that will directly improve TJA care and the outcomes. The CORE-TJA will serve as a disease (TJA) and theme-focused Center providing shared methodological expertise, education and data resources. The CORE-TJA will leverage big data resources for TJA research, provide customized methodology resources in epidemiology, biostatistics, health services research and medical informatics, and establish synergistic interactions around an integrated Core (American Joint Replacement Registry  AJRR). The Specific Aims of CORE-TJA are: (1) To provide administrative and scientific oversight of CORE-TJA activities (Administrative Core), (2) To provide integrated services, access to large databases and novel analytical methods for clinical research in TJA (Methodology Core); and (3) To meet the unique data needs of the TJA research community and to strengthen the national capacity for large-scale observational and interventional studies in TJA using national registry data (Resource Core). The CORE-TJA will be integrated within the long-standing and highly centralized clinical research environment of the Mayo Clinic, thereby leveraging existing expertise and infrastructure resources, including the Center for Clinical and Translational Science. All CORE-TJA activities will be evaluated using robust metrics to ensure continuous evaluation, flexibility and improvement in response to the most pressing needs of the TJA research community. NARRATIVE The Mayo Core Center for Clinical Research in Total Joint Arthroplasty (CORE-TJA) will provide methodological expertise and access to nationwide data resources to facilitate innovative, methodologically rigorous and interdisciplinary clinical research in TJA. The clinical research needs of the TJA research community that will be addressed by the CORE-TJA include training of the next generation of TJA researchers, customized consultations, facilitated access to high quality, rich data sources and national TJA registry data as well as informatics and methodology support.",CORE CENTER FOR CLINICAL RESEACH IN TOTAL JOINT ARTHROPLASTY (CORE-TJA),10019333,P30AR076312,"['Address', 'Adopted', 'Adoption', 'Advisory Committees', 'American', 'Area', 'Berry', 'Big Data', 'Biometry', 'Characteristics', 'Clinic', 'Clinical', 'Clinical Data', 'Clinical Research', 'Clinical Sciences', 'Collaborations', 'Communication', 'Communities', 'Consultations', 'Custom', 'Data', 'Data Analyses', 'Data Collection', 'Data Element', 'Data Sources', 'Databases', 'Development', 'Disease', 'Documentation', 'Education', 'Electronic Health Record', 'Ensure', 'Environment', 'Epidemiology', 'Evaluation', 'Future', 'Goals', 'Health Services Research', 'Hip Prosthesis', 'Implant', 'Informatics', 'Information Technology', 'Infrastructure', 'Intervention', 'Intervention Studies', 'Joint Prosthesis', 'Knee Prosthesis', 'Leadership', 'Link', 'Medical Informatics', 'Methodology', 'Modeling', 'Musculoskeletal', 'Natural Language Processing', 'Observational Study', 'Operative Surgical Procedures', 'Outcome', 'Patient Care', 'Patients', 'Policies', 'Positioning Attribute', 'Procedures', 'Productivity', 'Registries', 'Replacement Arthroplasty', 'Research', 'Research Methodology', 'Research Personnel', 'Resources', 'Secure', 'Services', 'Surgeon', 'Technology', 'Time', 'Training', 'Translating', 'Translational Research', 'Translations', 'United States', 'Vision', 'analytical method', 'base', 'care outcomes', 'clinical center', 'cost', 'data registry', 'data resource', 'education resources', 'evidence base', 'experience', 'flexibility', 'improved', 'improved outcome', 'innovation', 'next generation', 'novel', 'outreach', 'programs', 'response', 'skills', 'tool', 'willingness']",NIAMS,MAYO CLINIC ROCHESTER,P30,2020,629384,0.1206360952458808
"CORE CENTER FOR CLINICAL RESEACH IN TOTAL JOINT ARTHROPLASTY (CORE-TJA) ABSTRACT - OVERALL Total joint arthroplasty (TJA) is the most common and fastest growing surgery in the nation. There are currently more than 7 million Americans living with artificial joints. Despite the high surgery volume, the evidence base for TJA procedures, technologies and associated interventions are limited. Many surgical approaches and implant technologies in TJA are adopted based on theoretical grounds with limited clinical evidence. The wider TJA research community needs access to large, high quality and rich data sources and state-of-the-art clinical research standards and information technologies to overcome methodological and practical challenges in studies of surgical and nonsurgical interventions in TJA. The overarching goal of Mayo Core Center for Clinical Research in Total Joint Arthroplasty (CORE-TJA) is to facilitate innovative, methodologically rigorous and interdisciplinary clinical research that will directly improve TJA care and the outcomes. The CORE-TJA will serve as a disease (TJA) and theme-focused Center providing shared methodological expertise, education and data resources. The CORE-TJA will leverage big data resources for TJA research, provide customized methodology resources in epidemiology, biostatistics, health services research and medical informatics, and establish synergistic interactions around an integrated Core (American Joint Replacement Registry  AJRR). The Specific Aims of CORE-TJA are: (1) To provide administrative and scientific oversight of CORE-TJA activities (Administrative Core), (2) To provide integrated services, access to large databases and novel analytical methods for clinical research in TJA (Methodology Core); and (3) To meet the unique data needs of the TJA research community and to strengthen the national capacity for large-scale observational and interventional studies in TJA using national registry data (Resource Core). The CORE-TJA will be integrated within the long-standing and highly centralized clinical research environment of the Mayo Clinic, thereby leveraging existing expertise and infrastructure resources, including the Center for Clinical and Translational Science. All CORE-TJA activities will be evaluated using robust metrics to ensure continuous evaluation, flexibility and improvement in response to the most pressing needs of the TJA research community. NARRATIVE The Mayo Core Center for Clinical Research in Total Joint Arthroplasty (CORE-TJA) will provide methodological expertise and access to nationwide data resources to facilitate innovative, methodologically rigorous and interdisciplinary clinical research in TJA. The clinical research needs of the TJA research community that will be addressed by the CORE-TJA include training of the next generation of TJA researchers, customized consultations, facilitated access to high quality, rich data sources and national TJA registry data as well as informatics and methodology support.",CORE CENTER FOR CLINICAL RESEACH IN TOTAL JOINT ARTHROPLASTY (CORE-TJA),9850367,P30AR076312,"['Address', 'Adopted', 'Adoption', 'Advisory Committees', 'American', 'Area', 'Berry', 'Big Data', 'Biometry', 'Characteristics', 'Clinic', 'Clinical', 'Clinical Data', 'Clinical Research', 'Clinical Sciences', 'Collaborations', 'Communication', 'Communities', 'Consultations', 'Custom', 'Data', 'Data Analyses', 'Data Collection', 'Data Element', 'Data Sources', 'Databases', 'Development', 'Disease', 'Documentation', 'Education', 'Electronic Health Record', 'Ensure', 'Environment', 'Epidemiology', 'Evaluation', 'Future', 'Goals', 'Health Services Research', 'Hip region structure', 'Implant', 'Informatics', 'Information Technology', 'Infrastructure', 'Intervention', 'Intervention Studies', 'Joint Prosthesis', 'Knee', 'Leadership', 'Link', 'Medical Informatics', 'Methodology', 'Modeling', 'Musculoskeletal', 'Natural Language Processing', 'Observational Study', 'Operative Surgical Procedures', 'Outcome', 'Patient Care', 'Patients', 'Policies', 'Positioning Attribute', 'Procedures', 'Productivity', 'Registries', 'Replacement Arthroplasty', 'Research', 'Research Methodology', 'Research Personnel', 'Resources', 'Secure', 'Services', 'Surgeon', 'Technology', 'Time', 'Training', 'Translating', 'Translational Research', 'Translations', 'United States', 'Vision', 'analytical method', 'base', 'care outcomes', 'cost', 'data registry', 'data resource', 'education resources', 'evidence base', 'experience', 'flexibility', 'improved', 'improved outcome', 'innovation', 'next generation', 'novel', 'outreach', 'programs', 'response', 'skills', 'tool', 'willingness']",NIAMS,MAYO CLINIC ROCHESTER,P30,2019,644134,0.1206360952458808
"Endothelial Cell Phenotypes in Health and Disease Vascular diseases are among the most common causes of morbidity and mortality in the Western world. A remarkable feature of these disorders is the local nature of their distribution; virtually all diseases are associated with focal pathological lesions in characteristic sites of the vascular tree. A key to understanding the mechanisms of focal vasculopathy is found within the endothelium. Endothelial cell (EC) phenotypes are differentially regulated in space and time. Phenotypic heterogeneity is governed largely at the level of gene expression. The integrating theme of this program is that cis-trans and epigenetics contribute to lineage determination and EC heterogeneity. The overall goal is to apply multidisciplinary approaches, including cutting-edge epigenetic assays, gene targeting, embryoid body differentiation assays, flow models and sepsis models to dissect the relative contribution of cis-trans and epigenetic forces in mediating lineage- and vascular bed-specific endothelial gene expression and phenotypes. The PPG integrates investigators with diverse expertise required to advance our understanding of gene regulation in the endothelium. Project 1 (""Spatial and temporal dynamics of von Willebrand factor (vWF) gene expression""; William C. Aird, Project Leader) focuses on molecular mechanisms governing vWF expression in health and disease. Project 2 (""Transcriptional regulation of endothelial differentiation by ERG""; Peter Oettgen, Project Leader) explores the role of the ETS transcription factor ERG in the regulation of EC differentiation, vascular development, and human endothelial progenitor cell function. Project 3 (""Endothelial lineage diversity: role of epigenetics""; Philip Marsden, Project Leader) examines the role of epigenetic forces in mediating endothelial cell-specific gene expression of eNOS. Core A (""Administrative Support""; William C. Aird, Core Leader) provides standard administrative support, including the coordination of all applicable statutory compliance, for the Program. Core B (""Epigenetics Core""; John Whetstine, Core Leader) provides expertise and technical support for studying epigenetic modification of endothelial genes. Core C (""Gene Targeting Core""; William C. Aird, Core Leader) provides the necessary tools for targeting the Hprt locus and the loci of endogenous genes in ES cells and mice. n/a",Endothelial Cell Phenotypes in Health and Disease,8697092,P01HL076540,"['Address', 'Advisory Committees', 'Alberta province', 'Area', 'Award', 'Azacitidine', 'Biological Assay', 'Biology', 'Blood Circulation', 'Blood Vessels', 'Cell Differentiation process', 'Cell physiology', 'Characteristics', 'Collaborations', 'Complementary DNA', 'Country', 'Cues', 'DNA Methylation', 'DNA Methyltransferase Inhibitor', 'Data', 'Development', 'Disease', 'E-Selectin', 'Endothelial Cells', 'Endothelium', 'Environment', 'Enzymes', 'Epigenetic Process', 'Foundations', 'Functional RNA', 'Funding', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic', 'Goals', 'Grant', 'Health', 'Health Sciences', 'Heterogeneity', 'Histone Deacetylase Inhibitor', 'Histones', 'Human', 'Human Development', 'Hypoxia', 'Individual', 'Inherited', 'Institutes', 'Institution', 'Lead', 'Lesion', 'Mediating', 'Mediator of activation protein', 'Messenger RNA', 'MicroRNAs', 'Mission', 'Modeling', 'Modification', 'Molecular', 'Morbidity - disease rate', 'Mus', 'Nature', 'Ocular orbit', 'Organ', 'Paper', 'Phenotype', 'Poly A', 'Population', 'Principal Investigator', 'Process', 'Publishing', 'RNA', 'Recovery', 'Recruitment Activity', 'Regulation', 'Relative (related person)', 'Repression', 'Research', 'Research Personnel', 'Resources', 'Role', 'Scientist', 'Seminal', 'Sepsis', 'Site', 'Smooth Muscle Myocytes', 'Stem cells', 'Talents', 'Technical Expertise', 'Techniques', 'Technology', 'Time', 'Tissues', 'Transcriptional Regulation', 'Trees', 'Trichostatin A', 'Umbilical vein', 'United States', 'Universities', 'Vascular Diseases', 'Vascular Endothelial Growth Factor Receptor-2', 'Western World', 'Wisconsin', 'Writing', 'base', 'cadherin 5', 'cell type', 'chromatin remodeling', 'embryonic stem cell', 'experience', 'extracellular', 'histone modification', 'human NOS3 protein', 'inhibitor/antagonist', 'insight', 'interdisciplinary approach', 'interest', 'medical schools', 'meetings', 'member', 'mortality', 'new technology', 'novel therapeutics', 'programs', 'promoter', 'success', 'text searching', 'tool', 'transcription factor', 'vascular bed', 'von Willebrand Factor']",NHLBI,BETH ISRAEL DEACONESS MEDICAL CENTER,P01,2014,2035064,0.14874973750771167
"Endothelial Cell Phenotypes in Health and Disease Vascular diseases are among the most common causes of morbidity and mortality in the Western world. A remarkable feature of these disorders is the local nature of their distribution; virtually all diseases are associated with focal pathological lesions in characteristic sites of the vascular tree. A key to understanding the mechanisms of focal vasculopathy is found within the endothelium. Endothelial cell (EC) phenotypes are differentially regulated in space and time. Phenotypic heterogeneity is governed largely at the level of gene expression. The integrating theme of this program is that cis-trans and epigenetics contribute to lineage determination and EC heterogeneity. The overall goal is to apply multidisciplinary approaches, including cutting-edge epigenetic assays, gene targeting, embryoid body differentiation assays, flow models and sepsis models to dissect the relative contribution of cis-trans and epigenetic forces in mediating lineage- and vascular bed-specific endothelial gene expression and phenotypes. The PPG integrates investigators with diverse expertise required to advance our understanding of gene regulation in the endothelium. Project 1 (""Spatial and temporal dynamics of von Willebrand factor (vWF) gene expression""; William C. Aird, Project Leader) focuses on molecular mechanisms governing vWF expression in health and disease. Project 2 (""Transcriptional regulation of endothelial differentiation by ERG""; Peter Oettgen, Project Leader) explores the role of the ETS transcription factor ERG in the regulation of EC differentiation, vascular development, and human endothelial progenitor cell function. Project 3 (""Endothelial lineage diversity: role of epigenetics""; Philip Marsden, Project Leader) examines the role of epigenetic forces in mediating endothelial cell-specific gene expression of eNOS. Core A (""Administrative Support""; William C. Aird, Core Leader) provides standard administrative support, including the coordination of all applicable statutory compliance, for the Program. Core B (""Epigenetics Core""; John Whetstine, Core Leader) provides expertise and technical support for studying epigenetic modification of endothelial genes. Core C (""Gene Targeting Core""; William C. Aird, Core Leader) provides the necessary tools for targeting the Hprt locus and the loci of endogenous genes in ES cells and mice. n/a",Endothelial Cell Phenotypes in Health and Disease,8511777,P01HL076540,"['Address', 'Advisory Committees', 'Alberta province', 'Area', 'Award', 'Azacitidine', 'Biological Assay', 'Biology', 'Blood Circulation', 'Blood Vessels', 'Cell Differentiation process', 'Cell physiology', 'Characteristics', 'Collaborations', 'Complementary DNA', 'Country', 'Cues', 'DNA Methylation', 'DNA Methyltransferase Inhibitor', 'Data', 'Development', 'Disease', 'E-Selectin', 'Endothelial Cells', 'Endothelium', 'Environment', 'Enzymes', 'Epigenetic Process', 'Foundations', 'Functional RNA', 'Funding', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic', 'Goals', 'Grant', 'Health', 'Health Sciences', 'Heterogeneity', 'Histone Deacetylase Inhibitor', 'Histones', 'Human', 'Human Development', 'Hypoxia', 'Individual', 'Inherited', 'Institutes', 'Institution', 'Lead', 'Lesion', 'Mediating', 'Mediator of activation protein', 'Messenger RNA', 'MicroRNAs', 'Mission', 'Modeling', 'Modification', 'Molecular', 'Morbidity - disease rate', 'Mus', 'Nature', 'Ocular orbit', 'Organ', 'Paper', 'Phenotype', 'Poly A', 'Population', 'Principal Investigator', 'Process', 'Publishing', 'RNA', 'Recovery', 'Recruitment Activity', 'Regulation', 'Relative (related person)', 'Repression', 'Research', 'Research Personnel', 'Resources', 'Role', 'Scientist', 'Seminal', 'Sepsis', 'Site', 'Smooth Muscle Myocytes', 'Stem cells', 'Talents', 'Technical Expertise', 'Techniques', 'Technology', 'Time', 'Tissues', 'Transcriptional Regulation', 'Trees', 'Trichostatin A', 'Umbilical vein', 'United States', 'Universities', 'Vascular Diseases', 'Vascular Endothelial Growth Factor Receptor-2', 'Western World', 'Wisconsin', 'Writing', 'base', 'cadherin 5', 'cell type', 'chromatin remodeling', 'embryonic stem cell', 'experience', 'extracellular', 'histone modification', 'human NOS3 protein', 'inhibitor/antagonist', 'insight', 'interdisciplinary approach', 'interest', 'medical schools', 'meetings', 'member', 'mortality', 'new technology', 'novel therapeutics', 'programs', 'promoter', 'success', 'text searching', 'tool', 'transcription factor', 'vascular bed', 'von Willebrand Factor']",NHLBI,BETH ISRAEL DEACONESS MEDICAL CENTER,P01,2013,1976921,0.14874973750771167
"Endothelial Cell Phenotypes in Health and Disease Vascular diseases are among the most common causes of morbidity and mortality in the Western world. A remarkable feature of these disorders is the local nature of their distribution; virtually all diseases are associated with focal pathological lesions in characteristic sites of the vascular tree. A key to understanding the mechanisms of focal vasculopathy is found within the endothelium. Endothelial cell (EC) phenotypes are differentially regulated in space and time. Phenotypic heterogeneity is governed largely at the level of gene expression. The integrating theme of this program is that cis-trans and epigenetics contribute to lineage determination and EC heterogeneity. The overall goal is to apply multidisciplinary approaches, including cutting-edge epigenetic assays, gene targeting, embryoid body differentiation assays, flow models and sepsis models to dissect the relative contribution of cis-trans and epigenetic forces in mediating lineage- and vascular bed-specific endothelial gene expression and phenotypes. The PPG integrates investigators with diverse expertise required to advance our understanding of gene regulation in the endothelium. Project 1 (""Spatial and temporal dynamics of von Willebrand factor (vWF) gene expression""; William C. Aird, Project Leader) focuses on molecular mechanisms governing vWF expression in health and disease. Project 2 (""Transcriptional regulation of endothelial differentiation by ERG""; Peter Oettgen, Project Leader) explores the role of the ETS transcription factor ERG in the regulation of EC differentiation, vascular development, and human endothelial progenitor cell function. Project 3 (""Endothelial lineage diversity: role of epigenetics""; Philip Marsden, Project Leader) examines the role of epigenetic forces in mediating endothelial cell-specific gene expression of eNOS. Core A (""Administrative Support""; William C. Aird, Core Leader) provides standard administrative support, including the coordination of all applicable statutory compliance, for the Program. Core B (""Epigenetics Core""; John Whetstine, Core Leader) provides expertise and technical support for studying epigenetic modification of endothelial genes. Core C (""Gene Targeting Core""; William C. Aird, Core Leader) provides the necessary tools for targeting the Hprt locus and the loci of endogenous genes in ES cells and mice. n/a",Endothelial Cell Phenotypes in Health and Disease,8305566,P01HL076540,"['Address', 'Advisory Committees', 'Alberta province', 'Area', 'Award', 'Azacitidine', 'Biological Assay', 'Biology', 'Blood Circulation', 'Blood Vessels', 'Cell Differentiation process', 'Cell physiology', 'Characteristics', 'Collaborations', 'Complementary DNA', 'Country', 'Cues', 'DNA Methylation', 'DNA Methyltransferase Inhibitor', 'Data', 'Development', 'Disease', 'E-Selectin', 'Endothelial Cells', 'Endothelium', 'Environment', 'Enzymes', 'Epigenetic Process', 'Foundations', 'Functional RNA', 'Funding', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic', 'Goals', 'Grant', 'Health', 'Health Sciences', 'Heterogeneity', 'Histone Deacetylase Inhibitor', 'Histones', 'Human', 'Human Development', 'Hypoxia', 'Individual', 'Inherited', 'Institutes', 'Institution', 'Lead', 'Lesion', 'Mediating', 'Mediator of activation protein', 'Messenger RNA', 'MicroRNAs', 'Mission', 'Modeling', 'Modification', 'Molecular', 'Morbidity - disease rate', 'Mus', 'Nature', 'Ocular orbit', 'Organ', 'Paper', 'Phenotype', 'Poly A', 'Population', 'Principal Investigator', 'Process', 'Publishing', 'RNA', 'Recovery', 'Recruitment Activity', 'Regulation', 'Relative (related person)', 'Repression', 'Research', 'Research Personnel', 'Resources', 'Role', 'Scientist', 'Seminal', 'Sepsis', 'Site', 'Smooth Muscle Myocytes', 'Stem cells', 'Talents', 'Technical Expertise', 'Techniques', 'Technology', 'Time', 'Tissues', 'Transcriptional Regulation', 'Trees', 'Trichostatin A', 'Umbilical vein', 'United States', 'Universities', 'Vascular Diseases', 'Vascular Endothelial Growth Factor Receptor-2', 'Western World', 'Wisconsin', 'Writing', 'base', 'cadherin 5', 'cell type', 'chromatin remodeling', 'embryonic stem cell', 'experience', 'extracellular', 'histone modification', 'human NOS3 protein', 'inhibitor/antagonist', 'insight', 'interdisciplinary approach', 'interest', 'medical schools', 'meetings', 'member', 'mortality', 'new technology', 'novel therapeutics', 'programs', 'promoter', 'success', 'text searching', 'tool', 'transcription factor', 'vascular bed', 'von Willebrand Factor']",NHLBI,BETH ISRAEL DEACONESS MEDICAL CENTER,P01,2012,2076597,0.14874973750771167
"UCSF Core Center for Patient-centric Mechanistic Phenotyping in Chronic Low Back Pain The proposed UCSF Core Center for Patient-centric Mechanistic Phenotyping in Chronic Low Back Pain (UCSF REACH) will be an interdisciplinary consortium of basic and clinical scientists dedicated to understanding and clarifying the biopsychosocial mechanisms of chronic low back pain (cLBP). The goal of UCSF REACH is to define chronic low back pain (cLBP) phenotypes and pain mechanisms that can lead to effective, personalized treatments for patients across the population. A fundamental challenge for improving lives of cLBP patients is that pain can perpetuate and worsen as a result of dynamic interaction among several patient-specific factors. However, the principle factors and their interactions remain obscure because they haven't been rigorously investigated in a single longitudinal cohort. REACH proposes to overcome this obstacle by forming a linkage between researchers who study disease biology, experts who develop advanced investigational tools and methods, scientists who analyze vast archives of clinical data, and practitioners who actively treat patients. UCSF REACH proposes six cores: 1) Administrative Core; 2) Clinical Core; 3) Informatics Core; 4) Bio-behavioral Core; 5) Pathophysiology Core; and 6) Physical Function and Biomechanics Core. These cores will provide support to a single research project that is focused on the challenge of developing validated and adoptable tools that enable comprehensive yet routine clinical assessment and treatment of CLBP patients. REACH will also foster scientific exchange through an Enrichment Program; the curriculum includes seminars featuring local and visiting scientists, an annual full-day retreat with the External Advisory Committee, and half- day symposia with a rotating topic relevant to the biopsychosocial model of cLBP. Another vital component of REACH is its Pilot/Ancillary Studies Program. This provides seed money to leverage REACH clinical data and cores. Overall, the object of REACH is to make optimum use of all available resources to catalyze discovery and translation of novel diagnostics and therapeutics that improve outcomes of cLBP patients. The overall goal of this BACPAC MRC is to define chronic low back pain (cLBP) phenotypes and pain mechanisms that can lead to effective, personalized treatments for patients across the population. To achieve this goal, we propose three administrative cores, three research cores, and a central research project. The central research project will: 1) validate and prioritize novel instruments that assess critical domains of the biopsychosocial model; 2) validate patient-centered outcome measures; and 3) investigate their clinical utility using the UCSF REACH cLBP cohorts.",UCSF Core Center for Patient-centric Mechanistic Phenotyping in Chronic Low Back Pain,9898132,U19AR076737,"['Adopted', 'Advisory Committees', 'Anatomy', 'Ancillary Study', 'Archives', 'Back Pain', 'Biological', 'Biology', 'Biomechanics', 'Blood specimen', 'Brain imaging', 'California', 'Chronic', 'Chronic low back pain', 'Clinic', 'Clinic Activity', 'Clinical', 'Clinical Data', 'Clinical Research', 'Clinical Sciences', 'Clinical Treatment', 'Clinical assessments', 'Common Data Element', 'Communication', 'Communities', 'Cytometry', 'Data', 'Data Set', 'Diagnostic', 'Disease', 'Educational Curriculum', 'Electronic Health Record', 'Enrollment', 'Etiology', 'Fostering', 'Functional disorder', 'Funding', 'Future', 'Genomics', 'Goals', 'Hospitals', 'Image', 'Imaging Device', 'Informatics', 'Infrastructure', 'Institutes', 'Investigation', 'Knowledge', 'Lead', 'Longitudinal cohort', 'Low Back Pain', 'Machine Learning', 'Measures', 'Medicine', 'Methods', 'Mission', 'Modeling', 'Monitor', 'Motion', 'Musculoskeletal', 'National Institute of Arthritis and Musculoskeletal and Skin Diseases', 'Outcome', 'Outcome Measure', 'Pain', 'Pathology', 'Pathway interactions', 'Patient Care', 'Patient advocacy', 'Patient-Focused Outcomes', 'Patients', 'Phenotype', 'Physical Function', 'Population', 'Prevention strategy', 'Psychology', 'Questionnaires', 'Reporting', 'Research', 'Research Personnel', 'Research Project Grants', 'Resources', 'Role', 'Sampling', 'Scientist', 'Severities', 'Structure', 'Supervision', 'Symptoms', 'Technology', 'Therapeutic Intervention', 'Tissue Sample', 'Tissues', 'Transcend', 'Translational Research', 'Translations', 'United States', 'United States National Institutes of Health', 'Universities', 'Variant', 'Vertebral column', 'Visit', 'analytical tool', 'biobehavior', 'biopsychosocial', 'central pain', 'clinical care', 'clinical imaging', 'clinical pain', 'clinical practice', 'cohort', 'deep learning', 'digital', 'disability', 'improved', 'improved outcome', 'insight', 'instrument', 'interdisciplinary collaboration', 'learning strategy', 'novel', 'novel diagnostics', 'novel therapeutics', 'outcome forecast', 'pain patient', 'pain processing', 'patient oriented', 'personalized medicine', 'prediction algorithm', 'prescription opioid', 'programs', 'psychologic', 'ranpirnase', 'social', 'symposium', 'targeted treatment', 'tool', 'treatment optimization', 'treatment response', 'wearable device']",NIAMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",U19,2019,29408845,-0.10926033588774571
"Prediction of Protein Crystallization and Diffraction Quality    DESCRIPTION (provided by applicant): Given the key role that crystallography plays in structural biology, protein crystallization remains a significant bottleneck affecting a broad range of research programs. We developing a data-mining framework, PROSPERO, that can predict crystallization success and crystal diffraction quality based on characterization of specific protein properties available prior to large-scale crystallization trials. This will increase the efficiency and overall success rates of diffraction studies by individual research programs as well as by genome-scale projects. PROSPERO will perform a meta-analysis of many individual predictors based on statistical and machine-learning methods. A key feature of this framework is that it can dynamically re-estimate success/failure rates based on the current contents of the underlying database, and on the set of physical characterization data provided by individual users. The design will be modular, in that we will define a standard set of application interfaces (APIs) for supplying new categories of data to the core data storage, meta-analysis and prediction components. This will allow use of PROSPERO to be tailored to individual research programs, to target-specific physical properties, and to incorporate new physical characterization techniques. Our long-term goal is to grow a user community that will benefit from the continually improving predictions made by a central PROSPERO web server, that will contribute new input modules based on data produced by standard laboratory protocols and apparatus, and will also contribute to the population of the underlying database of results used for prediction.      PUBLIC HEALTH RELEVANCE: X-ray crystallography is a core technique in fundamental research programs that seek to understand disease mechanisms based on the three-dimensional structure of individual proteins, of large multi-protein complexes, and of larger assemblies of proteins and nucleic acids into key components of the cell. It is also a core technique in highly targeted research programs such as the design of new drugs. This work will increase the efficiency and overall success rate of these research programs by ameliorating a key bottleneck, the difficulty of obtaining high-quality crystals of the biological entity being studied.           X-ray crystallography is a core technique in fundamental research programs that seek to understand disease mechanisms based on the three-dimensional structure of individual proteins, of large multi-protein complexes, and of larger assemblies of proteins and nucleic acids into key components of the cell. It is also a core technique in highly targeted research programs such as the design of new drugs. This work will increase the efficiency and overall success rate of these research programs by ameliorating a key bottleneck, the difficulty of obtaining high-quality crystals of the biological entity being studied.",Prediction of Protein Crystallization and Diffraction Quality,7903338,R21GM088518,"['Affect', 'Base Sequence', 'Biological', 'Biological Process', 'Categories', 'Cellular Structures', 'Communities', 'Crystallization', 'Crystallography', 'Data', 'Data Display', 'Data Set', 'Data Storage and Retrieval', 'Databases', 'Disease', 'Evaluation', 'Failure', 'Gel', 'Genome', 'Goals', 'Housing', 'Image', 'Individual', 'Internet', 'Laboratories', 'Machine Learning', 'Medical', 'Meta-Analysis', 'Methods', 'Molecular Sieve Chromatography', 'Nucleic Acids', 'Numerical value', 'Online Systems', 'Outcome', 'Pharmaceutical Preparations', 'Play', 'Population', 'Process', 'Property', 'Proteins', 'Protocols documentation', 'Protozoa', 'Research', 'Role', 'Sampling', 'Secure', 'Set protein', 'Source', 'Structure', 'Targeted Research', 'Techniques', 'Training', 'Work', 'X-Ray Crystallography', 'base', 'data mining', 'database design', 'design', 'fundamental research', 'gel electrophoresis', 'improved', 'light scattering', 'melting', 'physical property', 'predictive modeling', 'programs', 'protein complex', 'prototype', 'public health relevance', 'structural biology', 'structural genomics', 'success', 'three dimensional structure', 'tool', 'two-dimensional', 'web interface', 'web site']",NIGMS,UNIVERSITY OF WASHINGTON,R21,2010,231660,0.11327171203176299
"Prediction of Protein Crystallization and Diffraction Quality    DESCRIPTION (provided by applicant): Given the key role that crystallography plays in structural biology, protein crystallization remains a significant bottleneck affecting a broad range of research programs. We developing a data-mining framework, PROSPERO, that can predict crystallization success and crystal diffraction quality based on characterization of specific protein properties available prior to large-scale crystallization trials. This will increase the efficiency and overall success rates of diffraction studies by individual research programs as well as by genome-scale projects. PROSPERO will perform a meta-analysis of many individual predictors based on statistical and machine-learning methods. A key feature of this framework is that it can dynamically re-estimate success/failure rates based on the current contents of the underlying database, and on the set of physical characterization data provided by individual users. The design will be modular, in that we will define a standard set of application interfaces (APIs) for supplying new categories of data to the core data storage, meta-analysis and prediction components. This will allow use of PROSPERO to be tailored to individual research programs, to target-specific physical properties, and to incorporate new physical characterization techniques. Our long-term goal is to grow a user community that will benefit from the continually improving predictions made by a central PROSPERO web server, that will contribute new input modules based on data produced by standard laboratory protocols and apparatus, and will also contribute to the population of the underlying database of results used for prediction.      PUBLIC HEALTH RELEVANCE: X-ray crystallography is a core technique in fundamental research programs that seek to understand disease mechanisms based on the three-dimensional structure of individual proteins, of large multi-protein complexes, and of larger assemblies of proteins and nucleic acids into key components of the cell. It is also a core technique in highly targeted research programs such as the design of new drugs. This work will increase the efficiency and overall success rate of these research programs by ameliorating a key bottleneck, the difficulty of obtaining high-quality crystals of the biological entity being studied.           X-ray crystallography is a core technique in fundamental research programs that seek to understand disease mechanisms based on the three-dimensional structure of individual proteins, of large multi-protein complexes, and of larger assemblies of proteins and nucleic acids into key components of the cell. It is also a core technique in highly targeted research programs such as the design of new drugs. This work will increase the efficiency and overall success rate of these research programs by ameliorating a key bottleneck, the difficulty of obtaining high-quality crystals of the biological entity being studied.",Prediction of Protein Crystallization and Diffraction Quality,7707893,R21GM088518,"['Affect', 'Base Sequence', 'Biological', 'Biological Process', 'Categories', 'Cellular Structures', 'Communities', 'Crystallization', 'Crystallography', 'Data', 'Data Display', 'Data Set', 'Data Storage and Retrieval', 'Databases', 'Disease', 'Evaluation', 'Failure', 'Gel', 'Genome', 'Goals', 'Housing', 'Image', 'Individual', 'Internet', 'Laboratories', 'Machine Learning', 'Medical', 'Meta-Analysis', 'Methods', 'Molecular Sieve Chromatography', 'Nucleic Acids', 'Numerical value', 'Online Systems', 'Outcome', 'Pharmaceutical Preparations', 'Play', 'Population', 'Process', 'Property', 'Proteins', 'Protocols documentation', 'Protozoa', 'Research', 'Role', 'Sampling', 'Secure', 'Set protein', 'Source', 'Structure', 'Targeted Research', 'Techniques', 'Training', 'Work', 'X-Ray Crystallography', 'base', 'data mining', 'database design', 'design', 'fundamental research', 'gel electrophoresis', 'improved', 'light scattering', 'melting', 'physical property', 'predictive modeling', 'programs', 'protein complex', 'prototype', 'public health relevance', 'structural biology', 'structural genomics', 'success', 'three dimensional structure', 'tool', 'two-dimensional', 'web interface', 'web site']",NIGMS,UNIVERSITY OF WASHINGTON,R21,2009,195000,0.11327171203176299
"Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction DESCRIPTION (provided by applicant): Integration of dimensional parameters from brain, performance, and self and other-report measures is key towards refining intermediate phenotypes (IPs) within the Research Domain Criteria (RDoC) proposal by NIMH. Currently, IPs do not align well with the disjunctive categorical diagnostic systems. In reality, the symptoms of Major Depressive Disorder (MDD) and Bipolar Disorder (BD) NOS and subthreshold conditions have significant overlap in symptoms and impact. There are likely shared disruptions in cognitive and affective systems (IPs) that may confer risk for these disruptions in negative mood. IPs link genes to brain biology and physiology; IPs also link to subsets of different mood disorder groups. The proposal is a synergistic, integrated and applied series of investigations of core domains in any mood disorders (AMD) for 120 individuals, in remission to diminish state symptom confounds, including all BD, MDD, Mood Disorder, NOS, Adjustment Disorder with Depressed Mood, and subthreshold Mood groups. These AMD subjects will be combined with a healthy control (HC) group of 55 individuals. Domains of the RDoC matrix are measured using self-other- report, other/clinician report, lab-based performance, and brain physiology/circuit (fMRI) biomarker measures to address two Aims and two Exploratory Aims. Scale development tools are used to demonstrate scale reliability and construct validity. Advanced modeling and stratification techniques from biomedical engineering and statistical machine learning will identify across-diagnosis subgroups that share core dimensions of dysfunction, which can be linked to domain and subdomain abnormalities and impact of illness. Aim 1 studies core (shared) dysfunction in elevated Fear to Acute Threat (1.1) using anxiety measures/Neuroticism facets, emotion processing biases, amygdala and limbic reactivity to negative faces in the Emotion Faces Matching Task, and functional connectivity approaches. There is also a core dysfunction in Loss and Loss anticipation (1.2) using negative environmental loss/stresses, negative memory biases, and NAcc and OFC activation to anticipation of loss in the Monetary Incentive Delay (MID) task, and functional connectivity approaches. Aim 2 studies core dysfunction in four Cognitive System subdomains, Attention (2.1), Working Memory (2.2), Cognitive Control (Inhibition, 2.3), and Cognitive Control (Interference, 2.4) measured with self and observer reports, performance, and VL and DLPFC and DACC activation in the N-Back and Parametric Go/No-go/Stop tasks during fMRI. An Exploratory Aim in subdomain stability is conducted in 40 AMD stratified on functional outcome plus 20 HC. Exploratory Aim 2 is collection of blood for later targeted gene experiments and/or sharing in larger GWAS studies. In summary, the present proposal uses dimensional modeling anchored in core features of dysfunction across AMD spectrum, but also pursues areas of differentiation based upon diagnosis, domain and functioning. Our strategy is optimal for the study of RDoC dimensional approaches for classification of AMD spectrum by integrating and extending the existing knowledge base, and integrating with commonly used clinical tools and genetic studies for ready translation of novel findings. PUBLIC HEALTH RELEVANCE: Dimensional modeling is a new strategy for helping to resolve how genetics and brain function can be so disparate from current categories of psychiatric illness. The present project uses multimodal, dimensional assessment to capture and subtype, core features across diagnoses, and differentiating biomarkers in all mood disorders, including bipolar, major depressive, mood disorder, adjustment, subthreshold, and NOS categories. Use of these groups and measures from Cognitive and Negative Valence systems provide a full continuum of dimensional data for across modality evaluation of linear, dimensional relationships and determination of construct validity.",Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction,9097801,R01MH101487,"['Acute', 'Address', 'Adjustment Disorders', 'Affect', 'Affective', 'Amygdaloid structure', 'Anger', 'Anxiety', 'Area', 'Attention', 'Back', 'Behavior', 'Behavioral', 'Biological Markers', 'Biology', 'Biomedical Engineering', 'Biometry', 'Bipolar Disorder', 'Blood', 'Brain', 'Categories', 'Childhood', 'Classification', 'Clinical', 'Cognitive', 'Collection', 'Control Groups', 'DSM-IV', 'Data', 'Depressed mood', 'Development', 'Diagnosis', 'Diagnostic', 'Dimensions', 'Disease', 'Disease remission', 'Emotions', 'Evaluation', 'Event', 'Exhibits', 'Face', 'Fright', 'Functional Imaging', 'Functional Magnetic Resonance Imaging', 'Functional disorder', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic study', 'Goals', 'Health', 'Illness impact', 'Incentives', 'Indium', 'Individual', 'Investigation', 'Life', 'Link', 'Machine Learning', 'Major Depressive Disorder', 'Measures', 'Memory', 'Mental disorders', 'Modality', 'Modeling', 'Mood Disorders', 'Moods', 'National Institute of Mental Health', 'Negative Valence', 'Neurotic Disorders', 'Occupational', 'Outcome', 'Patient Self-Report', 'Perception', 'Performance', 'Phenotype', 'Physiology', 'Process', 'Recording of previous events', 'Reporting', 'Research Domain Criteria', 'Resolution', 'Risk', 'Series', 'Short-Term Memory', 'Social Functioning', 'Stratification', 'Stress', 'Subgroup', 'Symptoms', 'System', 'Techniques', 'Testing', 'Translations', 'Work', 'base', 'cognitive control', 'cognitive system', 'depressive symptoms', 'disorder risk', 'disturbance in affect', 'functional outcomes', 'functional status', 'genome wide association study', 'instrument', 'interest', 'knowledge base', 'negative mood', 'neuroimaging', 'neurophysiology', 'novel', 'research study', 'response', 'social', 'tool', 'tool development']",NIMH,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2016,562097,0.07754211068578948
"Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction     DESCRIPTION (provided by applicant): Integration of dimensional parameters from brain, performance, and self and other-report measures is key towards refining intermediate phenotypes (IPs) within the Research Domain Criteria (RDoC) proposal by NIMH. Currently, IPs do not align well with the disjunctive categorical diagnostic systems. In reality, the symptoms of Major Depressive Disorder (MDD) and Bipolar Disorder (BD) NOS and subthreshold conditions have significant overlap in symptoms and impact. There are likely shared disruptions in cognitive and affective systems (IPs) that may confer risk for these disruptions in negative mood. IPs link genes to brain biology and physiology; IPs also link to subsets of different mood disorder groups. The proposal is a synergistic, integrated and applied series of investigations of core domains in any mood disorders (AMD) for 120 individuals, in remission to diminish state symptom confounds, including all BD, MDD, Mood Disorder, NOS, Adjustment Disorder with Depressed Mood, and subthreshold Mood groups. These AMD subjects will be combined with a healthy control (HC) group of 55 individuals. Domains of the RDoC matrix are measured using self-other- report, other/clinician report, lab-based performance, and brain physiology/circuit (fMRI) biomarker measures to address two Aims and two Exploratory Aims. Scale development tools are used to demonstrate scale reliability and construct validity. Advanced modeling and stratification techniques from biomedical engineering and statistical machine learning will identify across-diagnosis subgroups that share core dimensions of dysfunction, which can be linked to domain and subdomain abnormalities and impact of illness. Aim 1 studies core (shared) dysfunction in elevated Fear to Acute Threat (1.1) using anxiety measures/Neuroticism facets, emotion processing biases, amygdala and limbic reactivity to negative faces in the Emotion Faces Matching Task, and functional connectivity approaches. There is also a core dysfunction in Loss and Loss anticipation (1.2) using negative environmental loss/stresses, negative memory biases, and NAcc and OFC activation to anticipation of loss in the Monetary Incentive Delay (MID) task, and functional connectivity approaches. Aim 2 studies core dysfunction in four Cognitive System subdomains, Attention (2.1), Working Memory (2.2), Cognitive Control (Inhibition, 2.3), and Cognitive Control (Interference, 2.4) measured with self and observer reports, performance, and VL and DLPFC and DACC activation in the N-Back and Parametric Go/No-go/Stop tasks during fMRI. An Exploratory Aim in subdomain stability is conducted in 40 AMD stratified on functional outcome plus 20 HC. Exploratory Aim 2 is collection of blood for later targeted gene experiments and/or sharing in larger GWAS studies. In summary, the present proposal uses dimensional modeling anchored in core features of dysfunction across AMD spectrum, but also pursues areas of differentiation based upon diagnosis, domain and functioning. Our strategy is optimal for the study of RDoC dimensional approaches for classification of AMD spectrum by integrating and extending the existing knowledge base, and integrating with commonly used clinical tools and genetic studies for ready translation of novel findings.         PUBLIC HEALTH RELEVANCE: Dimensional modeling is a new strategy for helping to resolve how genetics and brain function can be so disparate from current categories of psychiatric illness. The present project uses multimodal, dimensional assessment to capture and subtype, core features across diagnoses, and differentiating biomarkers in all mood disorders, including bipolar, major depressive, mood disorder, adjustment, subthreshold, and NOS categories. Use of these groups and measures from Cognitive and Negative Valence systems provide a full continuum of dimensional data for across modality evaluation of linear, dimensional relationships and determination of construct validity.                ",Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction,8848892,R01MH101487,"['Acute', 'Address', 'Adjustment Disorders', 'Affect', 'Affective', 'Amygdaloid structure', 'Anger', 'Anxiety', 'Area', 'Attention', 'Back', 'Behavior', 'Behavioral', 'Biological Markers', 'Biology', 'Biomedical Engineering', 'Biometry', 'Bipolar Disorder', 'Blood', 'Brain', 'Categories', 'Childhood', 'Classification', 'Clinical', 'Cognitive', 'Collection', 'Control Groups', 'DSM-IV', 'Data', 'Depressed mood', 'Development', 'Diagnosis', 'Diagnostic', 'Dimensions', 'Disease', 'Disease remission', 'Emotions', 'Evaluation', 'Event', 'Exhibits', 'Face', 'Fright', 'Functional Imaging', 'Functional Magnetic Resonance Imaging', 'Functional disorder', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic study', 'Goals', 'Illness impact', 'Incentives', 'Indium', 'Individual', 'Investigation', 'Life', 'Link', 'Machine Learning', 'Major Depressive Disorder', 'Measures', 'Memory', 'Modality', 'Modeling', 'Mood Disorders', 'Moods', 'National Institute of Mental Health', 'Negative Valence', 'Neurotic Disorders', 'Occupational', 'Outcome', 'Patient Self-Report', 'Perception', 'Performance', 'Phenotype', 'Physiology', 'Process', 'Recording of previous events', 'Relative (related person)', 'Reporting', 'Research Domain Criteria', 'Resolution', 'Risk', 'Series', 'Short-Term Memory', 'Social Functioning', 'Stratification', 'Stress', 'Subgroup', 'Symptoms', 'System', 'Techniques', 'Testing', 'Translations', 'Work', 'base', 'cognitive control', 'cognitive system', 'depressive symptoms', 'disorder risk', 'disturbance in affect', 'functional outcomes', 'functional status', 'genome wide association study', 'instrument', 'interest', 'knowledge base', 'negative mood', 'neuroimaging', 'neurophysiology', 'novel', 'public health relevance', 'research study', 'response', 'social', 'tool', 'tool development']",NIMH,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2015,590447,0.07754211068578948
"Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction     DESCRIPTION (provided by applicant): Integration of dimensional parameters from brain, performance, and self and other-report measures is key towards refining intermediate phenotypes (IPs) within the Research Domain Criteria (RDoC) proposal by NIMH. Currently, IPs do not align well with the disjunctive categorical diagnostic systems. In reality, the symptoms of Major Depressive Disorder (MDD) and Bipolar Disorder (BD) NOS and subthreshold conditions have significant overlap in symptoms and impact. There are likely shared disruptions in cognitive and affective systems (IPs) that may confer risk for these disruptions in negative mood. IPs link genes to brain biology and physiology; IPs also link to subsets of different mood disorder groups. The proposal is a synergistic, integrated and applied series of investigations of core domains in any mood disorders (AMD) for 120 individuals, in remission to diminish state symptom confounds, including all BD, MDD, Mood Disorder, NOS, Adjustment Disorder with Depressed Mood, and subthreshold Mood groups. These AMD subjects will be combined with a healthy control (HC) group of 55 individuals. Domains of the RDoC matrix are measured using self-other- report, other/clinician report, lab-based performance, and brain physiology/circuit (fMRI) biomarker measures to address two Aims and two Exploratory Aims. Scale development tools are used to demonstrate scale reliability and construct validity. Advanced modeling and stratification techniques from biomedical engineering and statistical machine learning will identify across-diagnosis subgroups that share core dimensions of dysfunction, which can be linked to domain and subdomain abnormalities and impact of illness. Aim 1 studies core (shared) dysfunction in elevated Fear to Acute Threat (1.1) using anxiety measures/Neuroticism facets, emotion processing biases, amygdala and limbic reactivity to negative faces in the Emotion Faces Matching Task, and functional connectivity approaches. There is also a core dysfunction in Loss and Loss anticipation (1.2) using negative environmental loss/stresses, negative memory biases, and NAcc and OFC activation to anticipation of loss in the Monetary Incentive Delay (MID) task, and functional connectivity approaches. Aim 2 studies core dysfunction in four Cognitive System subdomains, Attention (2.1), Working Memory (2.2), Cognitive Control (Inhibition, 2.3), and Cognitive Control (Interference, 2.4) measured with self and observer reports, performance, and VL and DLPFC and DACC activation in the N-Back and Parametric Go/No-go/Stop tasks during fMRI. An Exploratory Aim in subdomain stability is conducted in 40 AMD stratified on functional outcome plus 20 HC. Exploratory Aim 2 is collection of blood for later targeted gene experiments and/or sharing in larger GWAS studies. In summary, the present proposal uses dimensional modeling anchored in core features of dysfunction across AMD spectrum, but also pursues areas of differentiation based upon diagnosis, domain and functioning. Our strategy is optimal for the study of RDoC dimensional approaches for classification of AMD spectrum by integrating and extending the existing knowledge base, and integrating with commonly used clinical tools and genetic studies for ready translation of novel findings.         PUBLIC HEALTH RELEVANCE: Dimensional modeling is a new strategy for helping to resolve how genetics and brain function can be so disparate from current categories of psychiatric illness. The present project uses multimodal, dimensional assessment to capture and subtype, core features across diagnoses, and differentiating biomarkers in all mood disorders, including bipolar, major depressive, mood disorder, adjustment, subthreshold, and NOS categories. Use of these groups and measures from Cognitive and Negative Valence systems provide a full continuum of dimensional data for across modality evaluation of linear, dimensional relationships and determination of construct validity.                ",Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction,8573671,R01MH101487,"['Acute', 'Address', 'Adjustment Disorders', 'Affect', 'Affective', 'Amygdaloid structure', 'Anger', 'Anxiety', 'Area', 'Attention', 'Back', 'Behavior', 'Behavioral', 'Biological Markers', 'Biology', 'Biomedical Engineering', 'Biometry', 'Bipolar Disorder', 'Blood', 'Brain', 'Categories', 'Childhood', 'Classification', 'Clinical', 'Cognitive', 'Collection', 'Control Groups', 'DSM-IV', 'Data', 'Depressed mood', 'Diagnosis', 'Diagnostic', 'Dimensions', 'Disease', 'Disease remission', 'Emotions', 'Evaluation', 'Event', 'Exhibits', 'Face', 'Fright', 'Functional Imaging', 'Functional Magnetic Resonance Imaging', 'Functional disorder', 'Gene Targeting', 'Genes', 'Genetic', 'Goals', 'Illness impact', 'Incentives', 'Indium', 'Individual', 'Investigation', 'Life', 'Link', 'Machine Learning', 'Major Depressive Disorder', 'Measures', 'Memory', 'Modality', 'Modeling', 'Mood Disorders', 'Moods', 'National Institute of Mental Health', 'Neurotic Disorders', 'Occupational', 'Outcome', 'Patient Self-Report', 'Perception', 'Performance', 'Phenotype', 'Physiology', 'Process', 'Recording of previous events', 'Relative (related person)', 'Reporting', 'Research', 'Resolution', 'Risk', 'Series', 'Short-Term Memory', 'Social Functioning', 'Stratification', 'Stress', 'Subgroup', 'Symptoms', 'System', 'Techniques', 'Testing', 'Translations', 'Work', 'base', 'cognitive control', 'cognitive system', 'depressive symptoms', 'disorder risk', 'disturbance in affect', 'functional outcomes', 'functional status', 'genome wide association study', 'instrument', 'interest', 'knowledge base', 'negative mood', 'neuroimaging', 'neurophysiology', 'novel', 'public health relevance', 'research and development', 'research study', 'response', 'social', 'tool', 'tool development']",NIMH,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2013,627944,0.07754211068578948
"Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction     DESCRIPTION (provided by applicant): Integration of dimensional parameters from brain, performance, and self and other-report measures is key towards refining intermediate phenotypes (IPs) within the Research Domain Criteria (RDoC) proposal by NIMH. Currently, IPs do not align well with the disjunctive categorical diagnostic systems. In reality, the symptoms of Major Depressive Disorder (MDD) and Bipolar Disorder (BD) NOS and subthreshold conditions have significant overlap in symptoms and impact. There are likely shared disruptions in cognitive and affective systems (IPs) that may confer risk for these disruptions in negative mood. IPs link genes to brain biology and physiology; IPs also link to subsets of different mood disorder groups. The proposal is a synergistic, integrated and applied series of investigations of core domains in any mood disorders (AMD) for 120 individuals, in remission to diminish state symptom confounds, including all BD, MDD, Mood Disorder, NOS, Adjustment Disorder with Depressed Mood, and subthreshold Mood groups. These AMD subjects will be combined with a healthy control (HC) group of 55 individuals. Domains of the RDoC matrix are measured using self-other- report, other/clinician report, lab-based performance, and brain physiology/circuit (fMRI) biomarker measures to address two Aims and two Exploratory Aims. Scale development tools are used to demonstrate scale reliability and construct validity. Advanced modeling and stratification techniques from biomedical engineering and statistical machine learning will identify across-diagnosis subgroups that share core dimensions of dysfunction, which can be linked to domain and subdomain abnormalities and impact of illness. Aim 1 studies core (shared) dysfunction in elevated Fear to Acute Threat (1.1) using anxiety measures/Neuroticism facets, emotion processing biases, amygdala and limbic reactivity to negative faces in the Emotion Faces Matching Task, and functional connectivity approaches. There is also a core dysfunction in Loss and Loss anticipation (1.2) using negative environmental loss/stresses, negative memory biases, and NAcc and OFC activation to anticipation of loss in the Monetary Incentive Delay (MID) task, and functional connectivity approaches. Aim 2 studies core dysfunction in four Cognitive System subdomains, Attention (2.1), Working Memory (2.2), Cognitive Control (Inhibition, 2.3), and Cognitive Control (Interference, 2.4) measured with self and observer reports, performance, and VL and DLPFC and DACC activation in the N-Back and Parametric Go/No-go/Stop tasks during fMRI. An Exploratory Aim in subdomain stability is conducted in 40 AMD stratified on functional outcome plus 20 HC. Exploratory Aim 2 is collection of blood for later targeted gene experiments and/or sharing in larger GWAS studies. In summary, the present proposal uses dimensional modeling anchored in core features of dysfunction across AMD spectrum, but also pursues areas of differentiation based upon diagnosis, domain and functioning. Our strategy is optimal for the study of RDoC dimensional approaches for classification of AMD spectrum by integrating and extending the existing knowledge base, and integrating with commonly used clinical tools and genetic studies for ready translation of novel findings.         PUBLIC HEALTH RELEVANCE: Dimensional modeling is a new strategy for helping to resolve how genetics and brain function can be so disparate from current categories of psychiatric illness. The present project uses multimodal, dimensional assessment to capture and subtype, core features across diagnoses, and differentiating biomarkers in all mood disorders, including bipolar, major depressive, mood disorder, adjustment, subthreshold, and NOS categories. Use of these groups and measures from Cognitive and Negative Valence systems provide a full continuum of dimensional data for across modality evaluation of linear, dimensional relationships and determination of construct validity.                ",Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction,8891628,R01MH101487,"['Acute', 'Address', 'Adjustment Disorders', 'Affect', 'Affective', 'Amygdaloid structure', 'Anger', 'Anxiety', 'Area', 'Attention', 'Back', 'Behavior', 'Behavioral', 'Biological Markers', 'Biology', 'Biomedical Engineering', 'Biometry', 'Bipolar Disorder', 'Blood', 'Brain', 'Categories', 'Childhood', 'Classification', 'Clinical', 'Cognitive', 'Collection', 'Control Groups', 'DSM-IV', 'Data', 'Depressed mood', 'Development', 'Diagnosis', 'Diagnostic', 'Dimensions', 'Disease', 'Disease remission', 'Emotions', 'Evaluation', 'Event', 'Exhibits', 'Face', 'Fright', 'Functional Imaging', 'Functional Magnetic Resonance Imaging', 'Functional disorder', 'Gene Targeting', 'Genes', 'Genetic', 'Goals', 'Illness impact', 'Incentives', 'Indium', 'Individual', 'Investigation', 'Life', 'Link', 'Machine Learning', 'Major Depressive Disorder', 'Measures', 'Memory', 'Modality', 'Modeling', 'Mood Disorders', 'Moods', 'National Institute of Mental Health', 'Neurotic Disorders', 'Occupational', 'Outcome', 'Patient Self-Report', 'Perception', 'Performance', 'Phenotype', 'Physiology', 'Process', 'Recording of previous events', 'Relative (related person)', 'Reporting', 'Research Domain Criteria', 'Resolution', 'Risk', 'Series', 'Short-Term Memory', 'Social Functioning', 'Stratification', 'Stress', 'Subgroup', 'Symptoms', 'System', 'Techniques', 'Testing', 'Translations', 'Work', 'base', 'cognitive control', 'cognitive system', 'depressive symptoms', 'disorder risk', 'disturbance in affect', 'functional outcomes', 'functional status', 'genome wide association study', 'instrument', 'interest', 'knowledge base', 'negative mood', 'neuroimaging', 'neurophysiology', 'novel', 'public health relevance', 'research study', 'response', 'social', 'tool', 'tool development']",NIMH,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2014,95174,0.07754211068578948
"Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction     DESCRIPTION (provided by applicant): Integration of dimensional parameters from brain, performance, and self and other-report measures is key towards refining intermediate phenotypes (IPs) within the Research Domain Criteria (RDoC) proposal by NIMH. Currently, IPs do not align well with the disjunctive categorical diagnostic systems. In reality, the symptoms of Major Depressive Disorder (MDD) and Bipolar Disorder (BD) NOS and subthreshold conditions have significant overlap in symptoms and impact. There are likely shared disruptions in cognitive and affective systems (IPs) that may confer risk for these disruptions in negative mood. IPs link genes to brain biology and physiology; IPs also link to subsets of different mood disorder groups. The proposal is a synergistic, integrated and applied series of investigations of core domains in any mood disorders (AMD) for 120 individuals, in remission to diminish state symptom confounds, including all BD, MDD, Mood Disorder, NOS, Adjustment Disorder with Depressed Mood, and subthreshold Mood groups. These AMD subjects will be combined with a healthy control (HC) group of 55 individuals. Domains of the RDoC matrix are measured using self-other- report, other/clinician report, lab-based performance, and brain physiology/circuit (fMRI) biomarker measures to address two Aims and two Exploratory Aims. Scale development tools are used to demonstrate scale reliability and construct validity. Advanced modeling and stratification techniques from biomedical engineering and statistical machine learning will identify across-diagnosis subgroups that share core dimensions of dysfunction, which can be linked to domain and subdomain abnormalities and impact of illness. Aim 1 studies core (shared) dysfunction in elevated Fear to Acute Threat (1.1) using anxiety measures/Neuroticism facets, emotion processing biases, amygdala and limbic reactivity to negative faces in the Emotion Faces Matching Task, and functional connectivity approaches. There is also a core dysfunction in Loss and Loss anticipation (1.2) using negative environmental loss/stresses, negative memory biases, and NAcc and OFC activation to anticipation of loss in the Monetary Incentive Delay (MID) task, and functional connectivity approaches. Aim 2 studies core dysfunction in four Cognitive System subdomains, Attention (2.1), Working Memory (2.2), Cognitive Control (Inhibition, 2.3), and Cognitive Control (Interference, 2.4) measured with self and observer reports, performance, and VL and DLPFC and DACC activation in the N-Back and Parametric Go/No-go/Stop tasks during fMRI. An Exploratory Aim in subdomain stability is conducted in 40 AMD stratified on functional outcome plus 20 HC. Exploratory Aim 2 is collection of blood for later targeted gene experiments and/or sharing in larger GWAS studies. In summary, the present proposal uses dimensional modeling anchored in core features of dysfunction across AMD spectrum, but also pursues areas of differentiation based upon diagnosis, domain and functioning. Our strategy is optimal for the study of RDoC dimensional approaches for classification of AMD spectrum by integrating and extending the existing knowledge base, and integrating with commonly used clinical tools and genetic studies for ready translation of novel findings.         PUBLIC HEALTH RELEVANCE: Dimensional modeling is a new strategy for helping to resolve how genetics and brain function can be so disparate from current categories of psychiatric illness. The present project uses multimodal, dimensional assessment to capture and subtype, core features across diagnoses, and differentiating biomarkers in all mood disorders, including bipolar, major depressive, mood disorder, adjustment, subthreshold, and NOS categories. Use of these groups and measures from Cognitive and Negative Valence systems provide a full continuum of dimensional data for across modality evaluation of linear, dimensional relationships and determination of construct validity.                ",Dimensional RDoC Modeling across the Range of Negative Mood Dysfunction,8737315,R01MH101487,"['Acute', 'Address', 'Adjustment Disorders', 'Affect', 'Affective', 'Amygdaloid structure', 'Anger', 'Anxiety', 'Area', 'Attention', 'Back', 'Behavior', 'Behavioral', 'Biological Markers', 'Biology', 'Biomedical Engineering', 'Biometry', 'Bipolar Disorder', 'Blood', 'Brain', 'Categories', 'Childhood', 'Classification', 'Clinical', 'Cognitive', 'Collection', 'Control Groups', 'DSM-IV', 'Data', 'Depressed mood', 'Development', 'Diagnosis', 'Diagnostic', 'Dimensions', 'Disease', 'Disease remission', 'Emotions', 'Evaluation', 'Event', 'Exhibits', 'Face', 'Fright', 'Functional Imaging', 'Functional Magnetic Resonance Imaging', 'Functional disorder', 'Gene Targeting', 'Genes', 'Genetic', 'Goals', 'Illness impact', 'Incentives', 'Indium', 'Individual', 'Investigation', 'Life', 'Link', 'Machine Learning', 'Major Depressive Disorder', 'Measures', 'Memory', 'Modality', 'Modeling', 'Mood Disorders', 'Moods', 'National Institute of Mental Health', 'Neurotic Disorders', 'Occupational', 'Outcome', 'Patient Self-Report', 'Perception', 'Performance', 'Phenotype', 'Physiology', 'Process', 'Recording of previous events', 'Relative (related person)', 'Reporting', 'Research Domain Criteria', 'Resolution', 'Risk', 'Series', 'Short-Term Memory', 'Social Functioning', 'Stratification', 'Stress', 'Subgroup', 'Symptoms', 'System', 'Techniques', 'Testing', 'Translations', 'Work', 'base', 'cognitive control', 'cognitive system', 'depressive symptoms', 'disorder risk', 'disturbance in affect', 'functional outcomes', 'functional status', 'genome wide association study', 'instrument', 'interest', 'knowledge base', 'negative mood', 'neuroimaging', 'neurophysiology', 'novel', 'public health relevance', 'research study', 'response', 'social', 'tool', 'tool development']",NIMH,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2014,609146,0.07754211068578948
"Center for Modeling Complex Interactions Biomedical problems are innately complex, and their solutions require input from many fields. Many centers focus on a single disease or organ system. By contrast, the Center for Modeling Complex Interactions focuses on an approach that can address many biomedical problems: team-based, interdisciplinary research centered around modeling. Our goal is to support and facilitate biomedical discovery by integrating modeling into interdisciplinary research. Modeling improves research at all stageshypothesis formulation, experimental design, analysis, and interpretation. It provides a unifying language by which exchange of ideas can highlight commonalities and uncover unforeseen connections between problems. Formalization of ideas into this unifying language also improves rigor and reproducibility. We define modeling broadly to include everything from deterministic and stochastic mathematical approaches, to physical and computational models of three- dimensional objects, to agent-based and machine learning approaches where exact solutions are not possible. We seek to support modelers by increasing their numbers, and by giving them opportunities to play on interdisciplinary teams. We seek to support empiricists by giving them access to relevant modeling expertise, and by creating a community and a culture to facilitate interdisciplinary research. In Phase I, the Center for Modeling Complex Interactions created the intellectual, cultural, and physical environment to promote team- based, interdisciplinary research. In Phase II, we will build on that foundation by maintaining a strong interdisciplinary culture to foster collaboration among people who might otherwise never connect, and by adding additional faculty to expand our modeling expertise. We have four Aims: 1) Support faculty to carry out model-based, interdisciplinary biomedical research and increase their competitiveness for external funding. Research in the Center is carried out in the context of Working Groupszero-barrier, interdisciplinary, goal- focused teams that meet regularly to get work done. Supported research includes three Research Projects, Pilot Projects, Modeling Access Grants, and ad hoc teams. Our comprehensive plan for proposal preparation improves grantsmanship, and our staff assists with submission and grant management. 2) Increase University of Idahos faculty participation in biomedical research. We will add six new faculty as a commitment to this Phase II COBRE and attract broader participation from across the University. 3) Extend the reach of the Modeling Core into new areas of modeling to capitalize on emerging opportunities. The Modeling Core accelerates interdisciplinary research by placing Core Fellows at the hub of the research community. We have added new Core Initiatives in machine learning and geospatial modeling to stimulate research in these areas with high potential for future growth. 4) Establish a path to long-term sustainability under the umbrella of the Institute for Modeling Collaboration & Innovation. The major hurdle for sustainability is to maintain a robust Modeling Core. We have developed a business plan that calls for us to diversify our funding sources to include institutional, state, and private support to supplement federal grants. Human health is determined by interactions of complex biological systems at multiple scales, from the ecological to the biophysical; these are layered with spatial and temporal variation. To decipher these systems requires predictive modeling, coupled with strong empirical work, to be guided by and to feed the models. The Center for Modeling Complex Interactions generates model-based biomedical research and connects people who might otherwise never interact, which enhances the strong interdisciplinary culture of the University of Idaho.",Center for Modeling Complex Interactions,10026000,P20GM104420,"['Address', 'Area', 'Biological', 'Biomedical Research', 'Biophysics', 'Businesses', 'Centers of Research Excellence', 'Collaborations', 'Communication', 'Communities', 'Complex', 'Computer Models', 'Coupled', 'Data', 'Development', 'Disease', 'Ensure', 'Experimental Designs', 'Faculty', 'Feedback', 'Formulation', 'Fostering', 'Foundations', 'Funding', 'Funding Agency', 'Future', 'Generations', 'Goals', 'Grant', 'Growth', 'Health', 'Holly', 'Home environment', 'Human', 'Human Resources', 'Idaho', 'Incubators', 'Individual', 'Infrastructure', 'Institutes', 'Interdisciplinary Study', 'Language', 'Lead', 'Machine Learning', 'Modeling', 'Outcome', 'Phase', 'Physical environment', 'Pilot Projects', 'Play', 'Population', 'Postdoctoral Fellow', 'Preparation', 'Privatization', 'Progress Reports', 'Property', 'Reproducibility', 'Research', 'Research Institute', 'Research Project Grants', 'Research Support', 'Schedule', 'Scientist', 'Structure', 'Students', 'System', 'Testing', 'Time', 'Training', 'Uncertainty', 'Universities', 'Ursidae Family', 'Work', 'base', 'biological systems', 'body system', 'complex biological systems', 'experience', 'faculty support', 'improved', 'innovation', 'insight', 'interdisciplinary approach', 'mathematical methods', 'member', 'next generation', 'novel strategies', 'physical model', 'predictive modeling', 'spatial temporal variation', 'success', 'three-dimensional modeling', 'undergraduate student', 'working group']",NIGMS,UNIVERSITY OF IDAHO,P20,2020,2172986,0.10129365015467176
"Interrogating Epigenetic Changes in Cancer Genomes The investigators of the Ohio State University submit a center grant application in response to the RFA announcement of the Integrated Cancer Biology Program (ICBP). In addition, our colleagues at the neighboring Indiana University will join this endeavor. The proposed research will tackle a unique problem, i.e., epigenetic alteration, now being considered as important as genetic mutations in cancer. This phenomenon can be defined as a heritable change that modulates chromatin organization and gene  expression without altering nucleotide sequences. Bringing together experimental and computational biologists, our overall goals of this ICBP are 1) to increase our understanding of complex epigenetic interactions in neoplasms and 2) to use high-end information for improved prognosis, intervention, and treatment of human female cancers. Experimental biologists will use novel microarray platforms to interrogate DMA methylation, histone modifications, loss of heterozygosity, and transcription factor binding in cancer cell lines and neoplastic epithelium and the surrounding stroma. Computational biologists will use these experimental data for model building and refinement. Empirical Bayesian models will be used to predict how repressers, histone deacetylases, and DMA methyltransferases are recruited to establish epigenetic gene silencing (Project 1). Phylogenetic clustering algorithms will be developed to recapitulate genetic and epigenetic pathways in cancer stroma as they relate to tumor progression (Project 2). LASSO logistic regression and neural network approaches will be used to model the synergistic DNA-protein interactions and  the resulting change of chromatin landscape in cancer cells (Project 3). Pattern recognition and supervised learning techniques will be used to select genes that contain the characteristics of methylation-prone sequences in drug-resistant cancer cells (Project 4). These mathematical models will generate the first- or second-level hypotheses for experimental testing. The iterative process of model refinement and experimental verification will continue until models are derived that accurately predict specific epigenetic alterations in the interrogating cancer genome. All experimental data and modeling tools will be deposited in a centralized  database (Core B) and will be used for training future systems cancer biologists (Core C). The progress of these integrated studies will be evaluated by advisors and administrative leaders (Core A) to ensure the success of the proposed ICBP. n/a",Interrogating Epigenetic Changes in Cancer Genomes,8092077,U54CA113001,"['Applications Grants', 'Binding', 'Cancer Biology', 'DNA-Protein Interaction', 'Drug resistance', 'Epigenetic Process', 'Epithelium', 'Lasso', 'cancer genome', 'histone modification']",NCI,OHIO STATE UNIVERSITY,U54,2010,88000,0.08595070681213823
"Interrogating Epigenetic Changes in Cancer Genomes The investigators of the Ohio State University submit a center grant application in response to the RFA announcement of the Integrated Cancer Biology Program (ICBP). In addition, our colleagues at the neighboring Indiana University will join this endeavor. The proposed research will tackle a unique problem, i.e., epigenetic alteration, now being considered as important as genetic mutations in cancer. This phenomenon can be defined as a heritable change that modulates chromatin organization and gene  expression without altering nucleotide sequences. Bringing together experimental and computational biologists, our overall goals of this ICBP are 1) to increase our understanding of complex epigenetic interactions in neoplasms and 2) to use high-end information for improved prognosis, intervention, and treatment of human female cancers. Experimental biologists will use novel microarray platforms to interrogate DMA methylation, histone modifications, loss of heterozygosity, and transcription factor binding in cancer cell lines and neoplastic epithelium and the surrounding stroma. Computational biologists will use these experimental data for model building and refinement. Empirical Bayesian models will be used to predict how repressers, histone deacetylases, and DMA methyltransferases are recruited to establish epigenetic gene silencing (Project 1). Phylogenetic clustering algorithms will be developed to recapitulate genetic and epigenetic pathways in cancer stroma as they relate to tumor progression (Project 2). LASSO logistic regression and neural network approaches will be used to model the synergistic DNA-protein interactions and  the resulting change of chromatin landscape in cancer cells (Project 3). Pattern recognition and supervised learning techniques will be used to select genes that contain the characteristics of methylation-prone sequences in drug-resistant cancer cells (Project 4). These mathematical models will generate the first- or second-level hypotheses for experimental testing. The iterative process of model refinement and experimental verification will continue until models are derived that accurately predict specific epigenetic alterations in the interrogating cancer genome. All experimental data and modeling tools will be deposited in a centralized  database (Core B) and will be used for training future systems cancer biologists (Core C). The progress of these integrated studies will be evaluated by advisors and administrative leaders (Core A) to ensure the success of the proposed ICBP. n/a",Interrogating Epigenetic Changes in Cancer Genomes,8068372,U54CA113001,[' '],NCI,OHIO STATE UNIVERSITY,U54,2011,1728938,0.08595070681213823
"Phamarcogenomics of Statin Therapy (SUPPLEMENT) PARENT ABSTRACT The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing risk of cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin-treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well- characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin- induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects 1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs. ADMINISTRATIVE SUPPLEMENT ABSTRACT In response to NOT-AG-18-008, our goal is to extend the validation and application of our data integration methodologies into Alzheimers disease research. This administrative supplement is designed to extend the work of the existing subaward to the University of Pennsylvania subcontract for the POST Informatics Core. The PGRN POST Informatics Core serves as the central hub for data sharing and coordination across the three POST projects in the PGRN P50 award. One of our jobs is annotating the extensive information that will be collected and providing analysis expertise to the projects as needed. However, to make great strides in scientific progress and ensure that the collective whole of the Center is greater than the sum of the parts, a key function of the Informatics Core is to serve as The Integrator to combine these data and information. We and others have shown that integration of complementary omics-based data can provide emergent insights into biological processes compared to what can be learned through any single approach alone. The methods that we are developing to integrate data for statin pharmacogenomic phenotypes will be equally applicable in the area of Alzheimers disease. Additionally, recent emphasis on open data science by Alzheimers disease researchers provides ample data for us to interrogate our method. We have developed novel statistical analysis tools such as the Analysis Tool for Heritable and Environmental Network Associations (ATHENA), and data visualization tools, such as PhenoGram, both of which are designed to collect and combine information from diverse data sources. With these tools, we will leverage publicly available Alzheimers disease datasets to maximize the knowledge gleaned about disease risk for Alzheimers diseases. The methodologies that we have been developing as part of the PGRN POST award for the past 2.5 years are clearly applicable to the study of Alzheimers disease risk. An important validation step of the application of our methodologies is to apply them to different types of datasets and in different phenotypic areas. This administrative supplement focused on extended research into having an Alzheimers disease focus is a great mechanism to simultaneously allow us to validate our methodologies with different types of data and potentially identify important risk factors and pathways toward a better understanding of the etiology of Alzheimers disease. Finally, we may have the opportunity to identify cross biological implications due to the known pleiotropic relationships between Alzheimers disease and cardiovascular disease. PROJECT NARRATIVE This administrative supplement is focused on extended our data integration research into Alzheimers disease. This funding mechanism will simultaneously allow us to validate our methodologies with different types of data and also potentially identify important risk factors and pathways toward a better understanding of the etiology of Alzheimers disease.",Phamarcogenomics of Statin Therapy (SUPPLEMENT),9719267,P50GM115318,"['Administrative Supplement', 'Adverse effects', 'Affect', 'Alzheimer&apos', 's Disease', 'Alzheimer&apos', 's disease risk', 'Animal Model', 'Area', 'Autophagocytosis', 'Award', 'Bioinformatics', 'Biological', 'Biological Markers', 'Biological Process', 'California', 'Cardiovascular Diseases', 'Cell Line', 'Cell model', 'Clinical', 'Clinical Markers', 'Clinical Medicine', 'Clinical Pharmacology', 'DNA', 'Data', 'Data Analyses', 'Data Science', 'Data Set', 'Data Sources', 'Electronic Health Record', 'Ensure', 'Etiology', 'Event', 'Fostering', 'Funding Mechanisms', 'Genes', 'Genetic Variation', 'Genomics', 'Genotype', 'Glean', 'Goals', 'Heritability', 'Human', 'Inbred Strains Mice', 'Informatics', 'Knowledge', 'Leadership', 'Learning', 'Lipids', 'Machine Learning', 'Methodology', 'Methods', 'Modeling', 'Molecular', 'Mus', 'Myopathy', 'Non-Insulin-Dependent Diabetes Mellitus', 'Occupations', 'Parents', 'Pathway interactions', 'Patients', 'Pennsylvania', 'Pharmaceutical Preparations', 'Pharmacogenomics', 'Pharmacy facility', 'Phenotype', 'Population Heterogeneity', 'Process', 'Publishing', 'Research', 'Research Personnel', 'Risk Factors', 'Role', 'Sampling', 'Source', 'Statistical Data Interpretation', 'Sum', 'System', 'Transcript', 'Universities', 'Validation', 'Variant', 'Visual', 'Visualization software', 'Work', 'base', 'cardiovascular disorder risk', 'clinical efficacy', 'cohort', 'coronary event', 'data access', 'data hub', 'data integration', 'data sharing', 'data visualization', 'design', 'experimental study', 'genetic association', 'genome wide association study', 'genome-wide', 'genotyped patients', 'improved', 'innovation', 'insight', 'interdisciplinary approach', 'knowledge integration', 'lymphoblast', 'metabolomics', 'mouse model', 'multiple omics', 'novel', 'novel marker', 'open data', 'population based', 'predictive marker', 'programs', 'response', 'risk minimization', 'statistics', 'tool', 'training opportunity', 'transcriptomics']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2018,395986,0.005968105274488366
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,9772486,P50GM115318,"['Adverse effects', 'Adverse event', 'Affect', 'Animal Model', 'Autophagocytosis', 'Biocompatible Materials', 'Biological', 'Biological Markers', 'California', 'Candidate Disease Gene', 'Cardiovascular Diseases', 'Cause of Death', 'Cell Line', 'Cell model', 'Clinical', 'Clinical Markers', 'Clinical Medicine', 'Clinical Pharmacology', 'Collaborations', 'Coronary heart disease', 'Custom', 'DNA', 'Data', 'Data Analyses', 'Diabetes Mellitus', 'Disease Outcome', 'Drug effect disorder', 'Electronic Health Record', 'Environmental Risk Factor', 'Ethnic group', 'Event', 'Fostering', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Genotype', 'Goals', 'Health', 'Heritability', 'Human', 'Human Genetics', 'Hybrids', 'Hyperglycemia', 'In Vitro', 'Inbred Strains Mice', 'Informatics', 'Lead', 'Leadership', 'Lipids', 'Machine Learning', 'Metabolic', 'Modeling', 'Molecular', 'Mus', 'Muscle function', 'Myopathy', 'Non-Insulin-Dependent Diabetes Mellitus', 'Pathway interactions', 'Patients', 'Pharmaceutical Preparations', 'Pharmacogenomics', 'Pharmacy facility', 'Population Heterogeneity', 'Predisposition', 'Public Health', 'Race', 'Recombinants', 'Records', 'Research', 'Research Personnel', 'Residual state', 'Resistance', 'Risk', 'Role', 'Sampling', 'Simvastatin', 'Stroke', 'Symptoms', 'System', 'Testing', 'Transcript', 'Treatment outcome', 'United States', 'Variant', 'Visualization software', 'adverse outcome', 'alternative treatment', 'base', 'biological systems', 'biomarker identification', 'blood glucose regulation', 'candidate validation', 'cardiovascular disorder prevention', 'cardiovascular disorder risk', 'clinical efficacy', 'clinical phenotype', 'clinical practice', 'clinically relevant', 'cohort', 'coronary event', 'data integration', 'data visualization', 'design', 'disability', 'disorder risk', 'exome', 'genetic analysis', 'genetic association', 'genetic variant', 'genome wide association study', 'genome-wide', 'genotyped patients', 'improved', 'in vivo', 'informatics\xa0tool', 'innovation', 'inter-individual variation', 'interdisciplinary approach', 'lymphoblast', 'lymphoblastoid cell line', 'metabolomics', 'mouse model', 'multidisciplinary', 'new therapeutic target', 'novel', 'novel marker', 'novel strategies', 'population based', 'predictive marker', 'prevent', 'programs', 'public health relevance', 'response', 'risk minimization', 'side effect', 'statistics', 'tool', 'training opportunity', 'transcriptomics', 'treatment strategy']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2019,1524688,0.018391757543566485
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,9560840,P50GM115318,"['Adverse effects', 'Adverse event', 'Affect', 'Animal Model', 'Autophagocytosis', 'Biological', 'Biological Markers', 'California', 'Candidate Disease Gene', 'Cardiovascular Diseases', 'Cause of Death', 'Cell Line', 'Cell model', 'Clinical', 'Clinical Markers', 'Clinical Medicine', 'Clinical Pharmacology', 'Collaborations', 'Coronary heart disease', 'Custom', 'DNA', 'Data', 'Data Analyses', 'Diabetes Mellitus', 'Disease Outcome', 'Drug effect disorder', 'Electronic Health Record', 'Environmental Risk Factor', 'Ethnic group', 'Event', 'Fostering', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Genotype', 'Goals', 'Health', 'Heritability', 'Human', 'Human Genetics', 'Hybrids', 'Hyperglycemia', 'In Vitro', 'Inbred Strains Mice', 'Informatics', 'Lead', 'Leadership', 'Lipids', 'Machine Learning', 'Metabolic', 'Modeling', 'Molecular', 'Mus', 'Muscle function', 'Myopathy', 'Non-Insulin-Dependent Diabetes Mellitus', 'Pathway interactions', 'Patients', 'Pharmaceutical Preparations', 'Pharmacogenomics', 'Pharmacy facility', 'Population Heterogeneity', 'Predisposition', 'Public Health', 'Race', 'Recombinants', 'Records', 'Research', 'Research Personnel', 'Residual state', 'Resistance', 'Risk', 'Role', 'Sampling', 'Simvastatin', 'Stroke', 'Symptoms', 'System', 'Testing', 'Transcript', 'Treatment outcome', 'United States', 'Variant', 'Visualization software', 'adverse outcome', 'alternative treatment', 'base', 'biomarker identification', 'blood glucose regulation', 'candidate validation', 'cardiovascular disorder prevention', 'cardiovascular disorder risk', 'clinical efficacy', 'clinical phenotype', 'clinical practice', 'clinically relevant', 'cohort', 'coronary event', 'data integration', 'data visualization', 'design', 'disability', 'disorder risk', 'exome', 'genetic analysis', 'genetic association', 'genetic variant', 'genome wide association study', 'genome-wide', 'genotyped patients', 'improved', 'in vivo', 'innovation', 'inter-individual variation', 'interdisciplinary approach', 'lymphoblast', 'lymphoblastoid cell line', 'metabolomics', 'mouse model', 'multidisciplinary', 'new therapeutic target', 'novel', 'novel marker', 'novel strategies', 'population based', 'predictive marker', 'prevent', 'programs', 'public health relevance', 'response', 'risk minimization', 'statistics', 'tool', 'training opportunity', 'transcriptomics', 'treatment strategy']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2018,2667664,0.018391757543566485
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,9326327,P50GM115318,"['Adverse effects', 'Adverse event', 'Affect', 'Animal Model', 'Autophagocytosis', 'Biological', 'Biological Markers', 'California', 'Candidate Disease Gene', 'Cardiovascular Diseases', 'Cause of Death', 'Cell Line', 'Cell model', 'Clinical', 'Clinical Markers', 'Clinical Medicine', 'Clinical Pharmacology', 'Collaborations', 'Coronary', 'Coronary heart disease', 'Custom', 'DNA', 'Data', 'Data Analyses', 'Diabetes Mellitus', 'Disease Outcome', 'Drug effect disorder', 'Electronic Health Record', 'Environmental Risk Factor', 'Ethnic group', 'Event', 'Fostering', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Genotype', 'Goals', 'Health', 'Heritability', 'Human', 'Human Genetics', 'Hybrids', 'Hyperglycemia', 'In Vitro', 'Inbred Strains Mice', 'Informatics', 'Lead', 'Leadership', 'Lipids', 'Machine Learning', 'Metabolic', 'Modeling', 'Molecular', 'Mus', 'Muscle function', 'Myopathy', 'Non-Insulin-Dependent Diabetes Mellitus', 'Pathway interactions', 'Patients', 'Pharmaceutical Preparations', 'Pharmacogenomics', 'Pharmacy facility', 'Population Heterogeneity', 'Predisposition', 'Public Health', 'Race', 'Recombinants', 'Records', 'Research', 'Research Personnel', 'Residual state', 'Resistance', 'Risk', 'Role', 'Sampling', 'Simvastatin', 'Stroke', 'Symptoms', 'System', 'Testing', 'Transcript', 'Treatment outcome', 'United States', 'Variant', 'Visualization software', 'adverse outcome', 'alternative treatment', 'base', 'biomarker identification', 'blood glucose regulation', 'candidate validation', 'cardiovascular disorder prevention', 'cardiovascular disorder risk', 'clinical efficacy', 'clinical phenotype', 'clinical practice', 'clinically relevant', 'cohort', 'data integration', 'data visualization', 'design', 'disability', 'disorder risk', 'exome', 'genetic analysis', 'genetic association', 'genetic variant', 'genome wide association study', 'genome-wide', 'genotyped patients', 'improved', 'in vivo', 'innovation', 'inter-individual variation', 'interdisciplinary approach', 'lymphoblast', 'lymphoblastoid cell line', 'metabolomics', 'mouse model', 'multidisciplinary', 'new therapeutic target', 'novel', 'novel marker', 'novel strategies', 'population based', 'predictive marker', 'prevent', 'programs', 'public health relevance', 'response', 'risk minimization', 'statistics', 'tool', 'training opportunity', 'transcriptomics', 'treatment strategy']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2017,2688571,0.018391757543566485
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,9139479,P50GM115318,"['Adverse effects', 'Adverse event', 'Affect', 'Animal Model', 'Autophagocytosis', 'Biological', 'Biological Markers', 'California', 'Candidate Disease Gene', 'Cardiovascular Diseases', 'Cause of Death', 'Cell Line', 'Cell model', 'Clinical', 'Clinical Medicine', 'Clinical Pharmacology', 'Collaborations', 'Control Locus', 'Coronary', 'Coronary heart disease', 'Custom', 'DNA', 'Data', 'Data Analyses', 'Diabetes Mellitus', 'Disease Outcome', 'Drug effect disorder', 'Electronic Health Record', 'Electronics', 'Environmental Risk Factor', 'Ethnic group', 'Event', 'Fostering', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Genotype', 'Goals', 'Health', 'Heritability', 'Human', 'Human Genetics', 'Hybrids', 'Hyperglycemia', 'In Vitro', 'Inbred Strains Mice', 'Informatics', 'Lead', 'Leadership', 'Lipids', 'Machine Learning', 'Metabolic', 'Modeling', 'Molecular', 'Mus', 'Muscle function', 'Myopathy', 'Non-Insulin-Dependent Diabetes Mellitus', 'Pathway interactions', 'Patients', 'Pharmaceutical Preparations', 'Pharmacogenomics', 'Pharmacy facility', 'Population Heterogeneity', 'Predisposition', 'Public Health', 'Race', 'Recombinants', 'Records', 'Research', 'Research Personnel', 'Residual state', 'Resistance', 'Risk', 'Role', 'Sampling', 'Simvastatin', 'Stroke', 'Symptoms', 'System', 'Testing', 'Transcript', 'Treatment outcome', 'United States', 'Variant', 'adverse outcome', 'alternative treatment', 'base', 'biomarker identification', 'blood glucose regulation', 'candidate validation', 'cardiovascular disorder prevention', 'cardiovascular disorder risk', 'clinical efficacy', 'clinical phenotype', 'clinical practice', 'clinically relevant', 'cohort', 'data integration', 'data visualization', 'design', 'disability', 'disorder risk', 'exome', 'genetic analysis', 'genetic association', 'genetic variant', 'genome wide association study', 'genome-wide', 'genotyped patients', 'improved', 'in vivo', 'innovation', 'inter-individual variation', 'interdisciplinary approach', 'lymphoblast', 'lymphoblastoid cell line', 'metabolomics', 'mouse model', 'new therapeutic target', 'novel', 'novel marker', 'novel strategies', 'population based', 'predictive marker', 'prevent', 'programs', 'public health relevance', 'response', 'statistics', 'tool', 'training opportunity', 'transcriptomics', 'treatment strategy']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2016,2741022,0.018391757543566485
"Pharmacogenomics of Statin Therapy     DESCRIPTION (provided by applicant): The overall objective of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply genomic, transcriptomic, and metabolomic analyses, together with studies in cellular and animal models, and innovative informatic tools, to identify and validate biomarkers for efficacy of statin drugs in reducing riskof cardiovascular disease (CVD), and for adverse effects of statins, specifically myopathy and type 2 diabetes. This multidisciplinary approach is enabled by a team of investigators with expertise in genomics (human, mouse, and molecular), statistics and informatics, and clinical medicine and pharmacology. The Center is comprised of three Projects, two Research Cores, and an Administrative Core. A major aim of Project 1 is the identification of cellular transcriptomic and metabolomic markers for clinical efficacy and adverse effects of statins. This will be accomplished by analyses in statin-exposed lymphoblast cell lines derived from patients with major adverse coronary events, or onset of myopathy or type 2 diabetes on statin treatment, compared with unaffected statin- treated controls. In addition, using genome wide genotypes from these patients, DNA variants will be identified that are associated with statin-induced changes in the transcripts and metabolites that most strongly discriminate affected patients and controls. Project 2 will use a unique, well-characterized panel of 100 inbred mouse strains to discover genetic variation associated with statin-induced myopathy and dysglycemia. Mechanisms underlying these effects will be investigated, with emphasis on the role of dysregulation of autophagy by statin treatment. Projects 1 and 2 will also use relevant cellular and mouse models, respectively, to perform functional studies to validate effects of genes identified in all POST projects as strong candidates for modulating statin efficacy or adverse effects. In Project 3, information derived from genome-wide genotypes, electronic health records, and pharmacy data in a very large and diverse population-based patient cohort will be leveraged to identify and replicate genetic associations with statin efficacy (lipid lowering and CVD event reduction) and adverse effects (myopathy and type 2 diabetes), as well as to assess the overall heritability of these responses. The Clinical Core, based in Kaiser Permanente of Northern California, will provide the clinical information and biologic materials for both Projects1 and 3. Investigators in the Informatics Core will optimize data analysis and integration of results across all projects. The Administrative Core will provide scientific leadership and management of the Center, and foster scientific interactions and training opportunities. Overall, the research program of this Center provides an innovative model for a ""systems"" approach to pharmacogenomics that incorporates complementary investigative tools to discover and validate genetically influenced determinants of drug response. Moreover, the findings have the potential for guiding more effective use of statins for reducing CVD risk and minimizing adverse effects, and identifying biomarkers of pathways that modulate the multiple actions of this widely used class of drugs.           PUBLIC HEALTH RELEVANCE: Coronary heart disease and stroke are the leading causes of death and disability in the United States, and statins are the most widely prescribed class of drugs to prevent these conditions. There is however, considerable interindividual variation in efficacy of statins for reducing disease risk, as well as in susceptibility to the most common adverse statin effects, myopathy and type 2 diabetes. The goal of the Center ""Pharmacogenomics of Statin Therapy"" (POST) is to apply complementary investigative approaches and multidisciplinary expertise for discovering and validating the genetic and metabolic factors responsible for this variability. This information has the potential for optimizig use of statins in clinical practice, and for identifying new pathways that underlie the diverse biologic actions of this drug class.              ",Pharmacogenomics of Statin Therapy,8934878,P50GM115318,"['Adverse effects', 'Adverse event', 'Affect', 'Animal Model', 'Autophagocytosis', 'Biological', 'Biological Markers', 'California', 'Candidate Disease Gene', 'Cardiovascular Diseases', 'Cause of Death', 'Cell Line', 'Cell model', 'Clinical', 'Clinical Medicine', 'Clinical Pharmacology', 'Collaborations', 'Control Locus', 'Coronary', 'Coronary heart disease', 'Custom', 'DNA', 'Data', 'Data Analyses', 'Diabetes Mellitus', 'Disease Outcome', 'Drug effect disorder', 'Electronic Health Record', 'Electronics', 'Environmental Risk Factor', 'Ethnic Origin', 'Event', 'Fostering', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Genotype', 'Goals', 'Health', 'Heritability', 'Human', 'Human Genetics', 'Hybrids', 'Hyperglycemia', 'In Vitro', 'Inbred Strains Mice', 'Informatics', 'Lead', 'Leadership', 'Lipids', 'Machine Learning', 'Metabolic', 'Modeling', 'Molecular', 'Mus', 'Muscle function', 'Myopathy', 'Non-Insulin-Dependent Diabetes Mellitus', 'Pathway interactions', 'Patients', 'Pharmaceutical Preparations', 'Pharmacogenomics', 'Pharmacy facility', 'Population Heterogeneity', 'Predisposition', 'Public Health', 'Race', 'Recombinants', 'Records', 'Research', 'Research Personnel', 'Residual state', 'Resistance', 'Risk', 'Role', 'Sampling', 'Simvastatin', 'Stroke', 'Symptoms', 'System', 'Testing', 'Training', 'Transcript', 'Treatment outcome', 'United States', 'Variant', 'adverse outcome', 'alternative treatment', 'base', 'blood glucose regulation', 'candidate validation', 'cardiovascular disorder prevention', 'cardiovascular disorder risk', 'clinical efficacy', 'clinical phenotype', 'clinical practice', 'clinically relevant', 'cohort', 'data integration', 'data visualization', 'design', 'disability', 'disorder risk', 'exome', 'genetic analysis', 'genetic association', 'genetic variant', 'genome wide association study', 'genome-wide', 'improved', 'in vivo', 'innovation', 'interdisciplinary approach', 'lymphoblast', 'lymphoblastoid cell line', 'metabolomics', 'mouse model', 'new therapeutic target', 'novel', 'novel marker', 'novel strategies', 'population based', 'prevent', 'programs', 'public health relevance', 'response', 'statistics', 'tool', 'transcriptomics', 'treatment strategy']",NIGMS,CHILDREN'S HOSPITAL & RES CTR AT OAKLAND,P50,2015,2836708,0.018391757543566485
"SPORE in Skin Cancer The incidence of melanoma has risen dramatically in recent years, but no therapy has improved overall survival for the majority of patients with unresectable metastatic disease. The University of Pittsburgh Cancer Institute (UPCI) Melanoma and Skin Cancer Program (MSCP) will continue to conduct a Specialized Program of Research Excellence (SPORE) to improve our understanding of molecular and immunologic mechanisms of cancer progression and to validate prognostic and predictive biomarkers for personalized treatment of advanced melanoma and cutaneous T cell lymphoma (CTCL). Of our 4 Projects, 1 is continued from the prior funding period, and 3 new projects have been derived from developmental research conducted in the last period; 1 of the prior SPORE projects will be continued with independent ROI funding. Our highly integrated approach leverages complementary expertise in melanoma, oncology, dermatology, immunology, biostatistics, bioinformatics, machine learning, genomics, proteomics, and biomarker discovery to test hypotheses central to the improvement of therapeutic outcome in skin cancers. Regardless of clinical outcomes, these Projects will also generate urgently needed mechanistic data to inform development of new therapeutic strategies and pathways through which to monitor relapse and progression. Our 4 Projects will evaluate: (1) the prognostic and predictive value of the pro-inflammatory response and markers of immune suppression in relation to ipilimumab and interferon (IFN) adjuvant therapy (leveraging an Eastern Cooperative Oncology Group-led adjuvant trial); (2) an engineered, 3-antigen dendritic cell vaccine and IFN boost in patients with metastatic melanoma; (3) the safety and efficacy of vemurafenib modulation of immunotherapy with IFN2b in patients with metastatic melanoma; and (4) an entirely new personalized microneedle vaccination technology in patients with melanoma and CTCL. The Administrative Core (A) coordinates the clinical research and provides scientific and fiscal oversight of the entire SPORE. The Biospecimen Core (B) is housed in the UPCI Immunologic Monitoring and Cellular Products Laboratory, where all tissue banking, biospecimen processing, and immune assays are conducted. The Biostatistics Core (C) and Informatics Core (D) support all projects with data analysis and management, respectively. We will continue to solicit, review, and fund applications for the career development and developmental research programs, which in the prior funding period led to the design of a new full project in this application (Project 3)  and the promotion of career development recipients to co-investigators and a project leader. The goal of this application is to use a multi-disciplinary approach to improve outcomes in skin cancer and in particular, metastatic melanoma, a disease with a 15% 5-year survival rate. We will improve treatment and outcomes for skin cancer patients by identifying new ways to treat the disease based on the biology of the individual patient's tumor and new biomarkers that predict risk and response to therapy to prevent recurrence based on an individual patient's genetics and the tumor impact upon the microenvironment.",SPORE in Skin Cancer,9787830,P50CA121973,"['Adjuvant', 'Adjuvant Study', 'Adjuvant Therapy', 'Adverse effects', 'Antigens', 'Apoptotic', 'BRAF gene', 'Bioinformatics', 'Biological Markers', 'Biology', 'Biometry', 'Biostatistics Core', 'Blocking Antibodies', 'CTLA4 gene', 'Cancer Burden', 'Cancer Patient', 'Clinical', 'Clinical Research', 'Combined Modality Therapy', 'Communities', 'Cutaneous Melanoma', 'Cutaneous T-cell lymphoma', 'Data', 'Data Analyses', 'Dendritic Cell Vaccine', 'Dermatology', 'Development', 'Disease', 'Dose', 'Eastern Cooperative Oncology Group', 'Engineering', 'Faculty', 'Funding', 'Genes', 'Genetic', 'Genomics', 'Goals', 'Immune', 'Immune response', 'Immunization', 'Immuno-Chemotherapy', 'Immunologic Markers', 'Immunologic Monitoring', 'Immunologics', 'Immunology', 'Immunology procedure', 'Immunosuppression', 'Immunotherapeutic agent', 'Immunotherapy', 'In Situ', 'Incidence', 'Inflammation', 'Inflammatory Response', 'Informatics', 'Interferon Alfa-2b', 'Interferons', 'International', 'Laboratories', 'Length', 'Machine Learning', 'Metastatic Melanoma', 'Modality', 'Molecular', 'Monitor', 'Organ', 'Outcome', 'Pathway interactions', 'Patients', 'Phase', 'Predictive Value', 'Prognostic Marker', 'Program Development', 'Proteomics', 'Recurrence', 'Relapse', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resource Informatics', 'Resources', 'Risk', 'Role', 'Safety', 'Skin Cancer', 'Skin Carcinoma', 'Specialized Program of Research Excellence', 'Survival Rate', 'T-Lymphocyte', 'Technology', 'Testing', 'Therapeutic', 'Tissues', 'Translational Research', 'Translations', 'Treatment outcome', 'Tumor Immunity', 'University of Pittsburgh Cancer Institute', 'Unresectable', 'Vaccination', 'Vaccines', 'Viral Vector', 'base', 'biomarker discovery', 'career development', 'chemotherapeutic agent', 'data management', 'design', 'dosage', 'effective therapy', 'high risk', 'immunogenic cell death', 'immunogenicity', 'improved', 'improved outcome', 'in vivo', 'individual patient', 'inhibitor/antagonist', 'interdisciplinary approach', 'melanoma', 'new technology', 'novel', 'novel therapeutic intervention', 'novel vaccines', 'oncology', 'personalized medicine', 'personalized predictions', 'pre-clinical', 'predictive marker', 'prevent', 'prognostic value', 'programs', 'research and development', 'response', 'targeted treatment', 'therapy outcome', 'tumor', 'tumor progression']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P50,2018,500000,0.07569483480028881
"SPORE in Skin Cancer The incidence of melanoma has risen dramatically in recent years, but no therapy has improved overall survival for the majority of patients with unresectable metastatic disease. The University of Pittsburgh Cancer Institute (UPCI) Melanoma and Skin Cancer Program (MSCP) will continue to conduct a Specialized Program of Research Excellence (SPORE) to improve our understanding of molecular and immunologic mechanisms of cancer progression and to validate prognostic and predictive biomarkers for personalized treatment of advanced melanoma and cutaneous T cell lymphoma (CTCL). Of our 4 Projects, 1 is continued from the prior funding period, and 3 new projects have been derived from developmental research conducted in the last period; 1 of the prior SPORE projects will be continued with independent ROI funding. Our highly integrated approach leverages complementary expertise in melanoma, oncology, dermatology, immunology, biostatistics, bioinformatics, machine learning, genomics, proteomics, and biomarker discovery to test hypotheses central to the improvement of therapeutic outcome in skin cancers. Regardless of clinical outcomes, these Projects will also generate urgently needed mechanistic data to inform development of new therapeutic strategies and pathways through which to monitor relapse and progression. Our 4 Projects will evaluate: (1) the prognostic and predictive value of the pro-inflammatory response and markers of immune suppression in relation to ipilimumab and interferon (IFN) adjuvant therapy (leveraging an Eastern Cooperative Oncology Group-led adjuvant trial); (2) an engineered, 3-antigen dendritic cell vaccine and IFN boost in patients with metastatic melanoma; (3) the safety and efficacy of vemurafenib modulation of immunotherapy with IFN2b in patients with metastatic melanoma; and (4) an entirely new personalized microneedle vaccination technology in patients with melanoma and CTCL. The Administrative Core (A) coordinates the clinical research and provides scientific and fiscal oversight of the entire SPORE. The Biospecimen Core (B) is housed in the UPCI Immunologic Monitoring and Cellular Products Laboratory, where all tissue banking, biospecimen processing, and immune assays are conducted. The Biostatistics Core (C) and Informatics Core (D) support all projects with data analysis and management, respectively. We will continue to solicit, review, and fund applications for the career development and developmental research programs, which in the prior funding period led to the design of a new full project in this application (Project 3)  and the promotion of career development recipients to co-investigators and a project leader. The goal of this application is to use a multi-disciplinary approach to improve outcomes in skin cancer and in particular, metastatic melanoma, a disease with a 15% 5-year survival rate. We will improve treatment and outcomes for skin cancer patients by identifying new ways to treat the disease based on the biology of the individual patient's tumor and new biomarkers that predict risk and response to therapy to prevent recurrence based on an individual patient's genetics and the tumor impact upon the microenvironment.",SPORE in Skin Cancer,9323323,P50CA121973,"['Adjuvant', 'Adjuvant Study', 'Adjuvant Therapy', 'Adverse effects', 'Antigens', 'Apoptotic', 'BRAF gene', 'Bioinformatics', 'Biological Markers', 'Biology', 'Biometry', 'Biostatistics Core', 'Blocking Antibodies', 'CTLA4 gene', 'Cancer Burden', 'Cancer Patient', 'Cell Death', 'Clinical', 'Clinical Research', 'Combined Modality Therapy', 'Communities', 'Cutaneous', 'Cutaneous Melanoma', 'Data', 'Data Analyses', 'Dendritic Cell Vaccine', 'Dermatologic', 'Dermatology', 'Development', 'Disease', 'Dose', 'Eastern Cooperative Oncology Group', 'Engineering', 'Faculty', 'Funding', 'Genes', 'Genetic', 'Genomics', 'Goals', 'Immune', 'Immune response', 'Immunization', 'Immunologic Monitoring', 'Immunologics', 'Immunology', 'Immunology procedure', 'Immunosuppression', 'Immunotherapeutic agent', 'Immunotherapy', 'In Situ', 'Incidence', 'Inflammation', 'Inflammatory Response', 'Informatics', 'Interferon Alfa-2b', 'Interferons', 'International', 'Laboratories', 'Length', 'Machine Learning', 'Metastatic Melanoma', 'Modality', 'Molecular', 'Monitor', 'Organ', 'Outcome', 'Pathway interactions', 'Patients', 'Phase', 'Predictive Value', 'Prognostic Marker', 'Program Development', 'Proteomics', 'Recurrence', 'Relapse', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resource Informatics', 'Resources', 'Risk', 'Role', 'Safety', 'Skin Cancer', 'Skin Carcinoma', 'Specialized Program of Research Excellence', 'Survival Rate', 'T-Cell Lymphoma', 'T-Lymphocyte', 'Technology', 'Testing', 'Therapeutic', 'Tissues', 'Translational Research', 'Translations', 'Treatment outcome', 'Tumor Immunity', 'University of Pittsburgh Cancer Institute', 'Unresectable', 'Vaccination', 'Vaccines', 'Viral Vector', 'base', 'biomarker discovery', 'career development', 'chemotherapeutic agent', 'data management', 'design', 'dosage', 'effective therapy', 'high risk', 'immunogenic', 'immunogenicity', 'improved', 'improved outcome', 'in vivo', 'individual patient', 'inflammatory marker', 'inhibitor/antagonist', 'interdisciplinary approach', 'melanoma', 'new technology', 'novel', 'novel therapeutic intervention', 'novel vaccines', 'oncology', 'personalized medicine', 'pre-clinical', 'predictive marker', 'prevent', 'prognostic value', 'programs', 'research and development', 'response', 'targeted treatment', 'therapy outcome', 'tumor', 'tumor progression']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P50,2017,2350000,0.07569483480028881
"SPORE in Skin Cancer The incidence of melanoma has risen dramatically in recent years, but no therapy has improved overall survival for the majority of patients with unresectable metastatic disease. The University of Pittsburgh Cancer Institute (UPCI) Melanoma and Skin Cancer Program (MSCP) will continue to conduct a Specialized Program of Research Excellence (SPORE) to improve our understanding of molecular and immunologic mechanisms of cancer progression and to validate prognostic and predictive biomarkers for personalized treatment of advanced melanoma and cutaneous T cell lymphoma (CTCL). Of our 4 Projects, 1 is continued from the prior funding period, and 3 new projects have been derived from developmental research conducted in the last period; 1 of the prior SPORE projects will be continued with independent ROI funding. Our highly integrated approach leverages complementary expertise in melanoma, oncology, dermatology, immunology, biostatistics, bioinformatics, machine learning, genomics, proteomics, and biomarker discovery to test hypotheses central to the improvement of therapeutic outcome in skin cancers. Regardless of clinical outcomes, these Projects will also generate urgently needed mechanistic data to inform development of new therapeutic strategies and pathways through which to monitor relapse and progression. Our 4 Projects will evaluate: (1) the prognostic and predictive value of the pro-inflammatory response and markers of immune suppression in relation to ipilimumab and interferon (IFN) adjuvant therapy (leveraging an Eastern Cooperative Oncology Group-led adjuvant trial); (2) an engineered, 3-antigen dendritic cell vaccine and IFN boost in patients with metastatic melanoma; (3) the safety and efficacy of vemurafenib modulation of immunotherapy with IFN2b in patients with metastatic melanoma; and (4) an entirely new personalized microneedle vaccination technology in patients with melanoma and CTCL. The Administrative Core (A) coordinates the clinical research and provides scientific and fiscal oversight of the entire SPORE. The Biospecimen Core (B) is housed in the UPCI Immunologic Monitoring and Cellular Products Laboratory, where all tissue banking, biospecimen processing, and immune assays are conducted. The Biostatistics Core (C) and Informatics Core (D) support all projects with data analysis and management, respectively. We will continue to solicit, review, and fund applications for the career development and developmental research programs, which in the prior funding period led to the design of a new full project in this application (Project 3)  and the promotion of career development recipients to co-investigators and a project leader. The goal of this application is to use a multi-disciplinary approach to improve outcomes in skin cancer and in particular, metastatic melanoma, a disease with a 15% 5-year survival rate. We will improve treatment and outcomes for skin cancer patients by identifying new ways to treat the disease based on the biology of the individual patient's tumor and new biomarkers that predict risk and response to therapy to prevent recurrence based on an individual patient's genetics and the tumor impact upon the microenvironment.",SPORE in Skin Cancer,9091436,P50CA121973,"['Adjuvant', 'Adjuvant Study', 'Adjuvant Therapy', 'Adverse effects', 'Antigens', 'Apoptotic', 'BRAF gene', 'Bioinformatics', 'Biological Assay', 'Biological Markers', 'Biology', 'Biometry', 'Biostatistics Core', 'Blocking Antibodies', 'CTLA4 gene', 'Cancer Burden', 'Cancer Patient', 'Cell Death', 'Clinical', 'Clinical Research', 'Combined Modality Therapy', 'Communities', 'Cutaneous', 'Cutaneous Melanoma', 'Data', 'Data Analyses', 'Dendritic Cell Vaccine', 'Dermatology', 'Development', 'Disease', 'Dose', 'Eastern Cooperative Oncology Group', 'Engineering', 'Faculty', 'Funding', 'Genes', 'Genetic', 'Genomics', 'Goals', 'Housing', 'Immune', 'Immune response', 'Immunization', 'Immunologic Monitoring', 'Immunologics', 'Immunology', 'Immunosuppression', 'Immunotherapeutic agent', 'Immunotherapy', 'In Situ', 'Incidence', 'Inflammation', 'Inflammatory Response', 'Informatics', 'Interferon Alfa-2b', 'Interferons', 'International', 'Laboratories', 'Length', 'Machine Learning', 'Metastatic Melanoma', 'Modality', 'Molecular', 'Monitor', 'Organ', 'Outcome', 'Pathway interactions', 'Patients', 'Phase', 'Predictive Value', 'Process', 'Prognostic Marker', 'Proteomics', 'Recurrence', 'Relapse', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resource Informatics', 'Resources', 'Risk', 'Role', 'Safety', 'Skin Cancer', 'Skin Carcinoma', 'Specialized Program of Research Excellence', 'Survival Rate', 'T-Cell Lymphoma', 'T-Lymphocyte', 'Technology', 'Testing', 'Therapeutic', 'Tissue Banking', 'Tissue Banks', 'Translational Research', 'Translations', 'Treatment outcome', 'Tumor Immunity', 'University of Pittsburgh Cancer Institute', 'Unresectable', 'Vaccination', 'Vaccines', 'Viral Vector', 'base', 'biomarker discovery', 'career development', 'chemotherapeutic agent', 'data management', 'design', 'dosage', 'effective therapy', 'high risk', 'immunogenic', 'immunogenicity', 'improved', 'improved outcome', 'in vivo', 'individual patient', 'inflammatory marker', 'inhibitor/antagonist', 'melanoma', 'new technology', 'novel', 'novel therapeutic intervention', 'novel vaccines', 'oncology', 'personalized medicine', 'pre-clinical', 'predictive marker', 'prevent', 'prognostic value', 'programs', 'research and development', 'response', 'targeted treatment', 'therapy outcome', 'tumor', 'tumor progression']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P50,2016,2162000,0.07569483480028881
"SPORE in Skin Cancer The incidence of melanoma has risen dramatically in recent years, but no therapy has improved overall survival for the majority of patients with unresectable metastatic disease. The University of Pittsburgh Cancer Institute (UPCI) Melanoma and Skin Cancer Program (MSCP) will continue to conduct a Specialized Program of Research Excellence (SPORE) to improve our understanding of molecular and immunologic mechanisms of cancer progression and to validate prognostic and predictive biomarkers for personalized treatment of advanced melanoma and cutaneous T cell lymphoma (CTCL). Of our 4 Projects, 1 is continued from the prior funding period, and 3 new projects have been derived from developmental research conducted in the last period; 1 of the prior SPORE projects will be continued with independent ROI funding. Our highly integrated approach leverages complementary expertise in melanoma, oncology, dermatology, immunology, biostatistics, bioinformatics, machine learning, genomics, proteomics, and biomarker discovery to test hypotheses central to the improvement of therapeutic outcome in skin cancers. Regardless of clinical outcomes, these Projects will also generate urgently needed mechanistic data to inform development of new therapeutic strategies and pathways through which to monitor relapse and progression. Our 4 Projects will evaluate: (1) the prognostic and predictive value of the pro-inflammatory response and markers of immune suppression in relation to ipilimumab and interferon (IFN) adjuvant therapy (leveraging an Eastern Cooperative Oncology Group-led adjuvant trial); (2) an engineered, 3-antigen dendritic cell vaccine and IFN boost in patients with metastatic melanoma; (3) the safety and efficacy of vemurafenib modulation of immunotherapy with IFN2b in patients with metastatic melanoma; and (4) an entirely new personalized microneedle vaccination technology in patients with melanoma and CTCL. The Administrative Core (A) coordinates the clinical research and provides scientific and fiscal oversight of the entire SPORE. The Biospecimen Core (B) is housed in the UPCI Immunologic Monitoring and Cellular Products Laboratory, where all tissue banking, biospecimen processing, and immune assays are conducted. The Biostatistics Core (C) and Informatics Core (D) support all projects with data analysis and management, respectively. We will continue to solicit, review, and fund applications for the career development and developmental research programs, which in the prior funding period led to the design of a new full project in this application (Project 3)  and the promotion of career development recipients to co-investigators and a project leader. The goal of this application is to use a multi-disciplinary approach to improve outcomes in skin cancer and in particular, metastatic melanoma, a disease with a 15% 5-year survival rate. We will improve treatment and outcomes for skin cancer patients by identifying new ways to treat the disease based on the biology of the individual patient's tumor and new biomarkers that predict risk and response to therapy to prevent recurrence based on an individual patient's genetics and the tumor impact upon the microenvironment.",SPORE in Skin Cancer,8919260,P50CA121973,"['Adjuvant', 'Adjuvant Study', 'Adjuvant Therapy', 'Adverse effects', 'Antigens', 'Apoptotic', 'BRAF gene', 'Bioinformatics', 'Biological Assay', 'Biological Markers', 'Biology', 'Biometry', 'Biostatistics Core', 'Blocking Antibodies', 'CTLA4 gene', 'Cancer Burden', 'Cancer Patient', 'Cell Death', 'Clinical', 'Clinical Research', 'Combined Modality Therapy', 'Communities', 'Cutaneous', 'Cutaneous Melanoma', 'Data', 'Data Analyses', 'Dendritic Cell Vaccine', 'Dermatology', 'Development', 'Disease', 'Dose', 'Eastern Cooperative Oncology Group', 'Engineering', 'Faculty', 'Funding', 'Genes', 'Genetic', 'Genomics', 'Goals', 'Housing', 'Immune', 'Immune response', 'Immunization', 'Immunologic Monitoring', 'Immunologics', 'Immunology', 'Immunosuppression', 'Immunotherapeutic agent', 'Immunotherapy', 'In Situ', 'Incidence', 'Individual', 'Inflammation', 'Inflammatory Response', 'Informatics', 'Interferon Alfa-2b', 'Interferons', 'International', 'Laboratories', 'Length', 'Machine Learning', 'Metastatic Melanoma', 'Modality', 'Molecular', 'Monitor', 'Organ', 'Outcome', 'Pathway interactions', 'Patients', 'Phase', 'Predictive Value', 'Process', 'Proteomics', 'Recurrence', 'Relapse', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resource Informatics', 'Resources', 'Risk', 'Role', 'Safety', 'Skin Cancer', 'Skin Carcinoma', 'Specialized Program of Research Excellence', 'Survival Rate', 'T-Cell Lymphoma', 'T-Lymphocyte', 'Technology', 'Testing', 'Therapeutic', 'Tissue Banking', 'Tissue Banks', 'Translational Research', 'Translations', 'Treatment outcome', 'Tumor Immunity', 'University of Pittsburgh Cancer Institute', 'Unresectable', 'Vaccination', 'Vaccines', 'Viral Vector', 'base', 'career development', 'chemotherapeutic agent', 'data management', 'design', 'dosage', 'effective therapy', 'high risk', 'immunogenic', 'immunogenicity', 'improved', 'in vivo', 'inflammatory marker', 'inhibitor/antagonist', 'melanoma', 'new technology', 'novel', 'novel therapeutics', 'novel vaccines', 'oncology', 'personalized medicine', 'pre-clinical', 'predictive marker', 'prevent', 'prognostic', 'prognostic value', 'programs', 'research and development', 'response', 'therapeutic target', 'tumor', 'tumor progression']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P50,2015,2185000,0.07569483480028881
"SPORE in Skin Cancer The incidence of melanoma has risen dramatically in recent years, but no therapy has improved overall survival for the majority of patients with unresectable metastatic disease. The University of Pittsburgh Cancer Institute (UPCI) Melanoma and Skin Cancer Program (MSCP) will continue to conduct a Specialized Program of Research Excellence (SPORE) to improve our understanding of molecular and immunologic mechanisms of cancer progression and to validate prognostic and predictive biomarkers for personalized treatment of advanced melanoma and cutaneous T cell lymphoma (CTCL). Of our 4 Projects, 1 is continued from the prior funding period, and 3 new projects have been derived from developmental research conducted in the last period; 1 of the prior SPORE projects will be continued with independent ROI funding. Our highly integrated approach leverages complementary expertise in melanoma, oncology, dermatology, immunology, biostatistics, bioinformatics, machine learning, genomics, proteomics, and biomarker discovery to test hypotheses central to the improvement of therapeutic outcome in skin cancers. Regardless of clinical outcomes, these Projects will also generate urgently needed mechanistic data to inform development of new therapeutic strategies and pathways through which to monitor relapse and progression. Our 4 Projects will evaluate: (1) the prognostic and predictive value of the pro-inflammatory response and markers of immune suppression in relation to ipilimumab and interferon (IFN) adjuvant therapy (leveraging an Eastern Cooperative Oncology Group-led adjuvant trial); (2) an engineered, 3-antigen dendritic cell vaccine and IFN boost in patients with metastatic melanoma; (3) the safety and efficacy of vemurafenib modulation of immunotherapy with IFN2b in patients with metastatic melanoma; and (4) an entirely new personalized microneedle vaccination technology in patients with melanoma and CTCL. The Administrative Core (A) coordinates the clinical research and provides scientific and fiscal oversight of the entire SPORE. The Biospecimen Core (B) is housed in the UPCI Immunologic Monitoring and Cellular Products Laboratory, where all tissue banking, biospecimen processing, and immune assays are conducted. The Biostatistics Core (C) and Informatics Core (D) support all projects with data analysis and management, respectively. We will continue to solicit, review, and fund applications for the career development and developmental research programs, which in the prior funding period led to the design of a new full project in this application (Project 3)  and the promotion of career development recipients to co-investigators and a project leader. The goal of this application is to use a multi-disciplinary approach to improve outcomes in skin cancer and in particular, metastatic melanoma, a disease with a 15% 5-year survival rate. We will improve treatment and outcomes for skin cancer patients by identifying new ways to treat the disease based on the biology of the individual patient's tumor and new biomarkers that predict risk and response to therapy to prevent recurrence based on an individual patient's genetics and the tumor impact upon the microenvironment.",SPORE in Skin Cancer,8735848,P50CA121973,"['Adjuvant', 'Adjuvant Study', 'Adjuvant Therapy', 'Adverse effects', 'Antigens', 'Apoptotic', 'BRAF gene', 'Bioinformatics', 'Biological Assay', 'Biological Markers', 'Biology', 'Biometry', 'Biostatistics Core', 'Blocking Antibodies', 'CTLA4 gene', 'Cancer Burden', 'Cancer Patient', 'Cell Death', 'Clinical', 'Clinical Research', 'Combined Modality Therapy', 'Communities', 'Cutaneous', 'Cutaneous Melanoma', 'Data', 'Data Analyses', 'Dendritic Cell Vaccine', 'Dermatology', 'Development', 'Disease', 'Dose', 'Eastern Cooperative Oncology Group', 'Engineering', 'Faculty', 'Funding', 'Genes', 'Genetic', 'Genomics', 'Goals', 'Housing', 'Immune', 'Immune response', 'Immunization', 'Immunologic Monitoring', 'Immunologics', 'Immunology', 'Immunosuppression', 'Immunotherapeutic agent', 'Immunotherapy', 'In Situ', 'Incidence', 'Individual', 'Inflammation', 'Inflammatory Response', 'Informatics', 'Interferon-alpha', 'Interferons', 'International', 'Laboratories', 'Length', 'Machine Learning', 'Metastatic Melanoma', 'Modality', 'Molecular', 'Monitor', 'Organ', 'Outcome', 'Pathway interactions', 'Patients', 'Phase', 'Predictive Value', 'Process', 'Proteomics', 'Recurrence', 'Relapse', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resource Informatics', 'Resources', 'Risk', 'Role', 'Safety', 'Skin Cancer', 'Skin Carcinoma', 'Specialized Program of Research Excellence', 'Survival Rate', 'T-Cell Lymphoma', 'T-Lymphocyte', 'Technology', 'Testing', 'Therapeutic', 'Tissue Banking', 'Tissue Banks', 'Translational Research', 'Translations', 'Treatment outcome', 'Tumor Immunity', 'University of Pittsburgh Cancer Institute', 'Unresectable', 'Vaccination', 'Vaccines', 'Viral Vector', 'base', 'career development', 'chemotherapeutic agent', 'data management', 'design', 'dosage', 'effective therapy', 'high risk', 'immunogenic', 'immunogenicity', 'improved', 'in vivo', 'inflammatory marker', 'inhibitor/antagonist', 'melanoma', 'new technology', 'novel', 'novel therapeutics', 'novel vaccines', 'oncology', 'pre-clinical', 'prevent', 'prognostic', 'programs', 'research and development', 'response', 'therapeutic target', 'tumor', 'tumor progression']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P50,2014,2161838,0.07569483480028881
"SPORE in Skin Cancer The incidence of melanoma has risen dramatically in recent years, but no therapy has improved overall survival for the majority of patients with unresectable metastatic disease. The University of Pittsburgh Cancer Institute (UPCI) Melanoma and Skin Cancer Program (MSCP) will continue to conduct a Specialized Program of Research Excellence (SPORE) to improve our understanding of molecular and immunologic mechanisms of cancer progression and to validate prognostic and predictive biomarkers for personalized treatment of advanced melanoma and cutaneous T cell lymphoma (CTCL). Of our 4 Projects, 1 is continued from the prior funding period, and 3 new projects have been derived from developmental research conducted in the last period; 1 of the prior SPORE projects will be continued with independent ROI funding. Our highly integrated approach leverages complementary expertise in melanoma, oncology, dermatology, immunology, biostatistics, bioinformatics, machine learning, genomics, proteomics, and biomarker discovery to test hypotheses central to the improvement of therapeutic outcome in skin cancers. Regardless of clinical outcomes, these Projects will also generate urgently needed mechanistic data to inform development of new therapeutic strategies and pathways through which to monitor relapse and progression. Our 4 Projects will evaluate: (1) the prognostic and predictive value of the pro-inflammatory response and markers of immune suppression in relation to ipilimumab and interferon (IFN) adjuvant therapy (leveraging an Eastern Cooperative Oncology Group-led adjuvant trial); (2) an engineered, 3-antigen dendritic cell vaccine and IFN boost in patients with metastatic melanoma; (3) the safety and efficacy of vemurafenib modulation of immunotherapy with IFN2b in patients with metastatic melanoma; and (4) an entirely new personalized microneedle vaccination technology in patients with melanoma and CTCL. The Administrative Core (A) coordinates the clinical research and provides scientific and fiscal oversight of the entire SPORE. The Biospecimen Core (B) is housed in the UPCI Immunologic Monitoring and Cellular Products Laboratory, where all tissue banking, biospecimen processing, and immune assays are conducted. The Biostatistics Core (C) and Informatics Core (D) support all projects with data analysis and management, respectively. We will continue to solicit, review, and fund applications for the career development and developmental research programs, which in the prior funding period led to the design of a new full project in this application (Project 3)  and the promotion of career development recipients to co-investigators and a project leader. The goal of this application is to use a multi-disciplinary approach to improve outcomes in skin cancer and in particular, metastatic melanoma, a disease with a 15% 5-year survival rate. We will improve treatment and outcomes for skin cancer patients by identifying new ways to treat the disease based on the biology of the individual patient's tumor and new biomarkers that predict risk and response to therapy to prevent recurrence based on an individual patient's genetics and the tumor impact upon the microenvironment.",SPORE in Skin Cancer,8548580,P50CA121973,"['Adjuvant', 'Adjuvant Study', 'Adjuvant Therapy', 'Adverse effects', 'Antigens', 'Apoptotic', 'BRAF gene', 'Bioinformatics', 'Biological Assay', 'Biological Markers', 'Biology', 'Biometry', 'Biostatistics Core', 'Blocking Antibodies', 'CTLA4 gene', 'Cancer Burden', 'Cancer Patient', 'Cell Death', 'Clinical', 'Clinical Research', 'Combined Modality Therapy', 'Communities', 'Cutaneous', 'Cutaneous Melanoma', 'Data', 'Data Analyses', 'Dendritic Cell Vaccine', 'Dermatology', 'Development', 'Disease', 'Dose', 'Eastern Cooperative Oncology Group', 'Engineering', 'Faculty', 'Funding', 'Genes', 'Genetic', 'Genomics', 'Goals', 'Housing', 'Immune', 'Immune response', 'Immunization', 'Immunologic Monitoring', 'Immunologics', 'Immunology', 'Immunosuppression', 'Immunotherapeutic agent', 'Immunotherapy', 'In Situ', 'Incidence', 'Individual', 'Inflammation', 'Inflammatory Response', 'Informatics', 'Interferon-alpha', 'Interferons', 'International', 'Laboratories', 'Length', 'Machine Learning', 'Metastatic Melanoma', 'Modality', 'Molecular', 'Monitor', 'Organ', 'Outcome', 'Pathway interactions', 'Patients', 'Phase', 'Predictive Value', 'Process', 'Proteomics', 'Recurrence', 'Relapse', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resource Informatics', 'Resources', 'Risk', 'Role', 'Safety', 'Skin Cancer', 'Skin Carcinoma', 'Specialized Program of Research Excellence', 'Survival Rate', 'T-Cell Lymphoma', 'T-Lymphocyte', 'Technology', 'Testing', 'Therapeutic', 'Tissue Banking', 'Tissue Banks', 'Translational Research', 'Translations', 'Treatment outcome', 'Tumor Immunity', 'University of Pittsburgh Cancer Institute', 'Unresectable', 'Vaccination', 'Vaccines', 'Viral Vector', 'base', 'career development', 'chemotherapeutic agent', 'data management', 'design', 'dosage', 'effective therapy', 'high risk', 'immunogenic', 'immunogenicity', 'improved', 'in vivo', 'inflammatory marker', 'inhibitor/antagonist', 'melanoma', 'new technology', 'novel', 'novel therapeutics', 'novel vaccines', 'oncology', 'pre-clinical', 'prevent', 'prognostic', 'programs', 'research and development', 'response', 'therapeutic target', 'tumor', 'tumor progression']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,P50,2013,2150500,0.07569483480028881
"Phase III COBRE:  Multimodal Imaging of Neuropsychiatric Disorders (MIND) Project Summary/Abstract  This Phase III (P-III) COBRE project will extend the cores that have been successfully leveraged in our Phase I (P-I) and Phase II (P-II) COBRE projects and sustain these unique resources in New Mexico through the im- plementation of a business plan. Over the past eight years we have built up infrastructure and created a cutting edge brain imaging center, our P-II project is just over half-way through and is even more successful than our P- I was at this point in time. The Mind Research Network (MRN) houses an Elekta Neuromag 306-channel MEG System, a high density EEG lab, a 3T Siemens Trio MRI scanner, and a mobile 1.5T Siemens Avanto MRI scanner. Additional resources include a centralized neuroinformatics system, a strong IT management plan, and state-of-the-art image analysis expertise and tools. This P-III COBRE center will continue our momentum and move the cores we have developed into a position of long term sustainability. We will continue with the technical cores established during the P-II project including multimodal data acquisition (MDA), algorithm and data analy- sis (ADA), and biostatistics and neuro-informatics (BNI). These cores have begun to serve MRN and the greater community, as well as other institutions including extensive collaborations with IDeA funded projects in New Mexico and other states. We believe this P-III COBRE is extremely well-positioned to establish and sustain New Mexico as one of the premier brain imaging sites. We include an extensive pilot project program (PPP) that is built on the successful pilot programs implemented as part of the earlier COBRE phases. This includes an ex- tensive educational, mentoring, and faculty development program to carefully mentor and position faculty who use the cores to maximize their potential to successfully compete for external funding, thus fulfilling the ultimate goals of the COBRE program. 2 Narrative  This Phase III COBRE project is a natural extension of our Phase I and II COBRE projects which were cen- tered on mentoring individual researchers along with building the necessary infrastructure to support multimodal neuroimaging in mental illness. During this time, cutting-edge cores were developed that facilitated not only our local projects but also research at multiple institutions across New Mexico; the cores served as neuroimaging facilities and training centers for others to utilize. The Phase III project will ensure the sustainability of these cores as they transition to being fully funded by a broad cadre of users with various funding sources. We propose three technical cores including a multimodal data acquisition (MDA) core, an algorithm and data analysis (ADA) core, and a biostatistics and neuro-informatics (BNI) core. These cores have already shown their utility and have begun to be leveraged by users outside the COBRE. In addition, we propose a robust pilot project program (PPP) to continue to seed and enable new users of the cores to ultimately grow and sustain world class brain imaging research within our IDeA state, thus fulfilling the ultimate goals of the COBRE program. 1",Phase III COBRE:  Multimodal Imaging of Neuropsychiatric Disorders (MIND),9700159,P30GM122734,"['Algorithmic Analysis', 'Appointment', 'Area', 'Awareness', 'Biology', 'Biometry', 'Bipolar Depression', 'Bipolar Disorder', 'Brain', 'Brain Diseases', 'Brain imaging', 'Businesses', 'Centers of Research Excellence', 'Chemistry', 'Classification', 'Collaborations', 'Communities', 'Complex', 'Computers', 'Core Facility', 'Data', 'Data Analyses', 'Department of Energy', 'Development', 'Devices', 'Diffusion Magnetic Resonance Imaging', 'Dimensions', 'Disease', 'Electroencephalography', 'Engineering', 'Ensure', 'Environment', 'Equipment', 'Faculty', 'Functional Magnetic Resonance Imaging', 'Funding', 'Funding Agency', 'Genetic', 'Goals', 'Grant', 'Image', 'Image Analysis', 'Imaging technology', 'Individual', 'Infrastructure', 'Institution', 'Interdisciplinary Study', 'Leadership', 'Magnetic Resonance Imaging', 'Magnetic Resonance Spectroscopy', 'Magnetoencephalography', 'Major Depressive Disorder', 'Mental Depression', 'Mental disorders', 'Mentors', 'Methods', 'Mind-Body Method', 'Mission', 'Multimodal Imaging', 'Neurobiology', 'Neurologic', 'Neurosciences', 'New Mexico', 'Paper', 'Patients', 'Peer Review', 'Phase', 'Pilot Projects', 'Positioning Attribute', 'Principal Investigator', 'Program Development', 'Psychiatry', 'Publications', 'Recording of previous events', 'Research', 'Research Domain Criteria', 'Research Personnel', 'Research Project Grants', 'Research Training', 'Resources', 'Role', 'Schizophrenia', 'Seeds', 'Site', 'Structure', 'System', 'Teacher Professional Development', 'Time', 'Training', 'Training Programs', 'Translational Research', 'United States National Institutes of Health', 'Universities', 'Vision', 'base', 'cohesion', 'computer science', 'computerized data processing', 'data acquisition', 'data management', 'deep learning', 'density', 'design', 'distinguished professor', 'improved', 'independent component analysis', 'meetings', 'multimodal data', 'multimodality', 'neuroimaging', 'neuroinformatics', 'neuromechanism', 'neuropsychiatric disorder', 'programs', 'tool']",NIGMS,THE MIND RESEARCH NETWORK,P30,2019,1290517,0.21112285681537066
"Phase III COBRE:  Multimodal Imaging of Neuropsychiatric Disorders (MIND) Project Summary/Abstract  This Phase III (P-III) COBRE project will extend the cores that have been successfully leveraged in our Phase I (P-I) and Phase II (P-II) COBRE projects and sustain these unique resources in New Mexico through the im- plementation of a business plan. Over the past eight years we have built up infrastructure and created a cutting edge brain imaging center, our P-II project is just over half-way through and is even more successful than our P- I was at this point in time. The Mind Research Network (MRN) houses an Elekta Neuromag 306-channel MEG System, a high density EEG lab, a 3T Siemens Trio MRI scanner, and a mobile 1.5T Siemens Avanto MRI scanner. Additional resources include a centralized neuroinformatics system, a strong IT management plan, and state-of-the-art image analysis expertise and tools. This P-III COBRE center will continue our momentum and move the cores we have developed into a position of long term sustainability. We will continue with the technical cores established during the P-II project including multimodal data acquisition (MDA), algorithm and data analy- sis (ADA), and biostatistics and neuro-informatics (BNI). These cores have begun to serve MRN and the greater community, as well as other institutions including extensive collaborations with IDeA funded projects in New Mexico and other states. We believe this P-III COBRE is extremely well-positioned to establish and sustain New Mexico as one of the premier brain imaging sites. We include an extensive pilot project program (PPP) that is built on the successful pilot programs implemented as part of the earlier COBRE phases. This includes an ex- tensive educational, mentoring, and faculty development program to carefully mentor and position faculty who use the cores to maximize their potential to successfully compete for external funding, thus fulfilling the ultimate goals of the COBRE program. 2 Narrative  This Phase III COBRE project is a natural extension of our Phase I and II COBRE projects which were cen- tered on mentoring individual researchers along with building the necessary infrastructure to support multimodal neuroimaging in mental illness. During this time, cutting-edge cores were developed that facilitated not only our local projects but also research at multiple institutions across New Mexico; the cores served as neuroimaging facilities and training centers for others to utilize. The Phase III project will ensure the sustainability of these cores as they transition to being fully funded by a broad cadre of users with various funding sources. We propose three technical cores including a multimodal data acquisition (MDA) core, an algorithm and data analysis (ADA) core, and a biostatistics and neuro-informatics (BNI) core. These cores have already shown their utility and have begun to be leveraged by users outside the COBRE. In addition, we propose a robust pilot project program (PPP) to continue to seed and enable new users of the cores to ultimately grow and sustain world class brain imaging research within our IDeA state, thus fulfilling the ultimate goals of the COBRE program. 1",Phase III COBRE:  Multimodal Imaging of Neuropsychiatric Disorders (MIND),9281577,P30GM122734,"['Algorithmic Analysis', 'Appointment', 'Area', 'Awareness', 'Biology', 'Biometry', 'Bipolar Depression', 'Bipolar Disorder', 'Brain', 'Brain Diseases', 'Brain imaging', 'Businesses', 'Centers of Research Excellence', 'Chemistry', 'Classification', 'Collaborations', 'Communities', 'Complex', 'Computers', 'Core Facility', 'Data', 'Data Analyses', 'Department of Energy', 'Development', 'Devices', 'Diffusion Magnetic Resonance Imaging', 'Dimensions', 'Disease', 'Electroencephalography', 'Engineering', 'Ensure', 'Environment', 'Equipment', 'Faculty', 'Functional Magnetic Resonance Imaging', 'Funding', 'Funding Agency', 'Genetic', 'Goals', 'Grant', 'Image', 'Image Analysis', 'Imaging technology', 'Individual', 'Institution', 'Interdisciplinary Study', 'Leadership', 'Magnetic Resonance Imaging', 'Magnetic Resonance Spectroscopy', 'Magnetoencephalography', 'Major Depressive Disorder', 'Mental Depression', 'Mental disorders', 'Mentors', 'Methods', 'Mind-Body Method', 'Mission', 'Multimodal Imaging', 'Neurobiology', 'Neurologic', 'Neurosciences', 'New Mexico', 'Paper', 'Patients', 'Peer Review', 'Phase', 'Pilot Projects', 'Positioning Attribute', 'Principal Investigator', 'Program Development', 'Psychiatry', 'Publications', 'Recording of previous events', 'Research', 'Research Domain Criteria', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Research Training', 'Resources', 'Role', 'Schizophrenia', 'Seeds', 'Site', 'Structure', 'System', 'Teacher Professional Development', 'Time', 'Training', 'Training Programs', 'Translational Research', 'United States National Institutes of Health', 'Universities', 'Vision', 'base', 'cohesion', 'computer science', 'computerized data processing', 'data acquisition', 'data management', 'deep learning', 'density', 'design', 'distinguished professor', 'improved', 'independent component analysis', 'meetings', 'multimodality', 'neuroimaging', 'neuroinformatics', 'neuromechanism', 'neuropsychiatric disorder', 'programs', 'tool']",NIGMS,THE MIND RESEARCH NETWORK,P30,2018,1320387,0.21112285681537066
"Deep Fractions Learning: A Core Curriculum of Games, Inquiry, and Collaboration Project Summary/Abstract  There is an enormous deficit in students understanding of fractions in the United States. Fifth grade fraction knowledge predicts high school math performance, even when controlling for working memory, whole number knowledge, IQ, reading ability, and demographic factors (Siegler et al., 2012). Therefore, addressing this deficit is a particularly important area for early intervention. With this Fast-Track grant, Deep Fractions Learning, we propose to transform the way in which students learn core math curriculum so that materials are more interactive and engaging, promote deeper learning of content, and are aligned with the Common Core. More specifically, we will develop and evaluate a digital curriculum for grades 3-5 covering the fractions domain that combines games, collaboration, and an inquiry approach. We propose to develop an innovative technology infrastructure that will integrate Teachley learning games, Success for Alls (SFA) cooperative learning framework, and rigorous lesson content. We will integrate research into the design process and work with Johns Hopkins University to evaluate the efficacy of the intervention.  Outcomes. The intervention will encourage four direct outcomes for students, namely improved: 1) conceptual understanding of fractions, 2) procedural fluency with fractions operations, 3) mathematical justification, and 4) motivation. First, the curriculum will build both conceptual understanding and procedural fluency, providing strong visual models within engaging games that motivate students to practice. The collaborative learning model and inquiry approach will improve students mathematical justification. Finally, we encourage these outcomes within a motivational support structure designed to foster engagement and self-efficacy.  Improving students academic outcomes and self-efficacy in the area of fractions during elementary school will promote later success in high school mathematics. Since each additional math class students complete in high school more than doubles the odds of college completion (Adelman, 2006), the intervention has the potential to make a real difference in whether students achieve sustainable careers versus being stuck in low-wage jobs. Project Narrative  Fractions knowledge in the fifth grade strongly predicts high school math performance, even when controlling for working memory, whole number knowledge, IQ, reading ability, and demographic factors (Siegler et al., 2012). Intervention in this essential content area will improve students math ability in the short and long term, which in turn will lead to several positive distal outcomes, such as greater high school graduation rates and college attendance.","Deep Fractions Learning: A Core Curriculum of Games, Inquiry, and Collaboration",9617983,R44GM130162,"['Active Learning', 'Address', 'Area', 'Behavior', 'Child', 'Childhood Cancer Survivor Study', 'Collaborations', 'Common Core', 'Control Groups', 'Demographic Factors', 'Distal', 'Early Intervention', 'Educational Curriculum', 'Ethnic Origin', 'Fostering', 'Goals', 'Graduation Rates', 'Grant', 'High School Student', 'Instruction', 'Intervention', 'Investments', 'Knowledge', 'Learning', 'Maps', 'Mathematics', 'Mathematics Curriculum', 'Measures', 'Modeling', 'Motivation', 'Occupations', 'Online Systems', 'Outcome', 'Performance', 'Phase', 'Privatization', 'Process', 'Research', 'Research Infrastructure', 'Sampling', 'Self Efficacy', 'Services', 'Short-Term Memory', 'Structure', 'Students', 'Treatment Efficacy', 'United States', 'Universities', 'Visual', 'Wages', 'Work', 'boys', 'career', 'college', 'dashboard', 'deep learning', 'design', 'digital', 'elementary school', 'fifth grade', 'fourth grade', 'girls', 'high school', 'improved', 'innovation', 'innovative technologies', 'mathematical ability', 'operation', 'prototype', 'reading ability', 'success', 'teacher', 'third grade', 'usability']",NIGMS,"TEACHLEY, LLC",R44,2018,149650,0.08995645450907094
"Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center Modified Project Summary/Abstract Section  This innovative integrated systems biology application seeks to delineate the complex host/pathogen interactions occurring at the alveolar level that lead to unsuccessful response to therapy in serious pneumonia, including serious viral pneumonia. To achieve this objective, we will leverage our unique access to alveolar fluid collected as part of routine clinical care in mechanically ventilated patients with suspected pneumonia in our medical intensive care unit. Bronchoalveolar lavage fluid will be obtained serially from well characterized mechanically ventilated patients with serious viral or Pseudomonas or Acinetobacter bacterial pneumonias. Both of these CDC-designated serious hazard level bacterial pathogens have clinical failure rates as high as 50%. A robust clinical definition will allow comparison of both host and pathogen signatures associated with failure of therapy vs. success. These clinical specimens and extensive patient phenomics will anchor two mutually supportive and iterative research projects. Project One will deploy robust tools for flow sorting macrophage and lymphocyte subset populations, isolating RNA from these populations, and performing transcriptomic and epigenomic analysis to compare successful and unsuccessful host response. Project Two will focus on both specific pathogen genomic profiles associated with unsuccessful outcome and the differential microbiome response. Specific pathogen genomic profiles identified will be tested for causality in a unique humanized alveolar macrophage mouse model by the Technology Core. Changes in microbiome communities will be comprehensively assessed by shotgun deep sequencing to detect bacteriophage, other virus, and fungal DNA, in addition to bacterial. A Technical Core will perform cell sorting of BAL macrophage and lymphocyte subsets, RNA sequencing, and whole genome methylation, as well as perform the mouse pneumonia model studies. A Data Management and Bioinformatics Core will develop tools to reduce the dimensionality of these large comprehensive datasets, including the clinical phenomics, and provide them to the Modeling Core. The Modeling Core will then use an ecosystem-based approach to this complex adaptive system combined with unique machine learning tools and neural networks to generate biomarkers of host, pathogen and/or microbiome patterns predictive of successful pneumonia outcome. Predictive biomarkers developed in the Modeling Core will then be validated in a prospective confirmatory cohort of patients in whom analogous data will be generated. Biomarkers will also be tested for causality the mouse model. The Administrative Core will perform the outward- facing role of education and outreach to the community and sponsor, as well as regularly exchanging datasets, analytic tools, and specimens with NIH-sponsored/approved repository sites. Modified Public Health Relevance Section.   The Successful Clinical Response In Pneumonia Treatment (SCRIPT) systems biology center seeks to delineate the complex host/pathogen interactions occurring at the alveolar level that lead to unsuccessful response to therapy in serious pneumonia, including severe viral pneumonia. We will leverage our unique access to alveolar fluid collected as part of routine clinical care in mechanically ventilated patients to generate clinical phenomic, transcriptomic, epigenomic and metagenomic data that describe the host response, pathogen characteristics and microbiome of the alveolar space during pneumonia. We will then integrate this comprehensive phenotypic data into an ecosystem-based model to generate predictive biomarkers of pneumonia outcome for subsequent validation in a second cohort and tested for causality in a humanized alveolar macrophage mouse model.",Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center,9843971,U19AI135964,"['Acinetobacter', 'Address', 'Alveolar', 'Alveolar Macrophages', 'Alveolus', 'Animal Model', 'Antibiotic Therapy', 'Bacteriophages', 'Bioinformatics', 'Biological Markers', 'Bronchoalveolar Lavage', 'Bronchoalveolar Lavage Fluid', 'Cause of Death', 'Cell Separation', 'Cells', 'Centers for Disease Control and Prevention (U.S.)', 'Characteristics', 'Clinical', 'Clinical Data', 'Clinical Medicine', 'Clinical Microbiology', 'Clinical Trials', 'Collection', 'Communities', 'Complex', 'DNA Viruses', 'DNA sequencing', 'Data', 'Data Set', 'Development', 'Dimensions', 'Disease', 'Ecosystem', 'Education and Outreach', 'Equilibrium', 'Etiology', 'Failure', 'Fungal DNA', 'Generations', 'Genes', 'Genetic', 'Goals', 'Human', 'Immune response', 'Infection', 'Intensive Care Units', 'Lead', 'Link', 'Liquid substance', 'Lymphocyte Subset', 'Lymphoid Cell', 'Machine Learning', 'Mechanics', 'Medical', 'Metagenomics', 'Methylation', 'Modeling', 'Multiomic Data', 'Myeloid Cells', 'Nosocomial Infections', 'Nosocomial pneumonia', 'Outcome', 'Pathway interactions', 'Patients', 'Pattern', 'Pneumonia', 'Population', 'Preparation', 'Prospective cohort', 'Protocols documentation', 'Pseudomonas', 'Pseudomonas aeruginosa', 'Pseudomonas aeruginosa infection', 'RNA', 'Reproducibility', 'Research', 'Research Personnel', 'Research Project Grants', 'Role', 'Sampling', 'Science', 'Secondary to', 'Shotguns', 'Site', 'Sorting - Cell Movement', 'Specimen', 'Standardization', 'Stream', 'System', 'Systems Biology', 'Technology', 'Testing', 'Treatment Failure', 'United States National Institutes of Health', 'Validation', 'Virulence', 'analytical tool', 'base', 'clinical care', 'cohort', 'data management', 'data pipeline', 'deep sequencing', 'epigenomics', 'experience', 'genomic data', 'genomic profiles', 'hazard', 'humanized mouse', 'improved', 'innovation', 'macrophage', 'microbiome', 'microbiome composition', 'mouse model', 'multiple omics', 'neural network', 'new therapeutic target', 'novel', 'pathogen', 'pathogen genomics', 'phenomics', 'phenotypic data', 'pneumonia model', 'predictive marker', 'predictive tools', 'prospective', 'repository', 'response', 'success', 'tool', 'transcriptome sequencing', 'transcriptomics', 'viral DNA', 'whole genome']",NIAID,NORTHWESTERN UNIVERSITY AT CHICAGO,U19,2020,2400000,0.06704180879061797
"Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center Overall Project Summary: This innovative integrated systems biology application seeks to delineate the complex host/pathogen interactions occurring at the alveolar level that lead to unsuccessful response to therapy in serious pneumonia. To achieve this objective, we will leverage our unique access to alveolar fluid collected as part of routine clinical care in mechanically ventilated patients with suspected pneumonia in our medical intensive care unit. Bronchoalveolar lavage fluid will be obtained serially from well characterized mechanically ventilated patients with Pseudomonas or Acinetobacter pneumonia. Both of these CDC- designated serious hazard level pathogens have clinical failure rates as high as 50%. A robust clinical definition will allow comparison of both host and pathogen signatures associated with failure of therapy vs. success. These clinical specimens and extensive patient phenomics will anchor two mutually supportive and iterative research projects. Project One will deploy robust tools for flow sorting macrophage and lymphocyte subset populations, isolating RNA from these populations, and performing transcriptomic and epigenomic analysis to compare successful and unsuccessful host responses to infection. Project Two will focus on both specific pathogen genomic profiles associated with unsuccessful outcome. Changes in microbiome communities will be comprehensively assessed by shotgun deep sequencing to detect bacteriophage, other virus, and fungal DNA, in addition to bacterial. The Technology Core will perform cell sorting of NBBAL macrophage and lymphocyte subsets, RNA sequencing, and whole genome methylation, and perform parallel studies in a unique humanized alveolar macrophage mouse model. A Data Management and Bioinformatics Core will develop tools to reduce the dimensionality of these large comprehensive datasets, including the clinical phenomics, and provide them to the Modeling Core. The Modeling Core will then use innovative modeling approaches including a model of the alveolus during pneumonia as an ecosystem out of balance combined with unique machine learning tools and neural networks to generate biomarkers of host, pathogen and/or microbiome patterns predictive of successful pneumonia outcome. Predictive biomarkers developed in the Modeling Core will then be validated in a prospective confirmatory cohort of patients in whom analogous data will be generated. The Administrative Core will perform the outward-facing role of education and outreach to the community and sponsor, as well as regularly exchanging datasets, analytic tools, and specimens with NIH-sponsored/approved repository sites. Project Narrative: The Successful Clinical Response In Pneumonia Treatment (SCRIPT) systems biology center seeks to delineate the complex host/pathogen interactions occurring at the alveolar level that lead to unsuccessful response to therapy in serious pneumonia. We will leverage our unique access to alveolar fluid collected as part of routine clinical care in mechanically ventilated patients to generate clinical phenomic, transcriptomic, epigenomic and metagenomic data that describe the host response, pathogen characteristics and microbiome of the alveolar space during pneumonia. We will then integrate this comprehensive phenotypic data into an ecosystem-based model to generate predictive biomarkers of pneumonia outcome for subsequent validation in a second cohort and tested for causality in a humanized alveolar macrophage mouse model.",Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center,9626377,U19AI135964,"['Acinetobacter', 'Address', 'Alveolar', 'Alveolar Macrophages', 'Alveolus', 'Animal Model', 'Antibiotic Therapy', 'Bacteriophages', 'Bioinformatics', 'Biological Markers', 'Bronchoalveolar Lavage', 'Bronchoalveolar Lavage Fluid', 'Cause of Death', 'Cell Separation', 'Cells', 'Centers for Disease Control and Prevention (U.S.)', 'Characteristics', 'Clinical', 'Clinical Data', 'Clinical Medicine', 'Clinical Microbiology', 'Clinical Trials', 'Collection', 'Communities', 'Complex', 'DNA Viruses', 'DNA sequencing', 'Data', 'Data Set', 'Development', 'Dimensions', 'Disease', 'Ecosystem', 'Education and Outreach', 'Equilibrium', 'Etiology', 'Failure', 'Fungal DNA', 'Generations', 'Genes', 'Genetic', 'Goals', 'Human', 'Immune response', 'Infection', 'Intensive Care Units', 'Lead', 'Link', 'Liquid substance', 'Lymphocyte Subset', 'Lymphoid Cell', 'Machine Learning', 'Mechanics', 'Medical', 'Metagenomics', 'Methylation', 'Modeling', 'Multiomic Data', 'Myeloid Cells', 'Nosocomial Infections', 'Nosocomial pneumonia', 'Outcome', 'Pathway interactions', 'Patients', 'Pattern', 'Pneumonia', 'Population', 'Preparation', 'Prospective cohort', 'Protocols documentation', 'Pseudomonas', 'Pseudomonas aeruginosa', 'Pseudomonas aeruginosa infection', 'RNA', 'Reproducibility', 'Research', 'Research Personnel', 'Research Project Grants', 'Role', 'Sampling', 'Science', 'Secondary to', 'Shotguns', 'Site', 'Sorting - Cell Movement', 'Specimen', 'Standardization', 'Stream', 'System', 'Systems Biology', 'Technology', 'Testing', 'Treatment Failure', 'United States National Institutes of Health', 'Validation', 'Virulence', 'analytical tool', 'base', 'clinical care', 'cohort', 'data management', 'data pipeline', 'deep sequencing', 'epigenomics', 'experience', 'genomic data', 'genomic profiles', 'hazard', 'humanized mouse', 'improved', 'innovation', 'macrophage', 'microbiome', 'microbiome composition', 'mouse model', 'multiple omics', 'neural network', 'new therapeutic target', 'novel', 'pathogen', 'pathogen genomics', 'phenomics', 'phenotypic data', 'pneumonia model', 'predictive marker', 'predictive tools', 'prospective', 'repository', 'response', 'success', 'tool', 'transcriptome sequencing', 'transcriptomics', 'viral DNA', 'whole genome']",NIAID,NORTHWESTERN UNIVERSITY AT CHICAGO,U19,2019,2400000,0.07494074890333595
"Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center Overall Project Summary: This innovative integrated systems biology application seeks to delineate the complex host/pathogen interactions occurring at the alveolar level that lead to unsuccessful response to therapy in serious pneumonia. To achieve this objective, we will leverage our unique access to alveolar fluid collected as part of routine clinical care in mechanically ventilated patients with suspected pneumonia in our medical intensive care unit. Bronchoalveolar lavage fluid will be obtained serially from well characterized mechanically ventilated patients with Pseudomonas or Acinetobacter pneumonia. Both of these CDC- designated serious hazard level pathogens have clinical failure rates as high as 50%. A robust clinical definition will allow comparison of both host and pathogen signatures associated with failure of therapy vs. success. These clinical specimens and extensive patient phenomics will anchor two mutually supportive and iterative research projects. Project One will deploy robust tools for flow sorting macrophage and lymphocyte subset populations, isolating RNA from these populations, and performing transcriptomic and epigenomic analysis to compare successful and unsuccessful host responses to infection. Project Two will focus on both specific pathogen genomic profiles associated with unsuccessful outcome. Changes in microbiome communities will be comprehensively assessed by shotgun deep sequencing to detect bacteriophage, other virus, and fungal DNA, in addition to bacterial. The Technology Core will perform cell sorting of NBBAL macrophage and lymphocyte subsets, RNA sequencing, and whole genome methylation, and perform parallel studies in a unique humanized alveolar macrophage mouse model. A Data Management and Bioinformatics Core will develop tools to reduce the dimensionality of these large comprehensive datasets, including the clinical phenomics, and provide them to the Modeling Core. The Modeling Core will then use innovative modeling approaches including a model of the alveolus during pneumonia as an ecosystem out of balance combined with unique machine learning tools and neural networks to generate biomarkers of host, pathogen and/or microbiome patterns predictive of successful pneumonia outcome. Predictive biomarkers developed in the Modeling Core will then be validated in a prospective confirmatory cohort of patients in whom analogous data will be generated. The Administrative Core will perform the outward-facing role of education and outreach to the community and sponsor, as well as regularly exchanging datasets, analytic tools, and specimens with NIH-sponsored/approved repository sites. Project Narrative: The Successful Clinical Response In Pneumonia Treatment (SCRIPT) systems biology center seeks to delineate the complex host/pathogen interactions occurring at the alveolar level that lead to unsuccessful response to therapy in serious pneumonia. We will leverage our unique access to alveolar fluid collected as part of routine clinical care in mechanically ventilated patients to generate clinical phenomic, transcriptomic, epigenomic and metagenomic data that describe the host response, pathogen characteristics and microbiome of the alveolar space during pneumonia. We will then integrate this comprehensive phenotypic data into an ecosystem-based model to generate predictive biomarkers of pneumonia outcome for subsequent validation in a second cohort and tested for causality in a humanized alveolar macrophage mouse model.",Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center,9454818,U19AI135964,"['Acinetobacter', 'Address', 'Alveolar', 'Alveolar Macrophages', 'Alveolus', 'Animal Model', 'Antibiotic Therapy', 'Bacteriophages', 'Bioinformatics', 'Biological Markers', 'Biological Neural Networks', 'Bronchoalveolar Lavage', 'Bronchoalveolar Lavage Fluid', 'Cause of Death', 'Cell Separation', 'Cells', 'Centers for Disease Control and Prevention (U.S.)', 'Characteristics', 'Clinical', 'Clinical Data', 'Clinical Medicine', 'Clinical Microbiology', 'Clinical Trials', 'Collection', 'Communities', 'Complex', 'DNA Viruses', 'DNA sequencing', 'Data', 'Data Set', 'Development', 'Dimensions', 'Disease', 'Ecosystem', 'Education and Outreach', 'Equilibrium', 'Etiology', 'Failure', 'Fungal DNA', 'Generations', 'Genes', 'Genetic', 'Goals', 'Human', 'Immune response', 'Infection', 'Intensive Care Units', 'Lead', 'Link', 'Liquid substance', 'Lymphocyte Subset', 'Lymphoid Cell', 'Machine Learning', 'Mechanics', 'Medical', 'Metagenomics', 'Methylation', 'Modeling', 'Myeloid Cells', 'Nosocomial Infections', 'Nosocomial pneumonia', 'Outcome', 'Pathway interactions', 'Patients', 'Pattern', 'Pneumonia', 'Population', 'Preparation', 'Prospective cohort', 'Protocols documentation', 'Pseudomonas', 'Pseudomonas aeruginosa', 'RNA', 'Reproducibility', 'Research', 'Research Personnel', 'Research Project Grants', 'Role', 'Sampling', 'Science', 'Secondary to', 'Shotguns', 'Site', 'Sorting - Cell Movement', 'Specimen', 'Standardization', 'Stream', 'System', 'Systems Biology', 'Technology', 'Testing', 'Treatment Failure', 'United States National Institutes of Health', 'Validation', 'Virulence', 'analytical tool', 'base', 'clinical care', 'cohort', 'data management', 'deep sequencing', 'epigenomics', 'experience', 'genomic data', 'genomic profiles', 'hazard', 'humanized mouse', 'improved', 'innovation', 'macrophage', 'microbiome', 'microbiome composition', 'mouse model', 'multiple omics', 'new therapeutic target', 'novel', 'pathogen', 'phenomics', 'phenotypic data', 'pneumonia model', 'predictive marker', 'predictive tools', 'prospective', 'repository', 'response', 'success', 'tool', 'transcriptome sequencing', 'transcriptomics', 'viral DNA', 'whole genome']",NIAID,NORTHWESTERN UNIVERSITY AT CHICAGO,U19,2018,2400000,0.07494074890333595
"Measuring, Modeling and Controlling Heterogeneity ABSTRACT - Overall The overall goal of the Measuring, Modeling and Controlling Heterogeneity Center in the Cancer Systems Biol- ogy Consortium (M2CH-CSBC Center) is to improve management of triple negative breast cancer (TNBC) by developing systems level strategies to prevent the emergence of cancer subpopulations that are resistant to treatment. We postulate that heterogeneity arising from epigenomic instability intrinsic to cancer cells and di- verse signals from extrinsic microenvironments in which cancer cells reside are root causes of resistance. We will learn how intrinsic and extrinsic factors influence differentiation state, proliferation and therapeutic re- sponse in TNBC through experimental manipulation and computational modeling of cancer cell lines, 3D engi- neered multicellular systems, xenografts and clinical specimens. We will deploy single cell `omic and imaging technologies that allow quantitative assessment of molecular, cellular, and structural heterogeneity. We will interpret these data using computational models that define control networks and structures in heterogeneous systems as well as transitions between states of therapeutic resistance and sensitivity. This will be accom- plished in three related Projects and three Cores. Project 1 will focus on measuring and managing resistance- associated heterogeneity intrinsic to cancer cells. Project 2 will focus on identifying resistance-associated sig- nals from the microenvironment and on mitigating effects from these signals on therapeutic response. Project 3 will apply spatial systems biology approaches to TNBC specimens and multicell type models thereof to dis- cover molecular control networks that influence how cell intrinsic plasticity and microenvironment signaling al- ter therapeutic responses in complex tissues. All three Projects will include analysis of 5 core cell lines (HCC1143, HCC1599, MDA-MB-468, SUM149PT, and HCC1806), 5 patient derived cultures, and 6 FDA ap- proved, pathway-targeted drugs (afatinib, ruxolotinib, trametinib, BYL719, cabozantinib, and everolimus). The computational network discovery, data integration, spatial systems analysis and modeling approaches are the same in all Projects and serve to integrate the work of the overall M2CH-CSBC Center. Multiple integrative computational strategies are proposed to identify candidate heterogeneity control networks. These include analysis of existing genomic, epigenomic, pharmacologic response, and metabolomic characteristics of prima- ry tumors and models thereof. An Imaging Management and Analysis Core will provide infrastructure and image analytics that will enable efficient image data management, quantitative analysis of image features, and visualization of images and metadata generated using multiscale light and electron microscopy. An Outreach Core will make educational materials, experimental and computational tools and data available to the CSB Consortium, to the CSBC/PS-ON Coordinating Center and to the broader scientific community. An Administrative Core serves as the organization, integration, and evaluation hub of the M2CH-CSBC Center. Project narrative This Project will improve management of triple negative breast cancer (TNBC) by understanding and managing heterogeneity arising from epigenomic instability intrinsic to cancer cells and from diverse signals from extrinsic microenvironments in which cancer cells reside.","Measuring, Modeling and Controlling Heterogeneity",9964674,U54CA209988,"['3-Dimensional', 'Breast Cancer Cell', 'Cancer Control', 'Cancer cell line', 'Cell Line', 'Cell model', 'Cells', 'Cellular Structures', 'Characteristics', 'Clinical', 'Clonal Expansion', 'Communities', 'Complex', 'Computer Models', 'Custom', 'Data', 'Data Analyses', 'Databases', 'Drug Targeting', 'Educational Materials', 'Electron Microscopy', 'Engineering', 'Ensure', 'Environment', 'Evaluation', 'Exhibits', 'FDA approved', 'Genomics', 'Goals', 'Heterogeneity', 'Image', 'Image Analysis', 'Imaging technology', 'Immunofluorescence Immunologic', 'In Vitro', 'Infrastructure', 'Leadership', 'Learning', 'Link', 'MDA-MB-468', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Metadata', 'Methods', 'Microarray Analysis', 'Modeling', 'Molecular', 'Pathway interactions', 'Patients', 'Periodicity', 'Pharmaceutical Preparations', 'Pharmacology', 'Phenotype', 'Pilot Projects', 'Plant Roots', 'Procedures', 'Proteins', 'Reagent', 'Resistance', 'SDZ RAD', 'Signal Transduction', 'Site', 'Source', 'Specimen', 'Stress', 'Structure', 'System', 'Systems Analysis', 'Systems Biology', 'Therapeutic', 'Tissues', 'Training', 'Visualization', 'Work', 'Xenograft procedure', 'analytical tool', 'bioimaging', 'bioprinting', 'cancer cell', 'combinatorial', 'computational suite', 'computerized tools', 'data integration', 'data management', 'epigenomics', 'experimental study', 'feature extraction', 'image visualization', 'improved', 'in vivo', 'light microscopy', 'metabolomics', 'multidisciplinary', 'network models', 'novel', 'open source', 'outreach', 'prevent', 'quantitative imaging', 'response', 'targeted treatment', 'therapy resistant', 'treatment response', 'triple-negative invasive breast carcinoma', 'tumor']",NCI,OREGON HEALTH & SCIENCE UNIVERSITY,U54,2020,2053370,0.038620157791990795
"Measuring, Modeling and Controlling Heterogeneity ABSTRACT - Overall The overall goal of the Measuring, Modeling and Controlling Heterogeneity Center in the Cancer Systems Biol- ogy Consortium (M2CH-CSBC Center) is to improve management of triple negative breast cancer (TNBC) by developing systems level strategies to prevent the emergence of cancer subpopulations that are resistant to treatment. We postulate that heterogeneity arising from epigenomic instability intrinsic to cancer cells and di- verse signals from extrinsic microenvironments in which cancer cells reside are root causes of resistance. We will learn how intrinsic and extrinsic factors influence differentiation state, proliferation and therapeutic re- sponse in TNBC through experimental manipulation and computational modeling of cancer cell lines, 3D engi- neered multicellular systems, xenografts and clinical specimens. We will deploy single cell `omic and imaging technologies that allow quantitative assessment of molecular, cellular, and structural heterogeneity. We will interpret these data using computational models that define control networks and structures in heterogeneous systems as well as transitions between states of therapeutic resistance and sensitivity. This will be accom- plished in three related Projects and three Cores. Project 1 will focus on measuring and managing resistance- associated heterogeneity intrinsic to cancer cells. Project 2 will focus on identifying resistance-associated sig- nals from the microenvironment and on mitigating effects from these signals on therapeutic response. Project 3 will apply spatial systems biology approaches to TNBC specimens and multicell type models thereof to dis- cover molecular control networks that influence how cell intrinsic plasticity and microenvironment signaling al- ter therapeutic responses in complex tissues. All three Projects will include analysis of 5 core cell lines (HCC1143, HCC1599, MDA-MB-468, SUM149PT, and HCC1806), 5 patient derived cultures, and 6 FDA ap- proved, pathway-targeted drugs (afatinib, ruxolotinib, trametinib, BYL719, cabozantinib, and everolimus). The computational network discovery, data integration, spatial systems analysis and modeling approaches are the same in all Projects and serve to integrate the work of the overall M2CH-CSBC Center. Multiple integrative computational strategies are proposed to identify candidate heterogeneity control networks. These include analysis of existing genomic, epigenomic, pharmacologic response, and metabolomic characteristics of prima- ry tumors and models thereof. An Imaging Management and Analysis Core will provide infrastructure and image analytics that will enable efficient image data management, quantitative analysis of image features, and visualization of images and metadata generated using multiscale light and electron microscopy. An Outreach Core will make educational materials, experimental and computational tools and data available to the CSB Consortium, to the CSBC/PS-ON Coordinating Center and to the broader scientific community. An Administrative Core serves as the organization, integration, and evaluation hub of the M2CH-CSBC Center. Project narrative This Project will improve management of triple negative breast cancer (TNBC) by understanding and managing heterogeneity arising from epigenomic instability intrinsic to cancer cells and from diverse signals from extrinsic microenvironments in which cancer cells reside.","Measuring, Modeling and Controlling Heterogeneity",9691279,U54CA209988,"['3-Dimensional', 'Breast Cancer Cell', 'Cancer Control', 'Cancer cell line', 'Cell Line', 'Cell model', 'Cells', 'Cellular Structures', 'Characteristics', 'Clinical', 'Clonal Expansion', 'Communities', 'Complex', 'Computer Simulation', 'Custom', 'Data', 'Data Analyses', 'Databases', 'Drug Targeting', 'Educational Materials', 'Electron Microscopy', 'Engineering', 'Ensure', 'Environment', 'Evaluation', 'Exhibits', 'FDA approved', 'Genomics', 'Goals', 'Heterogeneity', 'Image', 'Image Analysis', 'Imagery', 'Imaging technology', 'Immunofluorescence Immunologic', 'In Vitro', 'Infrastructure', 'Leadership', 'Learning', 'Link', 'MDA-MB-468', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Metadata', 'Methods', 'Microarray Analysis', 'Modeling', 'Molecular', 'Pathway interactions', 'Patients', 'Periodicity', 'Pharmaceutical Preparations', 'Pharmacology', 'Phenotype', 'Pilot Projects', 'Plant Roots', 'Procedures', 'Proteins', 'Reagent', 'Resistance', 'SDZ RAD', 'Signal Transduction', 'Site', 'Source', 'Specimen', 'Stress', 'Structure', 'System', 'Systems Analysis', 'Systems Biology', 'Therapeutic', 'Tissues', 'Training', 'Work', 'Xenograft procedure', 'analytical tool', 'bioimaging', 'bioprinting', 'cancer cell', 'combinatorial', 'computational suite', 'computerized tools', 'data integration', 'data management', 'epigenomics', 'experimental study', 'image visualization', 'improved', 'in vivo', 'light microscopy', 'metabolomics', 'multidisciplinary', 'network models', 'novel', 'open source', 'outreach', 'prevent', 'quantitative imaging', 'response', 'targeted treatment', 'therapy resistant', 'treatment response', 'triple-negative invasive breast carcinoma', 'tumor']",NCI,OREGON HEALTH & SCIENCE UNIVERSITY,U54,2019,2164435,0.038620157791990795
"Measuring, Modeling and Controlling Heterogeneity ABSTRACT - Overall The overall goal of the Measuring, Modeling and Controlling Heterogeneity Center in the Cancer Systems  Biology Consortium (M2CH-CSBC Center) is to improve management of triple negative breast cancer (TNBC) by developing systems level strategies to prevent the emergence of cancer subpopulations that are resistant to treatment. We postulate that heterogeneity arising from epigenomic instability intrinsic to cancer cells and  diverse signals from extrinsic microenvironments in which cancer cells reside are root causes of resistance. We will learn how intrinsic and extrinsic factors influence differentiation state, proliferation and therapeutic  response in TNBC through experimental manipulation and computational modeling of cancer cell lines, 3D  engineered multicellular systems, xenografts and clinical specimens. We will deploy single cell `omic and imaging technologies that allow quantitative assessment of molecular, cellular, and structural heterogeneity. We will interpret these data using computational models that define control networks and structures in heterogeneous systems as well as transitions between states of therapeutic resistance and sensitivity. This will be  accomplished in three related Projects and three Cores. Project 1 will focus on measuring and managing  resistance-associated heterogeneity intrinsic to cancer cells. Project 2 will focus on identifying resistance-associated  signals from the microenvironment and on mitigating effects from these signals on therapeutic response. Project 3 will apply spatial systems biology approaches to TNBC specimens and multicell type models thereof to  discover molecular control networks that influence how cell intrinsic plasticity and microenvironment signaling  alter therapeutic responses in complex tissues. All three Projects will include analysis of 5 core cell lines (HCC1143, HCC1599, MDA-MB-468, SUM149PT, and HCC1806), 5 patient derived cultures, and 6 FDA  approved, pathway-targeted drugs (afatinib, ruxolotinib, trametinib, BYL719, cabozantinib, and everolimus). The computational network discovery, data integration, spatial systems analysis and modeling approaches are the same in all Projects and serve to integrate the work of the overall M2CH-CSBC Center. Multiple integrative computational strategies are proposed to identify candidate heterogeneity control networks. These include analysis of existing genomic, epigenomic, pharmacologic response, and metabolomic characteristics of  primary tumors and models thereof. An Imaging Management and Analysis Core will provide infrastructure and image analytics that will enable efficient image data management, quantitative analysis of image features, and visualization of images and metadata generated using multiscale light and electron microscopy. An Outreach Core will make educational materials, experimental and computational tools and data available to the CSB Consortium, to the CSBC/PS-ON Coordinating Center and to the broader scientific community. An Administrative Core serves as the organization, integration, and evaluation hub of the M2CH-CSBC Center. Project narrative This Project will improve management of triple negative breast cancer (TNBC) by understanding and managing heterogeneity arising from epigenomic instability intrinsic to cancer cells and from diverse signals from extrinsic microenvironments in which cancer cells reside.","Measuring, Modeling and Controlling Heterogeneity",9830174,U54CA209988,"['3-Dimensional', 'Breast Cancer Cell', 'Cancer Control', 'Cancer cell line', 'Cell Line', 'Cell model', 'Cells', 'Cellular Structures', 'Characteristics', 'Clinical', 'Clonal Expansion', 'Communities', 'Complex', 'Computer Simulation', 'Custom', 'Data', 'Data Analyses', 'Databases', 'Drug Targeting', 'Educational Materials', 'Electron Microscopy', 'Engineering', 'Ensure', 'Environment', 'Evaluation', 'Exhibits', 'FDA approved', 'Genomic Instability', 'Genomics', 'Goals', 'Heterogeneity', 'Image', 'Image Analysis', 'Imagery', 'Imaging technology', 'Immunofluorescence Immunologic', 'In Vitro', 'Infrastructure', 'Leadership', 'Learning', 'Link', 'MDA-MB-468', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Metadata', 'Methods', 'Microarray Analysis', 'Modeling', 'Molecular', 'Pathway interactions', 'Patients', 'Periodicity', 'Pharmaceutical Preparations', 'Pharmacology', 'Phenotype', 'Pilot Projects', 'Plant Roots', 'Primary Neoplasm', 'Procedures', 'Proteins', 'Reagent', 'Resistance', 'Resource Sharing', 'SDZ RAD', 'Signal Transduction', 'Site', 'Specimen', 'Stress', 'Structure', 'System', 'Systems Analysis', 'Systems Biology', 'Therapeutic', 'Tissues', 'Training', 'Work', 'Xenograft procedure', 'analytical tool', 'bioimaging', 'bioprinting', 'cancer cell', 'combinatorial', 'computational suite', 'computerized tools', 'data integration', 'data management', 'epigenomics', 'experimental study', 'image visualization', 'improved', 'in vivo', 'light microscopy', 'metabolomics', 'multidisciplinary', 'network models', 'novel', 'open source', 'outreach', 'prevent', 'quantitative imaging', 'response', 'targeted treatment', 'therapy resistant', 'treatment response', 'triple-negative invasive breast carcinoma', 'tumor']",NCI,OREGON HEALTH & SCIENCE UNIVERSITY,U54,2019,83652,0.03649682193211895
"Measuring, Modeling and Controlling Heterogeneity ABSTRACT - Overall The overall goal of the Measuring, Modeling and Controlling Heterogeneity Center in the Cancer Systems Biol- ogy Consortium (M2CH-CSBC Center) is to improve management of triple negative breast cancer (TNBC) by developing systems level strategies to prevent the emergence of cancer subpopulations that are resistant to treatment. We postulate that heterogeneity arising from epigenomic instability intrinsic to cancer cells and di- verse signals from extrinsic microenvironments in which cancer cells reside are root causes of resistance. We will learn how intrinsic and extrinsic factors influence differentiation state, proliferation and therapeutic re- sponse in TNBC through experimental manipulation and computational modeling of cancer cell lines, 3D engi- neered multicellular systems, xenografts and clinical specimens. We will deploy single cell `omic and imaging technologies that allow quantitative assessment of molecular, cellular, and structural heterogeneity. We will interpret these data using computational models that define control networks and structures in heterogeneous systems as well as transitions between states of therapeutic resistance and sensitivity. This will be accom- plished in three related Projects and three Cores. Project 1 will focus on measuring and managing resistance- associated heterogeneity intrinsic to cancer cells. Project 2 will focus on identifying resistance-associated sig- nals from the microenvironment and on mitigating effects from these signals on therapeutic response. Project 3 will apply spatial systems biology approaches to TNBC specimens and multicell type models thereof to dis- cover molecular control networks that influence how cell intrinsic plasticity and microenvironment signaling al- ter therapeutic responses in complex tissues. All three Projects will include analysis of 5 core cell lines (HCC1143, HCC1599, MDA-MB-468, SUM149PT, and HCC1806), 5 patient derived cultures, and 6 FDA ap- proved, pathway-targeted drugs (afatinib, ruxolotinib, trametinib, BYL719, cabozantinib, and everolimus). The computational network discovery, data integration, spatial systems analysis and modeling approaches are the same in all Projects and serve to integrate the work of the overall M2CH-CSBC Center. Multiple integrative computational strategies are proposed to identify candidate heterogeneity control networks. These include analysis of existing genomic, epigenomic, pharmacologic response, and metabolomic characteristics of prima- ry tumors and models thereof. An Imaging Management and Analysis Core will provide infrastructure and image analytics that will enable efficient image data management, quantitative analysis of image features, and visualization of images and metadata generated using multiscale light and electron microscopy. An Outreach Core will make educational materials, experimental and computational tools and data available to the CSB Consortium, to the CSBC/PS-ON Coordinating Center and to the broader scientific community. An Administrative Core serves as the organization, integration, and evaluation hub of the M2CH-CSBC Center. Project narrative This Project will improve management of triple negative breast cancer (TNBC) by understanding and managing heterogeneity arising from epigenomic instability intrinsic to cancer cells and from diverse signals from extrinsic microenvironments in which cancer cells reside.","Measuring, Modeling and Controlling Heterogeneity",9764617,U54CA209988,"['Breast Cancer Cell', 'Cancer Control', 'Cancer cell line', 'Cell Line', 'Cell model', 'Cells', 'Characteristics', 'Clinical', 'Clonal Expansion', 'Communities', 'Complex', 'Computer Simulation', 'Custom', 'Data', 'Data Analyses', 'Databases', 'Drug Targeting', 'Educational Materials', 'Electron Microscopy', 'Engineering', 'Ensure', 'Environment', 'Evaluation', 'Exhibits', 'FDA approved', 'Genomics', 'Goals', 'Heterogeneity', 'Image', 'Image Analysis', 'Imagery', 'Imaging technology', 'Immunofluorescence Immunologic', 'In Vitro', 'Leadership', 'Learning', 'Link', 'MDA-MB-468', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Metadata', 'Methods', 'Microarray Analysis', 'Modeling', 'Molecular', 'Pathway interactions', 'Patients', 'Periodicity', 'Pharmaceutical Preparations', 'Pharmacology', 'Phenotype', 'Pilot Projects', 'Plant Roots', 'Procedures', 'Proteins', 'Reagent', 'Research Infrastructure', 'Resistance', 'SDZ RAD', 'Signal Transduction', 'Site', 'Source', 'Specimen', 'Stress', 'Structure', 'System', 'Systems Analysis', 'Systems Biology', 'Therapeutic', 'Tissues', 'Training', 'Work', 'Xenograft procedure', 'analytical tool', 'bioimaging', 'bioprinting', 'cancer cell', 'combinatorial', 'computerized tools', 'data integration', 'data management', 'epigenomics', 'experimental study', 'image visualization', 'improved', 'in vivo', 'light microscopy', 'metabolomics', 'multidisciplinary', 'network models', 'novel', 'open source', 'outreach', 'prevent', 'quantitative imaging', 'response', 'targeted treatment', 'therapy resistant', 'treatment response', 'triple-negative invasive breast carcinoma', 'tumor']",NCI,OREGON HEALTH & SCIENCE UNIVERSITY,U54,2018,66990,0.038620157791990795
"Measuring, Modeling and Controlling Heterogeneity ABSTRACT - Overall The overall goal of the Measuring, Modeling and Controlling Heterogeneity Center in the Cancer Systems Biol- ogy Consortium (M2CH-CSBC Center) is to improve management of triple negative breast cancer (TNBC) by developing systems level strategies to prevent the emergence of cancer subpopulations that are resistant to treatment. We postulate that heterogeneity arising from epigenomic instability intrinsic to cancer cells and di- verse signals from extrinsic microenvironments in which cancer cells reside are root causes of resistance. We will learn how intrinsic and extrinsic factors influence differentiation state, proliferation and therapeutic re- sponse in TNBC through experimental manipulation and computational modeling of cancer cell lines, 3D engi- neered multicellular systems, xenografts and clinical specimens. We will deploy single cell `omic and imaging technologies that allow quantitative assessment of molecular, cellular, and structural heterogeneity. We will interpret these data using computational models that define control networks and structures in heterogeneous systems as well as transitions between states of therapeutic resistance and sensitivity. This will be accom- plished in three related Projects and three Cores. Project 1 will focus on measuring and managing resistance- associated heterogeneity intrinsic to cancer cells. Project 2 will focus on identifying resistance-associated sig- nals from the microenvironment and on mitigating effects from these signals on therapeutic response. Project 3 will apply spatial systems biology approaches to TNBC specimens and multicell type models thereof to dis- cover molecular control networks that influence how cell intrinsic plasticity and microenvironment signaling al- ter therapeutic responses in complex tissues. All three Projects will include analysis of 5 core cell lines (HCC1143, HCC1599, MDA-MB-468, SUM149PT, and HCC1806), 5 patient derived cultures, and 6 FDA ap- proved, pathway-targeted drugs (afatinib, ruxolotinib, trametinib, BYL719, cabozantinib, and everolimus). The computational network discovery, data integration, spatial systems analysis and modeling approaches are the same in all Projects and serve to integrate the work of the overall M2CH-CSBC Center. Multiple integrative computational strategies are proposed to identify candidate heterogeneity control networks. These include analysis of existing genomic, epigenomic, pharmacologic response, and metabolomic characteristics of prima- ry tumors and models thereof. An Imaging Management and Analysis Core will provide infrastructure and image analytics that will enable efficient image data management, quantitative analysis of image features, and visualization of images and metadata generated using multiscale light and electron microscopy. An Outreach Core will make educational materials, experimental and computational tools and data available to the CSB Consortium, to the CSBC/PS-ON Coordinating Center and to the broader scientific community. An Administrative Core serves as the organization, integration, and evaluation hub of the M2CH-CSBC Center. Project narrative This Project will improve management of triple negative breast cancer (TNBC) by understanding and managing heterogeneity arising from epigenomic instability intrinsic to cancer cells and from diverse signals from extrinsic microenvironments in which cancer cells reside.","Measuring, Modeling and Controlling Heterogeneity",9487958,U54CA209988,"['Breast Cancer Cell', 'Cancer Control', 'Cancer cell line', 'Cell Line', 'Cell model', 'Cells', 'Characteristics', 'Clinical', 'Clonal Expansion', 'Communities', 'Complex', 'Computer Simulation', 'Custom', 'Data', 'Data Analyses', 'Databases', 'Drug Targeting', 'Educational Materials', 'Electron Microscopy', 'Engineering', 'Ensure', 'Environment', 'Evaluation', 'Exhibits', 'FDA approved', 'Genomics', 'Goals', 'Heterogeneity', 'Image', 'Image Analysis', 'Imagery', 'Imaging technology', 'Immunofluorescence Immunologic', 'In Vitro', 'Leadership', 'Learning', 'Link', 'MDA-MB-468', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Metadata', 'Methods', 'Microarray Analysis', 'Modeling', 'Molecular', 'Pathway interactions', 'Patients', 'Periodicity', 'Pharmaceutical Preparations', 'Pharmacology', 'Phenotype', 'Pilot Projects', 'Plant Roots', 'Procedures', 'Proteins', 'Reagent', 'Research Infrastructure', 'Resistance', 'SDZ RAD', 'Signal Transduction', 'Site', 'Source', 'Specimen', 'Stress', 'Structure', 'System', 'Systems Analysis', 'Systems Biology', 'Therapeutic', 'Tissues', 'Training', 'Work', 'Xenograft procedure', 'analytical tool', 'bioimaging', 'bioprinting', 'cancer cell', 'combinatorial', 'computerized tools', 'data integration', 'data management', 'epigenomics', 'experimental study', 'image visualization', 'improved', 'in vivo', 'light microscopy', 'metabolomics', 'multidisciplinary', 'network models', 'novel', 'open source', 'outreach', 'prevent', 'quantitative imaging', 'response', 'targeted treatment', 'therapy resistant', 'treatment response', 'triple-negative invasive breast carcinoma', 'tumor']",NCI,OREGON HEALTH & SCIENCE UNIVERSITY,U54,2018,2191539,0.038620157791990795
"Measuring, Modeling and Controlling Heterogeneity ABSTRACT - Overall The overall goal of the Measuring, Modeling and Controlling Heterogeneity Center in the Cancer Systems Biol- ogy Consortium (M2CH-CSBC Center) is to improve management of triple negative breast cancer (TNBC) by developing systems level strategies to prevent the emergence of cancer subpopulations that are resistant to treatment. We postulate that heterogeneity arising from epigenomic instability intrinsic to cancer cells and di- verse signals from extrinsic microenvironments in which cancer cells reside are root causes of resistance. We will learn how intrinsic and extrinsic factors influence differentiation state, proliferation and therapeutic re- sponse in TNBC through experimental manipulation and computational modeling of cancer cell lines, 3D engi- neered multicellular systems, xenografts and clinical specimens. We will deploy single cell `omic and imaging technologies that allow quantitative assessment of molecular, cellular, and structural heterogeneity. We will interpret these data using computational models that define control networks and structures in heterogeneous systems as well as transitions between states of therapeutic resistance and sensitivity. This will be accom- plished in three related Projects and three Cores. Project 1 will focus on measuring and managing resistance- associated heterogeneity intrinsic to cancer cells. Project 2 will focus on identifying resistance-associated sig- nals from the microenvironment and on mitigating effects from these signals on therapeutic response. Project 3 will apply spatial systems biology approaches to TNBC specimens and multicell type models thereof to dis- cover molecular control networks that influence how cell intrinsic plasticity and microenvironment signaling al- ter therapeutic responses in complex tissues. All three Projects will include analysis of 5 core cell lines (HCC1143, HCC1599, MDA-MB-468, SUM149PT, and HCC1806), 5 patient derived cultures, and 6 FDA ap- proved, pathway-targeted drugs (afatinib, ruxolotinib, trametinib, BYL719, cabozantinib, and everolimus). The computational network discovery, data integration, spatial systems analysis and modeling approaches are the same in all Projects and serve to integrate the work of the overall M2CH-CSBC Center. Multiple integrative computational strategies are proposed to identify candidate heterogeneity control networks. These include analysis of existing genomic, epigenomic, pharmacologic response, and metabolomic characteristics of prima- ry tumors and models thereof. An Imaging Management and Analysis Core will provide infrastructure and image analytics that will enable efficient image data management, quantitative analysis of image features, and visualization of images and metadata generated using multiscale light and electron microscopy. An Outreach Core will make educational materials, experimental and computational tools and data available to the CSB Consortium, to the CSBC/PS-ON Coordinating Center and to the broader scientific community. An Administrative Core serves as the organization, integration, and evaluation hub of the M2CH-CSBC Center. Project narrative This Project will improve management of triple negative breast cancer (TNBC) by understanding and managing heterogeneity arising from epigenomic instability intrinsic to cancer cells and from diverse signals from extrinsic microenvironments in which cancer cells reside.","Measuring, Modeling and Controlling Heterogeneity",9350715,U54CA209988,"['Cancer Control', 'Cell Line', 'Cell model', 'Cells', 'Characteristics', 'Clinical', 'Clonal Expansion', 'Communities', 'Complex', 'Computer Simulation', 'Custom', 'Data', 'Data Analyses', 'Databases', 'Drug Targeting', 'Educational Materials', 'Electron Microscopy', 'Engineering', 'Ensure', 'Environment', 'Evaluation', 'Exhibits', 'FDA approved', 'Genomics', 'Goals', 'Heterogeneity', 'Image', 'Image Analysis', 'Imagery', 'Imaging technology', 'Immunofluorescence Immunologic', 'In Vitro', 'Leadership', 'Learning', 'Light', 'Link', 'MDA-MB-468', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Metadata', 'Methods', 'Microarray Analysis', 'Modeling', 'Molecular', 'Pathway interactions', 'Patients', 'Periodicity', 'Pharmaceutical Preparations', 'Pharmacology', 'Phenotype', 'Pilot Projects', 'Plant Roots', 'Procedures', 'Proteins', 'Reagent', 'Research Infrastructure', 'Resistance', 'SDZ RAD', 'Signal Transduction', 'Site', 'Source', 'Specimen', 'Stress', 'Structure', 'System', 'Systems Analysis', 'Systems Biology', 'Therapeutic', 'Tissues', 'Training', 'Work', 'Xenograft procedure', 'analytical tool', 'bioimaging', 'bioprinting', 'cancer cell', 'combinatorial', 'computerized tools', 'data integration', 'data management', 'epigenomics', 'experimental study', 'image visualization', 'improved', 'in vivo', 'light microscopy', 'metabolomics', 'multidisciplinary', 'network models', 'novel', 'open source', 'outreach', 'prevent', 'quantitative imaging', 'response', 'targeted treatment', 'therapy resistant', 'treatment response', 'triple-negative invasive breast carcinoma', 'tumor']",NCI,OREGON HEALTH & SCIENCE UNIVERSITY,U54,2017,1876979,0.038620157791990795
